Federal Register (official journal of the U.S. Federal Government)

published in (P1433)

Q73174848	"Guidance for Industry: For the Submission of Chemistry, Manufacturing and Controls and Establishment Description Information for Human Blood and Blood Components Intended for Transfusion or for Further Manufacture and for the Completion of the Form
Q73174681	"Guidance for Industry: On the Content and Format of Chemistry, Manufacturing and Controls Information and Establishment Description Information for an Allergenic Extract or Allergen Patch Test"; availability. Food and Drug Administration, HHS. No
Q73172432	"Guidance for industry: content and format of chemistry, manufacturing and controls information and establishment description information for a biological in vitro diagnostic product;" availability. Food and Drug Administration, HHS. Notice
Q77194116	"Guidance for industry: current good manufacturing practice for blood and blood components: (1). Quarantine and disposition of units from prior collections from donors with repeatedly reactive screening test for antibody to hepatitis C virus (anti-H
Q74677202	"Low income levels" for health professions and nursing programs--HRSA
Q73174937	"Low income levels" for health professions and nursing programs. Health Resources and Services Administration
Q30689385	2014 Edition Electronic Health Record certification criteria: revision to the definition of "common Meaningful Use (MU) Data Set." Interim final rule with comment period
Q39126994	2014 Edition Release 2 Electronic Health Record (EHR) certification criteria and the ONC HIT Certification Program; regulatory flexibilities, improvements, and enhanced health information exchange. Final rule.
Q95451395	2015 Edition Health Information Technology (Health IT) Certification Criteria, 2015 Edition Base Electronic Health Record (EHR) Definition, and ONC Health IT Certification Program Modifications. Final rule
Q61750160	24 FR 5348
Q89493720	340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation. Final rule
Q39345955	340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation. Final rule; further delay of effective date
Q54867416	43 FR 5162
Q47374806	44 FR 7416
Q48582012	45 FR 17446
Q47208731	46 FR 10622
Q47542497	47 FR 4932
Q47535939	48 FR 8626
Q54867255	49 FR 4608
Q77650343	60-bed nursing home care unit, VAMC, Reno, Nevada; finding of no significant impact
Q39299693	Abbreviated New Drug Applications and 505(b)(2) Applications. Final rule
Q74755141	Abnormal occurrences for first quarter CY 1992 dissemination of information--NRC
Q74742366	Abnormal occurrences for fourth quarter CY 1991; dissemination of information--NRC
Q74729698	Abnormal occurrences for second quarter CY 1991; dissemination of information--Nuclear Regulatory Commission
Q74758109	Abnormal occurrences for second quarter CY 1992; dissemination of information--NRC
Q74762638	Abnormal occurrences for third quarter CY 1992; dissemination of information--NRC
Q77649090	Abolition of Pharmaceutical Reimbursement Advisory Committee: final regulation
Q74768632	Abortions and related medical services in federally assisted programs of the Public Health Service
Q52108530	Abortions and related medical services in federally assisted programs of the Public Health Service.
Q77649634	Abortions and related medical services in federally assisted programs of the Public Health Service: final rule
Q30396967	Absence and leave; sick leave. Final rule
Q77516401	Access charges; MTS and WATS market structure--Federal Communications Commission. Final rule
Q40433903	Access to Federal Employees Health Benefits (FEHB) for Employees of Certain Indian Tribal Employers. Final rule
Q74813912	Access to employee exposure and medical records
Q74792453	Access to employee exposure and medical records; construction industry; lifting of administrative stay
Q74768601	Access to employee exposure and medical records; final rule
Q74769928	Access to telecommunications equipment and services by the hearing impaired and other disabled persons--FCC. Final rule; suspension of rule enforcement
Q77116758	Accessibility to new drugs for use in military and civilian exigencies when traditional human efficacy studies are not feasible; determination under the interim rule that informed consent is not feasible for military exigencies; request for comments
Q77718920	Accommodations for the physically handicapped
Q77516406	Accounting for long-term contract--Internal Revenue Service. Notice of proposed rulemaking
Q77496934	Accounting for station connections, optional payment in revenues and related capital costs, customer provided equipment and sale of terminal equipment--Federal Communications Commission. Order on reconsideration and clarification of first report and
Q57210798	Acid Rain Program: general provisions and permits, allowance system, continuous emissions monitoring, excess emissions and administrative appeals--EPA. Final rule
Q77601405	Acquired immunodeficiency syndrome drug reimbursement program-HRSA. Notice
Q74755145	Acquisition regulation; incremental funding and protests--HHS. Final rule
Q73018642	Addition of medical criteria for evaluating Down syndrome in adults. Social Security Administration (SSA). Final rule
Q48075388	Additional Compensation on Account of Children Adopted Out of Veteran's Family. Final rule
Q34512344	Additional criteria and procedures for classifying over-the-counter drugs as generally recognized as safe and effective and not misbranded. Final rule
Q77175231	Additional disability or death due to hospital care, medical or surgical treatment, examination, or training and rehabilitation services--VA. Final rule
Q77519516	Additional federal allotments to states for social services expenditures pursuant to the Title XX-Block Grants to States for Social Services--Office of Human Development Services, HHS
Q77516397	Additional protections for children involved as subjects in research--Department of Health and Human Services. Final rule
Q77437803	Additional protections pertaining to biomedical and behavioral research involving prisoners as subjects
Q77680791	Additional protections pertaining to research, development and related activities involving fetuses, pregnant women and in vitro fertilization
Q48534004	Additional requirements for charitable hospitals; community health needs assessments for charitable hospitals; requirement of a section 4959 excise tax return and time for filing the return. Final regulations and removal of temporary regulations
Q46347814	Additional safeguards for children in clinical investigations of food and drug administration-regulated products. Final rule.
Q77474963	Additional standards for human blood and blood products, source plasma (human); amendment of storage temperature requirements: Food and Drug Administration, Final rule
Q77489822	Additional standards for human blood and blood products; source plasma (human)--Food and Drug Administration. Final rule
Q95547753	Additions and Modifications to the List of Drug Products That Have Been Withdrawn or Removed From the Market for Reasons of Safety or Effectiveness. Final rule
Q73174816	Addressing asthma from a public health perspective. Notice of availability of funds. Centers for Disease Control and Prevention
Q74761429	Adjustment of status; certain H-1 nonimmigrant nurses--INS. Final rule
Q74714542	Adjustment of status; certain H-1 nonimmigrant nurses--INS. Interim rule with request for comments
Q74722077	Administration for Children and Families; general reorganization; statement of organization, functions and delegations of authority--HHS
Q77561985	Administration for Children, Youth and Families child abuse and neglect research, demonstration and service improvement projects--DHHS. Announcements of availability of funds and request for application under the HDS' Discretionary Grants Program
Q74808902	Administration of grants and agreements with institutions of higher education, hospitals, and other non-profit organizations; direct grant programs--DoE. Final regulations
Q77534362	Administration of grants to states other than block grants or open-end grants--HHS. Proposed rule
Q77602556	Administration of grants--HHS. Final rule
Q77680753	Administration of medical assistance programs: State Medicaid Fraud Control Units
Q77516281	Administration on Aging: SCAN data bases; activity notice--Office of Human Development Services, HHS. Announcement of availability of certain data bases for assumption at no cost to the federal government
Q38797926	Administrative Actions for Noncompliance; Lesser Administrative Actions. Direct final rule
Q86196428	Administrative Destruction of Certain Drugs Refused Admission to the United States. Final rule
Q95390630	Administrative detention of drugs intended for human or animal use. Final rule
Q30233254	Administrative detention of food for human or animal consumption under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule
Q77500269	Administrative practices and procedures--Office of the Secretary, HHS. Proposed rule
Q77193889	Administrative practices and procedures; internal agency review of decisions--FDA. Direct final rule; withdrawal
Q77163696	Administrative practices and procedures; internal agency review of decisions; companion document to direct final rule--FDA. Proposed rule
Q77193896	Administrative practices and procedures; internal agency review of decisions; companion document to direct final rule; correction--FDA. Proposed rule; correction
Q77163690	Administrative practices and procedures; internal review of agency decisions---FDA. Direct final rule
Q77784391	Administrative practices and procedures; internal review of decisions--FDA. Final rule
Q74709137	Administrative practices and procedures; promulgation of regulations for the efficient enforcement of law--FDA. Final rule
Q77516337	Administrative procedures and sanctions; questions and answers relating to the applicability to the petroleum violation escrow funds of regulations of the energy conservation programs--Department of Energy. Ruling
Q36436935	Administrative review process for adjudicating initial disability claims. Final rule
Q95405114	Administrative simplification: adoption of a standard for a unique health plan identifier; addition to the National Provider Identifier requirements; and a change to the compliance date for the International Classification of Diseases, 10th Edition
Q37899130	Administrative simplification: adoption of operating rules for eligibility for a health plan and health care claim status transactions. Interim final rule with comment period
Q43463205	Administrative simplification: adoption of operating rules for health care electronic funds transfers (EFT) and remittance advice transactions. Interim final rule with comment period.
Q83499873	Administrative simplification: adoption of standards for health care electronic funds transfers (EFTs) and remittance advice. Interim final rule with comment period
Q30842717	Administrative simplification: change to the compliance date for the International Classification of Diseases, 10th Revision (ICD-10-CM and ICD-10-PCS) medical data code sets. Final rule
Q39059148	Adoption and Foster Care Analysis and Reporting System. Final rule
Q90737694	Adoption of the Methodology for the HHS-Operated Permanent Risk Adjustment Program Under the Patient Protection and Affordable Care Act for the 2017 Benefit Year. Final rule
Q38779831	Advanced Practice Registered Nurses. Final rule with comment period
Q74776649	Advisory Committee on the Prevention of HIV Infection. Notice of establishment of subcommittees of the CDC Advisory Committee on the Prevention of HIV Infection--CDC
Q74758100	Advisory Council on Trauma Care Systems; establishment--HRSA
Q84618447	Advisory committee; Medical Imaging Drugs Advisory Committee; re-establishment
Q94379382	Advisory committee; Pediatric Advisory Committee; establishment. Final Rule
Q80733376	Advisory committee; Risk Communication Advisory Committee; establishment. Final Rule
Q74768346	Advisory committee; establishment of organ transplantation task force; notice
Q74724608	Advisory committees; OTC Drugs Advisory Committee; establishment--FDA. Final rule
Q74697049	Advisory committees; establishment and termination--FDA. Final rule
Q74674863	Advisory council; establishment of the Commission on the National Nursing Shortage--HRSA
Q80756690	Afterschool snacks in the Child and Adult Care Food Program. Final rule
Q81123352	Age Discrimination in Employment Act; retiree health benefits. Final rule
Q77457365	Age discrimination in employment; final interpretations--Equal Employment Opportunity Commission
Q77154716	Agency for Health Care Policy and Research. General reorganization; statement of organization, functions, and delegations of authority
Q77166923	Agency for Health Care Policy and Research. General reorganization; statement of organization, functions, and delegations of authority
Q74710157	Agency for Health Care Policy and Research; establishment--HHS
Q74817208	Agency for Health Care Policy and Research; general reorganization; statement of organization, functions, and delegations of authority--HHS
Q74677215	Agency for Health Care Policy and Research; statement of organization, functions and delegations of authority--PHS
Q77135395	Agency information collection activities: proposed collection: comment request--HRSA
Q77152105	Agency information collection activities: proposed collection; comment request--AHCPR. Notice
Q77116837	Agency information collection activities: proposed collection; comment request--HCFA
Q73174498	Agency information collection activities; announcement of OMB approval; Food Labeling: Nutrition Labeling of Dietary Supplements on a "Per Day" Basis. Food and Drug Administration, HHS. Notice
Q73172423	Agency information collection activities; announcement of OMB approval; medical devices: third-party review program under the U.S./EC MRA. Food and Drug Administration, HHS. Notice
Q73174951	Agreed minutes; meeting between the Food and Drug Administration and the Health Authorities of Switzerland. Food and Drug Administration, HHS. Notice
Q77494082	Aid to Families with Dependent Children: Social Security Administration. Final rule
Q74801944	Aid to Families with Dependent Children; extension of Medicaid when support collection results in termination of eligibility--HHS. Final rule
Q77440197	Air contaminants tables; corrections
Q77436586	Alcohol abuse and alcoholism: grants for prevention, treatment, and rehabilitation services and national alcohol research centers--final regulations
Q77711246	Alcohol, Drug Abuse, and Mental Health Administration; statement of organization, functions, and delegations of authority--PHS
Q77724526	Alcohol, Drug Abuse, and Mental Health Services block grant state waiver guidelines; construction or rehabilitation of substance abuse facilities--ADAMHA. Notice
Q77498514	Allocation of spectrum in a certain MHz band and to establish other rules, policies, and procedures for one-way paging stations in the Domestic Public Land Mobile Radio Service--Federal Communications Commission. Final rule
Q79375797	Allotments from federal employees. Interim rule with request for comments
Q73597510	Allowing central fill pharmacies and retail pharmacies to fill prescriptions for controlled substances on behalf of retail pharmacies. Final rule
Q74768575	Alpha-fetoprotein test kits: proposed restrictions and proposed additional quality control and testing requirements
Q77138089	Alternate method of acquisition for health care services; authorized by the federal acquisition regulations--IHS. General notice
Q77149392	Aluminum in large and small volume parenterals used in total parenteral nutrition--FDA. Proposed rule
Q77162024	Amended economic impact analysis of final rule requiring use of labeling on natural rubber containing devices--FDA. Final rule; amended economic analysis statement
Q77175265	Amended economic impact analysis of final rule requiring use of labeling on natural rubber containing devices--FDA. Final rule; amended economic analysis statement
Q77193882	Amended economic impact analysis of final rule requiring use of labeling on natural rubber containing devices--FDA. Final rule; amended economic analysis statement
Q77598340	Amendment of regulations regarding certain label statements on prescription drugs. Final rule
Q77516379	Amendment of the Commission's rule pursuant to its unregulatory program--Federal Communications Commission. Final rule
Q77498520	Amendment of the Commission's rules and establishment of a joint board--Federal Communications Commission. Decision and order amending separations manual
Q74788384	Amendment of the fee exemption for federal, state and local government employees--DEA, Justice. Final rule
Q73018457	Amendment of various device regulations to reflect current American Society for Testing and Material citations. Food and Drug Administration, HHS. Direct final rule
Q74368149	Amendment to Executive Order 13078, to expand the role of the National Task Force on Employment of Adults with Disabilities to include a focus on youth
Q77193929	Amendment to examination and investigation sample requirements--FDA. Direct final rule
Q80159276	Amendment to the current good manufacturing practice regulations for finished pharmaceuticals. Direct final rule
Q51900887	Amendment to the interim final regulation for mental health parity. Amendment to interim final regulation.
Q82517004	Amendment to the interim final rules for group health plans and health insurance coverage relating to status as a grandfathered health plan under the Patient Protection and Affordable Care Act. Amendment to interim final rules with request for comme
Q84583900	Amendments for regulations regarding major life-changing events affecting income-related monthly adjustment amounts to Medicare Part B premiums. Interim rule with request for comments
Q43357799	Amendments to Accreditation of Third-Party Certification Bodies To Conduct Food Safety Audits and To Issue Certifications To Provide for the User Fee Program. Final rule
Q74368265	Amendments to Summary Plan Description regulations. Pension and Welfare Benefits Administration, Labor. Final rule
Q53405774	Amendments to excepted benefits. Final rules.
Q82683279	Amendments to general regulations of the Food and Drug Administration. Direct final rule
Q37948063	Amendments to procedures for certain determinations and decisions. Final rules.
Q44336556	Amendments to regulations regarding eligibility for a Medicare prescription drug subsidy. Final rule.
Q44336128	Amendments to regulations regarding eligibility for a Medicare prescription drug subsidy. Interim final rule with request for comments.
Q82796125	Amendments to regulations regarding withdrawal of applications and voluntary suspension of benefits. Final rule with request for comments
Q38011184	Amendments to sterility test requirements for biological products. Final rule
Q81334869	Amendments to the quick disability determination process. Final rule
Q77456068	American Medical Association; prohibited trade practices, and affirmative corrective actions--Federal Trade Commission. Final order
Q77436601	American Society of Anesthesiologists, Inc.--consent agreement with analysis to aid public comment
Q77437787	American Society of Anesthesiologists, Inc: consent agreement with analysis to aid public comment; correction
Q89375457	Americans With Disabilities Act (ADA) Accessibility Guidelines for Transportation Vehicles. Final rule
Q77121643	Americans with Disabilities Act (ADA) accessibility guidelines for buildings and facilities. Architectural and Transportation Barriers Compliance Board. Final guidelines
Q74368127	Americans with Disabilities Act (ADA) accessibility guidelines for buildings and facilities; play areas. Architectural and Transportation Barriers Compliance Board. Final rule
Q51522147	Anesthesiology Devices; Reclassification of Membrane Lung for Long-Term Pulmonary Support; Redesignation as Extracorporeal Circuit and Accessories for Long-Term Respiratory/Cardiopulmonary Failure. Final order.
Q74794112	Animal welfare; standards; final rule
Q48075384	Animals on VA property. Final rule.
Q77670915	Announcement and proposed criteria for demonstration of joint nursing graduate education program projects--HRSA. Notice
Q77668579	Announcement and proposed criteria for rural health medical education demonstration projects--HRSA. Notice
Q77175252	Announcement of OMB approval for reporting and disclosure requirements in the final rule with comment period for Organ Procurement and Transplantation Network--HRSA
Q130308318	Announcement of Public Meeting to Discuss Potential Standards or Guidelines for Respiratory Protective Devices Used to Protect Emergency Response Workers Against Chemical, Biological, and Radiological Agents
Q94353145	Announcement of Requirements and Registration for Healthy Behavior Challenge
Q94338851	Announcement of Requirements and Registration for Million Hearts® Hypertension Control Challenge
Q73174977	Announcement of anticipated availability of funds for family planning services grants. Office of Population Affairs, OPHS, HHS. Notice
Q95621671	Announcement of ruling: implementing United States v.Windsor for purposes of entitlement and enrollment in Medicare hospital insurance and supplementary medical insurance. Notice of CMS ruling
Q74736430	Annual update of the HHS poverty guidelines--HHS. Notice
Q74765173	Annual update of the HHS poverty guidelines--HHS. Notice
Q74787461	Annual update of the HHS poverty guidelines--HHS. Notice
Q74808176	Annual update of the HHS poverty guidelines--HHS. Notice
Q77152922	Annual update of the HHS poverty guidelines--HHS. Notice
Q77099530	Annual update of the HHS poverty guidelines--HHS. Notice
Q74702835	Annual update of the HHS poverty income guidelines--HHS. Notice
Q77593639	Annual update of the poverty income guidelines--HHS. Notice
Q35210231	Anorectal drug products for over-the-counter human use. Final rule.
Q77121819	Anti-drug program for personnel engaged in specified aviation activities--Federal Aviation Administration. Final rule
Q35772383	Antidiarrheal drug products for over-the-counter human use; amendment of final monograph. Final rule.
Q35109944	Antidiarrheal drug products for over-the-counter human use; final monograph. Final rule
Q43844929	Antidrug and alcohol misuse prevention programs for personnel engaged in specified aviation activities. Final rule; technical amendment.
Q35149017	Antiperspirant drug products for over-the-counter human use; final monograph. Final rule
Q77149380	Application of HIPAA group market portability rules to health flexible spending arrangements--HCFA. Clarification of regulations
Q77149384	Application of HIPAA group market rules to individuals who were denied coverage due to a health status-related factor--HCFA. Clarification of regulations
Q37989474	Application, review, and reporting process for Waivers for State Innovation. Final rule.
Q95511372	Applications To Become Registered Under the Controlled Substances Act To Manufacture Marijuana To Supply Researchers in the United States. Policy statement
Q73546186	Applications for FDA approval to market a dew drug: patent submission and listing requirements and application of 30-month stays on approval of abbreviated new drug applications certifying that a patent claiming a drug is invalid or will not be infr
Q81512143	Applications for Food and Drug Administration application approval to market a new drug; revision of postmarketing reporting requirements. Final rule
Q51124829	Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Direct final rule.
Q51135151	Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Final rule.
Q37292562	Applications for approval to market a new drug; complete response letter; amendments to unapproved applications. Final rule.
Q73018491	Approval and promulgation of Hospital/Medical/Infectious Waste Incinerators: State Plan for designated facilities and pollutants: Idaho. Environmental Protection Agency (EPA). Direct final rule
Q73018551	Approval of Hospital/Medical/Infectious Waste Incinerator State Plan for designated facilities and pollutants: Indiana. Environmental Protection Agency (EPA). Direct final rule
Q77203552	Approval of an alternative requirement of the Mammography Quality Standards Act; availability--FDA. Notice
Q77656219	Approval of hospices to participate in Medicare--HCFA. Notice
Q77113028	Approval of information collection requirements for the joint interim rules for health insurance portability for group health plans, and the individual market health insurance reform: portability from group to individual coverage; federal rules for
Q77106232	Approval of the Commission on Office Laboratory Accreditation for Immunohematology--HCFA. Notice
Q74782496	Approval of the Commission on Office Laboratory Accreditation--HCFA. Notice
Q37993851	Approval tests and standards for closed-circuit escape respirators. Final rule.
Q77516342	Area health education center programs--Public Health Service. Final regulations
Q74368254	Asbestos worker protection. Environmental Protection Agency (EPA). Final rule
Q74731252	Assignment of agency component for review of premarket applications--FDA. Final rule
Q77651866	Assignment of benefits; collection of medical support and payments--Health Care Financing Administration. Final regulations
Q95361798	Assistance to States for the Education of Children With Disabilities and Preschool Grants for Children With Disabilities Program; Early Intervention Program for Infants and Toddlers With Disabilities. Final regulations
Q39061384	Assistance to States for the Education of Children With Disabilities; Preschool Grants for Children With Disabilities. Final regulations
Q74368440	Assistance to States for the Education of Children with Disabilities. Office of Special Education and Rehabilitative Services, Department of Education. Final regulations
Q73174734	Assistance to states for the education of children with disabilities. Office of Special Education and Rehabilitative Services, Department of Education. Final regulations; preamble amendment
Q77463508	Assistant Secretary for Housing--Federal Housing Commissioner--Revision no. 9, increases of fire safety requirements for HUD minimum property standards (MPS). Final rule
Q74792637	Assistant Secretary of Defense for Health Affairs--DoD. Final rule
Q77682473	Assumption of review responsibility by conditional PSROs; conclusive effect of PSRO determinations on claims payment; correlation of Title XI functions with functions required under Title XVIII and Title XIX of the Act
Q37471778	Astringent drug products that produce aluminum acetate; skin protectant drug products for over-the-counter human use; technical amendment. Final rule; technical amendment.
Q74787476	Attestations by facilities using nonimmigrant aliens as registered nurses--DOL. Final rule
Q74788372	Attestations by facilities using nonimmigrant aliens as registered nurses--Employment and Training Administration and Employment Standards Administration, Labor--Final rule and amendment and announcement of effective date
Q74788899	Attestations filed by facilities using nonimmigrant aliens as registered nurses--Employment and Training Administration, DOL. Notice
Q74711016	Audit requirements for institutions of higher education and other nonprofit organizations--Department of Commerce. Interim final rule with request for comments
Q52287853	Authority for practitioners to dispense or prescribe approved narcotic controlled substances for maintenance or detoxification treatment. Final rule.
Q90284616	Authority of Health Care Providers To Practice Telehealth. Final rule
Q48562681	Authorization for non-VA medical services. Direct final rule
Q81020247	Authorized sources of narcotic raw materials. Final rule
Q77589912	Automatic data processing equipment and services; conditions for federal financing participation--HCFA. Final Rule
Q45327761	Automobile or Other Conveyance and Adaptive Equipment Certificate of Eligibility for Veterans or Members of the Armed Forces With Amyotrophic Lateral Sclerosis Connected to Military Service. Final rule
Q45328218	Automobile or other conveyance and adaptive equipment certificate of eligibility for veterans or members of the armed forces with amyotrophic lateral sclerosis. Interim final rule
Q48655102	Autopsies at VA expense. Final rule
Q77065502	Autopsies--VA. Final rule
Q73174900	Availability of additional HRSA competitive grants. Health Resources and Services Administration, HHS. Notice of availability of funds
Q74742360	Availability of clinical practice guidelines on Acute Pain Management: Operative or Medical Procedures and Trauma and Urinary Incontinence in Adults--AHCPR
Q77516417	Availability of funds for Community Health Centers (CHCs)--Health Resources and Services Administration. Notice
Q77575266	Availability of funds for community and migrant health activities--HRA. Notice
Q77568841	Availability of funds for demonstration grants to states for projects of emergency medical service for children--HRA
Q74677923	Availability of funds for grants to provide for the delivery of AIDS/HIV services within community health facilities--HRSA. Notice of available funds
Q77531422	Availability of funds for home health services and training--HRSA
Q74677900	Availability of funds to provide health services in the Pacific Basin--HHS. Notice of availability of funds
Q77526357	Availability of information and records to the public; fees for providing information and records; procedures and appeals--SSA. Notice of proposed rulemaking
Q77498592	Availability of information to the public under the Freedom of Information Act; redelegation of authority--Office of the Secretary, HHS. Final regulation
Q77500290	Availability of information to the public--Department of Health and Human Services. Proposed rule
Q77138095	Availability of the HRSA competitive grants preview--HRSA. General notice
Q73174627	Avermectin; pesticide tolerances for emergency exemptions. Environmental Protection Agency (EPA). Final rule
Q51065007	Banned Devices; Powdered Surgeon's Gloves, Powdered Patient Examination Gloves, and Absorbable Powder for Lubricating a Surgeon's Glove. Final rule.
Q76384480	Bar code label requirement for human drug products and biological products. Final rule
Q38754336	Basic Health Program; Federal Funding Methodology for Program Years 2017 and 2018. Final methodology
Q41311271	Basic Health Program; federal funding methodology for program year 2016. Final methodology
Q51221889	Basic Program Elements for Federal employee Occupational Safety and Health Programs and related matters; Subpart I for Recordkeeping and Reporting Requirements. Final rule.
Q51518612	Basic health program: state administration of basic health programs; eligibility and enrollment in standard health plans; essential health benefits in standard health plans; performance standards for basic health programs; premium and cost sharing f
Q43922467	Basic health program; federal funding methodology for program year 2015. Final methodology
Q77516429	Bell Operating Co.; furnishing of customer premises equipment, enhanced services and cellular communications services and North American Telecommunications Association--Federal Communications Commission. Proposed rule
Q2329814	Belmont Report
Q81737898	Beneficiary travel under 38 U.S.C. 111 within the Unites. Final rule
Q73098064	Beverages: bottled water. Direct final rule
Q81828901	Beverages: bottled water. Final rule
Q43369358	Beverages: bottled water. Final rule.
Q78690051	Bioavailability and bioequivalence requirements: abbreviated applications. Final Rule
Q77784411	Bioavailability and bioequivalence requirements; abbreviated applications; proposed revisions--FDA. Proposed rule
Q77174704	Biological products regulated under Section 351 of the Public Health Service Act; implementation of biologics license; elimination of establishment license and product license; public workshop--FDA. Proposed rule; notice of workshop
Q77169752	Biological products regulated under Section 351 of the Public Health Services Act; implementation of biologics license; elimination of establishment license and product license--FDA. Proposed rule
Q77175309	Biological products regulated under Section 351 of the Public Health Services Act; implementation of biologics license; elimination of establishment license and product license; correction--FDA. Proposed rule; correction
Q74368200	Biological products: reporting of biological product deviations in manufacturing. Food and Drug Administration, HHS. Final rule
Q35669472	Biological products; bacterial vaccines and toxoids; implementation of efficacy review. Final rule and final order.
Q77183219	Biological products; blood specificity designators; technical amendments--FDA. Final rule; technical amendments
Q74743179	Biological technical amendment--FDA. Final rule; technical amendment
Q77657461	Biologics products; establishment registration and product listing for manufacturers of human blood and blood products; amendment to exempt certain transfusion services from registration--FDA. Final rule
Q77152182	Biomedical telemetry transmitters--FCC. Final rule
Q77479179	Biomedical waste disposal--Nuclear Regulatory Commission. Final rule
Q90308825	Black Lung Benefits Act: Medical Benefit Payments. Final rule
Q40117776	Black Lung Benefits Act: standards for chest radiographs. Direct final rule; request for comments
Q40185261	Black Lung Benefits Act: standards for chest radiographs. Final rule
Q77725716	Block grant programs--Office of the Secretary, HHS. Final rule with comment period
Q77522417	Block grant programs--Office of the Secretary, HHS. Final rules
Q77116860	Block grant programs: implementation of OMB Circular A-133--HHS. Interim final rule with request for comments
Q74732810	Blood Donor Locator Service--Social Security Administration. Final rules
Q77469768	Blood and blood components; error and accident reports--Food and Drug Administration. Proposed rule
Q83331601	Blood vessels recovered with organs and intended for use in organ transplantation. Direct final rule
Q80197050	Blood vessels recovered with organs and intended for use in organ transplantation. Final rule
Q37360101	Board of Veterans' Appeals: expedited claims adjudication initiative--pilot program. Final rule.
Q34485352	Board of Veterans' Appeals: rules of practice--notice of appeal in simultaneously contested claim. Final rule
Q34472509	Board of Veterans' Appeals: rules of practice--time for filing substantive appeal. Final rule
Q77445094	Boards of inquiry in health care industry collective bargaining disputes; proposed regulations
Q73162669	Bonus to reward states for high performance under the TANF program. Administration for Children and Families, HHS. Final rule
Q44337756	Branded prescription drug fee. Final regulations, temporary regulations, and removal of temporary regulations
Q77711476	Breast cancer screening program evaluation project; program announcement and notice of availability of funds for fiscal year 1987--CDC
Q74845899	Bureau of Program Operations, statement of organization, functions, and delegations of authority--HCFA
Q74717069	Burning of hazardous waste in boilers and industrial furnaces--EPA. Final rule: corrections; technical amendments
Q57118847	CDC recommendations for civilian communities near chemical weapons depots: guidelines for medical preparedness--CDC. Publication of final recommendations
Q113449362	CHIPS and Science Act
Q53406615	CLIA program and HIPAA privacy rule; patients' access to test reports. Final rule.
Q74808179	CLIA program; approval of the College of American Pathologists--HCFA. Notice
Q77128083	CLIA program; categorization of tests and personnel modifications--HCFA. Final rule with comment period
Q77116843	CLIA program; fee schedule revision--HCFA. General notice with comment period
Q77163685	CLIA program; simplifying CLIA regulations relating to accreditation, exemption of laboratories under a state licensure program, proficiency testing, and inspection--HCFA. Correction
Q77159972	CLIA program; simplifying CLIA regulations relating to accreditation, exemption of laboratories under a state licensure program, proficiency testing, and inspection--HCFA. Final rule
Q74844921	Cancer treatment clinical trials--DoD. Notice of demonstration project
Q77664826	Capital payments under the inpatient hospital prospective payment system--HCFA. Final rule
Q77665014	Capital payments under the inpatient hospital prospective payment system; correction--HCFA. Notice of correction
Q77664232	Cardiac pacemaker registry--FDA, HCFA. Final rule
Q51317598	Cardiovascular Devices; Reclassification of External Cardiac Compressor; Reclassification of Cardiopulmonary Resuscitation Aids. Final order.
Q51362229	Cardiovascular Devices; Reclassification of External Pacemaker Pulse Generator Devices; Reclassification of Pacing System Analyzers. Final order.
Q51560614	Cardiovascular and neurological devices; reclassification of two embolization devices. Final rule.
Q84584635	Cardiovascular devices; classification of electrocardiograph electrodes. Final rule
Q54316065	Cardiovascular devices; reclassification of certain percutaneous transluminal coronary angioplasty (PTCA) catheters. Final rule.
Q48545941	Cardiovascular devices; reclassification of external counter-pulsating devices for treatment of chronic stable angina; effective date of requirement for premarket approval for external counter-pulsating devices for other specified intended uses. Fin
Q44045074	Cardiovascular devices; reclassification of intra-aortic balloon and control systems for acute coronary syndrome, cardiac and non-cardiac surgery, or complications of heart failure; effective date of requirement for premarket approval for intra-aort
Q85332150	Cardiovascular devices; reclassification of nonroller-type cardiopulmonary bypass blood pumps for cardiopulmonary and circulatory bypass; effective date of requirement for premarket approval for nonroller-type cardiopulmonary bypass blood pumps for
Q73018377	Cardiovascular, orthopedic, and physical medicine diagnostic devices; reclassification of cardiopulmonary bypass accessory equipment, goniometer device, and electrode cable devices. Food and Drug Administration, HHS. Final rule
Q48136056	Caregivers program. Final rule
Q48875825	Caregivers program. Interim final rule
Q73174961	Center for Mental Health Services; Center for Substance Abuse Treatment; fiscal year 1999 funding opportunity. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services (CM
Q45750353	Centers for Disease Control and Prevention. Human immunodeficiency virus (HIV), sexually transmitted diseases (STDs), and tuberculosis (TB) related applied research projects.
Q73174649	Centers for Disease Control and Prevention; statement of organization, functions, and delegations of authority
Q77152171	Centers for Disease Control and Prevention; statement of organization, functions, and delegations of authority
Q77118950	Centers for Disease Control and Prevention; statement of organization, functions, and delegations of authority
Q74787506	Centers for Disease Control and Prevention; statement of organization, functions, and delegations of authority--PHS
Q74809923	Centers for Disease Control and Prevention; statement of organization, functions, and delegations of authority--PHS
Q74776546	Centers for Disease Control statement of organization, functions, and delegations of authority--PHS
Q77710284	Centers for Disease Control, PHS: statement of organization, functions, and delegations of authority
Q74776619	Centers for Disease Control; statement of organization, functions, and delegations of authority--PHS
Q73174711	Centers for Excellence in Health Statistics; notice of availability of funds. Centers for Disease Control and Prevention
Q74703894	Cessation of services to terminated Utes--Indian Health Service. Notice
Q44696714	Chafee National Youth in Transition database. Final rule.
Q77627614	Change in assessment policy applicable to Hill-Burton assisted facilities' uncompensated services programs--HRSA. Notice
Q38127184	Change in terminology: "mental retardation" to "intellectual disability." Final rule
Q46971322	Changes in the regulation of iodine crystals and chemical mixtures containing over 2.2 percent iodine. Final rule.
Q74701009	Changes to Medicare Secondary Payer (MSP) provisions--HCFA. Notice
Q77665010	Changes to Medicare secondary payer provisions; Omnibus Budget Reconciliation Act of 1986--HCFA. General notice
Q81591422	Changes to patient limitation for dispensing or prescribing approved narcotic controlled substances for maintenance or detoxification treatment by qualified individual practitioners. Final rule
Q77664805	Changes to rural referral center discharge standards; Medicare program--HCFA. Notice
Q50354810	Changes to scheduling and appearing at hearings. Final rules
Q45330940	Charges billed to third parties for prescription drugs furnished by VA to a veteran for a nonservice-connected disability. Final rule
Q84428727	Charging for investigational drugs under an investigational new drug application. Final rule
Q51946517	Charitable Choice regulations applicable to states receiving Substance Abuse Prevention and Treatment Block Grants, Projects for Assistance in Transition from Homelessness formula grants, and to public and private providers receiving discretionary g
Q77482105	Chest x-ray referral criteria panel draft report; availability--Food and Drug Administration
Q95546615	Child Care and Development Fund (CCDF) Program. Final rule
Q90423897	Child Nutrition Programs: Flexibilities for Milk, Whole Grains, and Sodium Requirements. Final rule
Q47195183	Child Nutrition Programs: Flexibilities for Milk, Whole Grains, and Sodium Requirements. Interim final rule
Q77660284	Child Support Enforcement program; medical support enforcement--HHS. Final rule
Q79714365	Child Support Enforcement program; medical support. Final regulation
Q77554269	Child abuse and neglect prevention and treatment program--HHS. Final rule
Q77548775	Child abuse and neglect prevention and treatment program--HHS. Notice of proposed rulemaking
Q77558008	Child abuse and neglect prevention and treatment program--HHS. Notice of proposed rulemaking
Q77519495	Child abuse and neglect prevention and treatment program--Office of Human Development Services. Final rule
Q47814969	Child and Adult Care Food Program: Meal Pattern Revisions Related to the Healthy, Hunger-Free Kids Act of 2010. Final rule
Q77152914	Child and Adult Care Food Program: improved targeting of day care home reimbursements--Food and Consumer Service, USDA. Final rule
Q77668231	Child support enforcement program, medical support enforcement--Office of Child Support Enforcement, HHS. Final rule
Q74803669	Child support enforcement program: paternity establishment and revision of child support enforcement program and audit regulations--Office of Child Support Enforcement. Final rule
Q74703882	Child support enforcement program; extension of services to Medicaid recipients and to former AFDC recipients--Office of Child Support Enforcement, HHS. Final rule
Q77655763	Child support enforcement program; medical support enforcement--Office of Child Support Enforcement. Notice of Proposed rulemaking
Q77149398	Child support enforcement program; state plan requirements, standards for program operations, and federal financial participation--Office of Child Support Enforcement, HHS. Notice of proposed rulemaking
Q77319820	Child-resistant packaging for certain over-the-counter drug products. Final rule
Q73174487	Childhood asthma and hazardous substances applied research and development; notice of the availability of funds. Agency for Toxic Substances and Disease Registry
Q73018666	Children suffering from spina bifida who are children of Vietnam veterans. Department of Veterans Affairs. Final rule
Q77167725	Children with serious emotional disturbance; estimation methodology--SAMHSA. Final notice
Q51550634	Children's Health Insurance Program (CHIP); allotment methodology and States' fiscal years 2009 through 2015 CHIP allotments. Final rule.
Q73018544	Chronic beryllium disease prevention program. Office of Environment, Safety and Health, Department of Energy. Final rule
Q82666039	Chronic beryllium disease prevention program; worker safety and health program. Final rule
Q83910671	Civil monetary penalties, assessments and recommended exclusions. Final rules
Q74714555	Civil money penalties for failure to report on medical malpractice payments and for breaching the confidentiality of information--HHS. Final rule
Q74809914	Civil money penalties for referrals to entities and for prohibited arrangements and schemes--HHS. Final rule with comment period
Q52566229	Civil money penalties: procedures for investigations, imposition of penalties, and hearings--extension of expiration date. Final rule.
Q53417769	Civil money penalties: procedures for investigations, imposition of penalties, and hearings. Interim final rule; request for comments.
Q77190034	Civilian Health and Medical Program of the Department of Veterans Affairs (CHAMPVA)--VA. Final rule
Q45331643	Civilian Health and Medical Program of the Department of Veterans Affairs (CHAMPVA): expansion of benefit coverage for prostheses and enuretic (bed-wetting) devices; miscellaneous provisions. Final rule.
Q37545869	Civilian Health and Medical Program of the Department of Veterans Affairs (CHAMPVA): preauthorization of durable medical equipment. Final rule.
Q74714550	Civilian Health and Medical Program of the Uniform Services (CHAMPUS); annual fiscal year deductible for outpatient services or supplies--DoD. Final rule
Q74367937	Civilian Health and Medical Program of the Uniformed Service (CHAMPUS); prosthetic devices. Office of the Secretary, DoD. Final rule
Q85845235	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)/TRICARE: Refills of Maintenance Medications Through Military Treatment Facility Pharmacies or National Mail Order Pharmacy Program. Interim final rule
Q53344727	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); TRICARE Reserve Select; TRICARE Dental Program; Early Eligibility for TRICARE for Certain Reserve Component Members. Final rule.
Q74728020	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)--Department of Defense. Notice of revised rates
Q74764337	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)--DoD. Notice of revised rates
Q73174973	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS). Office of the Secretary, DoD. Notice of expansion of cancer treatment clinical trials demonstration project
Q77491248	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS). Withdrawal of proposed rule
Q79778202	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)/ TRICARE; coverage of phase II and phase III clinical trials sponsored by the National Institutes of Health National Cancer Institute. Final rule
Q95369323	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)/TRICARE: Refills of Maintenance Medications Through Military Treatment Facility Pharmacies or National Mail Order Pharmacy Program. Final rule
Q85655878	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)/TRICARE: TRICARE Pharmacy Benefits Program. Final rule
Q85227716	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)/TRICARE: inclusion of TRICARE Retail Pharmacy Program in federal procurement of pharmaceuticals
Q38423157	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)/TRICARE: pilot program for refills of maintenance medications for TRICARE for Life beneficiaries through the TRICARE mail order program. Interim final rule
Q74369065	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)/TRICARE; partial implementation of Pharmacy Benefits Program; implementation of National Defense Authorization Act Medical Benefits for fiscal year 2001. Office of the Secretary
Q77720963	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS): Office of the Secretary, DoD. Amendment of final rule
Q77496907	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); Amendment on reimbursement methodology: Office of the Secretary. DOD. Amendment of final rule
Q74780866	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); DRG revised rates--DoD. Correction
Q74778641	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); DRG revised rates--DoD. Notice of DRG revised rates
Q74832529	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); FY 96 updates--DoD. Amendment to notice
Q74798963	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); FY95 DRG updates--DoD. Notice of DRG revised rates
Q74832508	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); FY96 DRG updates--DoD. Notice of DRG revised rates
Q77077616	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); FY97 DRG updates--DoD. Notice of DRG revised rates
Q74728025	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); Fiscal year 1992 update--Department of Defense. Notice of updated mental health per diem rates
Q77132444	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); Program for Persons with Disabilities; basic program--DoD. Final rule; administrative corrections
Q74368138	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); TRICARE Dental Program. Office of the Secretary, DoD. Final rule
Q74369087	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); TRICARE Dental Program. Office of the Secretary, DoD. Final rule
Q73174481	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); TRICARE Prime enrollment procedures. Office of the Secretary, DoD. Final rule
Q77175940	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); TRICARE Program; reimbursement--DoD. Final rule
Q81529132	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); TRICARE Reserve Select for certain members of the selected reserve; Transitional Assistance Management Program; early eligibility for TRICARE for certain reserve component memb
Q84683854	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); TRICARE Retired Reserve for members of the Retired Reserve. Interim final rule with comment period
Q95607918	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); TRICARE Retired Reserve. Final rule
Q77159804	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); TRICARE Retiree Dental Program (TRDP)--DoD. Final rule
Q77159800	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); TRICARE Selected Reserve Dental Program--DoD. Final rule
Q83995795	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); TRICARE Young Adult. Interim final rule with comment period
Q77784436	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); TRICARE claimcheck appeals--DOD. Notice
Q77153783	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); TRICARE prime balance billing--DOD. Interim final rule
Q77194109	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); TRICARE prime balance billing--DoD. Final rule
Q77166918	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); TRICARE prime enrollment procedures--DOD. Proposed rule
Q77152918	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); TRICARE program; nonavailability statement requirements--DoD. Final rule
Q77154712	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); TRICARE program; reimbursement--DoD. Proposed rule
Q74832511	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); TRICARE program; uniform HMO benefit; special health care delivery programs--DoD. Final rule
Q39121010	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); TRICARE uniform health maintenance organization (HMO) benefit--Prime enrollment fee exemption for survivors of active duty deceased sponsors and medically retired uniformed ser
Q77498588	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); amendment on electric-powered, cart-type vehicles--Office of the Secretary of Defense. Final rule
Q77498584	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); amendment on elimination of nonavailability statement where primary insurance covers 75 percent of the cost--Office of the Secretary of Defense. Final rule
Q77534366	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); certified clinical social workers--Office of the Secretary, DoD. Amendment of final rule
Q77450408	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); clarification of CHAMPUS last pay status: addendum to rule
Q77090026	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); clarification of the CHAMPUS exclusion of unproven drugs, devices and medical treatments and procedures--DoD. Final rule
Q74798955	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); continued health care benefit program--DoD. Final rule
Q74788896	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); continued health care benefit program--DoD. Interim rule
Q74766839	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); corrections to the CHAMPUS Diagnosis Related Group (DRG) payment system rates and weights--DoD. Corrections to notice of revised rates
Q74731989	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); corrections to the CHAMPUS diagnosis related group (DRG) payment system rates and weights--Department of Defense. Corrections to notice of revised rates
Q74787464	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); coverage of screening mammography and Papanicolaou (PAP) tests, certified marriage and family therapists, and requirements for coverage and reimbursement of services of physici
Q74769924	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); demonstration project--DoD. Notice of the implementation and operation of a health care demonstration project for CHAMPUS beneficiaries residing in selected base realignment an
Q74731280	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); drug benefits; appropriate level of care provisions--Department of Defense. Final rule
Q73162595	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); enhancement of dental benefits under the TRICARE retiree dental program. Office of the Secretary, DoD. Interim final rule with request for comments
Q74811953	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); establishment of national differentials for children's hospitals--DoD. Notice
Q77116825	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); exception of the CHAMPUS dual compensation/conflict of interest provisions--DoD. Proposed Rule
Q74834911	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); expanded active duty dependents dental benefit plan--DoD. Final rule
Q74762623	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); fiscal year 1993 updates--DoD. Notice of updated mental health per diem rates
Q74777184	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); fiscal year 1994 updates--DoD. Notice of updated partial hospitalization per diem rates
Q74777171	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); fiscal year 1994 updates--Office of the Secretary, DoD. Notice of updated mental health per diem rates
Q77082510	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); five separate changes--DoD. Final rule
Q77133107	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); health promotion and disease prevention visits and immunizations--DoD. Final rule
Q74793367	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); liver transplantation
Q74731287	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); medical documentation--Department of Defense. Final rule
Q74728589	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); mental health services--Department of Defense. Final rule
Q93920504	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); mental health services--Department of Defense. Final rule
Q74808196	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); mental health services--DoD. Final rule
Q74368712	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); methodology for coverage of phase II and phase III clinical trials sponsored by the National Institutes of Health. Office of the Secretary; DoD. Final rule
Q74772807	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); partial hospitalization--DoD. Final rule
Q74779757	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); partial hospitalization--DoD. Final rule; delay of grace period
Q77132389	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); program for persons with disabilities; basic program--DoD. Final rule
Q74722121	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); reimbursement of individual health providers--Department of Defense. Final rule
Q74724643	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); reimbursement of individual health providers--Department of Defense. Final rule
Q77125673	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); reimbursement of providers, claims filing, and participating provider program--DoD. Correction to final rule
Q74777178	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); reimbursement of providers, claims filing, and participating provider program--Office of the Secretary, DoD. Final rule
Q77159814	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); revisions to the eligibility requirements--DoD. Proposed rule
Q73175068	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); revisions to the eligibility requirements. Department of Defense (DOD), Office of the Secretary of Defense. Final rule
Q74780051	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); specialized treatment services; nonavailability statements; peer review organization program; supplemental care--DoD. Final rule
Q77203497	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); state victims of crime compensation programs; voice prostheses--DoD. Final rule
Q79793321	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); voluntary disenrollment from the TRICARE Retiree Dental Program (TRDP). Final rule
Q77162044	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); waiver of collection of payments due from certain persons unaware of loss of CHAMPUS eligibility--DoD. Final rule
Q77148208	Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); waiver of collection of payments due from certain persons unaware of loss of CHAMPUS eligibility--DoD. Proposed rule
Q84572252	Civilian health and medical program of the uniformed services (CHAMPUS)/TRICARE: inclusion of retail network pharmacies as authorized TRICARE providers for the administration of TRICARE covered vaccines. Final rule
Q48614554	Claimant identification pilot projects. Final rules
Q39061381	Claims Procedure for Plans Providing Disability Benefits. Final rule
Q95725101	Claims Procedure for Plans Providing Disability Benefits; 90-Day Delay of Applicability Date. Final rule; delay of applicability date
Q77193917	Claims based on exposure to ionizing radiation (prostate cancer and any other cancer)--VA. Final rule
Q77169857	Claims based on the effects of tobacco products. Final rule
Q77709597	Claims for medical benefits under the Federal Employees' Compensation Act. Office of Workers' Compensation Programs, Labor. Notice of proposed rulemaking
Q77135371	Claims procedures for employee benefit plans--Pension and Welfare Benefits Administration, Department of Labor. Request for information
Q38777173	Clarification of Employer's Continuing Obligation To Make and Maintain an Accurate Record of Each Recordable Injury and Illness. Final rule
Q39302120	Clarification of Employer’s Continuing Obligation To Make and Maintain an Accurate Record of Each Recordable Injury and Illness. Final rule
Q95725559	Clarification of Final Rules for Grandfathered Plans, Preexisting Condition Exclusions, Lifetime and Annual Limits, Rescissions, Dependent Coverage, Appeals, and Patient Protections Under the Affordable Care Act. Final rule; clarification
Q95724290	Clarification of When Products Made or Derived From Tobacco Are Regulated as Drugs, Devices, or Combination Products; Amendments to Regulations Regarding "Intended Uses." Final rule
Q79435651	Clarification of registration requirements for individual practitioners. Final rule
Q73892881	Clarification of rules involving residual functional capacity assessments; clarification of use of vocational experts and other sources at step 4 of the sequential evaluation process; incorporation of "special profile" into regulations. Final rules
Q77456064	Classification of anesthesiology devices; development of general provisions--Food and Drug Administration. Proposed rule
Q37729062	Classification of benzoyl peroxide as safe and effective and revision of labeling to drug facts format; topical acne drug products for over-the-counter human use; final rule.
Q77451477	Classification of general hospital and personal use devices; development of general provisions: proposed rule
Q43156759	Classification of three steroids as schedule III anabolic steroids under the Controlled Substances Act. Final rule.
Q84663795	Classification of two steroids, prostanozol and methasterone, as Schedule III anabolic steroids under the Controlled Substance Act. Final rule
Q20647055	Clean Water Rule
Q74752247	Clinical Laboratories Improvement Act program; granting and withdrawal of deeming authority to private nonprofit accreditation organizations and of CLIA exemption under state laboratory programs--HCFA. Final rule
Q77122432	Clinical Laboratory Improvement Act program fee collection--HCFA. Final rule with comment
Q95420490	Clinical Laboratory Improvement Amendments of 1988 (CLIA); Fecal Occult Blood (FOB) Testing. Final rule
Q36141499	Clinical Trials Registration and Results Information Submission. Final rule
Q74369077	Clinical chemistry and clinical toxicology devices; classification of B-type natriuretic peptide test system. Food and Drug Administration, HHS. Final rule
Q73018422	Clinical chemistry devices; classification of the biotinidase test system. Food and Drug Administration, HHS. Final rule
Q77169794	Clinical studies of safety and effectiveness of orphan products; availability of grants; request for applications--FDA. Notice
Q73175015	Clinical studies of safety and effectiveness of orphan products; availability of grants; request for applications. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Notice
Q50581936	Closed-circuit escape respirators; extension of transition period. Interim final rule.
Q74368359	Code of conduct for the International Space Station Crew. National Aeronautics and Space Administration (NASA). Interim final rule
Q73162568	Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for OTC antitussive drug products. Food and Drug Administration, HHS. Final rule
Q36283210	Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for over-the-counter nasal decongestant drug products. Final rule.
Q80067517	Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of monograph for OTC nasal decongestant drug products. Final rule
Q35037207	Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; final monograph for combination drug products. Final rule
Q37026883	Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; final rule for over-the-counter antitussive drug products; technical amendment. Final rule, technical amendment.
Q34471599	Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; partial final rule for combination drug products containing a bronchodilator. Final rule
Q77649609	Collection and compromise of Medicare overpayment claims from providers, physicians, and other suppliers of services: final rule
Q74755179	Collection from third party payers of reasonable costs of healthcare services--DoD. Final rule
Q74798950	Collection from third party payers of reasonable costs of healthcare services--DoD. Final rule
Q74845904	Collection from third party payers of reasonable costs of healthcare services--DoD. Final rule
Q77153818	Collection from third party payers of reasonable costs of healthcare services--DoD. Final rule with request for comments
Q77153827	Collection from third party payers of reasonable costs of healthcare services--DoD. Proposed rule
Q73174706	Community based Human Immunodeficiency Virus (HIV) prevention projects for African Americans; notice of availability of funds. Centers for Disease Control and Prevention
Q73174872	Community coalition development projects for African American communities; notice of availability of funds. Centers for Disease Control and Prevention
Q77131102	Community residential care program and contract program for veterans with alcohol and drug dependence disorders--VA. Final rule
Q47806629	Community residential care program. Final rule
Q48468032	Community residential care. Interim final rule
Q77193986	Compatibility of wireless services with enhanced 911--FCC. Proposed rule
Q74808905	Compensation for certain undiagnosed illnesses--VA. Final rule
Q77152951	Compensation for certain undiagnosed illnesses--VA. Final rule
Q77063447	Compensation for disability resulting from hospitalization, treatment, examination, or vocational rehabilitation--VA. Final rule
Q74810676	Compensation for disability resulting from hospitalization, treatment, examination, or vocational rehabilitation--VA. Interim final rule with request for comments
Q73174490	Compliance Guidance: The Mammography Quality Standards Act Final Regulations Document #1; availability. Food and Drug Administration, HHS. Notice
Q77393703	Compliance alternatives for provision of uncompensated services. Final rule
Q74794199	Compliance with host nation human immuno-deficiency (HIV) screening requirements for DOD civilian employees; final rule
Q39687497	Comprehensive Child Welfare Information System. Final rule
Q77783988	Comprehensive quality assurance in medical use and a standard of care--NRC. Advance notice of proposed rulemaking: withdrawal
Q77784022	Comprehensive quality assurance in medical use and a standard of care; correction--NRC. Advance notice of proposed rulemaking: withdrawal; correction
Q77498609	Compulsory license for cable systems--Copyright Office, Library of Congress. Interim regulations
Q50226603	Computation of, and rules relating to, medical loss ratio. Final regulations
Q77652084	Conditions for coverage of suppliers of ESRD services self-dialysis and home dialysis training--Health Care Financing Administration. Notice of proposed rulemaking
Q77649094	Conditions for coverage of suppliers of end stage renal disease (ESRD) services. Kidney Transplantation Centers: final regulation with comment period
Q77721456	Conditions for the use of methadone; intent to propose revisions to regulations and request for comments
Q77652860	Conditions of participation for hospitals; conditions for coverage of services of independent laboratories; immunohematological testing, transfusion services and bloodbanking: Health Care Financing Administration. Final rule
Q77652114	Conditions of participation for skilled nursing and intermediate care facilities: Health Care Financing Administration. Withdrawal of Secretarial approval
Q77608056	Conduct of persons and traffic on the National Institutes of Health Federal enclave; prohibition of smoking in buildings--HHS. Final rule
Q77566430	Confidentiality and disclosure of Professional Standards Review Organization (PSRO) information: proposed rule
Q77674992	Confidentiality and disclosure of information by Professional Standards Review Organizations
Q47823434	Confidentiality of Substance Use Disorder Patient Records. Final rule.
Q74816064	Confidentiality of alcohol and drug abuse patient records
Q77723289	Confidentiality of alcohol and drug abuse patient records--PHS. Final rule
Q52105303	Confidentiality of alcohol and drug abuse patient records.
Q52114044	Confidentiality of alcohol and drug abuse patient records. General provisions.
Q74813204	Confidentiality of alcohol and drug abuse patient records. Proposed rules
Q77129377	Confidentiality of certain medical records--VA. Final rule
Q77441223	Confidentiality of employee medical records: proposed rule
Q77094378	Confidentiality of medical quality assurance (QA) records and delegation of authority to Deputy Secretary of Defense; removal--DoD. Final rule
Q77721450	Confidentialty of alcohol and drug abuse patient records--PHS. Notice of proposed rulemaking
Q95369779	Conforming STOP Violence Against Women Formula Grant Program Regulations to Statutory Change; Definitions and Confidentiality Requirements Applicable to All OVW Grant Programs. Final rule
Q73174790	Conforming regulations regarding removal of section 507 of the Federal Food, Drug, and Cosmetic Act; confirmation of effective date. Food and Drug Administration, HHS. Direct final rule; confirmation of effective date
Q74368534	Consideration of potassium iodide in emergency plans. Nuclear Regulatory Commission. Final rule
Q77491237	Consolidated permit regulations and hazardous waste management system: Environmental Protection Agency. Notice of issuance of regulation interpretation memorandum
Q77524523	Consultation with state and local officiaLs prior to awarding community health center grants--PHS. Notice
Q77534373	Consultations with state and local officials prior to awarding community health center grants--HRSA. Notice
Q37763910	Consultative examination--annual onsite review of medical providers. Final rules.
Q77489806	Container and waste pile standards for owners and operators of hazardous waste facilities: consolidated permit regulations--Environmental Protection Agency. Amendments to interim final rule
Q77475787	Content and format for labeling for human prescription drugs; amendment of effective date for certain biological products--Food and Drug Administration. Final rule
Q41688511	Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule.
Q77116765	Content and format of labeling for human prescription drugs; pregnancy labeling; public hearing--FDA. Notice of public hearing; request for comments
Q73172402	Continuation coverage requirements applicable to group health plans. Internal Revenue Service (IRS). Treasury. Final rule
Q77152303	Continuation coverage requirements of group health plans--IRS. Notice of proposed rulemaking
Q81893050	Continuation of benefit payments to certain individuals who are participating in a program of vocational rehabilitation services, employment services, or other support services. Final rule
Q36626967	Continuing disability review failure to cooperate process. Final rules.
Q77489789	Continuing treatment for Hansen's disease patients after closure or transfer of PHS facilities: Public Health Service, Final rule
Q47189800	Continuum of Care Program--Increasing Mobility Options for Homeless Individuals and Families With Tenant-Based Rental Assistance. Interim rule
Q74733666	Contract health care services; reimbursement and Medicare allowable rates--Bureau of Prisons, Dept. of Justice. Notice
Q74694204	Contract medical care; non-federal hospital payment rates--DVA and HHS. Final regulations
Q77130710	Contract program for veterans with alcohol and drug dependence disorders--VA. Final rule
Q48562671	Contracts and provider agreements for State home nursing home care. Interim final rule.
Q40371929	Control of Communicable Diseases. Final rule
Q46298688	Control of a chemical precursor used in the illicit manufacture of fentanyl as a List I chemical. Final rule.
Q45292149	Control of a chemical precursor used in the illicit manufacture of fentanyl as a List I chemical. Interim rule with request for comments.
Q43834224	Control of alcohol and drug use: changes to conform to new DOT transportation workplace testing procedures. Final rule
Q42271760	Control of communicable disease; foreign--requirements for importers of nonhuman primates (NHP). Final rule.
Q51677654	Control of communicable diseases. Interim final rule with comment period
Q85790650	Control of communicable diseases: foreign; scope and definitions. Direct final rule and request for comments
Q85790645	Control of communicable diseases: interstate; scope and definitions. Direct final rule and request for comments
Q73162647	Control of communicable diseases; apprehension and detention of persons with specific diseases; transfer of regulations. Food and Drug Administration and Centers for Disease Control and Prevention, HHS. Final rule
Q46448983	Control of communicable diseases; restrictions on African rodents, prairie dogs, and certain other animals. Interim final rule; opportunity for public comment
Q44354426	Control of communicable diseases; restrictions on African rodents, prairie dogs, and certain other animals. Interim final rule; supplement and partial reopening of comment period
Q42979209	Control of immediate precursor used in the illicit manufacture of fentanyl as a schedule II controlled substance. Final rule.
Q35167107	Control of red phosphorus, white phosphorus and hypophosphorous acid (and its salts) as list I chemicals; exclusions and waivers. Final rule
Q49114877	Control, custody, care, treatment and instruction of inmates
Q52040566	Control, custody, care, treatment and instruction of inmates; administrative safeguards for psychiatric treatment and medication; interim rule.
Q45735183	Control, custody, care, treatment and instruction of inmates; human immunodeficiency virus (HIV) programs; final rule.
Q74793601	Control, custody, care, treatment, and instruction of inmates; interim rule
Q90313727	Controlled Substances Quotas. Final rule
Q83657363	Controlled substances and List I chemical registration and reregistration fees. Final rule
Q51023591	Cooperation in USDA studies and evaluations, and full use of federal funds in nutrition assistance programs nondiscretionary provisions of the Healthy, Hunger-Free Kids Act of 2010, Public Law 111-296. Final Rule.
Q74702842	Cooperation in identifying and providing information to assist states in pursuing third party health coverage--Family Support Administration, HHS. Final rule
Q73174646	Cooperative agreement for 1999 National Breast and Cervical Cancer Early Detection Program; notice of availability of funds. Centers for Disease Control and Prevention
Q73174850	Cooperative agreement for Applied Research on New Vaccines; notice of availability of funds. Centers for Disease Control and Prevention
Q73174841	Cooperative agreement for Applied Research on Surveillance of Vaccine Preventable Diseases in Managed Care Settings; notice of availability of funds. Centers for Disease Control and Prevention
Q73174640	Cooperative agreement for Promoting Prevention in Managed Care; notice of availability of funds. Centers for Disease Control and Prevention
Q73174891	Cooperative agreement for Surveillance of Intimate Partner Violence; notice of availability of funds. Centers for Disease Control and Prevention
Q73174887	Cooperative agreement for a Coordinated Community Response to prevent intimate partner violence; availability of funds. Centers for Disease Control and Prevention
Q73174838	Cooperative agreement for a Laboratory Medicine Sentinel Monitoring Network; notice of availability of funds. Centers for Disease Control and Prevention
Q73174877	Cooperative agreement for an evaluation research study in the area of aggression and interpersonal youth violence; notice of availability of funds. Centers for Disease Control and Prevention (CDC)
Q73174643	Cooperative agreement for promoting investigator-initiated prevention research in managed care; notice of availability of funds. Centers for Disease Control and Prevention
Q73174668	Cooperative agreement for the development of a national public health information infrastructure; notice of availability of funds
Q77638746	Cooperative agreement to support Healthy Cities and implementation of the year 2000 national health objectives for special populations--PHS
Q73174678	Cooperative agreement with Policy Research, Inc., to continue the National GAINS Center for People with Co-Occurring Disorders in the Justice System. Center for Substance Abuse Treatment (CSAT) and Center for Mental Health Services (CMHS), Substanc
Q77617814	Cooperative agreement with the American College of Preventive Medicine of the Science and Practice of Preventive Medicine; availability of funds for fiscal year 1988--PHS
Q73174935	Cooperative agreements for Capacity-Building Assistance (CBA) to community-based organizations serving African American populations heavily affected by the human-immunodeficiency virus (HIV); notice of availability of funds. Centers for Disease Con
Q73174788	Cooperative agreements for Non-Governmental Organization (NGO) Partnerships Pilot Project; notice of availability of funds. Centers for Disease Control and Prevention
Q77711523	Cooperative agreements for acquired immunodeficiency syndrome (AIDS) prevention and surveillance projects program announcement and notice of availability of funds for fiscal year 1988--CDC
Q77120477	Cooperative agreements for communications programs for the prevention of illegal drug use or the illegal use or abuse of alcohol--ADAMHA
Q74675997	Cooperative agreements for minority community-based human immunodeficiency virus (HIV) prevention projects--HHS. Program announcement and availability of funds for fiscal year 1990
Q73174829	Cooperative agreements for strategies to prevent genital herpes infections: building a national prevention program, notice of availability of funds. Centers for Disease Control and Prevention
Q77548783	Cooperative agreements to support national health promotion programs--PHS
Q77498562	Cooperative use and multiple licensing of stations in the private land mobile radio services--Federal Communications Commission. Final rule; report and order
Q28201286	Coordinated framework for regulation of biotechnology; announcement of policy; notice for public comment
Q74793270	Coordinated framework for regulation of biotechnology; establishment of the Biotechnology Science Coordinating Committee; notice
Q48392591	Copayment for extended care services. Final rule
Q48074432	Copayments for Medications in 2015. Final rule.
Q77454337	Copayments for inpatient hospital care and outpatient medical care. Interim and final rule
Q48286854	Copayments for medication in 2014. Final rule
Q48904209	Copayments for medications after June 30, 2010. Final rule.
Q51146643	Copayments for medications after June 30, 2010. Interim final rule.
Q48680030	Copayments for medications in 2012. Final rule.
Q46034495	Copayments for medications in 2013. Final rule.
Q48547729	Copayments for medications in 2013. Interim final rule.
Q48377379	Copayments for medications in 2014. Interim final rule
Q48183365	Copayments for medications in 2015. Interim final rule.
Q77454341	Copayments for medications. Final rule
Q51146411	Copayments for medications. Final rule.
Q51141654	Copayments for medications. Interim final rule.
Q74758095	Core Data Set Requirements--IHS. Changes to Indian Health Service Core Data Set requirements (CDSR)--correction
Q79699865	Cost allocation methodology applicable to the temporary assistance for needy families program. Final rule
Q77498548	Cost allocation plans for public assistance programs--Health and Human Services Department. Interim final rule with comment period
Q77491253	Cost of hospital and medical care and treatment furnished by the United States; certain rates regarding recovery from tortiously liable third persons
Q74778646	Cost of hospital and medical care and treatment furnished by the United States; certain rates regarding recovery from tortiously liable third persons--OMB
Q74795567	Cost of hospital and medical care and treatment furnished by the United States; certain rates regarding recovery from tortiously liable third persons--OMB
Q74836268	Cost of hospital and medical care and treatment furnished by the United States; certain rates regarding recovery from tortiously liable third persons--OMB
Q77080419	Cost of hospital and medical care and treatment furnished by the United States; certain rates regarding recovery from tortiously liable third persons--OMB
Q74729705	Cost of hospital and medical care and treatment furnished by the United States; certain rates regarding recovery from tortiously liable third persons--Office of Management and Budget
Q74758140	Cost of hospital and medical care and treatment furnished by the United States; certain rates regarding recovery from tortiously liable third persons--Office of Management and Budget
Q77194104	Cost of hospital and medical care treatment furnished by the United States; certain rates regarding recovery from tortiously liable third persons--OMB
Q77516332	Cost principles for nonprofit organizations--Office of Management and Budget. Notice
Q77800553	Cost-of-living adjustments and headstone or marker allowance rate--VA. Notice
Q30226925	Countermeasures Injury Compensation Program (CICP): administrative implementation, interim final rule. Interim final rule with request for comments
Q77685511	Coverage and reimbursement of rural health clinic services
Q48011412	Coverage of Certain Preventive Services Under the Affordable Care Act. Final rules.
Q95372975	Coverage of certain preventive services under the Affordable Care Act. Final rules
Q48066859	Coverage of certain preventive services under the Affordable Care Act. Interim final rules
Q74766008	Creation of the Emergency Medical Radio Service--FCC. Final rule
Q74688983	Criteria and standards for evaluating intermediary and carrier performance--HCFA. Correction
Q74688869	Criteria and standards for evaluating intermediary and carrier performance--HCFA. General notice with comment period
Q74690422	Criteria and standards for evaluating intermediary and carrier performance--HCFA. General notice with comment period
Q48391888	Criteria for a catastrophically disabled determination for purposes of enrollment. Final rule
Q74734134	Criteria for designation of mental health professional shortage areas--PHS. Final rule
Q77152146	Criteria for implementing permissive exclusion authority under Section 1128(b)(7) of the Social Security Act--Office of Inspector General, HHS. Notice
Q77437800	Criteria for radioactive wastes: recommendations for federal radiation guidance
Q77093585	Criteria for the release of individuals administered radioactive materials--NRC. Final rule
Q74797077	Criteria for use of blue "Star of Life" for emergency medical services. National Highway Traffic Safety Administration. Notice
Q77685549	Cumulative list of qualified Health Maintenance Organizations
Q37292567	Current good manufacturing practice and investigational new drugs intended for use in clinical trials. Final rule.
Q36948523	Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
Q82966717	Current good manufacturing practice for positron emission tomography drugs
Q43350692	Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements. Final rule.
Q74773804	Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; revision of certain labeling controls--FDA. Final rule
Q83818368	Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; revision of certain labeling controls. Final rule
Q82557537	Current good manufacturing practice regulation and investigational new drugs. Direct final rule
Q77072526	Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule
Q95407627	Current good manufacturing practices, quality control procedures, quality factors, notification requirements, and records and reports, for infant formula. Final rule
Q81054307	Current good tissue practice for human cell, tissue, and cellular and tissue-based product establishments; inspection and enforcement. Final rule
Q77152294	Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies, and laboratories that have withdrawn from the program--SAMHSA. Notice
Q74776142	Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies--ADAMHA. Notice
Q74776146	Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies--ADAMHA. Notice
Q77120758	Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies--ADAMHA. Notice
Q74690429	Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies--HHS. Notice
Q73018616	Currently effective Indian Health Service eligibility regulations. Indian Health Service, HHS. Republication of currently effective Indian Health Service eligibility regulations
Q36797018	Dandruff, seborrheic dermatitis, and psoriasis drug products containing coal tar and menthol for over-the-counter human use; amendment to the monograph. Final rule
Q31154736	Data breaches. Final rule.
Q31120656	Data breaches. Interim final rule.
Q31113528	Data collection related to the participation of faith-based and community organizations. Final rule
Q77551555	Debarment, suspension, and ineligibility of contractors--DHHS. Final rule
Q77540663	Debarment, suspension, and ineligibility of contractors--HHS. Proposed rule
Q77527828	Debarment, suspension, and ineligibility--DHHS. Proposed rule
Q81403995	Deemed duration of marriage for widows/widowers and removal of restriction on benefits to children of military parents overseas. Final rules
Q77436593	Deemed filing of waiver of tax exemption by religious, charitable, or other organization described in section 501 (c) (3) of the Internal Revenue code: final regulation
Q95360003	Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements fo
Q77498524	Deep discount industrial development bonds; proposed rulemaking--Internal Revenue Service, Treasury. Notice of proposed rulemaking
Q80159274	Definition of "positional isomer" as it pertains to the control of schedule I controlled substances. Final rule
Q91847707	Definition of Domiciliary Care. Final rule
Q77657466	Definition of medical services--VA
Q81113448	Definition of primary mode of action of a combination product. Final rule
Q80067507	Definition of psychoses for certain VA purposes. Final rule
Q95356489	Definition of spouse under the Family and Medical Leave Act. Final rule
Q77579986	Delegation of authority--PHS
Q77575258	Delegation of authority; Health Resources and Services Administration
Q74767761	Delegations of authority and organization--FDA. Final rule
Q77159826	Delegations of authority and organization--FDA. Final rule
Q74731259	Delegations of authority and organization; Center for Biologics Evaluation and Research, Center for Devices and Radiological Health, and Center for Drug Evaluation and Research--FDA. Final rule
Q74728017	Delegations of authority and organization; Center for Devices and Radiological Health--FDA. Final rule
Q74797058	Delegations of authority and organization; Center for Devices and Radiological Health--FDA. Final rule
Q77159982	Delegations of authority and organization; Center for Devices and Radiological Health--FDA. Final rule
Q73172401	Delegations of authority and organization; Center for Devices and Radiological Health. Food and Drug Administration, HHS. Final rule
Q74767767	Delegations of authority and organization; Center for Drug Evaluation and Research--FDA. Final rule
Q74767777	Delegations of authority and organization; National Childhood Vaccine Injury Act of 1986--FDA. Final rule
Q74731255	Delegations of authority and organization; Office of the Commissioner--FDA. Final rule
Q74722084	Delegations of authority and organization; Ryan White Comprehensive AIDS Resources Emergency Act of 1990--FDA. Final rule
Q74743210	Delegations of authority and organization; issuance of written notices--FDA. Final rule
Q77500263	Delegations of authority and organization; new drug applications--Food and Drug Administration. Final rule
Q77494107	Delegations of authority and organization; revised organization. Food and Drug Administration. Final rule
Q74767770	Delegations of authority to the Commissioner of Food and Drugs--FDA. Final rule
Q74773795	Delegations of authority/claims for cost of medical care and services--Department of Veterans Affairs. Final regulations
Q77494095	Deletion of regulations pertaining to certain social services programs under the Social Security act: Office of Human Development Services, HHS. Final rule
Q77784398	Demonstration to improve enrollment in state buy-in to Medicare for low-income Medicare beneficiaries--SSA. Notice, request for comments and solicitation for demonstration participation by states
Q51633923	Dental Devices; Reclassification of Electrical Salivary Stimulator System. Final order.
Q45331685	Dental care--provision of one-time outpatient dental care for certain veterans. Final rule.
Q48724432	Dental conditions. Final rule.
Q84350298	Dental devices: classification of dental amalgam, reclassification of dental mercury, designation of special controls for dental amalgam, mercury, and amalgam alloy. Final rule
Q84389241	Dental devices: classification of dental amalgam, reclassification of dental mercury, designation of special controls for dental amalgam, mercury, and amalgam alloy; technical amendment. Final rule; technical amendment
Q48645773	Dental devices; classification for intraoral devices for snoring and/or obstructive sleep apnea. Final rule
Q51627422	Dental devices; dental noble metal alloys and dental base metal alloys; designation of special controls. Final rule.
Q77784427	Dental devices; effective date of requirement for premarket approval; temporomandibular joint prostheses--FDA. Final rule
Q53505216	Dental devices; reclassification of blade-form endosseous dental implant. Final order.
Q51675354	Dental devices; reclassification of root-form endosseous dental implants and endosseous dental implant abutments. Final rule.
Q44719874	Dental devices; reclassification of temporary mandibular condyle prosthesis. Final order
Q51487916	Dental devices; reclassification of tricalcium phosphate granules and classification of other bone grafting material for dental bone repair. Final rule.
Q74368000	Dental products devices; reclassification of endosseous dental implant accessories. Food and Drug Administration, HHS. Final rule
Q77468431	Department of Defense--Implementation of the Civilian Health and Medical Program of the Uniformed Services; Amendment No. 4. Final rule
Q77469789	Department of Energy--appropriate technology small grants program: final rule
Q77473217	Department of Health and Human Services Public Health Services. Notification of a new system of records: Three Mile Island mental health survey, respondent records
Q77489831	Department of Health and Human Services--Grants and subgrants to for-profit organizations. Proposed rules
Q77651731	Department of Health and Human Services--Medicare program: inpatient hospital deductible for 1981. Notice
Q77653005	Department of Health and Human Services--Medicare program; inpatient hospital deductible for 1982. General notice
Q77693703	Department of Health and Human Services--Privacy Act 1974; report of a new system of records
Q77526381	Department of Health and Human Services--unified agenda of regulations. Publication of unified agenda of regulations
Q77463519	Department of Health and Human Services: statement of organization, functions, and delegations of authority
Q77650440	Department of Health, Education, and Welfare--abortions: final regulation
Q77650379	Department of Health, Education, and Welfare. Medicare hospital insurance program; inpatient hospital deductible for 1980
Q77482109	Department of Justice, Antitrust Division. United States v. Halifax Hospital Medical Center, et al.; proposed final judgment and competitive impact statement
Q77469792	Department of the Air Force--Obtaining medical, dental and veterinary care from civilian sources. Final rule
Q74755215	Departures from manufacturer's instructions; elimination of recordkeeping requirements--NRC. Final rule
Q48645240	Dependency and indemnity compensation (DIC) benefits for survivors of former prisoners of war rated totally disabled at time of death. Final rule
Q77522522	Deregulation of mobile customer premises equipment--FCC. Proposed rule
Q38570287	Designating Additions to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act. Final order
Q77685516	Designation and funding of state health planning and development agencies: requirements
Q48618992	Designation of Alpha-Phenylacetoacetonitrile (APAAN), a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine, as a List I Chemical. Final rule
Q77566328	Designation of alternate PSRO's: final rule
Q77500299	Designation of certain former Public Health Service facilities as uniformed services facilities
Q77529766	Designation of health manpower shortage areas (HMSAs); clarification of "non-federal" as used in practitioner counts--HRA
Q77543164	Designation of health services areas and health systems agency application information--HRSA. Notice designating health services areas in Ohio
Q77480827	Designation of medically underserved areas--Health Services Administration. Notice
Q77509617	Designation of medically underserved areas; list of final deletions--Health Resources and Services Administration. Notice
Q74677893	Designation of medically underserved populations and areas--HRSA. Notice
Q77175295	Designation of medically underserved populations and health professional shortage areas--HRSA. Proposed rules
Q77639808	Designation of medically underserved populations including areas recommended by the chief executive officer and local officials of a state--HHS. Notice
Q46969531	Designation of oripavine as a basic class of controlled substance. Final rule.
Q74767778	Determination of Secretary regarding recommendation on psychosurgery of the National Commission for the Protection of Human Subjects
Q77437796	Determination of Secretary regarding recommendation on psychosurgery of the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research
Q73174927	Determination of regulatory review period for purposes of patent extension; Therma Choice Uterine Ballon Therapy System. Food and Drug Administration, HHS. Notice
Q74368548	Determining adjusted income in HUD programs serving persons with disabilities: requiring mandatory deductions for certain expenses; and disallowance for earned income. Office of the Secretary, HUD. Final rule
Q73162476	Determining disability and blindness; substantial gainful activity guides. Social Security Administration. Final rules
Q73018410	Determining disability. Railroad Retirement Board. Final rule
Q74776611	Development of clinical guideline for smoking prevention and cessation with Centers for Disease Control--AHCPR
Q50575755	Developmental Disabilities Program. Final rule.
Q77721296	Developmental disabilities program--Department of Health and Human Services. Second notice of proposed rulemaking
Q77721920	Developmental disabilities program--HHS. Final rule
Q77153865	Developmental disabilities: request for public comments on proposed developmental disabilities funding priorities for Projects of National Significance for Fiscal Year 1998--Administration on Developmental Disabilities, HHS. Notice of request for pu
Q77429526	Diagnostic X-ray systems and their major components
Q77685506	Diagnostic X-ray systems and their major components: proposed amendment to performance standard
Q77447095	Diagnostic X-ray systems and their major components; amendments to performance standard: final rule
Q77442753	Diagnostic ultrasound equipment: development of action program
Q77148224	Diagnostic x-ray equipment performance standard; request for comments and information--FDA. Advance notice of proposed rulemaking
Q77451462	Diagnostic x-ray systems amendment of assembly and reassembly provision and performance standard: final rule
Q77431169	Diagnostic x-ray systems and their major components--amendments to performance standard: proposed rule
Q77543178	Diagnostic x-ray systems and their major components; amendments to performance standard--FDA. Final rule
Q74469017	Digoxin products for oral use; revocation of conditions for marketing. Final rule
Q73174493	Dipping and coating operations. Occupational Safety and Health Administration (OSHA), Labor. Final rule
Q73175035	Direct service connection (post-traumatic stress disorder). Department of Veterans Affairs (VA). Final rule
Q85186244	Disability determinations by state agency disability examiners. Final rules
Q77602560	Disability insurance and supplemental security income; qualifications of medical professionals evaluating mental impairments--SSA. Final rules
Q45327341	Disabled Veteran Leave and Other Miscellaneous Changes. Final rule
Q77456059	Disaster assistance: reorganization and revision of regulations--Federal Emergency Management Agency. Proposed rule
Q42043244	Disaster unemployment assistance program. Interim final rule; request for comments
Q80197032	Disclosure of children's free and reduced price meals and free milk eligibility information in the child nutrition programs. Final rule
Q81306356	Disclosure of information to organ procurement organizations. Interim final rule
Q83128297	Disclosure of information to organ, tissue and eye procurement organizations. Final rule
Q48904187	Disclosure of medical information to the surrogate of a patient who lacks decision-making capacity. Final rule.
Q44337014	Disclosure to participate in State Prescription Drug Monitoring Programs. Interim final rule
Q44337564	Disclosures to participate in State Prescription Drug Monitoring Programs. Final rule
Q77526362	Discontinuation of approval of modifications in notes, guaranteed under Title VI or VII of the Public Health Service Act, proposed to permit use of the notes as collateral for tax-exempt financings--PHS. Final rule
Q77547442	Discontinuation of the acceptance of applications for the repayment of educational loans for failure to complete studies--HRA. Notice
Q74793661	Discrimination against the handicapped by withholding treatment or nourishment; notice to health care providers
Q46824860	Disease associated with exposure to certain herbicide agents: peripheral neuropathy
Q77187952	Disease associated with exposure to certain herbicide agents: type 2 diabetes. Final rule
Q74814478	Disease subject to presumptive service connection (radiation risk activity)--VA. Final rule
Q47990158	Diseases Associated With Exposure to Contaminants in the Water Supply at Camp Lejeune. Final rule
Q45334142	Diseases specific to radiation-exposed veterans. Final rule.
Q49061751	Disenrollment procedures. Final rule
Q77524494	Dispensing controlled substances in institutional practitioner emergency rooms--Drug Enforcement Administration. Notice of proposed rulemaking
Q77400253	Dispensing of controlled substances to assist suicide. Interpretive rule
Q43323331	Disposal of controlled substances. Final rule.
Q77457394	Disposal of high-level radioactive wastes in geologic repositories; proposed licensing procedures: Nuclear Regulatory Commission. Proposed rule
Q77133103	Disqualification of a clinical investigator--FDA. Final rule
Q77784416	Dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices--FDA. Final rule
Q77163069	Dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices--FDA. Proposed rule
Q77116733	Distance learning and telemedicine loan and grant program--Rural Utilities Service, USDA. Final rule
Q44334434	Distribution of blood derivatives by registered blood establishments that qualify as health care entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; delay of applicability date. Final rule; delay of applicability
Q44335351	Distribution of certain drug products by registered blood establishments and comprehensive hemophilia diagnostic treatment centers that qualify as health care entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; p
Q77650340	Domicilliary and 54-bed nursing home care unit, VAMC, Prescott, Arizona; finding of no significant impact
Q74780863	Draft Guidelines for Preventing the Transmission of Tuberculosis in Health-Care Facilities, Second Edition; notice of comment period--CDC, PHS, DHHS. Notice
Q74804906	Draft National Institutes of Health guidelines for research involving human pluripotent stem cells (December 1999)
Q34409293	Draft Public Health Service Guideline on Infectious Disease Issues in Xenotransplantation (August 1996); notice.
Q77194091	Draft guidance for industry on developing medical imaging drugs and biologics; availability--FDA. Availability of guidance
Q77152262	Draft guidance for industry; container and closure integrity testing in lieu of sterility testing as a component of the stability protocol for sterile products; availability--FDA. Notice
Q77163674	Draft guidance for industry; exports and imports under the FDA Export Reform and Enhancement Act of 1996--FDA. Notice
Q77135376	Draft guideline for infection control in health care personnel, 1997--CDC. Notice
Q77163707	Draft guideline for the prevention of surgical site infection, 1998--CDC. Notice
Q48826436	Draft policy statement on industry-supported scientific and educational activities; notice.
Q45328169	Driving distance eligibility for the Veterans Choice Program. Interim final rule
Q77467277	Drug Enforcement Administration--Records and reports of registrants; central recordkeeping permits. Final rule
Q77463477	Drug Enforcement Administration--controlled substances in emergency kits for long term care facilities. Statement of policy
Q49484780	Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation. Final rule; further delay of effective date
Q48713724	Drug and drug-related supply promotion by pharmaceutical company representatives at VA facilities. Final rule.
Q35709218	Drug labeling; orally ingested over-the-counter drug products containing calcium, magnesium, and potassium. Final rule.
Q35966903	Drug labeling; sodium labeling for over-the-counter drugs. Final rule.
Q46218772	Duty periods for establishing eligibility for health care. Final rule
Q34470734	Duty to assist. Final rule
Q39558736	E2C(R2) Periodic Benefit-Risk Evaluation Report and E2C(R2) Periodic Benefit-Risk Evaluation Report--Questions and Answers; International Council for Harmonisation; Guidances for Industry; Availability. Notice
Q73172414	Ear, nose, and throat devices; classification of the nasal dilator, the intranasal splint, and the bone particle collector. Food and Drug Administration, HHS. Final rule
Q77546223	Early and periodic screening, diagnosis, and treatment (EPSDT) program--HCFA. Final rule
Q51852196	Early intervention program for infants and toddlers with disabilities. Final regulations.
Q84193528	Early retiree reinsurance program. Interim final rule with comment period
Q47547952	Ecclesiastical Endorsing Organizations. Final rule
Q77435912	Educational assistance to individuals from disadvantaged backgrounds: interim-final regulations
Q77397195	Effect of the Family and Medical Leave Act on the operation of cafeteria plans. Final regulations
Q48521818	Effective Date of Requirement for Premarket Approval for Surgical Mesh for Transvaginal Pelvic Organ Prolapse Repair. Final order
Q48559801	Effective date of requirement for premarket approval for a pacemaker programmer. Final rule
Q48559788	Effective date of requirement for premarket approval for an implantable pacemaker pulse generator. Final rule
Q48532024	Effective date of requirement for premarket approval for automated external defibrillator systems. Final rule
Q48559398	Effective date of requirement for premarket approval for cardiovascular permanent pacemaker electrode. Final rule.
Q48567486	Effective date of requirement for premarket approval for three class III preamendments devices. Final rule.
Q95518000	Effective date of requirement for premarket approval for transilluminator for breast evaluation and sorbent hemoperfusion system (SHS) devices for the treatment of hepatic coma and metabolic disturbances; reclassification of SHS and devices for the
Q77475771	Electrical standards: Occupational Safety and Health Administration. Final standard
Q77153883	Electronic Freedom of Information Act; implementation--USIA. Proposed rule
Q44312416	Electronic products; performance standard for diagnostic x-ray systems and their major components. Final rule.
Q37902627	Electronic substitutions for Form SSA-538. Final rule with request for comments
Q38228733	Electronic substitutions for SSA-538. Final rules
Q40508405	Eligibility determination for donors of human cells, tissues, and cellular and tissue-based products. Final rule
Q90278898	Eligibility for Supplemental Service-Disabled Veterans' Insurance. Final rule
Q45332835	Eligibility for health care benefits for certain Filipino veterans in the United States. Final rule.
Q77691738	Eligibility in the States, the District of Columbia and Guam, Puerto Rico, and the Virgin Islands; state residence requirements: final regulation
Q45329301	Eligibility of disabled veterans and members of the armed forces with severe burn injuries for financial assistance in the purchase of an automobile or other conveyance and adaptive equipment. Final rule.
Q77516350	Eligibility of foreign medical schools under the guaranteed student loan program (GSLP)--Department of Education. Final regulations
Q74758103	Eligibility rules for special emergency paging--FCC. Final rule
Q37871947	Eliminating the Decision Review Board. Final rules.
Q77654966	Elimination of Medicare indirect subsidy for private rooms--Health Care Financing Administration. Final rule
Q47201349	Elimination of co-payment for weight management counseling.
Q47234751	Elimination of co-payment for weight management counseling. Direct final rule.
Q46319476	Elimination of exemptions for chemical mixtures containing the list I chemicals ephedrine and/or pseudoephedrine. Final rule.
Q51865496	Elimination of requirement for prior signature consent and pre-and post-test counseling for HIV testing. Final rule.
Q73648394	Elimination of sanctions for refusal of vocational rehabilitation services without good cause. Final rule
Q77152273	Emergency clearance: public information collection requirements submitted to the Office of Management and Budget (OMB)--HCFA
Q77169907	Emergency medical equipment. Final rule
Q77710675	Emergency planning and action in a radiation emergency; memorandum of agreement between the Centers for Disease Control and the Health Resources and Service Administration
Q74368270	Employee Retirement Income Security Act of 1974: rules and regulations for administration and enforcement; claims procedure. Pension and Welfare Benefits Administration, Labor. Final regulation
Q77190058	Employee Retirement Income Security Act of 1974; rules and regulations for administration and enforcement; claims procedure--Department of Labor. Notice of proposed rulemaking
Q34450492	Employee Retirement Income Security Act of 1974; rules and regulations for administration and enforcement; claims procedure. Final regulation; delay of applicability date.
Q38456664	Employer comparable contributions to health savings accounts under section 4980G. Final regulations.
Q77480821	Employment discrimination: procedures for handling complaints--Equal Employment Opportunity Commission. Proposed rule
Q74730719	Employment-based immigrants--Immigration and Naturalization Service. Final rule
Q57211090	Energy measures and energy audits grant programs for schools and hospitals and buildings owned by units of local government and public care institutions: final rule
Q57211130	Energy measures and energy audits; grant programs for schools and hospitals, and buildings owned by units of local government and public care institutions: proposed rulemaking and public hearing
Q77120994	Enforcement of nondiscrimination on the basis of handicap in federally assisted programs. Final rule
Q77718956	Enforcement policy: recalls (including product corrections)--guidelines on policy, procedures, and industry responsibilities
Q77166931	Enrollment--provision of hospital and outpatient care to veterans--VA. Proposed rule
Q73018612	Enrollment--provision of hospital and outpatient care to veterans. Department of Veterans Affairs. Final rule
Q39061378	Ensuring Program Uniformity at the Hearing and Appeals Council Levels of the Administrative Review Process. Final rule
Q77649370	Entitlement to Medicare benefits based on end-stage renal disease: final regulation
Q77465587	Environmental Protection Agency--Hazardous waste and consolidated permit regulations, Parts II-IX. Revisions to final rule and interim final rule and requests for comments
Q77465590	Environmental Protection Agency--Hazardous waste and consolidated permit regulations, Parts X-XI. Final rule
Q77159990	Environmental assessments and findings of no significant impact--FDA. Notice
Q73174801	Environmental community based organization capacity building grant; notice of availability of funds. Centers for Disease Control and Prevention
Q73172386	Epidemiology and Laboratory Capacity for Infectious Diseases; notice of availability of funds. Centers for Disease Control and Prevention
Q77455088	Equal Employment Opportunity Commission: proposed guidelines on discrimination because of religion
Q77121657	Equal employment opportunity for individuals with disabilities--EEOC. Final rule
Q77655664	Equipment acquired under public assistance programs--HCFA. Final rule
Q77522443	Equipment acquired under public assistance programs--HHS. Final rule
Q94002839	Erratum: Findings of Misconduct in Science; Correction
Q94002855	Erratum: Findings of Misconduct in Science; Correction
Q58132007	Erratum: Findings of Research Misconduct; Correction
Q92098198	Erratum: Findings of Research Misconduct; Correction
Q94002488	Erratum: Findings of Research Misconduct; Correction
Q94002512	Erratum: Findings of Research Misconduct; Correction
Q94002559	Erratum: Findings of Research Misconduct; Correction
Q94002690	Erratum: Findings of Research Misconduct; Correction
Q94338972	Erratum: Findings of Research Misconduct; Correction
Q77163776	Erythrityl tetranitrate; drug efficacy study implementation; revocation of exemption; opportunity for a hearing--FDA. Notice
Q46882565	Establishing a list of qualifying pathogens under the Food and Drug Administration Safety and Innovation Act. Final rule
Q30233149	Establishment and maintenance of records under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule
Q77645800	Establishment of Acquired Immunodeficiency Syndrome Program Advisory Committee--NIH
Q73018484	Establishment of a Medical Implant Communications Service in the 402-405 MHz band. Federal Communications Commission. Final rule
Q46442286	Establishment of a New Drug Code for Marihuana Extract. Final rule
Q74773800	Establishment of a public docket for medical device/radiological health policy statements and operating procedure guides--FDA. Notice
Q74717676	Establishment of criteria for determining priorities among designated health professional shortage areas--HRA. Notice
Q77489793	Establishment of disaster radio response program in the local government radio service for states, territories, and possessions: Federal Communications Commission. Final rule
Q46271509	Establishment of drug codes for 26 substances. Final rule
Q81334886	Establishment of revisit user fee program for Medicare survey and certification activities. Final rule
Q19096578	Establishment of the Fort Ord National Monument
Q83282374	Establishment of the permanent certification program for health information technology. Final rule
Q84469960	Establishment of the temporary certification program for health information technology. Final rule
Q36019504	Establishment of vaccination clinics; user fees for investigational new drug (IND) influenza vaccine services and vaccines. Interim final rule and request for comments.
Q77159977	Establishment registration and listing for manufacturers of human cellular and tissue-based products--FDA. Proposed rule
Q77784009	Establishment registration and listing for manufacturers of human cellular and tissue-based products--FDA. Proposed rule; reopening of comment period
Q95579609	Establishment, maintenance, and availability of records: amendment to record availability requirements. Final rule
Q83544976	Establishment, maintenance, and availability of records: amendment to record availability requirements. Interim final rule; request for comments
Q58663515	Ethics Advisory Board; notice of establishment; request for public comment
Q77429523	Ethylene oxide, ethylene chlorohydrin, and ethylene glycol: proposed maximum residue limits and maximum levels of exposure
Q77541651	Ethylene oxide; certain pesticide products registered for the sterilization of equipment and supplies in hospitals and health care facilities; withdrawal of revised labeling notice--EPA. Withdrawal of notice
Q77741526	Evaluation of radiation exposure from diagnostic radiology examination; availability of final recommendations--FDA. Notice
Q77516311	Evaluation of the administrative compliance costs and the impact of the inflation factor for Titles VI and XVI assisted facilities--Health Resources and Services Administration. Rule related notice; request for comments
Q77516321	Evaluation of the impact and effectiveness of Title XVI uncompensated services assurance--Health Resources and Services Administration. Rule related notice
Q50138773	Evidence From Excluded Medical Sources of Evidence. Final rules
Q82785167	Evidentiary requirements for making findings about medical equivalence. Final rules
Q44847246	Excepted service--appointment of persons with intellectual disabilities, severe physical disabilities, and psychiatric disabilities. Final regulation.
Q41977217	Exceptions or alternatives to labeling requirements for products held by the Strategic National Stockpile. Final rule.
Q77516326	Exchange visitors program--criteria for evaluating comprehensive plan to reduce reliance on alien physicians--Public Health Service. Interim-final rule with request for comments
Q77444172	Exchange visitors: final rule
Q77685532	Exchange-visitor programs for alien physicians
Q45946447	Exclusion of orphan drugs for certain covered entities under 340B Program. Final rule.
Q19098609	Executive Order 10000
Q19098622	Executive Order 10016
Q19098636	Executive Order 10026
Q19098749	Executive Order 10180
Q19098768	Executive Order 10211
Q19098780	Executive Order 10236
Q5419847	Executive Order 10308
Q19098912	Executive Order 10369
Q19098984	Executive Order 10421
Q19099028	Executive Order 10453
Q19099038	Executive Order 10459
Q5419848	Executive Order 10479
Q19099430	Executive Order 10850
Q5419852	Executive Order 10925
Q19099628	Executive Order 11006
Q5419851	Executive Order 11063
Q1439077	Executive Order 11110
Q19099768	Executive Order 11130
Q16604334	Executive Order 11244
Q16604333	Executive Order 11245
Q5419853	Executive Order 11246
Q16149476	Executive Order 11478
Q19100063	Executive Order 11580
Q5419859	Executive Order 11921
Q5419862	Executive Order 12086
Q125349882	Executive Order 12127
Q5419864	Executive Order 12170
Q28059667	Executive Order 12172
Q58672618	Executive Order 12184 of December 17, 1979, relating to the President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research
Q19100541	Executive Order 12261
Q19100600	Executive Order 12291
Q19100770	Executive Order 12331
Q5419865	Executive Order 12333
Q19101043	Executive Order 12400
Q19101066	Executive Order 12406
Q5419868	Executive Order 12711
Q19102540	Executive Order 12759
Q19102584	Executive Order 12770
Q19115208	Executive Order 12818
Q19102870	Executive Order 12839
Q53668403	Executive Order 12891 of January 15, 1994: Advisory Committee on Human Radiation Experiments.
Q19115211	Executive Order 12901
Q5419874	Executive Order 12958
Q19103374	Executive Order 12963
Q5419869	Executive Order 12968
Q53637080	Executive Order 12975 of October 3, 1995: Protection of human research subjects and creation of National Bioethics Advisory Commission.
Q16835944	Executive Order 12999
Q19103556	Executive Order 13007
Q19103564	Executive Order 13009
Q5419872	Executive Order 13010
Q16878316	Executive Order 13026
Q19103797	Executive Order 13068
Q16890004	Executive Order 13072
Q19103818	Executive Order 13073
Q5419881	Executive Order 13087
Q19103978	Executive Order 13110
Q5419877	Executive Order 13111
Q19104029	Executive Order 13123
Q5419879	Executive Order 13126
Q19104041	Executive Order 13127
Q19104088	Executive Order 13141
Q74804814	Executive Order 13145 of February 8, 2000: to prohibit discrimination in federal employment based on genetic information
Q19104113	Executive Order 13147
Q19104144	Executive Order 13155
Q5419882	Executive Order 13166
Q19104189	Executive Order 13167
Q19115232	Executive Order 13168
Q19104201	Executive Order 13171
Q19104222	Executive Order 13178
Q5419885	Executive Order 13233
Q5419887	Executive Order 13303
Q19104657	Executive Order 13316
Q19104676	Executive Order 13325
Q19104794	Executive Order 13384
Q19104810	Executive Order 13392
Q19104885	Executive Order 13427
Q19104930	Executive Order 13450
Q19104960	Executive Order 13465
Q1383597	Executive Order 13470
Q19105018	Executive Order 13495
Q5419898	Executive Order 13514
Q19115245	Executive Order 13524
Q19105362	Executive Order 13658
Q15976431	Executive Order 13660
Q16055042	Executive Order 13661
Q16325559	Executive Order 13662
Q16325558	Executive Order 13663
Q16604335	Executive Order 13664
Q16604328	Executive Order 13665
Q16736322	Executive Order 13666
Q19105377	Executive Order 13673
Q19105409	Executive Order 13688
Q29651616	Executive Order 13691
Q29651619	Executive Order 13692
Q105522517	Executive Order 13694
Q39545348	Executive Order 13703
Q53130415	Executive Order 13704
Q105338414	Executive Order 13747
Q30589389	Executive Order 13754
Q28540350	Executive Order 13765
Q29096879	Executive Order 13766
Q28557967	Executive Order 13767
Q29096900	Executive Order 13768
Q28543928	Executive Order 13769
Q29651437	Executive Order 13770
Q28753343	Executive Order 13771
Q28753397	Executive Order 13772
Q29651445	Executive Order 13777
Q29651449	Executive Order 13778
Q28910562	Executive Order 13780
Q29651453	Executive Order 13782
Q29651462	Executive Order 13788
Q29651471	Executive Order 13792
Q105654481	Executive Order 13795
Q105654724	Executive Order 13807
Q42172603	Executive Order 13813
Q105654853	Executive Order 13834
Q105819591	Executive Order 13836
Q105654902	Executive Order 13868
Q63980257	Executive Order 13873
Q105337689	Executive Order 13880
Q105672482	Executive Order 13920
Q105675458	Executive Order 13927
Q96602928	Executive Order 13928
Q105332685	Executive Order 13950
Q105337427	Executive Order 13958
Q104698871	Executive Order 13971
Q105320567	Executive Order 13985
Q105332196	Executive Order 13986
Q105332295	Executive Order 13987
Q105332392	Executive Order 13988
Q105332532	Executive Order 13989
Q105332577	Executive Order 13990
Q105332619	Executive Order 13992
Q105339542	Executive Order 13993
Q105346869	Executive Order 13994
Q105347078	Executive Order 13995
Q105388436	Executive Order 13996
Q105388663	Executive Order 13997
Q105429903	Executive Order 13998
Q105430313	Executive Order 13999
Q105431559	Executive Order 14000
Q105445555	Executive Order 14001
Q105445607	Executive Order 14002
Q105445911	Executive Order 14003
Q105446321	Executive Order 14004
Q105076907	Executive Order 14005
Q105449712	Executive Order 14006
Q105457610	Executive Order 14007
Q105468509	Executive Order 14008
Q105468550	Executive Order 14009
Q105468753	Executive Order 14010
Q105468812	Executive Order 14011
Q105468858	Executive Order 14012
Q105468918	Executive Order 14013
Q105469002	Executive Order 14014
Q105550175	Executive Order 14015
Q105642139	Executive Order 14016
Q105723739	Executive Order 14017
Q105723813	Executive Order 14018
Q105857888	Executive Order 14019
Q105886508	Executive Order 14020
Q105886514	Executive Order 14021
Q106417534	Executive Order 14022
Q106446870	Executive Order 14023
Q106512841	Executive Order 14024
Q106647674	Executive Order 14025
Q106665781	Executive Order 14026
Q106827362	Executive Order 14027
Q108043073	Executive Order 14036
Q113212220	Executive Order 14076
Q5419904	Executive Order 8389
Q1383604	Executive Order 8802
Q19108437	Executive Order 8972
Q2159918	Executive Order 9066
Q5419905	Executive Order 9102
Q19108565	Executive Order 9396
Q19108660	Executive Order 9761
Q19108686	Executive Order 9857-A
Q19108700	Executive Order 9920
Q19108709	Executive Order 9928
Q19108719	Executive Order 9934-A
Q19108725	Executive Order 9939
Q19108771	Executive Order 9973-A
Q5419908	Executive Order 9981
Q19108788	Executive Order 9999
Q42979204	Exempt chemical mixtures containing gamma-butyrolactone. Final rule.
Q77148196	Exempt distribution of a radioactive drug containing one microcurie of carbon-14 urea--NRC. Final rule
Q48070835	Exempting Mental Health Peer Support Services From Copayments. Direct final rule; confirmation of effective date
Q48713712	Exempting in-home video telehealth from copayments. Direct final rule
Q48606372	Exempting in-home video telehealth from copayments. Direct final rule; confirmation of effective date
Q48167180	Exempting mental health peer support services from copayments. Direct final rule.
Q74368205	Exemption from federal preemption of state and local cigarette and smokeless tobacco requirements; revocation. Food and Drug Administration, HHS. Final rule
Q38575614	Exemption from import/export requirements for personal medical use. Final rule.
Q86052957	Exemption from registration for persons authorized under U.S. Nuclear Regulatory Commission or agreement state medical use licenses or permits and administering the drug product DaTscan(TM). Interim final rule with request for comment
Q74369071	Exemption from the make inoperative prohibition. National Highway Traffic Safety Administration (NHTSA), DOT. Final rule
Q77498581	Exemption of antibiotic drugs and antibiotic susceptibility medical devices from certification--Food and Drug Administration. Proposed rule
Q77522446	Exemption of certain research and demonstration projects from regulations for protection of human research subjects--DHHS. Notice of proposed rulemaking
Q77516374	Exemption of certain research and demonstration projects from regulations for protection of human research subjects--Office of the Secretary, HHS. Final rule
Q46147635	Exemption of certain systems of records under the Privacy Act. Final rule.
Q46147946	Exemption of certain systems of records under the Privacy Act. Proposed rule
Q77652023	Exemption of certain transfusion services and clinical laboratories from registration: Food and Drug Administration. Final rule
Q35118951	Exemption of chemical mixtures containing the List I chemicals ephedrine, N-methylephedrine, N-methylpseudoephedrine, norpseudoephedrine, phenylpropanolamine, and pseudoephedrine. Final rule
Q36798406	Exemption of chemical mixtures. Final rule
Q36660610	Exemption of work activity as a basis for a continuing disability review. Final rules.
Q77685562	Exemptions from Federal preemption of state and local device requirements: procedures for consideration of applications
Q45327877	Expanded Access to Non-VA Care Through the Veterans Choice Program. Final rule
Q90284610	Expanded Access to Non-VA Care Through the Veterans Choice Program. Final rule
Q45327826	Expanded Access to Non-VA Care Through the Veterans Choice Program. Interim final rule
Q56781662	Expanded access to investigational drugs for treatment use. Final rule
Q45328533	Expanded access to non-VA care through the Veterans Choice Program. Interim final rule.
Q74743202	Expanded availability of investigational new drugs through a parallel track mechanism for people with AIDS and other HIV-related disease--PHS. Notice final policy statement
Q77516256	Expanded phase out provisions of intermediate care facilities for the mentally retarded (ICFs/MR) correction plans--Health Care Financing Administration. Final rule
Q84025735	Expansion of enrollment in the VA health care system
Q84895870	Expansion of state home care for parents of a child who died while serving in the armed forces. Final rule
Q77153859	Expedited safety reporting requirements for human drug and biological products; correction--FDA. Final rule; correction
Q38029681	Expedited vocational assessment under the sequential evaluation process. Final rules.
Q77500288	Experiments and demonstration projects under the disability insurance and supplemental security income programs--Social Security Administration. Proposed rule
Q47674329	Extension of Effective Date for Temporary Pilot Program Setting the Time and Place for a Hearing Before an Administrative Law Judge. Final rule.
Q47573470	Extension of Expiration Dates for Four Body System Listings. Final rule
Q50187936	Extension of Expiration Dates for Four Body System Listings. Final rule
Q53093195	Extension of Expiration Dates for Two Body System Listings. Final rule.
Q48010891	Extension of Pharmacy Copayments for Medications. Interim final rule
Q47888308	Extension of Pharmacy Copayments for Medications. Resolution of interim final rule
Q38124861	Extension of effective date for temporary pilot program setting the time and place for a hearing before an administrative law judge. Final rule
Q47842275	Extension of expiration date for temporary pilot program setting the time and place for a hearing before an administrative law judge. Final rule
Q74367924	Extension of expiration date for the respiratory body system listings. Social Security Administration (SSA). Final rule
Q95563785	Extension of expiration dates for several body system listings. Final rule
Q37764326	Extension of expiration dates for several body system listings. Final rule.
Q50602862	Extension of expiration dates for several body system listings. Final rule.
Q38021460	Extension of expiration dates for several body systems listings. Final rule
Q38138101	Extension of expiration dates for two body system listings. Final rule.
Q48370704	Extension of statutory period for compensation for certain disabilities due to undiagnosed illnesses and medically unexplained chronic multi-symptom illnesses. Final rule.
Q37975501	Extension of statutory period for compensation for certain disabilities due to undiagnosed illnesses and medically unexplained chronic multi-symptom illnesses. Interim final rule
Q46864389	Extension of sunset date for attorney advisor program. Final rule
Q50768409	Extension of the Expiration Date for State Disability Examiner Authority To Make Fully Favorable Quick Disability Determinations and Compassionate Allowance Determinations. Final rule.
Q50114727	Extension of the Expiration Date for State Disability Examiner Authority To Make Fully Favorable Quick Disability Determinations and Compassionate Allowance Determinations. Final rule
Q45325854	Extension of the Presumptive Period for Compensation for Gulf War Veterans. Final rule
Q38789025	Extension of the Presumptive Period for Compensation for Gulf War Veterans. Interim final rule
Q31120654	Extension of the expiration data for several body system listings. Final rule.
Q35234170	Extension of the expiration data for state disability examiner authority to make fully favorable quick disability determinations and compassionate allowances. Final rule
Q36164979	Extension of the expiration date for several body system listings. Final rule.
Q46046246	Extension of the expiration date for state disability examiner authority to make fully favorable quick disability determinations and compassionate allowances. Final rule
Q45334194	Extension of the presumptive period for compensation for Gulf War veterans' undiagnosed illnesses. Interim final rule with request for comments.
Q40146210	Extension of the presumptive period for compensation for Gulf War veterans. Final rule.
Q40243631	Extension of the presumptive period for compensation for Gulf War veterans. Interim final rule
Q47680878	Extra-Schedular Evaluations for Individual Disabilities. Final rule
Q93920811	FDA Modernization Act of 1997: modifications to the list of recognized standards; availability; withdrawal of draft guidance "Use of IEC 60601 standards; medical electrical equipment"--FDA. Notice
Q77152936	FDA modernization act of 1997: guidance on medical device tracking; availability--FDA. Notice
Q77783972	FDA plan for statutory compliance. Notice of availability
Q77451425	FMCS services in health care industry, labor disputes: promulgation of final regulations
Q74368465	Facsimile transmission of prescriptions for patients enrolled in hospice programs. Drug Enforcement Administration (DEA), Justice. Final rule
Q77194022	Failure by certain charitable organizations to meet certain qualification requirements; taxes on excess benefit transactions--IRS. Correction to notice of proposed rulemaking
Q77169771	Failure by certain charitable organizations to meet certain qualification requirements; taxes on excess benefit transactions--IRS. Notice of proposed rulemaking
Q81522176	Fair credit reporting medical information regulations. Final rules
Q47183231	Family Violence Prevention and Services Programs. Final rule
Q95569776	Family and Medical Leave Act; Definition of Spouse. Final rule
Q73018561	Family and medical leave. Office of Personnel Management. Final rule
Q77656067	Federal Claims Collection Act; claims collection and compromise--HCFA. Final rule with comment period
Q77496922	Federal Coal Mine Health and Safety Act of 1969, Title IV, as amended (The Black Lung Benefits Act); payment of benefits--withholding Part B benefits where Part C payments are made for the same period. Social Security Administration. Final rule
Q77469785	Federal Emergency Management Agency--emergency health and medical occupations: final rule
Q73018663	Federal Employees Health Benefits (FEHB) Program and Department of Defense (DoD) demonstration project. Office of Personnel Management. Final rule
Q73018686	Federal Employees Health Benefits (FEHB) program and Department of Defense (DoD) demonstration project; and other miscellaneous changes. Office of Personnel Management. Final rule
Q90313707	Federal Employees Health Benefits Program and Federal Employees Dental and Vision Insurance Program: Expiration of Coverage of Children of Same-Sex Domestic Partners; Federal Flexible Benefits Plan: Pre-Tax Payment of Health Benefits Premiums: Confo
Q95509035	Federal Employees Health Benefits Program and Federal Employees Dental and Vision Insurance Program: eligibility for Pathway Programs participants. Interim final rule with request for comments
Q77194098	Federal Employees Health Benefits Program improving carrier performance; conforming changes--OPM. Final rule
Q77167704	Federal Employees Health Benefits Program improving carrier performance; conforming changes--OPM. Proposed rulemaking
Q51270024	Federal Employees Health Benefits Program miscellaneous changes: Medically Underserved Areas. Direct final rule.
Q77175331	Federal Employees Health Benefits Program, Medically Underserved Areas for 1999--OPM. Notice of medically underserved areas for 1999
Q77519503	Federal Employees Health Benefits Program--Office of Personnel Management. Final rule
Q95469408	Federal Employees Health Benefits Program: Enrollment Options Following the Termination of a Plan or Plan Option. Final rule
Q49848200	Federal Employees Health Benefits Program: Removal of Eligible and Ineligible Individuals From Existing Enrollments. Final rule
Q77175258	Federal Employees Health Benefits Program: contributions and withholdings--OPM. Interim regulations with request for comments
Q74742350	Federal Employees Health Benefits Program: limitation on inpatient hospital charges and FEHB program payments--OPM. Interim regulation with request for comments
Q74813219	Federal Employees Health Benefits Program: limitation on physician charges and FEHB program payments--OPM. Interim regulation with request for comments
Q74722096	Federal Employees Health Benefits Program: medically underserved areas for 1992--Office of Personnel Management. Notice of medically underserved areas for 1992
Q54742072	Federal Employees Health Benefits Program: members of Congress and Congressional staff. Final rule.
Q77498544	Federal Employees Health Benefits Program; benefits for medically underserved areas--Office of Personnel Management. Final rule
Q77516433	Federal Employees Health Benefits Program; benefits for medically underserved areas--Office of Personnel Management. Final rule
Q77447114	Federal Employees Health Benefits Program; benefits for members of medically underserved populations: proposed rulemaking
Q95410446	Federal Employees Health Benefits and Federal Employees Dental and Vision Insurance Programs' Coverage Exception for Children of Same-Sex Domestic Partners. Interim final rule
Q74734140	Federal Employees Health Benefits program: direct payment of FEHB premiums for annuitants--OPM. Final rule
Q95538003	Federal Housing Administration (FHA): Section 232 Healthcare Facility Insurance Program--Strengthening Accountability and Regulatory Revisions Update Final Rule Amendment--revision of date of applicability. Final rule amendment
Q77522421	Federal Old-Age, Survivors, and Disability Insurance and Supplemental Security Income for the Aged, Blind and Disabled; representative payment--SSA. Final rule
Q77500252	Federal Old-Age, Survivors, and Disability Insurance benefits annual earnings test--Social Security Administration. Proposed rule
Q77536826	Federal Old-Age, Survivors, and Disability Insurance; coverage of employees of private nonprofit organizations--SSA. Proposed rules
Q77498568	Federal Old-Age, Survivors, and Disability Insurance; revised medical criteria for the determination of disability--Social Security Administration. Proposed rules
Q77498535	Federal Old-Age, Survivors, and Disability insurance benefits; limitations on benefit payments to prisoners; restrictions on disability determinations for felony-related and prison-related impairments--Social Security Administration. Proposed rules
Q40436698	Federal Policy for the Protection of Human Subjects. Final rule
Q77524519	Federal allotments to states for social services expenditures pursuant to the Title XX-Social Services Block Grant Act; promulgation for fiscal year 1984-HHS. Notification of allocation of Title XX
Q77527815	Federal allotments to states for social services expenditures pursuant to the Title XX-Social Services Block Grant Act; promulgation for fiscal year 1985--HHS
Q74677905	Federal assistance for rural hospitals for advancement and improvement of health care services and the enhancement of quality care--fiscal year 1990--HRSA
Q77632577	Federal assistance for rural hospitals for the advancement and improvement of health care services and the enhancement of quality care--HRSA
Q77591299	Federal claims collection--HHS. Final Rule
Q79718544	Federal employees dental and vision insurance program. Final rule
Q79793318	Federal employees health benefits acquisition regulation: Board of Contract Appeals. Final rule
Q36147118	Federal employees health benefits acquisition regulation: large provider agreements, subcontracts, and miscellaneous changes. Final rule.
Q80603679	Federal employees health benefits children's equity. Final rule
Q85848024	Federal employees health benefits program modification of eligibility to certain employees on temporary appointments and certain employees on seasonal and intermittent schedules. Final rule
Q74798961	Federal employees health benefits program: debarment--OPM. Final rule
Q42012077	Federal employees health benefits program: discontinuance of health plan in an emergency. Final regulation.
Q77783964	Federal employees health benefits program: disenrollment--OPM. Correction
Q77201772	Federal employees health benefits program: disenrollment--OPM. Final rule
Q77175275	Federal employees health benefits program: effective dates--OPM. Proposed rule
Q77077605	Federal employees health benefits program: limitation on physician charges and FEHB Program payments--Office of Personnel Management. Final rule
Q74745234	Federal employees health benefits program: miscellaneous changes--Office of Personnel Management. Final rulemaking
Q74775378	Federal employees health benefits program; coverage of temporary employees--OPM. Interim rule with request for comments
Q74772813	Federal employees health benefits program; limitation on inpatient hospital charges and FEHB program payments--OPM. Final rule
Q77116877	Federal employees health benefits program; medically underserved areas for 1998--OPM. Notice of medically underserved areas for 1998
Q81804129	Federal employees health benefits program; revision of contract cost principles and procedures, and miscellaneous changes. Final rule
Q40243148	Federal employees health benefits: payment of premiums for periods of leave without pay or insufficient pay. Final rule
Q51923882	Federal enforcement in group and individual health insurance markets. Final rule.
Q74767724	Federal financial participation in expenditures for abortions funded through various HEW programs
Q74731249	Federal financial participation in state assistance expenditures--HHS. Notice
Q77656047	Federal financial participation in state assistance expenditures--HHS. Notice of federal matching shares for AFDC, Medicaid
Q77652014	Federal financial participation in state assistance expenditures--Office of the Secretary, HHS. Notice of federal matching shares for aid to families with dependent children. Medicaid and aid to needy aged, blind, or disabled persons for October 1,
Q74782483	Federal financial participation in state assistance expenditures; federal matching shares for Aid to Families With Dependent Children, Medicaid, and aid to needy aged, blind, or disabled persons for October 1, 1994 through September 30, 1995--HHS. N
Q77129818	Federal financial participation in state assistance expenditures; federal matching shares for Aid to Families with Dependent Children, Medicaid, and Aid to Needy Aged, Blind, or Disabled Persons for October 1, 1996 through September 20, 1997--HHS. N
Q74694233	Federal financial participation in state assistance expenditures; federal matching shares for Aid to Families with Dependent Children, Medicaid, and aid to needy aged, blind, or disabled persons for October 1, 1991 through September 30, 1992--HHS. N
Q74761834	Federal financial participation in state assistance expenditures; federal matching shares for Aid to Families with Dependent Children, foster care and adoption assistance, job opportunities and basic skills training, Medicaid, and aid to needy aged,
Q77159897	Federal financial participation in state assistance expenditures; federal matching shares for aid to families with dependent children, Medicaid, and aid to aged, blind, or disabled persons for October 1, 1997 through October 1, 1998 and for October
Q77665183	Federal financial participation in state assistance expenditures; federal matching shares for aid to families with dependent children, Medicaid, and aid to needy aged, blind, or disabled persons for October 1, 1988 through September 30, 1989--HHS. N
Q77672306	Federal financial participation in state assistance expenditures; federal matching shares for aid to needy aged, blind, or disabled persons for October 1, 1990 through September 30, 1991--HHS. Notice
Q77429373	Federal financial participation in state claims for abortions
Q77649362	Federal health insurance for the aged and disabled medical assistance programs--protection of patients' funds: notice of proposed rulemaking
Q77649437	Federal health insurance for the aged and disabled--coverage of dialysis supplies, equipment, and support services: final rule
Q77649455	Federal health insurance for the aged and disabled--intermediary nominations contracts, evaluations, and notices: proposed rule
Q77649435	Federal health insurance for the aged and disabled--requirements for self-dialysis units and self-dialysis services: final rule
Q74710151	Federal old-age, survivors and disability insurance (1950- ); determining disability and blindness; extension of expiration date for cardiovascular system listing--Social Security Administration. Final rule
Q73018679	Federal old-age, survivors and disability insurance and Supplemental Security Income for the Aged, Blind, and Disabled; medical and other evidence of your impairment(s) and definition of medical consultant. Social Security Administration. Final rule
Q77529764	Federal old-age, survivors and disability insurance computation of benefits under totalization agreements--SSA. Notice of proposed rulemaking
Q73174942	Federal old-age, survivors and disability insurance; determining disability and blindness; extension of expiration dates for several body system listings. Social Security Administration (SSA). Final rule
Q77390587	Federal old-age, survivors and disability insurance; determining disability and blindness; revision to medical-vocational guidelines. Final rules
Q73018437	Federal old-age, survivors, and disability insurance and supplemental security income for the aged, blind, and disabled; evaluating opinion evidence. Social Security Administration. Final rules
Q77494085	Federal old-age, survivors, and disability insurance; earnings test: Social Security Administration. Interim regulations
Q77549859	Federal old-age, survivors, and disability insurance; listing of impairments--mental disorders--SSA. Proposed rules
Q77564375	Federal old-age, survivors, and disability insurance; listing of impairments--mental disorders. Final rule
Q74769926	Federal performance standard for diagnostic X-ray systems and their major components--FDA. Final rule
Q74790293	Federal performance standard for diagnostic x-ray systems and their major components--FDA. Final rule
Q74714531	Federal policy for the protection of human subjects. Final rule
Q74768542	Federal policy for the protection of human subjects; notice and proposed rules
Q74140946	Federal sector equal employment opportunity. Final rule
Q77475760	Federal support for hospital construction in overbedded areas
Q77168781	Federal universal service support mechanisms--FCC. Proposed rule; request for comments
Q77174726	Federal-State Joint Board on Universal Service--FCC. Final rule
Q77204659	Federal-state joint board on universal service--FCC. Proposed rule; recommended decision
Q74812790	Federally Supported Health Centers Assistance Act of 1992--PHS. Final rule
Q74724638	Fees for certifying insulin drugs--FDA. Interim rule; opportunity for public comment
Q85641790	Fees on health insurance policies and self-insured plans for the patient-centered outcomes research trust fund. Final regulations
Q30151460	Fertility Counseling and Treatment for Certain Veterans and Spouses. Interim final rule
Q90313718	Fiduciary Activities. Final rule
Q48600729	Filing of applications and requirements for widow's and widower's benefits. Final rule.
Q39589920	Filipino veterans' benefits improvements. Interim final rule
Q90308773	Final Determination Regarding Partially Hydrogenated Oils. Notification; declaratory order; extension of compliance date
Q85938611	Final Priority and Definitions--Rehabilitation Training: Vocational Rehabilitation Technical Assistance Center-Target Communities. Final priority and definitions
Q85845238	Final Priority and Definitions; Demonstration and Training Program: Career Pathways for Individuals With Disabilities. Final priority and definitions
Q50348847	Final Priority--Training of Interpreters for Individuals Who Are Deaf or Hard of Hearing and Individuals Who Are Deaf-Blind Program. Final priority
Q50422904	Final Priority--Training of Interpreters for Individuals Who Are Deaf or Hard of Hearing and Individuals Who Are Deaf-Blind Program. Final priority
Q85938609	Final Priority. Rehabilitation Training: Vocational Rehabilitation Workforce Innovation Technical Assistance Center. Final priority
Q45786794	Final Priority; National Institute on Disability and Rehabilitation Research--Rehabilitation Research and Training Centers. Final priority
Q85679238	Final Priority; Rehabilitation Training: Vocational Rehabilitation Technical Assistance Center--Youth With Disabilities. Final priority
Q91353811	Final Requirement--State Technical Assistance Projects To Improve Services and Results for Children Who Are Deaf-Blind and National Technical Assistance and Dissemination Center for Children Who Are Deaf-Blind (TA&D–DB). Final requirement
Q38643783	Final Rules for Grandfathered Plans, Preexisting Condition Exclusions, Lifetime and Annual Limits, Rescissions, Dependent Coverage, Appeals, and Patient Protections Under the Affordable Care Act. Final rules
Q77640812	Final funding categories, final review criteria and funding preference for training grants for acquired immunodeficiency syndrome (AIDS) Regional Education and Training Centers Program--HRSA
Q77630958	Final funding preferences for grants for geriatric education centers--HRSA
Q77627620	Final funding priorities for grants for faculty development in family medicine--HRSA
Q77627626	Final funding priorities for grants for residency training in general internal medicine and general pediatrics--HRSA
Q77625782	Final funding priorities for the health careers opportunity program--HRSA
Q74771959	Final notice regarding section 602 of the Veterans Health Care Act of 1992 duplicate discounts and rebates on drug purchases--HRSA. Final notice
Q74790289	Final notice regarding section 602 of the Veterans Health Care Act of 1992 entity guidelines--PHS. Final notice
Q46189779	Final priorities; National Institute on Disability and Rehabilitation Research--Disability and Rehabilitation Research Projects and Centers Program--Rehabilitation Engineering Research Centers. Final priorities
Q50745249	Final priorities; National Institute on Disability and Rehabilitation Research--Rehabilitation Research and Training Centers. Final priorities.
Q50639140	Final priorities; Rehabilitation Services Administration--Capacity Building Program for Traditionally Underserved Populations--vocational rehabilitation training institute for the preparation of personnel in American Indian Vocation Rehabilitation S
Q43699966	Final priority--National Institute on Disability and Rehabilitation Research--Rehabilitation Research and Training Centers. Final priority
Q50795218	Final priority--National Institute on Disability and Rehabilitation Research--Rehabilitation Research and Training Centers. Final priority.
Q50670439	Final priority. National Institute on Disability and Rehabilitation Research--Rehabilitation Research and Training Centers. Final priority.
Q50855521	Final priority. National Institute on Disability and Rehabilitation Research--Traumatic Brain Injury Model Systems Centers Collaborative Research Project. Final priority.
Q85206295	Final priority. Rehabilitation Training: Job-Driven Vocational Rehabilitation Technical Assistance Center. Final priority
Q50803511	Final priority; National Institute on Disability and Rehabilitation Research--Advanced Rehabilitation Research Training Program. Final priority.
Q50801636	Final priority; National Institute on Disability and Rehabilitation Research--Disability and Rehabilitation Projects and Centers Program--Rehabilitation Engineering Research Centers. Final priority.
Q44377485	Final priority; National Institute on Disability and Rehabilitation Research--Disability and Rehabilitation Research Projects and Centers Program--Rehabilitation Engineering Research Centers. Final priority
Q44941498	Final priority; National Institute on Disability and Rehabilitation Research--Disability and Rehabilitation Research Projects and Centers Program--Rehabilitation Research Training Centers. Final priority
Q50645545	Final priority; National Institute on Disability and Rehabilitation Research--Disability and Rehabilitation Research Projects and Centers Program. Final priority.
Q50354792	Final priority; National Institute on Disability and Rehabilitation Research--Rehabilitation Engineering Research Centers. Final priority
Q50672201	Final priority; National Institute on Disability and Rehabilitation Research--Rehabilitation Engineering Research Centers. Final priority.
Q50633719	Final priority; National Institute on Disability and Rehabilitation Research--Rehabilitation Research and Training Centers. Final priority.
Q50658090	Final priority; National Institute on Disability and Rehabilitation Research--Rehabilitation Research and Training Centers.
Q95351449	Final priority; National Institute on Disability and Rehabilitation Research--Rehabilitation Research and Training Centers. Final priority
Q95384367	Final priority; National Institute on Disability and Rehabilitation Research--Rehabilitation Research and Training Centers. Final priority
Q95449827	Final priority; National Institute on Disability and Rehabilitation Research--Rehabilitation Research and Training Centers. Final priority
Q95481948	Final priority; National Institute on Disability and Rehabilitation Research--Rehabilitation Research and Training Centers. Final priority
Q50649656	Final priority; National Institute on Disability and Rehabilitation Research--Rehabilitation and Research Training Centers. Final priority.
Q50645531	Final priority; National Institute on Disability and Rehabilitation Research--Research Fellowships Program (also known as the Mary E. Switzer Research Fellowships). Final priority.
Q53462399	Final priority; Rehabilitation Services Administration--Assistive Technology Alternative Financing Program. Final priority.
Q50354731	Final priority; Rehabilitation Training: Rehabilitation Long-Term Training program--rehabilitation specialty areas. Final priority
Q30842721	Final priority; Technical Assistance on State Data Collection--IDEA Data Management Center. Final priority
Q30628496	Final priority; technical assistance to improve state data capacity--National Technical Assistance Center to improve state capacity to accurately collect and report IDEA data. Final priority
Q77457376	Final program criteria for screening of applications for grants made by American schools and hospitals abroad (ASHA) program--Agency for International Development
Q74814888	Final regulations amending basic HHS policy for the protection of human research subjects
Q77477283	Final regulations amending basic HHS policy for the protection of human research subjects--Department of Health and Human Services. Final rule
Q53415202	Final regulations for health coverage portability for group health plans and group health insurance issuers under HIPAA Titles I & IV. Final regulation.
Q34299212	Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule.
Q82686315	Final rules for group health plans and health insurance issuers under the Newborns' and Mothers' Health Protection Act. Final rules
Q77911878	Final rules relating to use of electronic communication and recordkeeping technologies by employee pension and welfare benefit plans. Notice of final rulemaking
Q28301890	Final rules under the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008; technical amendment to external review for multi-state plan program. Final rules
Q77617801	Final special consideration for nursing special project grants, purpose no. 2 (fiscal year 1988)--HRSA
Q77602552	Final special considerations for nursing special project grants; demonstration activities--HRSA
Q77152289	Financial disclosure by clinical investigators--FDA. Final rule
Q77800548	Financial disclosure by clinical investigators--FDA. Final rule; action on petition for reconsideration
Q77165200	Financial disclosure by clinical investigators; correction--FDA. Final rule; correction
Q77566505	Financing of PSRO hospital review activities: proposed rule
Q94002587	Findings of Misconduct in Science
Q94002813	Findings of Misconduct in Science
Q94002825	Findings of Misconduct in Science
Q94002844	Findings of Misconduct in Science
Q94002992	Findings of Misconduct in Science
Q94003024	Findings of Misconduct in Science
Q94003037	Findings of Misconduct in Science
Q94003096	Findings of Misconduct in Science
Q94003104	Findings of Misconduct in Science
Q94003111	Findings of Misconduct in Science
Q94002630	Findings of Misconduct in Science/Research Misconduct
Q94002767	Findings of Misconduct in Science/Research Misconduct
Q57825524	Findings of Research Misconduct
Q58133622	Findings of Research Misconduct
Q58574964	Findings of Research Misconduct
Q58782330	Findings of Research Misconduct
Q58799767	Findings of Research Misconduct
Q59340033	Findings of Research Misconduct
Q60046046	Findings of Research Misconduct
Q60927548	Findings of Research Misconduct
Q60933103	Findings of Research Misconduct
Q61803714	Findings of Research Misconduct
Q64092100	Findings of Research Misconduct
Q64283567	Findings of Research Misconduct
Q91366425	Findings of Research Misconduct
Q92590678	Findings of Research Misconduct
Q93046433	Findings of Research Misconduct
Q94002423	Findings of Research Misconduct
Q94002427	Findings of Research Misconduct
Q94002431	Findings of Research Misconduct
Q94002435	Findings of Research Misconduct
Q94002437	Findings of Research Misconduct
Q94002441	Findings of Research Misconduct
Q94002445	Findings of Research Misconduct
Q94002452	Findings of Research Misconduct
Q94002457	Findings of Research Misconduct
Q94002463	Findings of Research Misconduct
Q94002467	Findings of Research Misconduct
Q94002472	Findings of Research Misconduct
Q94002476	Findings of Research Misconduct
Q94002480	Findings of Research Misconduct
Q94002485	Findings of Research Misconduct
Q94002492	Findings of Research Misconduct
Q94002497	Findings of Research Misconduct
Q94002503	Findings of Research Misconduct
Q94002509	Findings of Research Misconduct
Q94002519	Findings of Research Misconduct
Q94002523	Findings of Research Misconduct
Q94002530	Findings of Research Misconduct
Q94002534	Findings of Research Misconduct
Q94002540	Findings of Research Misconduct
Q94002545	Findings of Research Misconduct
Q94002553	Findings of Research Misconduct
Q94002564	Findings of Research Misconduct
Q94002570	Findings of Research Misconduct
Q94002576	Findings of Research Misconduct
Q94002581	Findings of Research Misconduct
Q94002592	Findings of Research Misconduct
Q94002597	Findings of Research Misconduct
Q94002603	Findings of Research Misconduct
Q94002608	Findings of Research Misconduct
Q94002613	Findings of Research Misconduct
Q94002617	Findings of Research Misconduct
Q94002623	Findings of Research Misconduct
Q94002635	Findings of Research Misconduct
Q94002641	Findings of Research Misconduct
Q94002646	Findings of Research Misconduct
Q94002651	Findings of Research Misconduct
Q94002659	Findings of Research Misconduct
Q94002665	Findings of Research Misconduct
Q94002670	Findings of Research Misconduct
Q94002675	Findings of Research Misconduct
Q94002680	Findings of Research Misconduct
Q94002686	Findings of Research Misconduct
Q94002695	Findings of Research Misconduct
Q94002700	Findings of Research Misconduct
Q94002706	Findings of Research Misconduct
Q94002710	Findings of Research Misconduct
Q94002716	Findings of Research Misconduct
Q94002721	Findings of Research Misconduct
Q94002726	Findings of Research Misconduct
Q94002731	Findings of Research Misconduct
Q94002736	Findings of Research Misconduct
Q94002740	Findings of Research Misconduct
Q94002745	Findings of Research Misconduct
Q94002750	Findings of Research Misconduct
Q94002755	Findings of Research Misconduct
Q94002759	Findings of Research Misconduct
Q94002772	Findings of Research Misconduct
Q94002776	Findings of Research Misconduct
Q94002782	Findings of Research Misconduct
Q94002788	Findings of Research Misconduct
Q94002793	Findings of Research Misconduct
Q94002798	Findings of Research Misconduct
Q94002802	Findings of Research Misconduct
Q94002808	Findings of Research Misconduct
Q94002818	Findings of Research Misconduct
Q94002835	Findings of Research Misconduct
Q94002850	Findings of Research Misconduct
Q94002861	Findings of Research Misconduct
Q94002869	Findings of Research Misconduct
Q94002879	Findings of Research Misconduct
Q94002894	Findings of Research Misconduct
Q94002904	Findings of Research Misconduct
Q94002910	Findings of Research Misconduct
Q94002921	Findings of Research Misconduct
Q94002936	Findings of Research Misconduct
Q94002998	Findings of Research Misconduct
Q94003004	Findings of Research Misconduct
Q94003031	Findings of Research Misconduct
Q94003050	Findings of Research Misconduct
Q94003055	Findings of Research Misconduct
Q94003089	Findings of Research Misconduct
Q94003118	Findings of Research Misconduct
Q94003125	Findings of Research Misconduct
Q94003131	Findings of Research Misconduct
Q94003144	Findings of Research Misconduct
Q95548937	Findings of Research Misconduct
Q95548965	Findings of Research Misconduct
Q95553287	Findings of Research Misconduct
Q95553290	Findings of Research Misconduct
Q98164719	Findings of Research Misconduct
Q98649284	Findings of Research Misconduct
Q103836901	Findings of Research Misconduct
Q104495421	Findings of Research Misconduct
Q94004077	Findings of Research Misconduct
Q94005388	Findings of Research Misconduct
Q94021960	Findings of Research Misconduct
Q94049352	Findings of Research Misconduct
Q94063084	Findings of Research Misconduct
Q94194479	Findings of Research Misconduct
Q94322213	Findings of Research Misconduct
Q94368211	Findings of Research Misconduct
Q94370096	Findings of Research Misconduct
Q94371261	Findings of Research Misconduct
Q94378871	Findings of Research Misconduct
Q94392671	Findings of Research Misconduct
Q94427651	Findings of Research Misconduct
Q95260263	Findings of Research Misconduct
Q57952041	Findings of Scientific Misconduct
Q94002396	Findings of Scientific Misconduct
Q94002399	Findings of Scientific Misconduct
Q94002403	Findings of Scientific Misconduct
Q94002407	Findings of Scientific Misconduct
Q94002411	Findings of Scientific Misconduct
Q94002416	Findings of Scientific Misconduct
Q94002419	Findings of Scientific Misconduct
Q94002829	Findings of Scientific Misconduct
Q94002874	Findings of Scientific Misconduct
Q94002884	Findings of Scientific Misconduct
Q94002889	Findings of Scientific Misconduct
Q94002899	Findings of Scientific Misconduct
Q94002916	Findings of Scientific Misconduct
Q94002926	Findings of Scientific Misconduct
Q94002932	Findings of Scientific Misconduct
Q94002940	Findings of Scientific Misconduct
Q94002945	Findings of Scientific Misconduct
Q94002954	Findings of Scientific Misconduct
Q94002957	Findings of Scientific Misconduct
Q94002963	Findings of Scientific Misconduct
Q94002968	Findings of Scientific Misconduct
Q94002973	Findings of Scientific Misconduct
Q94002980	Findings of Scientific Misconduct
Q94002987	Findings of Scientific Misconduct
Q94003011	Findings of Scientific Misconduct
Q94003018	Findings of Scientific Misconduct
Q94003044	Findings of Scientific Misconduct
Q94003062	Findings of Scientific Misconduct
Q94003068	Findings of Scientific Misconduct
Q94003075	Findings of Scientific Misconduct
Q94003082	Findings of Scientific Misconduct
Q94003138	Findings of Scientific Misconduct
Q94003151	Findings of Scientific Misconduct
Q94003157	Findings of Scientific Misconduct
Q94003165	Findings of Scientific Misconduct
Q94003172	Findings of Scientific Misconduct
Q94003178	Findings of Scientific Misconduct
Q94003185	Findings of Scientific Misconduct
Q94003191	Findings of Scientific Misconduct
Q94003199	Findings of Scientific Misconduct
Q94003203	Findings of Scientific Misconduct
Q94003210	Findings of Scientific Misconduct
Q94003216	Findings of Scientific Misconduct
Q94003222	Findings of Scientific Misconduct
Q94003229	Findings of Scientific Misconduct
Q94003236	Findings of Scientific Misconduct
Q94003244	Findings of Scientific Misconduct
Q94003253	Findings of Scientific Misconduct
Q94003260	Findings of Scientific Misconduct
Q94003266	Findings of Scientific Misconduct
Q94003272	Findings of Scientific Misconduct
Q94003279	Findings of Scientific Misconduct
Q94003286	Findings of Scientific Misconduct
Q94003291	Findings of Scientific Misconduct
Q94003298	Findings of Scientific Misconduct
Q94003305	Findings of Scientific Misconduct
Q94003313	Findings of Scientific Misconduct
Q94003321	Findings of Scientific Misconduct
Q94003328	Findings of Scientific Misconduct
Q94003334	Findings of Scientific Misconduct
Q94003342	Findings of Scientific Misconduct
Q94003348	Findings of Scientific Misconduct
Q94003357	Findings of Scientific Misconduct
Q94003364	Findings of Scientific Misconduct
Q94003369	Findings of Scientific Misconduct
Q94003374	Findings of Scientific Misconduct
Q94003379	Findings of Scientific Misconduct
Q94003384	Findings of Scientific Misconduct
Q94003390	Findings of Scientific Misconduct
Q94003392	Findings of Scientific Misconduct
Q94003397	Findings of Scientific Misconduct
Q94003403	Findings of Scientific Misconduct
Q94003409	Findings of Scientific Misconduct
Q94003413	Findings of Scientific Misconduct
Q94003419	Findings of Scientific Misconduct
Q94003425	Findings of Scientific Misconduct
Q94003431	Findings of Scientific Misconduct
Q94003437	Findings of Scientific Misconduct
Q94003443	Findings of Scientific Misconduct
Q94003450	Findings of Scientific Misconduct
Q94003457	Findings of Scientific Misconduct
Q94003463	Findings of Scientific Misconduct
Q94003472	Findings of Scientific Misconduct
Q94003479	Findings of Scientific Misconduct
Q94003484	Findings of Scientific Misconduct
Q94003495	Findings of Scientific Misconduct
Q94003502	Findings of Scientific Misconduct
Q94003508	Findings of Scientific Misconduct
Q94003515	Findings of Scientific Misconduct
Q94003523	Findings of Scientific Misconduct
Q94003529	Findings of Scientific Misconduct
Q94003535	Findings of Scientific Misconduct
Q94003543	Findings of Scientific Misconduct
Q94003550	Findings of Scientific Misconduct
Q94003559	Findings of Scientific Misconduct
Q94003563	Findings of Scientific Misconduct
Q94003570	Findings of Scientific Misconduct
Q94003583	Findings of Scientific Misconduct
Q94003589	Findings of Scientific Misconduct
Q94003600	Findings of Scientific Misconduct
Q94003607	Findings of Scientific Misconduct
Q94003613	Findings of Scientific Misconduct
Q94003621	Findings of Scientific Misconduct
Q94003626	Findings of Scientific Misconduct
Q94003632	Findings of Scientific Misconduct
Q94003653	Findings of Scientific Misconduct
Q94003658	Findings of Scientific Misconduct
Q94003663	Findings of Scientific Misconduct
Q94003671	Findings of Scientific Misconduct
Q94003678	Findings of Scientific Misconduct
Q94003686	Findings of Scientific Misconduct
Q94003694	Findings of Scientific Misconduct
Q94003702	Findings of Scientific Misconduct
Q94003710	Findings of Scientific Misconduct
Q94003717	Findings of Scientific Misconduct
Q94003725	Findings of Scientific Misconduct
Q94003733	Findings of Scientific Misconduct
Q94003743	Findings of Scientific Misconduct
Q94003751	Findings of Scientific Misconduct
Q94003759	Findings of Scientific Misconduct
Q94003768	Findings of Scientific Misconduct
Q94003774	Findings of Scientific Misconduct
Q94003781	Findings of Scientific Misconduct
Q94003787	Findings of Scientific Misconduct
Q94003795	Findings of Scientific Misconduct
Q94003802	Findings of Scientific Misconduct
Q94003813	Findings of Scientific Misconduct
Q94003821	Findings of Scientific Misconduct
Q94003825	Findings of Scientific Misconduct
Q94003832	Findings of Scientific Misconduct
Q94003838	Findings of Scientific Misconduct
Q94003843	Findings of Scientific Misconduct
Q94003850	Findings of Scientific Misconduct
Q94003854	Findings of Scientific Misconduct
Q94003861	Findings of Scientific Misconduct
Q94003868	Findings of Scientific Misconduct
Q94003876	Findings of Scientific Misconduct
Q95548633	Findings of Scientific Misconduct
Q95548658	Findings of Scientific Misconduct
Q95548667	Findings of Scientific Misconduct
Q95548733	Findings of Scientific Misconduct
Q95548747	Findings of Scientific Misconduct
Q95548799	Findings of Scientific Misconduct
Q95548820	Findings of Scientific Misconduct
Q95553266	Findings of Scientific Misconduct
Q95553269	Findings of Scientific Misconduct
Q95553272	Findings of Scientific Misconduct
Q95553275	Findings of Scientific Misconduct
Q95553278	Findings of Scientific Misconduct
Q95553281	Findings of Scientific Misconduct
Q95553284	Findings of Scientific Misconduct
Q94003880	Findings of Scientific Misconduct
Q94003889	Findings of Scientific Misconduct
Q94003896	Findings of Scientific Misconduct
Q94003902	Findings of Scientific Misconduct
Q94003910	Findings of Scientific Misconduct
Q94003915	Findings of Scientific Misconduct
Q94003923	Findings of Scientific Misconduct
Q94003930	Findings of Scientific Misconduct
Q94003936	Findings of Scientific Misconduct
Q94003941	Findings of Scientific Misconduct
Q94003946	Findings of Scientific Misconduct
Q94003951	Findings of Scientific Misconduct
Q94003958	Findings of Scientific Misconduct
Q94003966	Findings of Scientific Misconduct
Q94003972	Findings of Scientific Misconduct
Q94003978	Findings of Scientific Misconduct
Q94003986	Findings of Scientific Misconduct
Q94003990	Findings of Scientific Misconduct
Q94003996	Findings of Scientific Misconduct
Q94003576	Findings of Scientific Misconduct; Terry D. Reisine, Ph.D.
Q74767391	Findings of scientific misconduct; notice
Q77158190	Fiscal Year (FY) 1998 funding opportunities--SAMHSA. Notice of funding availability
Q77159852	Fiscal year (FY) 1998 funding opportunities--SAMHSA. Notice of funding availability
Q73172407	Fiscal year (FY) 1999 funding opportunities. Substance Abuse and Mental Health Services Administration, HHS. Notice of funding availability
Q73174690	Fiscal year (FY) 1999 funding opportunities. Substance Abuse and Mental Health Services Administration, HHS. Notice of funding availability
Q93927666	Fiscal year (FY) 1999 funding opportunities. Substance Abuse and Mental Health Services Administration, HHS. Notice of funding availability
Q93927668	Fiscal year (FY) 1999 funding opportunities. Substance Abuse and Mental Health Services Administration, HHS. Notice of funding availability
Q77578051	Fiscal year 1986 funding preference for grants for residency training and advanced education in the general practice of dentistry
Q74687915	Fiscal year 1990 estimated national average monthly payments for extended care services under Part A of Title XVIII of the Social Security Act--HRSA Notice
Q74764727	Fiscal year 1993 state home per diem rates for domiciliary, nursing home, and hospital care--DVA. Notice of state home program per diem rates for FY 1993
Q77431174	Flammability standards for children's sleepwear: withdrawal of proposed amendment
Q77456039	Flammability standards for children's sleepwear; proposed statements of enforcement policy--Consumer Product Safety Commission
Q79793256	Fluid milk substitutions in the school nutrition programs. Final rule
Q89272385	Food Additives Permitted for Direct Addition to Food for Human Consumption; Folic Acid. Final rule
Q53794553	Food Labeling: Health Claims; Dietary Saturated Fat and Cholesterol and Risk of Coronary Heart Disease. Interim final rule; request for comments.
Q39728003	Food Labeling: Revision of the Nutrition and Supplement Facts Labels. Final rule
Q47300455	Food Labeling: Serving Sizes of Foods That Can Reasonably Be Consumed at One Eating Occasion; Dual-Column Labeling; Updating, Modifying, and Establishing Certain Reference Amounts Customarily Consumed; Serving Size for Breath Mints; and Technical Am
Q73174687	Food and Drug Administration Modernization Act of 1997; list of documents issued by the Food and Drug Administration that apply to medical devices regulated by the Center for Biologics Evaluation and Research. Food and Drug Administration, HHS. No
Q39025671	Food and Drug Administration Review and Action on Over-the-Counter Time and Extent Applications. Final rule
Q77740368	Food and Drug Administration, HHS.--General; dental radiographs. Final recommendations
Q77463513	Food and Drug Administration--Delegations of authority and organization, health information and health promotion programs. Final rule
Q77471959	Food and Drug Administration--General hospital and personal use devices; general provisions. Final rule
Q77471417	Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule
Q77455078	Food and Drug Administration--classification of hematology and pathology devices; development of general provisions: proposed rule
Q77462016	Food and Drug Administration--infant formulas; interim guidelines for nutrient composition; notice to manufacturers, packers, and distributors. Notice
Q77467273	Food and Drug Administration-Redesignation of the Department of Health, Education, and Welfare as the Department of Health and Human Services. Final rule
Q77453721	Food and Drug Administration: classification of physical medicine devices; development of general provisions--proposed role
Q77500273	Food and Drug Administration; statement of organization, functions, and delegations of authority
Q74760951	Food and Drug Administration; statement of organization, functions, and delegations of authority: Center for Biologics Evaluation and Research (CBER)--HHS
Q74760947	Food and Drug Administration; statement of organization, functions, and delegations of authority: Center for Food Safety and Applied Nutrition (CFSAN)--HHS
Q74724580	Food and Drug Administration; statement of organizations, functions, and delegations of authority
Q74368319	Food labeling, safe handling statements, labeling of shell eggs; refrigeration of shell eggs held for retail distribution. Food and Drug Administration, HHS. Final rule
Q47837889	Food labeling: gluten-free labeling of foods. Final rule
Q74367979	Food labeling: health claims and labeling statements; dietary fiber and cancer; antioxidant vitamins and cancer; omega-3 fatty acids and coronary heart disease; folate and neural tube defects; revocation. Food and Drug Administration, HHS. Final ru
Q77163736	Food labeling: health claims; B-complex vitamins, lowered homocysteine levels, and the risk in adults of cardiovascular disease--FDA. Interim final rule
Q44504707	Food labeling: health claims; D-tagatose and dental caries. Final rule.
Q77163731	Food labeling: health claims; antioxidant vitamin A and beta-carotene and the risk in adults of atherosclerosis, coronary heart disease, and in cancers--FDA. Interim final rule
Q77163727	Food labeling: health claims; antioxidant vitamins C and E and the risk of atherosclerosis, coronary heart disease, certain cancers, and cataracts--FDA. Interim final rule
Q79793290	Food labeling: health claims; calcium and osteoporosis, and calcium, vitamin D, and osteoporosis. Final rule
Q77163742	Food labeling: health claims; calcium consumption by adolescents and adults, bone density and the risk of fractures--FDA. Interim final rule
Q77163748	Food labeling: health claims; chromium and the risk in adults of hyperglycemia and the effects of glucose intolerance--FDA. Interim final rule
Q81591426	Food labeling: health claims; dietary noncariogenic carbohydrate sweeteners and dental caries. Final rule
Q34506897	Food labeling: health claims; dietary noncariogenic carbohydrate sweeteners and dental caries. Final rule.
Q77163759	Food labeling: health claims; garlic, reduction of serum cholesterol, and the risk of cardiovascular disease in adults--FDA. Interim final rule
Q77163755	Food labeling: health claims; omega-3 fatty acids and the risk in adults of cardiovascular disease--FDA. Interim final rule
Q74367914	Food labeling: health claims; plant sterol/stanol esters and coronary heart disease. Food and Drug Administration, HHS. Interim final rule
Q77294894	Food labeling: health claims; plant sterol/stanol esters and coronary heart disease. Interim final rule; notice of extension of period for issuance of final rule
Q73716905	Food labeling: health claims; soluble dietary fiber from certain foods and coronary heart disease. Final rule
Q83910677	Food labeling: health claims; soluble dietary fiber from certain foods and coronary heart disease. Final rule
Q33961721	Food labeling: health claims; soluble dietary fiber from certain foods and coronary heart disease. Interim final rule
Q79714387	Food labeling: health claims; soluble fiber from certain foods and risk of coronary heart disease. Final rule
Q81487856	Food labeling: health claims; soluble fiber from certain foods and risk of coronary heart disease. Final rule
Q46663420	Food labeling: health claims; soluble fiber from certain foods and risk of coronary heart disease. Interim final rule
Q73018621	Food labeling: health claims; soy protein and coronary heart disease. Food and Drug Administration, HHS. Final rule
Q77163771	Food labeling: health claims; vitamin K and promotion of proper blood clotting and improvements in bone health in adults--FDA. Interim final rule
Q77163766	Food labeling: health claims; zinc and the body's ability to fight infection and heal wounds in adults--FDA. Interim final rule
Q79760557	Food labeling: nutrient content claims, expansion of the nutrient content claim "lean". Final rule
Q81232198	Food labeling: safe handling statements: labeling of shell eggs. Final rule
Q73658180	Food labeling: trans fatty acids in nutrition labeling, nutrient content claims, and health claims. Final rule
Q86088238	Food labeling; calorie labeling of articles of food in vending machines. Final rule
Q81282681	Food labeling; nutrient content claims, definition of sodium levels for the term "healthy." Final rule
Q86088237	Food labeling; nutrition labeling of standard menu items in restaurants and similar retail food establishments. Final rule
Q77500282	Food stamp program; recertification of SSI households--Food and Nutrition Service, USDA. Final rule
Q73174623	Foods--adulteration involving hard or sharp foreign objects; compliance policy guide; availability. Food and Drug Administration, HHS. Notice
Q77447710	Foreign establishment registration and listing. Final rule
Q77124470	Form for reporting serious adverse events and product problems with human drug and biological products and devices; availability--FDA. Notice
Q77652004	Freedom of information; modified policy on disclosure of amounts paid to individual physicians under the Medicare program: Department of Health and Human Services
Q74831395	Full reporting by health maintenance organizations (HMOs) and competitive medical plans (CMPs) paid on a cost basis--HCFA. Correction notice
Q74816574	Full reporting by health maintenance organizations (HMOs) and competitive medical plans (CMPs) paid on a cost basis--HCFA. Final rule
Q77475799	Funding of health-related facilities and other projects under the Public Works and Development Facilities Program--Economic Development Administration. Interim rule
Q77492735	Funding reductions in fiscal year 1982. Health Services Administration. Notice
Q83499901	Further amendments to general regulations of the Food and Drug Administration to incorporate tobacco products. Final rule
Q77083877	Future of VA Long-Term Care Advisory Committee, notice of establishment--VA
Q74367930	Gastroenterology and urology devices; effective date of requirement for premarket approval of the implanted mechanical/hydraulic urinary continence device. Food and Drug Administration, HHS. Final rule
Q73162592	Gastroenterology and urology devices; reclassification of the extracorporeal shock wave lithotripter. Food and Drug Administration, HHS. Final rule
Q50940936	Gastroenterology-Urology Devices; Manual Gastroenterology-Urology Surgical Instruments and Accessories. Final rule; technical amendment.
Q73018452	Gastroenterology-urology devices: reclassification of the penile rigidity implant. Food and Drug Administration, HHS. Final rule
Q51560621	Gastroenterology-urology devices; classification for external penile rigidity devices. Final rule.
Q77228623	Gastroenterology-urology devices; classification of tissue culture media for human ex vivo tissue and cell culture processing applications. Final rule
Q73018379	Gastroenterology-urology devices; effective date of requirement for premarket approval of the penile inflatable implant. Food and Drug Administration, HHS. Final rule
Q95481926	Gastroenterology-urology devices; reclassification of implanted blood access devices. Final rule
Q51065004	General Hospital and Personal Use Devices: Renaming of Pediatric Hospital Bed Classification and Designation of Special Controls for Pediatric Medical Crib; Classification of Medical Bassinet. Final rule.
Q90279113	General Hospital and Personal Use Devices; Reclassification of Sharps Needle Destruction Device. Final order
Q77193935	General administrative rulings and decisions; amendment to the examination and investigation sample requirements; companion document to direct final rule--FDA. Proposed rule
Q53531312	General and plastic surgery devices: reclassification of ultraviolet lamps for tanning, henceforth to be known as sunlamp products and ultraviolet lamps intended for use in sunlamp products. Final order.
Q51634139	General and plastic surgery devices; classification of silicone sheeting. Final rule.
Q73018601	General and plastic surgery devices; classification of the nonresorbable gauze/sponge for external use, the hydrophilic wound dressing, the occlusive wound dressing, and the hydrogel wound dressing. Food and Drug Administration, HHS. Final rule
Q73175071	General and plastic surgery devices; effective date of requirement for premarket approval of the silicone inflatable breast prosthesis. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA).
Q47590879	General and plastic surgery devices; reclassification of the tissue adhesive for topical approximation of skin device. Final rule
Q77522507	General and procurement by negotiation--DHHS. Proposed rule
Q45735122	General biological products standards, additional standards for human blood and blood products; test for antibody to human immunodeficiency virus (HIV); final rule.
Q77203515	General hospital and personal use devices: proposed classification of liquid chemical sterilants and general purpose disinfectants--FDA. Proposed rule
Q77153823	General hospital and personal use devices; classification of the Apgar timer, lice removal kit, and infusion stand--FDA. Proposed rule
Q77575253	General hospital and personal use devices; premarket approval of the infant radiant warmer--FDA. Proposed rule
Q77668587	General notice of quarterly listing of program issuances--HCFA
Q77649356	General policies and procedures on grants for medical assistance: proposed rule
Q73172418	General reorganization; statement of organization, functions, and delegations of authority. Agency for Health Care Policy and Research
Q40674056	General requirements for blood, blood components, and blood derivatives; donor notification. Final rule
Q47427299	Genetic Information Nondiscrimination Act. Final rule
Q77620491	Geographic composition of the Health Service Delivery Areas (HSDA) established by regulations of the Indian Health Service--PHS. Notice
Q77685483	Governing body requirements for Health Systems Agencies: notice of proposed rulemaking
Q77522405	Governing body requirements for health systems agencies--PHS. Final rule
Q77475782	Governing body requirements for health systems agencies: Public Health Service. Notice of proposed rulemaking
Q73172310	Government-owned inventions; availability for licensing. National Institutes of Health, Public Health Service, DHHS. Notice
Q73172356	Government-owned inventions; availability for licensing. National Institutes of Health, Public Health Service, DHHS. Notice
Q93927649	Government-owned inventions; availability for licensing. National Institutes of Health, Public Health Service, DHHS. Notice
Q93927652	Government-owned inventions; availability for licensing. National Institutes of Health, Public Health Service, DHHS. Notice
Q93927654	Government-owned inventions; availability for licensing. National Institutes of Health, Public Health Service, DHHS. Notice
Q93927656	Government-owned inventions; availability for licensing. National Institutes of Health, Public Health Service, DHHS. Notice
Q93927659	Government-owned inventions; availability for licensing. National Institutes of Health, Public Health Service, DHHS. Notice
Q93927661	Government-owned inventions; availability for licensing. National Institutes of Health, Public Health Service, DHHS. Notice
Q93927664	Government-owned inventions; availability for licensing. National Institutes of Health, Public Health Service, DHHS. Notice
Q73172347	Government-owned inventions; availability for licensing. National Institutes of Health, Public Health Service, DHHS. Notice
Q77475816	Graduate and professional study fellowships--Department of Education. Final regulations with invitation to comment
Q77531430	Grant application cycles; health systems agency grants and state health planning and development agency grants--HRSA
Q73174905	Grant award to the Division of Mental Health and Developmental Disabilities, Department of Health and Social Services, State of Alaska. Center for Substance Abuse Treatment (CSAT), Center for Mental Health Services (CMHS), Substance Abuse and Menta
Q77692016	Grant programs for schools and hospitals and buildings owned by units of local government and public care institutions; regulatory analysis: Department of Energy
Q77482119	Grant programs for schools and hospitals and for buildings owned by units of local government and public care institutions, amendment of regulations: Department of Energy. Final rule
Q77475764	Grant programs for schools and hospitals and for buildings owned by units of local government and public care institutions--Department of Energy. Notice of proposed rulemaking and public hearings
Q77456047	Grant programs for schools and hospitals, and buildings owned by units of local government and public care institutions: Department of Energy. Final rule; technical and editorial corrections
Q77116853	Grants and cooperative agreements to state and local governments, universities, hospitals, and other non-profit organizations--USDA. Interim final rule
Q77524515	Grants and subgrants to for-profit organizations--HHS. Final rules
Q77711567	Grants for Centers for Research and Demonstration of Health Promotion and Disease Prevention; program announcement and notice of availability of funds for fiscal year 1988--CDC
Q73174822	Grants for Minority Health Statistics Dissertation Research; notice of availability of funds. Centers for Disease Control and Prevention
Q44559553	Grants for States for construction or acquisition of State homes. Final rule
Q45328168	Grants for adaptive sports programs for disabled veterans and disabled members of the Armed Forces. Final rule
Q45328792	Grants for adaptive sports programs for disabled veterans and disabled members of the Armed Forces. Interim final rule
Q77441208	Grants for allied health projects: proposed rulemaking
Q77712254	Grants for construction of teaching facilities, educational improvements, scholarships, and student loans programs for the training of physician assistants: final rule
Q77451430	Grants for demonstrating the training of personnel to provide home health services: final rule
Q73174635	Grants for education programs in occupational safety and health; notice of availability of funds for fiscal year 2000. Centers for Disease Control and Prevention
Q77437791	Grants for emergency medical services systems: final rule
Q77627609	Grants for faculty training projects in geriatric medicine and dentistry--HHS. Notice for proposed rulemaking
Q77585505	Grants for graduate programs in health administration and grants for traineeships in health administration--PHS. Amendments to final regulations
Q77599986	Grants for graduate programs in health administration--PHS. Final regulations
Q77710232	Grants for health education-risk reduction. Center for Disease Control -- final rule
Q77431206	Grants for health services research, evaluation and demonstration projects: final rules
Q77578042	Grants for hospital construction and modernization; federal right of recovery and waiver of recovery--PHS. Final rule
Q77551573	Grants for hospital construction and modernization; federal right of recovery and waiver of recovery--PHS. Notice of proposed rulemaking
Q77582909	Grants for nurse practitioner traineeship programs--PHS. Final regulations
Q77543160	Grants for nurse practitioner traineeship programs--PHS. Interim final regulations
Q77712049	Grants for physician assistant training programs
Q77534357	Grants for residency training in general internal medicine or general pediatrics--PHS. Amendments to final regulations
Q77451442	Grants for state and community programs on aging: notice of proposed rulemaking
Q45329632	Grants for the Rural Veterans Coordination Pilot (RVCP). Final rule.
Q74814463	Grants for the establishment of Departments of Family Medicine--HRSA. Final rule
Q77431164	Grants for traineeships for the advanced training of allied health personnel: interim-final regulations
Q77435914	Grants for traineeships in health administration, hospital administration, or health policy analysis and planning at public or nonprofit private educational institutions other than schools of public health: interim-final regulations
Q45329575	Grants for transportation of veterans in highly rural areas. Final rule
Q77538073	Grants for various health professions projects--PHS. Final regulations
Q77566167	Grants to Professional Standards Review Organizations: final rule
Q77547446	Grants to State Health Planning and Development Agencies--HRSA. Notice regarding grants to State Health Planning and Development Agencies--determination of population of the States
Q77489827	Grants to for-profit organizations; implementing amendments--Public Health Service. Final rule
Q77589914	Grants to schools of medicine, osteopathy, dentistry, public health, veterinary medicine, optometry, pharmacy, and podiatry for support of their education programs--PHS. Final regulation
Q77522409	Grants to state health planning and development agencies determination of population of the states
Q77519526	Grants to state health planning and development agencies determination of population of the states--Health Resources and Services Administration
Q77228715	Grants to states for construction and acquisition of state home facilities. Interim final rule
Q77655629	Grants to states for construction of state home facilities--VA. Interim regulation
Q74709158	Grants to states for construction or acquisition of state home facilities--VA. Final regulations
Q77152233	Grants to states for construction or acquisition of state home facilities--VA. final rule
Q39883491	Grants to states for construction or acquisition of state home facilities--update of authorized beds. Final rule.
Q79835836	Grants to states for operation of qualified high risk pools. Final rule
Q81235736	Grants to states for operation of qualified high risk pools. Final rule
Q73358767	Grants to states for operation of qualified high risk pools. Final rule with comment period
Q77522399	Grants, loans and loan guarantees for construction and modernization of hospitals and medical facilities--PHS. Reinstatement of rule
Q77437776	Ground-fault protection; supplemental statement of reasons: final rule
Q48474981	Group health plans and health insurance issuers relating to coverage of preventive services under the Patient Protection and Affordable Care Act. Final rules.
Q48618235	Group health plans and health insurance issuers relating to coverage of preventive services under the Patient Protection and Affordable Care Act. Interim final rules with request for comments.
Q37898662	Group health plans and health insurance issuers: rules relating to internal claims and appeals and external review processes. Amendment to interim final rules with request for comments
Q73172335	Guidance for industry on Population Pharmacokinetics; availability. Food and Drug Administration, HHS. Notice
Q77193950	Guidance for industry: donor screening for antibodies to HTLV-II; availability--FDA. Notice
Q77570186	Guidance for the emergency use of unapproved medical devices; availability--FDA. Notice
Q77163795	Guidance of FDA's expectations of medical device manufacturers concerning the year 2000 date problem--FDA. Notice
Q52393156	Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs; notice.
Q83499910	Guidelines for determining probability of causation under the Energy Employees Occupational Illness Compensation Program Act of 2000; revision of guidelines on non-radiogenic cancers. Final rule
Q77487279	Guidelines for development and implementation of state solid waste management plans and criteria for classification of solid waste disposal facilities and practices--Environmental Protection Agency. Final rule
Q77148213	Guidelines for furnishing sensorineural aids (e.g., eyeglasses, contact lenses, hearing aids)--VA. Final rule
Q74798966	Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994--CDC. Notice of final revisions to the "Guidelines for Preventing the Transmission of Mycobacterium Tuberculosis in health-care facilities, 1994
Q56925749	Guidelines for research involving recombinant DNA molecules
Q74767819	Guidelines for research involving recombinant DNA molecules
Q74793016	Guidelines for research involving recombinant DNA molecules
Q74814818	Guidelines for research involving recombinant DNA molecules
Q77522433	Guidelines for research involving recombinant DNA molecules
Q77142001	Guidelines for the use of antiretroviral agents in pediatric HIV infection--HRSA. Request for comments
Q77168766	HHS management and budget office; statement of organization, function, and delegations of authority
Q77159794	HIPAA Mental Health Parity Act--IRS. Notice of proposed rulemaking by cross-reference to temporary regulations
Q77194160	HIPAA Newborns' and Mothers' Health Protection Act--IRS. Notice of proposed rulemaking by cross-reference to temporary regulations
Q31116204	HIPAA administrative simplification: National Plan and Provider Enumeration System Data Dissemination. Notice
Q50466988	HIPAA administrative simplification: enforcement. Final rule.
Q53410267	HIPAA administrative simplification: enforcement. Interim final rule; request for comments.
Q33380301	HIPAA administrative simplification: modification to medical data code set standards to adopt ICD-10-CM and ICD-10-PCS. Proposed rule
Q33433534	HIPAA administrative simplification: modifications to medical data code set standards to adopt ID-10-CM and ICD-10-PCS. Final rule.
Q38423793	HIPAA administrative simplification: standard unique health identifier for health care providers. Final rule.
Q53414320	HIPAA administrative simplification: standards for electronic health care claims attachments. Proposed rule.
Q77551550	HUD board and care home regulations--HUD. Proposed rule
Q85010428	Hawaii State Plan for Occupational Safety and Health. Final rule
Q43355358	Hazardous materials: revision to standards for infectious substances. Final rule
Q77498604	Hazardous waste management program: phase I interim authorization for Nebraska--Environmental Protection Agency, region VII. Phase I interim authorization
Q77498575	Hazardous waste management programs; Florida: authorization for interim authorization phase I--Environmental Protection Agency. Notice of final determination
Q77494101	Hazardous waste management system standards for owners and operators of hazardous waste treatment, storage, and disposal facilities and EPA administered permit programs; hazardous waste permit program. Environmental Protection Agency. Interim final
Q77516302	Hazardous waste management system--Environmental Protection Agency. Notice of regulatory reform actions; request for comments
Q77489809	Hazardous waste management system: identification and listing of hazardous waste--Environmental Protection Agency. Interim final rule and request for comments
Q77509611	Hazardous waste management system: standards applicable to generators of hazardous waste and standards applicable to owners and operators of hazardous waste treatment, storage, and disposal facilities--Environmental Protection Agency. Proposed rule
Q74732823	Hazardous waste management system; identification and listing of hazardous waste--EPA. Final rule and response to comments
Q77491274	Hazardous waste management system; standards applicable to generators of hazardous waste; state program requirements. Environmental Protection Agency. Final rule
Q77460372	Hazardous waste management; Environmental Protection Agency. Final rule
Q77666700	Health Care Financing Administration Privacy Act of 1974; system of records--HCFA. Notice of new system of records
Q77468441	Health Care Financing Administration--Adoption of the National Bureau of Standards fire safety evaluation system for health care facilities. Final notice
Q77651366	Health Care Financing Administration--Exclusion of heart transplantation procedures from Medicare coverage. Notice of HCFA ruling to discontinue medicare coverage of heart transplantation procedures
Q77650917	Health Care Financing Administration--Federal health insurance for the aged and disabled; quality control and proficiency testing standards for laboratories in Medicare hospitals. Final rule
Q77651122	Health Care Financing Administration--Fiscal year 1980 regulation plan. Notice of regulation plan
Q77650741	Health Care Financing Administration--Medicaid program; Medicaid management information systems. Final rule
Q77650928	Health Care Financing Administration--Medicaid program; miscellaneous corrections. Final rule
Q77692323	Health Care Financing Administration--Medicaid program; payments for long-term care facility services. Final rule with request for additional comments
Q77650420	Health Care Financing Administration--Medicaid program; quality control system error rate: proposed rule
Q77742805	Health Care Financing Administration--Medicaid provider records and grants to Professional Standard Review Organizations: technical amendments. Final regulations
Q77651369	Health Care Financing Administration--Medicare and Medicaid programs, Medicare and Medicaid disclosure of provider information and access to provider records; correction notice. Correction of final regulation
Q77650845	Health Care Financing Administration--Medicare and Medicaid programs: annual hospital report. Proposed rule
Q77651531	Health Care Financing Administration--Medicare and Medicaid programs; protection of patients' funds. Final regulation
Q77651118	Health Care Financing Administration--Medicare and Medicaid programs; schedule of limits on home health agency costs per visit. Final notice
Q77650725	Health Care Financing Administration--Medicare and Medicaid programs; schedule of limits on home health agency costs per visit. Proposed notice
Q77650925	Health Care Financing Administration--Medicare and Medicaid; provider agreements: redesignation and rewrite of Medicare regulations; effective dates; effect of change in ownership. Final rule with comment period
Q77650737	Health Care Financing Administration--Medicare and Medicaid; utilization review. Proposed rule
Q77651242	Health Care Financing Administration--Medicare program; clarification of urban location classification in New England. Notice
Q77651544	Health Care Financing Administration--Medicare program; cost reporting requirements for home health agencies. Final rule
Q77650720	Health Care Financing Administration--Medicare program; cost reporting requirements for home health agencies. Proposed rule
Q77651850	Health Care Financing Administration--Medicare program; definition and reimbursement of hospital intensive care type units. Correction of a final rule
Q77651987	Health Care Financing Administration--Medicare program; definition and reimbursement of hospital intensive care type units. Final rule
Q77651358	Health Care Financing Administration--Medicare program; economic index for physicians' services for the period July 1, 1980 through June 30, 1981. Notice
Q77651245	Health Care Financing Administration--Medicare program; intermediary nominations, contracts, evaluations, and notices. Final regulation
Q77651249	Health Care Financing Administration--Medicare program; payment for durable medical equipment. Final rule
Q77650716	Health Care Financing Administration--Medicare program; provider reimbursement review board. Proposed rule
Q77650921	Health Care Financing Administration--Medicare program; recodification of Medicare regulations. Notice of decision to recodify regulations
Q77651363	Health Care Financing Administration--Medicare program; reimbursement for costs of approved internship and residency programs. Final rule
Q77651536	Health Care Financing Administration--Medicare program; reimbursement for radiological services furnished to a hospital inpatient by a physician in the field of radiology. Final rule
Q77650749	Health Care Financing Administration--Medicare program; reimbursement of hospital-based physicians. Rule, uniform implementation
Q77651539	Health Care Financing Administration--Medicare program; schedule of guidelines for respiratory therapy services. Correction to final notice
Q77651547	Health Care Financing Administration--Medicare program; schedule of limits on skilled nursing facility inpatient routine service costs. Final notice
Q77650746	Health Care Financing Administration--Medicare program; schedule of target reimbursement rates for institutions furnishing home dialysis supplies, equipment, and support services. Final notice
Q77650436	Health Care Financing Administration--Medicare program; schedule of target reimbursement rates for institutions furnishing home dialysis supplies, equipment, and support services: final notice
Q77651115	Health Care Financing Administration--Medicare program; schedules of guidelines for respiratory therapy services. Notice
Q77651855	Health Care Financing Administration--Medicare program; technical amendments on reconsideration and appeals under the hospital insurance program. Final regulation
Q77566780	Health Care Financing Administration--PSRO hospital review; financing of activities. Final regulation
Q77650430	Health Care Financing Administration--Privacy Act of 1974; system of records and notice of proposed routine uses; Health Maintenance Organization prospective reimbursement demonstrations
Q77566750	Health Care Financing Administration--Professional Standards Review; redesignation of PSRO areas in California. Final regulation
Q77526376	Health Care Financing Administration--Statement of organization, functions, and delegations of authority
Q77651998	Health Care Financing Administration--Validation of accreditation surveys of hospitals. Final regulation
Q77463497	Health Care Financing Administration--conditions for coverage of suppliers of ESRD services; revocation of requirements for emergency generator and ground fault interrupters. Final rule
Q77650728	Health Care Financing Administration--imposition of sanctions on health care practitioners and providers of health care services; program integrity. Final regulation
Q77650841	Health Care Financing Administration--requirements for certification of Medicare and Medicaid long term care facilities with repeat deficiencies. Proposed rule
Q77519499	Health Care Financing Administration--statement of organization, functions, and delegations of authority
Q77660966	Health Care Financing Administration. Privacy Act of 1974; proposed amendment to systems of records--HCFA. Notice of proposed new routine: use for existing systems of records
Q77693415	Health Care Financing Administration. Privacy Act of 1974; report of new system. Notice of new system of records
Q74814470	Health Care Financing Administration. Statement of organization, functions, and delegations of authority
Q74801946	Health Care Financing Administration. Statement of organization, functions, and delegations of authority; Bureau of Policy Development
Q77650596	Health Care Financing Administration: Medicaid agency fraud detection and investigation program; verification of services--proposed rule
Q77651861	Health Care Financing Administration: Medicaid program; deeming of income between spouses. Final rule
Q77652008	Health Care Financing Administration: Medicare Program; collection of unpaid Medicare premiums. Final rule with comment period
Q77650331	Health Care Financing Administration: Pharmaceutical Reimbursement Board; final maximum allowable cost determinations
Q77652470	Health Care Financing Administration: Privacy Act of 1974. Report of new and amended routine
Q77463460	Health Care Financing Administration: adoption of the National Bureau of Standards fire safety evaluation system for health care facilities. Notice of comment period
Q77456032	Health Care Financing Administration: clinical laboratories; personnel standards--notice of proposed rulemaking
Q77650424	Health Care Financing Administration: medical assistance program; penalty for failure to make a satisfactory showing of an effective institutional utilization control program--final regulation
Q77566648	Health Care Financing Administration: professional standards review; redesignation of PSRO areas in California. Proposed rule
Q77650932	Health Care Financing Administration: prohibition of reassignment of claims by providers and suppliers. Final rule
Q77489818	Health Care Financing Administration; statement of organization, functions, and delegations of authority
Q77784431	Health Care Fraud and Abuse Data Collection Program: reporting of final adverse actions--extension of comment period--OIG, HHS. Notice of proposed rulemaking; extension of comment period
Q89911663	Health Care Programs: Fraud and Abuse; Revisions to the Office of Inspector General's Exclusion Authorities. Final rule
Q45327564	Health Care for Certain Children of Vietnam Veterans and Certain Korea Veterans--Covered Birth Defects and Spina Bifida. Final rule
Q40281387	Health Care for Homeless Veterans program. Final rule
Q49902153	Health Education Assistance Loan (HEAL) Program. Final rule
Q77524551	Health Education Assistance Loan (HEAL) program--PHS. Final regulations
Q77516437	Health Financing Research and Demonstration grants; availability of funds for grants--Health Care Financing Administration. General notice
Q47599520	Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule and the National Instant Criminal Background Check System (NICS). Final rule
Q77685495	Health Maintenance Organizations and State Medicaid contracts
Q77431182	Health Maintenance Organizations: continued regulation of HMO's and other entities
Q77685558	Health Maintenance Organizations: employees' health benefits plan
Q77685500	Health Maintenance Organizations: interim regulations
Q77450413	Health Maintenance Organizations; requirements
Q77626847	Health Professions Student Loan program--PHS. Final regulations
Q77465569	Health Resources Administration--Application announcement for grants for faculty development in family medicine
Q77471956	Health Resources Administration--Hill-Burton "uncompensated services" assurance; priorities for handling complaints. Notice
Q77462021	Health Resources Administration--grants to state health planning and development agencies, determination of population of the states
Q77489802	Health Resources Administration: announcement of amendments to PHS act; special project grants and contracts
Q77462004	Health Resources Administration: determination of population of health service areas
Q77494111	Health Resources Administration: determination of population of health service areas
Q77480830	Health Resources Administration: list of health manpower shortage areas designated under Section 332 of the Public Health Service Act
Q77458581	Health Resources Administration: notice of health planning agency responsibility for review of hospital applications for assistance for energy conservation measures under the National Energy Conservation Policy Act, Pub. L. 95-619
Q77435916	Health Resources Administration: statement of organization, functions, and delegations of authority
Q85623253	Health Resources Priority and Allocations System (HRPAS). Interim final rule
Q77152255	Health Resources and Service Administration; statement of delegation of authority
Q73175083	Health Resources and Services Administration. Final eligibility criteria, preferences, and priorities for scholarships for disadvantaged students
Q74814474	Health Resources and Services Administration. Statement of organization, functions and delegations of authority
Q77579991	Health Resources and Services Administration; delegation of authority under Title III of the Public Health Service Act--PHS
Q77561991	Health Resources and Services Administration; grants. Notice regarding grants to health systems agencies
Q77516317	Health Resources and Services Administration; medical reimbursement rates for fiscal year 1983; inpatient and outpatient medical care
Q74697070	Health Resources and Services Administration; nurse training; delegation of authority
Q74676460	Health Resources and Services Administration; statement of organization, functions and delegations of authority--PHS
Q74700999	Health Resources and Services Administration; statement of organization, functions and delegations of authority--PHS
Q74738128	Health Resources and Services Administration; statement of organization, functions and delegations of authority--PHS
Q74760472	Health Resources and Services Administration; statement of organization, functions and delegations of authority--PHS
Q74700986	Health Resources and Services Administration; statement of organizations, functions and delegations of authority--PHS
Q77720358	Health Services Administration--Maternal and child health/crippled children's service program; policy statement on third-party reimbursement for services to mothers and children. General notice
Q77654527	Health Services Review Organization--Veterans Administration. Final regulations
Q77652847	Health Services Review Organization: Veterans Administration. Proposed regulations
Q77492743	Health Systems Agencies: Public Health Service. Amendment to final rule
Q77685584	Health Systems Agency and State Agency reviews of the appropriateness of existing institutional health services and of proposed new institutional health services
Q74792630	Health and Human Services policy for protection of human subjects research--HHS. Final rule
Q77632581	Health and allied health professions eligibility for scholarship consideration under the Health Profession Preparatory and Pregraduate Scholarship Programs for Indians, and the Indian Health Service Scholarship Program--PHS
Q77135425	Health care continuation coverage--Pension and Welfare Benefits Administration--Department of Labor. Request for information
Q80132465	Health care continuation coverage. Final rules
Q45330485	Health care for homeless veterans. Final rule.
Q77194196	Health care fraud and abuse data collection program: reporting of final adverse actions--Office of Inspector General (OIG), HHS. Notice of proposed rulemaking
Q73882056	Health care fraud and abuse data collection program: reporting of final adverse actions. Office of Inspector General (OIG), HHS. Final rule
Q30961484	Health care fraud and abuse data collection program: technical revisions to Healthcare Integrity and Protection Data Bank data collection activities. Final rule.
Q33203849	Health care fraud and abuse data collection program: technical revisions to healthcare integrity and protection data bank data collection activities. Interim final rule with comment period.
Q74735238	Health care programs: fraud and abuse; amendments to OIG exclusion and CMP authorities resulting from Public Law 100-93--HHS. Final rule
Q74740761	Health care programs: fraud and abuse; amendments to OIG exclusion and CMP authorities resulting from Public Law 100-93--HHS. Final rule; correction
Q73018498	Health care programs: fraud and abuse; revised OIG civil money penalties resulting from public law 104-191. Office of Inspector General (OIG), HHS. Final rule
Q77153849	Health care programs: fraud and abuse; revised OIG civil money penalties resulting from the Health Insurance Portability and Accountability Act of 1996--Office of Inspector General (OIG), HHS. Notice of proposed rulemaking
Q77135363	Health care programs: fraud and abuse; revised OIG exclusion authorities resulting from Public Law 104-191--HHS. Notice of proposed rulemaking
Q77175302	Health care programs: fraud and abuse; revised OIG exclusion authorities resulting from Public Law 104-191--OIG. Final rule
Q77194178	Health care programs: fraud and abuse; revised OIG exclusion authorities resulting from Public Law 104-191; correction--Office of Inspector General (OIG). HHS. Final rule; correcting amendment
Q77175314	Health care programs: fraud and abuse; revised OIG sanction authorities resulting from Public Law 105-33--OIG. Notice of proposed rulemaking
Q77106174	Health care programs: fraud and abuse; revised PRO sanctions for failing to meet statutory obligations--HHS. Final rule
Q74840319	Health care programs: fraud and abuse; revisions to the PRO sanctions process--HHS. Final rule
Q74844915	Health care programs: fraud and abuse; revisions to the PRO sanctions process-HHS. Correction to final regulations
Q74835745	Health care programs: fraud and abuse; revisions to the civil money penalty provisions relating to the misuse of certain names, symbols and emblems--HHS. Final rule
Q74815747	Health care programs: fraud and abuse; technical revision to the scope and effect of the OIG exclusion regulations--HHS. Final rule
Q74763806	Health care programs; fraud and abuse; amendments to OIG exclusion and CMP authorities resulting from Public Law 100-93-- Office of Inspector General, HHS. Final rule and clarification
Q84193531	Health care reform insurance Web portal requirements. Interim final rule with comment period
Q44354599	Health claims and other health-related statements in the labeling and advertising of alcohol beverages (99R-199P). Final rule, Treasury decision.
Q77475791	Health education assistance loan program: Public Health Service. Final regulations
Q77431200	Health education assistance loan program: interim final regulations
Q77638282	Health education assistance loan program; maximum interest rates for quarter ending September 30, 1989--HRSA
Q77685554	Health financing research and demonstration grants
Q77522440	Health financing research and demonstration grants; availability of funds for grants--HCFA. General notice
Q77527823	Health financing research and demonstration grants; availability of funds for grants--HCFA. General notice
Q77561995	Health information policy council; 1984 revision of the Uniform Hospital Discharge Data Set--HHS. Notice
Q84631686	Health information technology: initial set of standards, implementation specifications, and certification criteria for electronic health record technology. Final rule
Q53410146	Health information technology: initial set of standards, implementation specifications, and certification criteria for electronic health record technology. Interim final rule.
Q85186249	Health information technology: revisions to initial set of standards, implementation specifications, and certification criteria for electronic health record technology. Interim final rule with request for comments
Q45981900	Health information technology: revisions to the 2014 edition electronic health record certification criteria; and Medicare and Medicaid programs; revisions to the Electronic Health Record Incentive Program. Interim final rule with comment period.
Q38430573	Health information technology: standards, implementation specifications, and certification criteria for electronic health record technology, 2014 edition; revisions to the permanent certification program for health information technology. Final rule
Q82683295	Health insurance issuers implementing medical loss ratio (MLR) requirements under the Patient Protection and Affordable Care Act. Interim final rule with request for comments
Q77103080	Health insurance portability for group health plans--IRS. Notice of proposed rulemaking by cross-reference to temporary regulations
Q86340088	Health insurance premium tax credit. Final regulations
Q95356493	Health insurance providers fee. Final and temporary regulations
Q30770661	Health insurance reform: modifications to electronic data transaction standards and code sets. Final rule.
Q79718557	Health insurance reform: modifications to the Health Insurance Portability and Accountability Act (HIPAA) electronic transaction standards. Proposed rule
Q77163703	Health insurance reform: national standard employer identifier--HCFA. Proposed rule
Q73026274	Health insurance reform: security standards. Final rule
Q38434217	Health insurance reform: standard unique employer indentifier. Final rule
Q77159901	Health insurance reform: standards for electronic transactions--HCFA. Proposed rule
Q73162650	Health insurance reform: standards for electronic transactions. Office of the Secretary, HHS. Final rule
Q33717168	Health insurance reform; announcement of maintenance changes to electronic data transaction standards adopted under the Health Insurance Portability and Accountability Act of 1996. Notification.
Q83701648	Health insurance reform; modifications to the Health Insurance Portability and Accountability Act (HIPAA) electronic transaction standards. Final rule
Q77659617	Health maintenance organization; qualification of entities--HRA. Notice
Q77540668	Health maintenance organizations--HRSA. Notice; qualified health maintenance organizations
Q77540686	Health maintenance organizations--HRSA. Notice; qualified health maintenance organizations
Q77551568	Health maintenance organizations--HRSA. Notice; qualified health maintenance organizations
Q77543174	Health maintenance organizations--PHS
Q77522424	Health maintenance organizations--PHS. Final regulations
Q77549867	Health maintenance organizations--PHS. Final rule
Q77526369	Health maintenance organizations--PHS. Final rule; confirmation of interim rule
Q77524491	Health maintenance organizations--PHS. Notice, July
Q77456042	Health maintenance organizations--Public Health Service, HEW. Notice: exclusion from basic health services provided by health maintenance organizations
Q77496925	Health maintenance organizations--Public Health Service. Final regulations
Q77519519	Health maintenance organizations--Public Health Service. Interim rule with request for comments
Q77062930	Health maintenance organizations: employer contribution to HMOs--HCFA. Final rule
Q77437782	Health maintenance organizations: final regulations
Q77442766	Health maintenance organizations: loans and loan guarantees for initial operating costs--interim regulations
Q74775374	Health maintenance organizations: organizational structure and services--HCFA. Correction notice
Q77436583	Health maintenance organizations: proposed requirements
Q74773798	Health maintenance organizations: qualification determinations and compliance actions during the period January 1, 1993 through March 31, 1993--HCFA. Notice
Q74787482	Health maintenance organizations: qualification determinations and compliance actions during the period July 1, 1993, through September 30, 1993--HCFA. Notice
Q74771640	Health maintenance organizations: qualification determinations and compliance actions for calendar year 1992, fourth quarter--HCFA. Notice
Q74797070	Health maintenance organizations: qualification determinations during the period January 1, 1994 through March 31, 1994--HCFA. Notice
Q74763802	Health maintenance organizations; HMO qualification determinations and compliance actions--HCFA. Notice
Q77585294	Health maintenance organizations; Health Central--Health Resources and Services Administration
Q77458570	Health maintenance organizations; July list--Public Health Service, HEW
Q77585127	Health maintenance organizations; MetroCare Inc.; revocation of federal qualification--Public Health Service. Notice, continued regulation of health maintenance organizations: determination of noncompliance and revocation of federal qualification
Q77741593	Health maintenance organizations; Midwest Health Plan--Health Resources and Services Administration
Q77741596	Health maintenance organizations; North Central Connecticut Health Maintenance Organization--Health Resources and Services Administration
Q77516421	Health maintenance organizations; amendments of 1981--Health Resources and Services Administration. Notice of proposed rulemaking
Q77545250	Health maintenance organizations; basic health services; exclusion of in vitro fertilization--HRSA. Notice
Q77652763	Health maintenance organizations; cumulative list--Public Health Service. Notice
Q77451420	Health maintenance organizations; employees' health benefits plans--final regulation
Q74777180	Health maintenance organizations; exclusion of gamete intrafallopian transfer and zygote intrafallopian transfer as basic health services--HCFA. Notice
Q77451416	Health maintenance organizations; federal financial assistance: general--final regulations
Q77447109	Health maintenance organizations; procedures for enforcement of employer compliance
Q74777187	Health maintenance organizations; qualification determinations and compliance actions during the period April 1, 1993, through June 30, 1993--HCFA. Notice
Q77741315	Health maintenance organizations; qualified list--HRSA. Notice
Q77494092	Health maintenance organizations; reestablishment of compliance by Kaiser Foundation Health Plan, Inc.: Public Health Service. Notice, continued regulation of health maintenance organizations
Q77451408	Health maintenance organizations; relationships between federally qualified health maintenance organizations and other parties: notice of proposed rulemaking
Q77680784	Health manpower shortage areas: criteria for designation
Q79828848	Health promotion and disease prevention research centers special interest projects competitive supplements. Notice
Q74817751	Health standards and quality bureau: statement of organization, functions, and delegations of authority--HCFA
Q73018629	Health standards for occupational noise exposure. Mine Safety and Health Administration (MSHA), Labor. Final rule
Q77554255	Health system agencies and state health planning development agencies; certificate of need reviews--HRSA. Notice regarding adjustment of the expenditure minimum for capital expenditures and the expenditure minimum for annual operating costs
Q77685522	Health systems agencies and state health planning and development agencies: proposed rulemaking
Q77516441	Health systems agencies and state health planning and development agencies; certificate of need reviews--Health Resources and Services Administration. Notice regarding adjustment of the expenditure minimum for capital expenditures and the expenditur
Q77495541	Health systems agencies and state health planning and development agencies; certificate of need reviews: Health Resources Administration. Notice regarding adjustment of the expenditure minimum for capital expenditures and the expenditure minimum for
Q77538070	Health systems agencies and state health planning development agencies; certificate of need reviews--HRSA. Notice regarding adjustment of the expenditure minimum for annual operating costs
Q77682491	Health systems agencies: designation and funding
Q77566624	Health systems agency and state agency reviews of the appropriateness of existing institutional health services: Public Health Service, HEW. Final regulations
Q77444182	Health systems agency and state health planning and development agency review of new institutional health services: final regulations
Q77551591	Health systems agency and state health planning and development agency reviews; certificate of need programs--PHS
Q77522491	Health systems agency and state health planning and development agency reviews; certificate of need programs--PHS. Notice of proposed rulemaking
Q77451454	Health systems agency reviews of certain proposed uses of Federal health funds: final regulations
Q77685574	Health systems agency: reviews of certain proposed uses of Federal health funds
Q79760566	Healthy Tomorrows Partnership for Children program (HTPC). Final rule
Q90308783	Hearing Aid Compatibility Standards. Final rule; announcement of effective date
Q50317260	Hearing Aid-Compatible Mobile Handsets. Final rule
Q47624778	Hearing aid-compatible mobile handsets, petition of American National Standards Committee C63 (EMC) ANSO ASC C63 (TM). Final rule.
Q77666691	Hearings by administrative law judges of certain Medicare claims--HCFA, SSA. General notice
Q77516198	Hematology and pathology devices; reclassification of the automated differential cell counter. Final rule
Q77153809	Hematology and pathology devices; reclassification; restricted devices; OTC test sample collection systems for drugs of abuse testing--FDA. Proposed rule
Q73018361	Hematology and pathology devices; reclassification; restricted devices; OTC test sample collection systems for drugs of abuse testing. Food and Drug Administration, HHS. Final rule
Q37833030	Herbicide exposure and veterans with covered service in Korea. Final rule
Q80733382	High risk pools. Interim final rule with comment period. Interim final rule with comment period
Q77456035	Hill-Burton and health professions educational facilities programs. Health Resources Administration -- notice of moratorium on approving "refinancings" of certain federally guaranteed loans
Q77524558	Hill-Burton health facilities; review--HRSA. Notice of review
Q77587295	Hill-Burton loan guarantees and direct loans; user charges for modification requests--PHS. Final Rule
Q77543187	Hill-Burton program; medical facility construction and modernization; federal right of recovery and calculation of interest charges--HRSA. Notice
Q48158966	Home Improvements and Structural Alterations (HISA) benefits program. Final rule
Q74768760	Home improvement and structural alterations (HISA); increase in the limit for home improvement and structural alterations (HISA)--VA. Final regulations
Q74776171	Hospital Infection Control Practices Advisory Committee; establishment--CDC. Notice of establishment
Q77546229	Hospital and health services credit union; prohibited trade practices, and affirmative corrective actions--Federal Trade Commission. Consent Order
Q77441199	Hospital and medical facilities--standards of construction and equipment: final rule
Q38254258	Hospital care and medical services for Camp Lejeune veterans. Final rule.
Q77124550	Hospital care and medical services in non-VA facilities--VA. Final rule and regulation
Q77477279	Hospital employee protection program: procedures and guidelines--Labor Management Services Administration, Labor. Notice of proposed rulemaking
Q77649612	Hospital insurance monthly premium: premium rate for the uninsured aged
Q83544973	How we collect and consider evidence of disability. Final rule
Q73174621	Human Health Studies--Applied Research and Development; notice of availability of funds. Agency for Toxic Substances and Disease Registry
Q56571387	Human Subject Protection; Acceptance of Data From Clinical Investigations for Medical Devices. Final rule
Q77719248	Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products
Q81783542	Human cells, tissues, and cellular and tissue-based products; donor screening and testing, and related labeling. Interim final rule; opportunity for public comment
Q74368539	Human cells, tissues, and cellular and tissue-based products; establishment registration and listing. Food and Drug Administration, HHS. Final rule
Q76346052	Human cells, tissues, and cellular and tissue-based products; establishment registration and listing. Interim final rule; opportunity for public comment
Q73018606	Human drugs and biologics; determination that informed consent is NOT feasible or is contrary to the best interests of recipients; revocation of 1990 interim final rule; establishment of new interim final rule. Food and Drug Administration, HHS. Int
Q95552214	Human exposure to radiofrequency electromagnetic fields. Final rule
Q73174882	Human immunodeficiency virus (HIV) related applied research and professional education projects; notice of availability of funds. Centers for Disease Control and Prevention
Q45735117	Human immunodeficiency virus (HIV-1); proposed rule
Q37195912	Human subject protection; foreign clinical studies not conducted under an investigational new drug application. Final rule.
Q74782772	Human tissue intended for transplantation--FDA. Interim rule; opportunity for public comment
Q77431161	Human uses of byproduct material--misadministration reporting requirements: proposed rule
Q77585115	Illinois, phase I interim authorization of state hazardous waste management program--Environmental Protection Agency, Region V. Granting of phase I interim authorization to state hazardous waste program
Q77471952	Immigration and Naturalization Service--documentary requirements: derivative third and sixth preference and nonpreference immigrants; reference to form 1-551. Final rule
Q77463499	Immigration and Naturalization Service--nonimmigrant alien (H-1) nurses; state license or examination requirements. Final rule
Q77455083	Immigration and Naturalization Service: voluntary departure for out-of-status nonimmigrant H-1 nurses
Q74368279	Immunology and Microbiology Devices; Classification of Anti-Saccharomyces cerevisiae (S. cerevisiae) Antibody (ASCA) Test Systems. Food and Drug Administration, HHS. Final rule
Q43963914	Immunology and microbiology devices; reclassification of the herpes simplex virus serological assay device. Final rule.
Q73174715	Immunotoxicity testing guidance; availability. Food and Drug Administration, HHS. Notice
Q77719986	Implementation of Executive Order No. 11914; nondiscrimination on the basis of handicap in federally assisted programs--Equal Employment Opportunity Commission. Proposed regulations
Q74803672	Implementation of Pro-Children Act of 1994--HHS. Notice to prohibit smoking in certain facilities
Q77162077	Implementation of Section 255 of the Telecommunications Act of 1996: access to telecommunications services, telecommunications equipment, and customer premises equipment by persons with disabilities--FCC. Notice of proposed rulemaking
Q74787489	Implementation of provisions of the Ryan White Comprehensive AIDS Resources Emergency Act regarding emergency response employees--CDC. Final notice
Q73174658	Implementation of section 403(a)(2) of Social Security Act; bonus to reward decrease in illegitimacy ratio. Administration for Children and Families, HHS. Final rule
Q57120120	Implementation of state assistance program for training and education in emergency management--Federal Emergency Management Agency. Final rule
Q77720843	Implementation of the Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)--Office of the secretary, DoD. Interim notice of policy
Q77456056	Implementation of the Civilian Health and Medical Program of the Uniformed Services; proposed amendment No. 3--Office of the Secretary of Defense
Q43938985	Implementation of the Comprehensive Methamphetamine Control Act of 1996; regulation of pseudoephedrine, phenylpropanolamine, and combination ephedrine drug products and reports of certain transactions to nonregulated persons. Final rule.
Q77526374	Implementation of the Equal Access to Justice Act in agency proceedings--HHS. Final rule
Q44611535	Implementation of the Methamphetamine Anti-Proliferation Act; thresholds for retailers and for distributors required to submit mail order reports; changes to mail order reporting requirements. Final rule.
Q82824553	Implementation of the Methamphetamine Production Prevention Act of 2008. Final rule
Q49848187	Implementation of the Provision of the Comprehensive Addiction and Recovery Act of 2016 Relating to the Dispensing of Narcotic Drugs for Opioid Use Disorder. Final rule
Q45977179	Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008. Interim final rule with request for comments.
Q95546593	Implementation of the Twenty-First Century Communications and Video Accessibility Act of 2010, Section 105, Relay Services for Deaf-Blind Individuals. Final rule
Q73172438	Implementation of the mutual recognition agreement between the United States and the European Community; pharmaceutical GMP's and medical devices; establishment of a public docket and FDA contact points. Food and Drug Administration, HHS. Establis
Q51104429	Import and production quotas for certain List I chemicals. Interim final rule with request for comment.
Q77783969	Import for export; reporting and recordkeeping requirements for unapproved or violative products imported for further processing or incorporation and subsequent export--FDA. Proposed rule
Q39756316	Improve Tracking of Workplace Injuries and Illnesses. Final rule
Q47278695	Improvements to Benchmarks and Related Requirements Governing Hearing Aid-Compatible Mobile Handsets. Final rule
Q47882239	Incentives for nondiscriminatory wellness programs in group health plans. Final rule
Q77445089	Inclusion of computed tomographic scanning services: interim regulations
Q77475768	Income and employment taxes; self-insured medical reimbursement plans--Internal Revenue Service. Final regulations
Q77484787	Income tax; definition of a private foundation--Internal Revenue Service. Final regulations
Q77719790	Income tax; expenditures to remove architectural and transportation barriers to handicapped and elderly: adoption of final regulations and deletion of temporary regulations
Q93234425	Income-Related Monthly Adjustment Amounts for Medicare Part B and Prescription Drug Coverage Premiums. Final rule
Q40697232	Indian Child Welfare Act Proceedings. Final rule
Q56884857	Indian Entities Recognized and Eligible To Receive Services from the United States Bureau of Indian Affairs - July 23, 2018
Q127419548	Indian Entities Recognized by and Eligible To Receive Services From the United States Bureau of Indian Affairs (2024)
Q77602562	Indian Health Service--PHS. Final rule
Q77061313	Indian Health Service. Reimbursement rates for calendar year 1996
Q77150339	Indian Health Service. Statement of mission, organization, functions and delegation of authority
Q77153893	Indian Health Service. Statement of mission, organization, functions and delegation of authority
Q74674858	Indian Health Service; contract health services--PHS. Final rule
Q74701003	Indian Health Service; medical reimbursement rates for calendar year 1991; inpatient and outpatient medical care--PHS
Q74735241	Indian Health Service; medical reimbursement rates for calendar year 1992 inpatient and outpatient medical care--PHS
Q74704751	Indian Health Service; method for evaluating and establishing reimbursement rates for health care services authorized under the Indian Health Service contract health service regulations--Portland area--PHS. General notice
Q74709164	Indian Health Service; statement of organization, functions and delegations of authority--PHS
Q74696102	Indian Health Service; statement of organization, functions, and delegations of authority--PHS
Q74715701	Indian Health Service; statement of organization, functions, and delegations of authority--PHS
Q74724567	Indian Health Service; statement of organization, functions, and delegations of authority--PHS
Q74729747	Indian Health Service; statement of organization, functions, and delegations of authority--PHS
Q74740755	Indian Health Service; statement of organization, functions, and delegations of authority--PHS
Q74844928	Indian Self-Determination and Education Assistance Act amendments--BIA, IHS. Notice of proposed rulemaking
Q93922481	Indian health--PHS. Proposed rule
Q77431211	Indian health--contract health services: final rule
Q77585123	Indiana application for interim authorization, phase I, hazardous waste management program--Environmental Protection Agency. Notice of public hearing and public comment period
Q77103092	Individual market health insurance reform: portability from group to individual coverage: federal rules for access in the individual market; state alternative mechanisms to federal rules--HHS. Interim final rule with comment period
Q77116727	Individual market health insurance reform: portability from group to individual coverage; federal rules for access in the individual market; state alternative mechanism to federal rules; correction--HCFA. Interim final rule; correction
Q77436597	Industrial, scientific and medical equipment: proposed rulemaking
Q77442763	Industrial, scientific, and medical equipment: second notice of proposed rulemaking; overall revision
Q85443939	Infant Formula: The Addition of Minimum and Maximum Levels of Selenium to Infant Formula and Related Labeling Requirements. Final rule
Q74732817	Infant formula record and record retention requirements--FDA. Final rule
Q74724631	Infectious substances (etiologic agents); revisions to transitional provisions--Department of Transportation. Final rule; partial response to petition for reconsideration
Q74831434	Infectious substances--DOT. Final rule
Q51037736	Information and Communication Technology (ICT) Standards and Guidelines. Final rule.
Q43103315	Information on foreign chain of distribution for ephedrine, pseudoephedrine, and phenylpropanolamine. Final rule.
Q77551581	Information regarding requirements for health maintenance organizations--HRSA. Notice; information regarding requirements for qualified health maintenance organizations
Q38421326	Information reporting by applicable large employers on health insurance coverage offered under employer-sponsored plans. Final regulations
Q95576625	Information reporting of minimum essential coverage. Final regulations
Q33801387	Informed consent elements. Final rule.
Q34409394	Informed consent for human drugs and biologics; determination that informed consent is not feasible; interim rule and opportunity for public comment.
Q77152119	Informed consent for patient care--VA. Final rule
Q35123723	Ingrown toenail relief drug products for over-the-counter human use. Final rule
Q80935077	Inmate fees for health care services. Final rule
Q77682484	Inpatient psychiatric facility/program certification for individuals under 21
Q77516268	Institutional Radiation Safety Committee--Nuclear Regulatory Commission. Final rule
Q34411944	Institutional review boards; request for information
Q77545255	Insured maximum mortgage amount for hospitals--Office of the Assistant Secretary for Housing. HUD. Proposed rule
Q73174811	Integration of HIV and other prevention services training into reproductive health settings; notice of availability of funds. Centers for Disease Control and Prevention
Q77106254	Interagency Committee for Medical Records (ICMR). Automation of medical optional form 523B--GSA. Guideline on automating medical standard forms
Q77106247	Interagency Committee for Medical Records (ICMR); automation of medical standard form 526--GSA. Guideline on automating medical standard forms
Q77106241	Interagency Committee for Medical Records (ICMR); automation of medical standard form 558--GSA. Guideline on automating medical standard forms
Q77498559	Interconnection arrangements between and among the domestic and international record carriers--Federal Communications Commission. Interim guidelines and temporary waiver of rules
Q77498553	Interconnection of private land mobile radio systems with the public switched telephone network in certain MHz bands--Federal Communications Commission. Final rule
Q74743190	Interest rate on overdue debts--HHS
Q39861781	Interim final rules for group health plans and health insurance coverage relating to status as a grandfathered health plan under the Patient Protection and Affordable Care Act. Interim final rules with request for comments
Q84583902	Interim final rules for group health plans and health insurance issuers relating to coverage of preventive services under the Patient Protection and Affordable Care Act. Interim final rules with request for comments
Q54508298	Interim final rules for group health plans and health insurance issuers relating to dependent coverage of children to age 26 under the Patient Protection and Affordable Care Act. Interim final rules with request for comments.
Q37774984	Interim final rules for group health plans and health insurance issuers relating to internal claims and appeals and external review processes under the Patient Protection and affordable Care Act. Interim final rules with request for comments
Q74368435	Interim final rules for nondiscrimination in health coverage in the group market. Internal Revenue Service, Department of the Treasury; Pension and Welfare Benefits Administration, Department of Labor; Health Care Financing Administration, Departmen
Q53061617	Interim final rules prohibiting discrimination based on genetic information in health insurance coverage and group health plans. Interim final rules with request for comments.
Q51853519	Interim final rules under the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008. Interim final rules with request for comments.
Q73172322	Interim polio vaccine information materials. Centers for Disease Control and Prevention (CDC), Department of Health and Human Services. Notice
Q77194077	Interim procedures for certain health care workers--INS. Interim rule with request for comments
Q77135419	Interim recommendations for deferral of donors at increased risk for HIV-1 Group O infection; guidance document; availability--FDA. Notice
Q77190046	Interim rule amending Summary Plan Description regulation--Department of Labor. Interim rule with request for comments
Q77103085	Interim rules amending ERISA disclosure requirements for group health plans--DoL. Interim rules with request for comments
Q77113826	Interim rules for amending ERISA disclosure requirements for group health plans; approval of information collection requirements--DoL. Interim rules; approval of information collection requirements
Q77194148	Interim rules for group health plans and health insurance issuers under the Newborns' and Mothers' Health Protection Act--IRS; DoL; HCFA. Interim rules with request for comments
Q77103097	Interim rules for health insurance portability for group health plans and individual market health insurance reform: portability from group to individual coverage; and federal rules for access in the individual market; state alternative mechanisms t
Q77116714	Interim rules for health insurance portability for group health plans--HCFA. Correction
Q77103075	Interim rules for health insurance portability for group health plans--HCFA. Interim rules with request for comments
Q77116720	Interim rules for health insurance portability for group health plans; correction--HCFA. Correction to interim rules
Q77159790	Interim rules for mental health parity--IRS, DoL, HCFA. Interim rules with request for comments
Q77489813	Interim status standards for owners and operators of hazardous waste treatment, storage, and disposal facilities--Environmental Protection Agency. Interim final rule and interim final amendments to rules and request for comments
Q77494104	Interim status standards for owners and operators of hazardous waste treatment, storage, and disposal facilities: Environmental Protection Agency. Proposed amendments to rule
Q74070209	Internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final rule for professional labeling of aspirin, buffered aspirin, and aspirin in combination with antacid drug products; technical amendments. Departm
Q78810259	International Conference on Harmonisation: guidance on Q1D bracketing and matrixing designs for stability testing of new drug substances and products; availability. Notice
Q77065129	International Conference on Harmonisation: guidance on testing for carcinogenicity of pharmaceuticals. Notice. Food and Drug Administration, HHS
Q30773632	International Conference on Harmonisation; E2B(R3) Electronic Transmission of Individual Case Safety Reports; Data Elements and Message Specification; Appendix on Backwards and Forwards Compatibility; availability. Notice
Q95450976	International Conference on Harmonisation; Electronic Transmission of Postmarket Individual Case Safety Reports for Drugs and Biologics, Excluding Vaccines; Availability of Food and Drug Administration Regional Implementation Specifications for
Q53210999	International Conference on Harmonisation; Guidance on E15 Pharmacogenomics Definitions and Sample Coding; Availability. Notice.
Q53148294	International Conference on Harmonisation; Guidance on E16 Biomarkers Related to Drug or Biotechnology Product Development: Context, Structure, and Format of Qualification Submissions; availability. Notice.
Q51169366	International Conference on Harmonisation; Guidance on E2F Development Safety Update Report; availability. Notice.
Q45047622	International Conference on Harmonisation; Guidance on E7 Studies in Support of Special Populations; Geriatrics; Questions and Answers; availability. Notice.
Q53176480	International Conference on Harmonisation; Guidance on M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals; availability. Notice.
Q85641786	International Conference on Harmonisation; Guidance on Q11 Development and Manufacture of Drug Substances; availability. Notice
Q53211002	International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions; Annex on Residue on Ignition/Sulphated Ash General Chapter; Availability. Notice.
Q64930376	International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 10 on Polyacrylamide Gel Electrophoresis General Chapter; availa
Q44531186	International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 13 on Bulk Density and Tapped Density of Powders General Chapter
Q51775474	International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 14 on Bacterial Endotoxins Test General Chapter; availability. N
Q83929102	International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 5 on Disintegration Test General Chapter; availability. Notice
Q84041156	International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 7 on Dissolution Test General Chapter; availability. Notice
Q53176643	International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 8 on Sterility Test General Chapter; availability. Notice.
Q84041153	International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 9 on Tablet Friability General Chapter; availability. Notice
Q53202743	International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex on Test for Extractable Volume of Parenteral Preparations Genera
Q53202740	International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex on Test for Particulate Contamination: Subvisible Particles Gene
Q81737868	International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; availability. Notice
Q83910681	International Conference on Harmonisation; Guidance on Q8 Pharmaceutical Development; availability. Notice
Q83151461	International Conference on Harmonisation; Guidance on S8 Immunotoxicity Studies for Human Pharmaceuticals; availability. Notice
Q84041138	International Conference on Harmonisation; Guidance on S9 Nonclincal Evaluation for Anticancer Pharmaceuticals; availability. Notice
Q49154955	International Conference on Harmonisation; S10 Photosafety Evaluation of Pharmaceuticals; guidance for industry; availability. Notice
Q30884577	International Conference on Harmonisation; Stability Data Package for Registration Applications in Climatic Zones III and IV; Stability Testing of New Drug Substances and Products; availability. Notice.
Q84192369	International Conference on Harmonisation; addendum to International Conference on Harmonisation Guidance on S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals; availability. Notice
Q78303177	International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice
Q51124430	International Conference on Harmonisation; draft guidance on E2F Development Safety Update Report; availability. Notice.
Q79714368	International Conference on Harmonisation; draft guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex on Disintegration Test General Chapter; availability. Noti
Q77163074	International Conference on Harmonisation; draft guidance on specifications: test procedures and acceptance criteria for biotechnological/biological products--FDA. Notice
Q30937218	International Conference on Harmonisation; evaluation of stability data; availability. Notice.
Q53134557	International Conference on Harmonisation; final recommendation for the revision of the permitted daily exposure for the solvent cumene according to the maintenance procedures for the guidance Q3C Impurities: Residual Solvents; availability. Notice.
Q44656965	International Conference on Harmonisation; final recommendations on the revision of the permitted daily exposures for two solvents, n-methylpyrrolidone and tetrahydrofuran, according to the maintenance procedures for the guidance Q3C Impurities: Res
Q30906019	International Conference on Harmonisation; guidance on Addendum to E2C Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs; availability. Notice.
Q53308302	International Conference on Harmonisation; guidance on E11 clinical investigation of medicinal products in the pediatric population; availability. Notice.
Q53265213	International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice.
Q81601886	International Conference on Harmonisation; guidance on E2E Pharmacovigilance Planning; availability. Notice
Q53308390	International Conference on Harmonisation; guidance on M4 common technical document; availability. Notice.
Q84025719	International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice
Q53308386	International Conference on Harmonisation; guidance on Q1A stability testing of new drug substances and products; availability. Notice.
Q84025723	International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 4A on Microbiological Examination of Nonsterile Products: Microb
Q84025716	International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 4B on Microbiological Examination of nonsterile products: Tests
Q51069178	International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 6 on Uniformity of Dosage Units General Chapter; availability. N
Q84025727	International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for use in the International Conference on Harmonisation Regions; Annex 4C on Microbiological Examination of Nonsterile Products: Accept
Q53168581	International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial texts for use in the International Conference on Harmonisation Regions; Annex 12 on Analytical Sieving General Chapter; availability. Notice
Q81910402	International Conference on Harmonisation; guidance on Q5E Comparability of Biotechnological/Biological Products Subject to Changes in Their Manufacturing Process; availability. Notice
Q78303172	International Conference on Harmonisation; guidance on Q6A specifications: test procedures and acceptance criteria for new drug substances and new drug products: chemical substances. Notice
Q84199616	International Conference on Harmonisation; guidance on Q8(R1) Pharmaceutical Development; addition of annex; availability. Notice
Q53253747	International Conference on Harmonisation; guidance on Q9 Quality Risk Management; availability. Notice.
Q34295987	International Conference on Harmonisation; guidance on S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals intended for Human Use; availability. Notice
Q53308423	International Conference on Harmonisation; guidance on S7A safety pharmacology studies for human pharmaceuticals; availability. Notice.
Q53265221	International Conference on Harmonisation; guidance on S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals; availability. Notice.
Q77144682	International Conference on Harmonisation; guidance on data elements for transmission of individual case safety reports; availability. Notice. Food and Drug Administration, HHS
Q35098191	International Conference on Harmonisation; guidance on electronic common technical document specification; availability. Notice.
Q77163086	International Conference on Harmonisation; guidance on ethnic factors in the acceptability of foreign clinical data; availability--FDA. Notice
Q53308395	International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice.
Q77065141	International Conference on Harmonisation; guidance on quality of biotechnological/biological products: derivation and characterization of cell substrates used for production of biotechnological/biological products; availability. Notice. Food and Dr
Q78303168	International Conference on Harmonisation; guidance on specifications: test procedures and acceptance criteria for biotechnological/biological products. Notice. Food and Drug Administration, HHS
Q48609538	International Conference on Harmonisation; guidance on the M4 Common Technical Document--Quality: Questions and Answers/Location Issues; availability. Notice.
Q78303163	International Conference on Harmonisation; guidance on the duration of chronic toxicity testing in animals (rodent and nonrodent toxicity testing); availability. Notice. Food and Drug Administration, HHS
Q77193922	International Conference on Harmonisation; guidance on viral safety evaluation of biotechnology products derived from cell lines of human or animal origin; availability--FDA. Notice
Q46232119	International Conference on Harmonisation; proposed change to rodent carcinogenicity testing of pharmaceuticals; request for comments. Notice; request for comments
Q72989751	International Conference on Harmonisation; revised guidance on Q3A impurities in new drug substances; availability. Notice
Q79297560	International Conference on Harmonisation; revised guidance on Q3B(R) Impurities in New Drug Products; Availability. Notice
Q53308384	International Cooperation on Harmonisation of Technical Requirements for Approval of Veterinary Medicinal Products (VICH); final guidance for industry on "studies to evaluate the safety of residues of veterinary drugs in human food: genotoxicity tes
Q78332270	International Cooperation on Harmonisation of Technical requirements for Approval of Veterinary Medicinal Products (VICH); final guidance on " Safety studies for veterinary drug residues in human food: reproduction toxicity testing" (VICH GL22); ava
Q77190064	International conference on harmonisation; guidance on statistical principles for clinical trials; availability--FDA. Notice
Q74814834	Interpretive guidelines on employment discrimination and reproductive hazards
Q77457369	Interstate shipment of etiologic agents; proposed rule--Center for Disease Control
Q73174786	Intervention epidemiologic research studies of HIV/AIDS. Centers for Disease Control and Prevention
Q73174860	Interventional epidemiologic research studies of HIV/AIDS among pregnant women, children, and adolescents; availability of funds. Centers for Disease Control and Prevention
Q77116740	Investigational new drug application; exception from informed consent; technical amendment--FDA. Final rule
Q77153776	Investigational new drug applications and new drug applications--FDA. Final rule
Q73018677	Investigational new drug applications; amendment to clinical hold regulations for products intended for life-threatening diseases and conditions. Food and Drug Administration, HHS. Final rule
Q77204680	Investigational new drug applications; clinical holds--FDA. Direct final rule
Q77204693	Investigational new drug applications; clinical holds; companion document to direct final rule--FDA. Proposed rule
Q37794119	Investigational new drug safety reporting requirements for human drug and biological products and safety reporting requirements for bioavailability and bioequivalence studies in humans. Final rule
Q74743196	Investigational new drug, antibiotic, and biological product applications; clinical hold and termination--FDA. Final rule
Q81522178	Investigational new drugs: export requirements for unapproved new drug products. Final rule
Q79183890	Iron-containing supplements and drugs; label warning statements and unit-dose packaging requirements; removal of regulations for unit-dose packaging requirements for dietary supplements and drugs. Final rule; removal of regulatory provisions in resp
Q79718541	Irradiation in the production, processing and handling of food. Final rule
Q85641788	Irradiation in the production, processing and handling of food. Final rule
Q95469949	Irradiation in the production, processing and handling of food. Final rule
Q34316293	Irradiation in the production, processing, and handling of food. Final rule
Q81069388	Irradiation in the production, processing, and handling of food. Final rule
Q74768461	Issuance of experimental use permits; genetically engineered microbial pesticides; Advanced Genetic Sciences, Inc.; notice
Q79994247	Issuance of multiple prescriptions for schedule II controlled substances. Final rule
Q74793583	Joint advisory notice; Department of Labor/Department of Health and Human Services; HBV/HIV
Q84383592	Labeling and effectiveness testing; sunscreen drug products for over-the-counter human use. Final rule
Q38011185	Labeling and effectiveness testing; sunscreen drug products for over-the-counter human use; delay of compliance dates. Final rule; delay of compliance dates; request for comments
Q37907220	Labeling for bronchodilators to treat asthma; cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use. Final rule.
Q28195699	Labeling for oral and rectal over-the-counter drug products containing aspirin and nonaspirin salicylates; Reye's Syndrome warning. Final rule
Q34163635	Labeling of diphenhydramine-containing drug products for over-the-counter human use. Final rule.
Q78958085	Labeling requirements for systemic antibacterial drug products intended for human use. Final rule
Q74729717	Labor condition applications and requirements for employers using aliens on H-1B visas in specialty occupations--Department of Labor. Interinal final rule; request for comments
Q74793413	Laboratory animal welfare: Public Health Service policy on humane care and use of laboratory animals by awardee institutions; notice
Q74793436	Laboratory animal welfare; U.S. government principles for the utilization and care of vertebrate animals used in testing, research and training; notice
Q74793242	Laboratory animal welfare; proposed U.S. government principles for the utilization and care of vertebrate animals used in testing, research and training
Q77440179	Laser products: final rule
Q77568838	Laser products; amendments to performance standard--FDA. Final rule
Q73172380	Laxative drug products for over-the-counter human use. Food and Drug Administration, HHS. Final rule
Q36798414	Laxative drug products for over-the-counter human use; psyllium ingredients in granular dosage forms. Final rule
Q77390591	Legal assistance matters. Final rule
Q74797093	Letter to manufacturers of blood establishment computer software products--FDA. Notice
Q77116750	License term for medical use licenses--NRC. Proposed rule
Q77163077	License terms for medical use licenses--NRC. Final rule
Q74755187	Licensing of low-power medical devices in the 450-470 MHz band--FCC. Final rule
Q77495532	Limitation on Federal participation for capital expenditures; policy notice. Public Health Service. Interpretive ruling
Q77522488	Limitation on federal participation for capital expenditures--PHS. Notice of proposed rulemaking
Q77491242	Limitation on federal participation for capital expenditures; policy on lack of timely notice: Public Health Service. Final rule
Q74743205	Limited revision of fee schedules--NRC. Final rule
Q77608059	List of designated primary care health manpower shortage areas (HMSAs); list of withdrawals from primary care HMSA designation--HRA
Q77659818	List of designated primary care health manpower shortage areas (HMSAs); list of withdrawals from primary care HMSA designation--HRA
Q74683959	List of designated primary medical care health manpower shortage areas (HMSAs); list of withdrawals from primary medical care HMSA designation--PHS. Notice
Q74788366	List of designated primary medical care health professional shortage areas (HPSAs); list of withdrawals from primary medical care HPSA designation--HHS. Notice
Q74760468	List of designated primary medical care health professional shortage areas (HPSAs); list of withdrawals from primary medical care HPSA designation--HRSA. Notice
Q74727196	List of designated primary medical care health professional shortage areas (HPSAs); list of withdrawals from primary medical care HPSA designation--PHS. Notice
Q77107510	List of designated primary medical care, mental health, and dental health professional shortage areas--HRSA. Notice
Q77194038	List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness--FDA. Proposed rule
Q73172412	List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness. Food and Drug Administration, HHS. Final rule
Q77431171	List of health manpower shortage areas designated under section 332 of the Public Health Service Act
Q77451446	List of health manpower shortage areas designated under section 332 of the Public Health Service Act
Q77436589	List of health manpower shortage areas: designated under section 332 of Public Health Service Act
Q77498540	List of primary care and dental health manpower shortage areas designated under section 332 of the Public Health Service Act
Q77549872	List of primary care health manpower shortage areas designated under Section 332 of the Public Health Service Act
Q77522518	List of primary care, dental and psychiatric health manpower shortage areas designated under Section 332 of the Public Health Service Act
Q43834231	Listed chemicals; establishment of non-regulated transactions in anhydrous hydrogen chloride. Final rule confirmation
Q73174736	Listing of color additives for coloring sutures; [phthalocyaninato(2-)] copper. Food and Drug Administration, HHS. Final rule
Q74831442	Lists of designated primary medical care, mental health, and dental health professional shortage areas--HRSA. Notice
Q77090577	Lists of designated primary medical care, mental health, and dental health professional shortage areas--HRSA. Notice
Q77516389	Loans to state and local development companies--Small Business Administration. Proposed rulemaking
Q47727382	Local School Wellness Policy Implementation Under the Healthy, Hunger-Free Kids Act of 2010. Final rule
Q77649083	Lowest charge level for medical services, supplies, and equipment: final regulations
Q77163791	M.D. Physicians of Southwest Louisiana, Inc.; analysis to aid public comment--FTC. Proposed consent agreement
Q77500258	MTS and WATS market structure--Federal Communications Commission. Fourth supplementary notice of inquiry and proposed rule
Q77203591	MacDill 65 demonstration of military managed care--DoD. Notice of demonstration project
Q77631422	Magnetic resonance diagnostic device; panel recommendation and report on petitions for magnetic resonance reclassification and codification of reclassification--FDA. Final rule
Q74755200	Mailability of sharps and other medical devices--Postal Service. Amendment to final rule
Q44532498	Mailing of tickets under the Ticket to Work program. Final rule
Q79699921	Management of donated foods in child nutrition programs, the Nutrition Services Incentive Program, and charitable institutions. Final rule
Q77431176	Manufacture, packing, storage and installation of medical devices: regulations establishing good manufacturing practices
Q77090014	Manufacturer audit guidelines and dispute resolution process 0905-ZA-19--HRSA. Final notice
Q74731520	Maternal and child assistance programs; model application form--HHS, Department of Agriculture. Notice
Q77451404	Maternal and child health and crippled children's services; disclosure of ownership and related information: final regulation
Q77485573	Measurement of the activity of radiopharmaceutical dosages: Nuclear Regulatory Commission. Proposed rule
Q37318087	Medicaid Integrity Program; eligible entity and contracting requirements for the Medicaid Integrity audit program. Final rule.
Q95549853	Medicaid Program; Covered Outpatient Drugs. Final rule with comment period
Q47927302	Medicaid Program; Disproportionate Share Hospital Payments--Treatment of Third Party Payers in Calculating Uncompensated Care Costs. Final rule
Q51469751	Medicaid Program; Face-to-Face Requirements for Home Health Services; Policy Changes and Clarifications Related to Home Health. Final rule.
Q38659797	Medicaid Program; Mechanized Claims Processing and Information Retrieval Systems (90/10). Final rule
Q77067829	Medicaid Program; Medicaid eligibility quality control, progressive reductions in federal financial participation for FYs 1982-84, payment for physician billing for clinical laboratory services, and utilization control of skilled nursing facility se
Q38622513	Medicaid Program; Methods for Assuring Access to Covered Medicaid Services. Final rule with comment period
Q53565746	Medicaid Program; The Use of New or Increased Pass-Through Payments in Medicaid Managed Care Delivery Systems. Final rule.
Q74710148	Medicaid Program; eligibility groups, coverage, and conditions of eligibility; legislative changes under OBRA '87, COBRA, and TEFRA--HCFA. Final rule; correction notice
Q77083859	Medicaid and Aid to Families with Dependent Children; certain provisions of the National Voter Registration Act of 1993--HHS. Final rule
Q51462326	Medicaid and Children's Health Insurance Program (CHIP) Programs; Medicaid Managed Care, CHIP Delivered in Managed Care, and Revisions Related to Third Party Liability. Final rule.
Q50314048	Medicaid and Children's Health Insurance Programs: Eligibility Notices, Fair Hearing and Appeal Processes for Medicaid and Other Provisions Related to Eligibility and Enrollment for Medicaid and CHIP. Final rule
Q50356839	Medicaid and Children's Health Insurance Programs: essential health benefits in alternative benefit plans, eligibility notices, fair hearing and appeal processes, and premiums and cost sharing; exchanges: eligibility and enrollment. Final rule
Q77053030	Medicaid and Medicaid programs: requirements for physician incentive plans in prepaid health care organizations--HCFA. Final rule with comment period
Q77169804	Medicaid and Title IV-E programs; revision to the definition of an unemployed parent--Administration for Children and Families (ACF) and HCFA. Final rule with comment period
Q77649077	Medicaid and medicare programs--rural health clinic services: final regulations
Q37026879	Medicaid integrity program; limitation on contractor liability. Final rule
Q77652758	Medicaid management information systems performance standards: Health Care Financing Administration. Notice with comment period
Q37780178	Medicaid program and Children's Health Insurance program (CHIP); revisions to the Medicaid Eligibility Quality Control and Payment Error Rate Measurement programs. Final rule
Q80188510	Medicaid program and State Children's Health Insurance Program (SCHIP) payment error rate measurement. Interim final rule with comment period
Q36277391	Medicaid program and State Children's Health Insurance Program (SCHIP) payment error rate measurement. Interim final rule with comment period.
Q36948526	Medicaid program and State Children's Health Insurance Program (SCHIP); payment error rate measurement. Final rule.
Q77665787	Medicaid program payments to institutions--HCFA. Final rule
Q77661163	Medicaid program--mental retardation; definition of "persons with related conditions"--HCFA. Final rule
Q77649890	Medicaid program--redesignation and rewrite: final rules
Q74732801	Medicaid program: Medicaid eligibility quality control program--HCFA. Response to comments on final rule
Q77658866	Medicaid program: adjustment of federal share for uncashed or cancelled (voided) checks--HCFA. Proposed rule
Q77658858	Medicaid program: claims processing assessment system (CPAS)--HCFA. Final rule
Q77655775	Medicaid program: claims processing assessment system--HCFA. Proposed rule
Q74787451	Medicaid program: computer matching and privacy protection for Medicaid eligibility--HCFA. Final rule
Q77085928	Medicaid program: family planning services and supplies for individuals of child-bearing age--HCFA. Correcting amendment
Q77135391	Medicaid program: final limitations on aggregate payments to disproportionate share hospitals: federal fiscal year 1997--HCFA. Notice
Q74835749	Medicaid program: nurse-midwife services--HCFA. Final rule
Q74798946	Medicaid program: outstation intake locations for certain low-income pregnant women, infants, and children under age 19--HCFA. Interim final rule with comment period
Q77653098	Medicaid program: payment for long-term care facility services and inpatient hospital services--Health Care Financing Administration. Interim final rule with comment period
Q77131238	Medicaid program: redeterminations of Medicaid eligibility due to welfare reform--HCFA. Final rule with comment period
Q51820610	Medicaid program: rescission of School-Based Administration/Transportation final rule, Outpatient Hospital Services final rule, and partial rescission of Case Management Interim final rule. Final rule.
Q82966699	Medicaid program: state flexibility for Medicaid benefit packages and premiums and cost sharing. Final rule
Q84163979	Medicaid program; Community First Choice option. Final rule
Q74760474	Medicaid program; Drug Use Review program and electronic claims management system for outpatient drug claims--HCFA. Interim final rule with comment period
Q77664812	Medicaid program; FFP for services of long-term care facilities--HCFA
Q77659870	Medicaid program; FFP for services of long-term care facilities--HCFA. Proposed rule
Q74690074	Medicaid program; MMIS system performance review revisions--HCFA. Final notice
Q74755170	Medicaid program; Medicaid Management Information System (MMIS) performance review; notification procedures for changes in requirements, performance standards, and reapproval conditions--HCFA. Final rule
Q77655397	Medicaid program; Medicaid Management Information System proposed system requirements--HCFA. Proposed notice
Q77659860	Medicaid program; Medicaid Management Information System requirements for physician and supplier services--HCFA. Final notice
Q77658155	Medicaid program; Medicaid Management Information System; system requirements--HCFA. Final rule
Q77659221	Medicaid program; Medicaid Management Information Systems; conditions of approval and reapproval and procedures for reduction of Federal financial participation--HCFA. Final rule
Q77655012	Medicaid program; Medicaid Management Information Systems; conditions of approval and reapproval and procedures for reduction of federal financial participation--Health Care Financing Administration. Proposed rule
Q77655731	Medicaid program; Medicaid Management Information Systems; performance standards--HCFA. General notice
Q77653100	Medicaid program; Medicaid eligibility and coverage criteria--Health Care Financing Administration. Interim final rule with comment period
Q74689512	Medicaid program; Medicaid eligibility quality control (MEQC) program requirements--HCFA. Final rule with comment period
Q77193960	Medicaid program; Medicaid managed care--HCFA. Proposed rule
Q74368554	Medicaid program; Medicaid managed care. Health Care Financing Administration (HCFA), HHS. Final rule with comment period
Q74311884	Medicaid program; Medicaid managed care. Withdrawal of final rule with comment period
Q74311886	Medicaid program; Medicaid managed care: new provisions. Final rule
Q77671622	Medicaid program; Medicaid management information system: revised definition of "mechanized claims processing and information retrieval system"--HCFA. Final rule with comment period
Q77655032	Medicaid program; Medicaid overpayment reporting requirements--Health Care Financing Administration. Proposed rule
Q77657352	Medicaid program; OMB approval of forms for reporting quarterly expenditures for medical assistance--HCFA. Final rule
Q74722126	Medicaid program; State share of financial participation--HCFA. Interim final rule with comment
Q74729734	Medicaid program; State share of financial participation--HCFA. Interim final rule with comment
Q77661856	Medicaid program; adjustment of federal share for uncashed or cancelled (voided) checks--HCFA. Final rule
Q77106207	Medicaid program; allocation of enhanced federal matching funds for increased administrative costs resulting from welfare reform--HCFA. Notice with comment period
Q77667651	Medicaid program; appeals from cancellation of approval of Medicaid long-term care facilities--HCFA. Final rule
Q74368470	Medicaid program; change in application of Federal Financial Participation limits. Health Care Financing Administration (HCFA), HHS. Final rule
Q39332077	Medicaid program; citizenship documentation requirements. Final rule.
Q79951506	Medicaid program; citizenship documentation requirements. Interim final rule with comment period
Q83107596	Medicaid program; clarification of outpatient hospital facility (including outpatient hospital clinic) services definition. Final rule
Q77666695	Medicaid program; conditions for intermediate care facilities for the mentally retarded--HCFA. Final rule
Q77656036	Medicaid program; contracts with health maintenance organizations and prepaid health plans--HCFA. Proposed rules
Q74747730	Medicaid program; coordination of Medicaid with Special Supplemental Food program for Women, Infants, and Children (WIC)--HCFA. Final regulations
Q74714572	Medicaid program; correction and reduction plans for intermediate care facilities for the mentally retarded--HCFA. Final rule
Q77665784	Medicaid program; correction and reduction plans for intermediate care facilities for the mentally retarded--HCFA. Final rule
Q80497681	Medicaid program; cost limit for providers operated by units of government and provisions to ensure the integrity of federal-state financial partnership. Final rule with comment period
Q82683286	Medicaid program; cost limit for providers operated by units of government and provisions to ensure the integrity of federal-state financial partnership. Final rule; implementation of court orders
Q77655625	Medicaid program; cost sharing demonstrations--HCFA. General notice
Q77135386	Medicaid program; coverage of personal care services--HCFA. Final rule
Q77665340	Medicaid program; coverage of qualified pregnant women and children and newborn children--HCFA. Final rule
Q77660294	Medicaid program; coverage of qualified pregnant women and children and newborn children--HCFA. Proposed rule
Q74689921	Medicaid program; deadline for submitting moratorium state plan amendments--HCFA. Notice
Q77656083	Medicaid program; deduction of incurred medical expenses (spend down)--HCFA. Proposed rule
Q74787504	Medicaid program; deduction of incurred medical expenses (spenddown)--HCFA. Final rule with comment period
Q77650528	Medicaid program; deeming of income between spouses--Health Care Financing Administration. Proposed rule
Q77656074	Medicaid program; deeming of income between spouses; categorically needy--HCFA. Final rule with comment period
Q77654515	Medicaid program; deeming of income between spouses; categorically needy--Health Care Financing Administration. Proposed rule
Q74798951	Medicaid program; demonstration proposals pursuant to section 1115(a) of the Social Security Act; policies and procedures--HCFA and ACF. Public notice
Q51766181	Medicaid program; disproportionate share hospital payments--uninsured definition. Final rule.
Q77194048	Medicaid program; disproportionate share hospital payments-institutions for mental disease--HCFA. Notice
Q44408788	Medicaid program; disproportionate share hospital payments. Final rule.
Q74798948	Medicaid program; drug use review program and electronic claims management system for outpatient drug claims--HCFA. Final rule
Q77524544	Medicaid program; early and periodic screening, diagnosis, and treatment (EPSDT) program--HCFA. Proposed rule
Q74797088	Medicaid program; eligibility and coverage requirements--HCFA. Final Rule
Q77124063	Medicaid program; eligibility and coverage requirements--HCFA. Final rule with comment period
Q74765462	Medicaid program; eligibility and coverage requirements--HCFA. Notice of delay of effective dates and compliance dates
Q74775356	Medicaid program; eligibility and coverage requirements--HCFA. Notice of delay of effective dates and compliance dates
Q74788379	Medicaid program; eligibility and coverage requirements--HCFA. Notice of delay of effective dates and compliance dates
Q77671594	Medicaid program; eligibility and coverage requirements--HCFA. Proposed rule
Q51540798	Medicaid program; eligibility changes under the Affordable Care Act of 2010. Final rule, Interim final rule.
Q77672315	Medicaid program; eligibility determinations based on disability--HCFA. Final rule
Q77669510	Medicaid program; eligibility groups, coverage, and conditions of eligibility; legislative changes under OBRA '87, COBRA, and TEFRA--HCFA. Action notice of proposed rulemaking
Q74704658	Medicaid program; eligibility groups, coverage, and conditions of eligibility; legislative changes under OBRA '87, COBRA, and TEFRA--HCFA. Final rule
Q74705508	Medicaid program; eligibility groups, coverage, and conditions of eligibility; legislative changes under OBRA '87, COBRA, and TEFRA--HCFA. Final rule; correction notice
Q74689976	Medicaid program; eligibility of aliens for Medicaid--HCFA. Final rule
Q77668245	Medicaid program; eligibility of aliens for Medicaid--HCFA. Proposed rule
Q77120731	Medicaid program; eligibility of qualified severely impaired individuals who work--HCFA. Final rule with comment period
Q74761414	Medicaid program; elimination of certain written documentation pertaining to Medicaid long-term care facilities--HCFA. Final rule
Q81123355	Medicaid program; elimination of reimbursement under Medicaid for school administration expenditures and costs related to transportation of school-age children between home and school. Final rule
Q77655634	Medicaid program; entitlement of children for whom payments are made under the foster care maintenance payments program or the adoption assistance program--HCFA. Final rule
Q74763024	Medicaid program; exemption of poverty level pregnant women from the cooperation requirements of establishing paternity and obtaining medical support and payments as a condition of eligibility; technical correction--HCFA. Final rule with comment per
Q77652877	Medicaid program; extended phase out provisions of intermediates care facilities for the mentally retarded (ICFs/MR) correction plans: Health Care Financing Administration. Notice of proposed rulemaking
Q35052618	Medicaid program; external quality review of Medicaid managed care organizations. Final rule.
Q77658550	Medicaid program; federal financial participation for inmates in public institutions and individuals in an institution for mental disease or tuberculosis--HCFA. Final rule
Q77655026	Medicaid program; federal financial participation for inmates in public institutions and individuals in an institution for mental disease or tuberculosis--Health Care Financing Administration. Proposed rule
Q77659824	Medicaid program; federal financial participation for inmates in public institutions and individuals in an institution for mental diseases; correction--HCFA
Q37867996	Medicaid program; federal funding for Medicaid eligibility determination and enrollment activities. Final rule.
Q77077600	Medicaid program; final limitations on aggregate payments to disproportionate share hospitals: Federal fiscal year 1996--HCFA. Notice
Q77660969	Medicaid program; fire safety standards for ICFs/MR--HCFA. Final rule
Q77660025	Medicaid program; fire safety standards for ICFs/MR--HCFA. Proposed rule
Q74787455	Medicaid program; freedom of choice waiver; conforming changes--HCFA. Interim final rule with comment period
Q77653125	Medicaid program; freedom of choice: waivers of and exceptions to state plan requirements--Health Care Financing Administration. Interim final rule with comment period
Q77655722	Medicaid program; freedom of choice; waivers of and exceptions to state plan requirements--HCFA. Final rule
Q39321404	Medicaid program; health care-related taxes
Q84199627	Medicaid program; health care-related taxes. Final rule
Q77659606	Medicaid program; hearing: reconsideration of disapproval of a New York State plan amendment--HCFA. Notice of hearing
Q77585343	Medicaid program; hearing; reconsideration of disapproval of Ohio State Plan Amendment--HCFA. Notice of hearing
Q74795000	Medicaid program; home and community-based services and respiratory care for ventilator-dependent individuals--HCFA. Final rule with comment period
Q74748647	Medicaid program; home and community-based services waivers for individuals age 65 or older--HCFA. Interim final rule with comment period
Q77658283	Medicaid program; home and community-based services--HCFA. Final rule
Q77653130	Medicaid program; home and community-based services--Health Care Financing Administration. Interim final rule with comment period
Q74368015	Medicaid program; home and community-based services. Health Care Financing Administration (HCFA), HHS. Final rule with comment period
Q77663231	Medicaid program; identification of third party liability resources for medical assistance--HCFA. Final rule
Q77658862	Medicaid program; imposition of cost sharing charges under Medicaid--HCFA. Final rule
Q77654962	Medicaid program; imposition of cost sharing charges under Medicaid--Health Care Financing Administration. Final rule with comment period
Q43941434	Medicaid program; increased Federal Medical Assistance Percentage changes under the Affordable Care Act of 2010. Final rule with request for comments
Q77784407	Medicaid program; inpatient psychiatric services benefit for individuals under age 21--HCFA. Final rule
Q77655747	Medicaid program; interest on disputed Medicaid claims--HCFA. Final rule
Q77655644	Medicaid program; interest on disputed Medicaid claims--HCFA. Proposed rule
Q77655700	Medicaid program; liens, adjustments, and recoveries--HCFA. Final rule with comment period
Q77152114	Medicaid program; limitation on provider-related donations and health care-related taxes; revision of waiver criteria for tax programs based exclusively on regional variations; correction--HCFA. Correcting amendment
Q74805041	Medicaid program; limitations on aggregate payments to disproportionate share hospitals: FFY 1995--HCFA. Notice
Q74787457	Medicaid program; limitations on aggregate payments to disproportionate share hospitals: federal fiscal year 1994--HCFA. Notice
Q74789164	Medicaid program; limitations on aggregate payments to disproportionate share hospitals: federal fiscal year 1994--HCFA. Notice
Q74831417	Medicaid program; limitations on aggregate payments to disproportionate share hospitals: federal fiscal year 1995--HCFA. Notice
Q77063460	Medicaid program; limitations on aggregate payments to disproportionate share hospitals: federal fiscal year 1996--HCFA. Notice
Q77065505	Medicaid program; limitations on aggregate payments to disproportionate share hospitals: federal fiscal year 1996; correction--HCFA. Correction notice
Q74761420	Medicaid program; limitations on aggregate payments to disproportionate share hospitals: fiscal year 1993--HCFA. Notice
Q74774601	Medicaid program; limitations on aggregate payments to disproportionate share hospitals; Federal Fiscal Year 1993--HCFA. Notice
Q74774599	Medicaid program; limitations on provider-related donations and health care-related taxes; limitations on payments to disproportionate share hospitals--HCFA. Final rule
Q74761418	Medicaid program; limitations on provider-related donations and health care-related taxes; limitations on payments to disproportionate share hospitals--HCFA. Interim final rule with comment period
Q74689278	Medicaid program; medical eligibility quality control (MEQC) program requirements--HCFA. Correction
Q77654999	Medicaid program; mental retardation--definition of "persons with related conditions"--Health Care Financing Administration. Proposed rule
Q77653143	Medicaid program; miscellaneous Medicaid provisions--increased state flexibility--Health Care Financing Administration. Interim final rule with comment period
Q74732480	Medicaid program; model Medicaid application form--HCFA. Notice
Q74704745	Medicaid program; modification of certain requirements for health insuring organizations--HCFA. Correction notice
Q74697055	Medicaid program; modification of certain requirements for health insuring organizations--HCFA. Final rule
Q34499992	Medicaid program; modification of the Medicaid upper payment limit for non-state government-owned or operated hospitals. Final rule
Q77390614	Medicaid program; modification of the Medicaid upper payment limit transition period for inpatient hospital services, outpatient hospital services, nursing facility services, intermediate care facility services for the mentally retarded, and clinic
Q37318091	Medicaid program; multiple source drug definition. Final rule.
Q77653108	Medicaid program; offset based on third party liability recoveries against reductions in Medicaid payments--Health Care Financing Administration. Notice of proposed rulemaking
Q84282463	Medicaid program; payment adjustment for provider-preventable conditions including health care-acquired conditions. Final rule
Q77697562	Medicaid program; payment for long-term care facility services and inpatient hospital services--HCFA
Q38429341	Medicaid program; payments for services furnished by certain primary care physicians and charges for vaccine administration under the Vaccines for Children program. Final rule
Q77658287	Medicaid program; payments to institutions--HCFA. Proposed rule
Q77652123	Medicaid program; plans of correction for intermediate care facilities for the mentally retarded--Health Care Financing Administration. Final rule with comment period
Q39309017	Medicaid program; premiums and cost sharing. Final rule
Q39285270	Medicaid program; premiums and cost sharing. Final rule with comment period.
Q33433537	Medicaid program; premiums and cost sharing. Final rule; delay of effective data and reopening of comment period.
Q83776353	Medicaid program; premiums and cost sharing. Final rule; delay of effective date and reopening of comment period
Q80733367	Medicaid program; prescription drugs. Final rule with comment period
Q77657479	Medicaid program; preventive services under Medicaid--HCFA. Notice
Q74761411	Medicaid program; prohibitions on FFP for educational and vocational training for institutionalized individuals--HCFA. Final rule
Q49323745	Medicaid program; provider qualifications for audiologists. Final rule.
Q74777168	Medicaid program; qualified family members--HCFA. Final rule
Q84973437	Medicaid program; recovery audit contractors. Final rule
Q77656070	Medicaid program; reduction in error rate tolerance beginning October 1, 1983; Medicaid quality control program--HCFA. Proposed rule
Q77656534	Medicaid program; reduction in error rate tolerance; Medicaid quality control program--HCFA. Final rule
Q77656688	Medicaid program; reduction in error rate tolerance; Medicaid quality control program--HCFA. Final rule
Q77655740	Medicaid program; reduction in error rate tolerance; Medicaid quality control program--HCFA. Interim final rule with comment period
Q77653104	Medicaid program; reductions in payments to the states--Health Care Financing Administration. Interim final rule with comment period
Q77669374	Medicaid program; refunding of federal share of overpayments made to Medicaid providers--HCFA. Final regulations
Q77655017	Medicaid program; relation with other agencies and miscellaneous Medicaid definitions--Health Care Financing Administration. Proposed rule
Q77665501	Medicaid program; relations with other agencies, miscellaneous Medicaid definitions, third party liability quality control, and limitations on federal funds for abortions--HCFA. Final rule
Q74811510	Medicaid program; required coverage of nurse practitioner services--HCFA. Final rule
Q74810684	Medicaid program; rescission of the guidelines for documenting Medicaid recipient access to immunizations under the Vaccines for Children (VFC) Program--HCFA. Notice
Q37989473	Medicaid program; review and approval process for Section 1115 demonstrations. Final rule.
Q74368454	Medicaid program; revision to Medicaid upper payment limit requirements for hospital services, nursing facility services, intermediate care facility services for the mentally retarded, and clinic services. Health Care Financing Administration (HCFA)
Q77664581	Medicaid program; revisions to Medicaid payments for hospital and long-term care facility services--HCFA. Final rule
Q77653090	Medicaid program; revocation of sixty-day public notice of changes in method or level of reimbursement--Health Care Financing Administration. Proposed rule
Q79793305	Medicaid program; self-directed personal assistance services program State Plan option (cash and counseling). Final rule
Q77153771	Medicaid program; state allotments for payment of Medicare Part B premiums for qualifying individuals: federal fiscal year 1998--HCFA. Notice with comment period
Q81150145	Medicaid program; state allotments for payment of Medicare Part B premiums for qualifying individuals: federal fiscal year 2005. Interim final rule with comment period
Q79244826	Medicaid program; state allotments for payment of Medicare Part B premiums for qualifying individuals: federal fiscal year 2006 and fiscal year 2007. Final rule
Q83331595	Medicaid program; state allotments for payment of Medicare Part B premiums for qualifying individuals: federal fiscal year 2006. Interim final rule with comment period
Q51225371	Medicaid program; state disproportionate share hospital allotment reductions. Final rule.
Q83776355	Medicaid program; state flexibility for Medicaid benefit packages
Q83184783	Medicaid program; state flexibility for Medicaid benefit packages. Final rule
Q84193524	Medicaid program; state flexibility for Medicaid benefit packages. Final rule
Q95517996	Medicaid program; state plan home and community-based services, 5-year period for waivers, provider payment reassignment, and home and community-based setting requirements for Community First Choice and home and community-based services (HCBS) waive
Q74688520	Medicaid program; state plan requirements and other provisions relating to state third party liability programs--HCFA. Final rule
Q77668233	Medicaid program; state plans and grants to states--HCFA. Final rules with comment period
Q77654013	Medicaid program; state residency for institutionalized individuals--Health Care Financing Administration. Interim final rule with comment period
Q77656947	Medicaid program; state residency requirements--HCFA. Final rule
Q77656040	Medicaid program; state residency requirements--HCFA. Proposed rule
Q74731505	Medicaid program; state share of financial participation--HCFA. Withdrawal of interim final rule with comment
Q77669729	Medicaid program; targeting information for income and eligibility verification systems--HCFA
Q77106168	Medicaid program; third party liability (TPL) cost-effectiveness waivers--HCFA. Correcting amendment
Q74816205	Medicaid program; third party liability (TPL) cost-effectiveness waivers--HCFA. Final rule
Q77660041	Medicaid program; third party liability for medical assistance; FFP rates for skilled professional medical personnel and supporting staff; and sources of state share of financial participation--HCFA. Final regulations
Q77657097	Medicaid program; third party liability for medical assistance; FFP rates for skilled professional medical personnel and supporting staff; and sources of state share of financial participation--HCFA. Proposed rules
Q77661172	Medicaid program; third party liability for medical assistance; correction--HCFA. Final rule
Q47639115	Medicaid program; time limitation on price recalculations and recordkeeping requirements under the drug rebate program. Final rule with comment period
Q47201459	Medicaid program; time limitation on record keeping requirements under the drug rebate program. Interim final rule with comment period.
Q81061850	Medicaid program; time limitation on recordkeeping requirements under the drug rebate program. Final rule
Q77658559	Medicaid program; treatment of social security cost of living increases for individuals who lose SSI eligibility--HCFA. Proposed rule
Q51961820	Medicaid program; use of restraint and seclusion in psychiatric residential treatment facilities providing inpatient psychiatric services to individuals under age 21. Interim final rule; amendment and clarification with request for comment.
Q74368691	Medicaid program; use of restraint and seclusion in psychiatric residential treatment facilities providing psychiatric services to individuals under age 21. Health Care Financing Administration (HCFA), HHS. Interim final rule with comment period
Q82516988	Medicaid program; withdrawal of determination of average manufacturer prices, multiple source drug definition, and upper limits for multiple source drugs. Final rule
Q77665507	Medicaid program; withholding of Medicaid payments for fraud or willful misrepresentation--HHS. Final rule
Q77649377	Medicaid regulations: reorganization and rewriting
Q77650054	Medicaid requirements for state programs of early and periodic screening, diagnosis, and treatment of individuals under 21: final regulation
Q51435460	Medicaid/CHIP Program; Medicaid Program and Children's Health Insurance Program (CHIP); Changes to the Medicaid Eligibility Quality Control and Payment Error Rate Measurement Programs in Response to the Affordable Care Act. Final rule.
Q74705504	Medicaid; eligibility of aliens for Medicaid--HCFA. Technical amendments
Q77656043	Medicaid; reductions in payments to the states--HCFA. Final rule
Q84959932	Medical Area Body Network. Final rule
Q77685538	Medical Assistance Program: rural health clinic services, proposed rule
Q77691210	Medical Assistance Program; reasonable cost-related reimbursement for skilled nursing and intermediate care facility services: proposed rule
Q90308865	Medical Care in Foreign Countries and Filing for Reimbursement for Community Care Not Previously Authorized by VA. Final rule
Q90587811	Medical Device Classification Procedures: Incorporating Food and Drug Administration Safety and Innovation Act Procedures. Final rule
Q77164912	Medical Device; exemption from premarket notification; class II devices; pharmacy compounding systems. Final rule
Q95725907	Medical Devices and Device-Led Combination Products; Voluntary Malfunction Summary Reporting Program for Manufacturers. Notification; order granting alternative
Q47221990	Medical Devices; Anesthesiology Devices; Classification of the External Negative Pressure Airway Aid. Final order
Q58542675	Medical Devices; Anesthesiology Devices; Classification of the High Flow Humidified Oxygen Delivery Device. Final order
Q57810053	Medical Devices; Anesthesiology Devices; Classification of the Positive Airway Pressure Delivery System. Final order
Q51674897	Medical Devices; Cardiovascular Devices; Classification of the Coronary Vascular Physiologic Simulation Software Device. Final order.
Q50801980	Medical Devices; Cardiovascular Devices; Classification of the Steerable Cardiac Ablation Catheter Remote Control System. Final order.
Q47870490	Medical Devices; Cardiovascular Devices; Classification of the Adjunctive Cardiovascular Status Indicator. Final order
Q51090650	Medical Devices; Cardiovascular Devices; Classification of the Apical Closure Device. Final order.
Q47874924	Medical Devices; Cardiovascular Devices; Classification of the Balloon Aortic Valvuloplasty Catheter. Final order
Q51801316	Medical Devices; Cardiovascular Devices; Classification of the Esophageal Thermal Regulation Device. Final order.
Q49821102	Medical Devices; Cardiovascular Devices; Classification of the Temporary Catheter for Embolic Protection During Transcatheter Intracardiac Procedures. Final order
Q47392120	Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Acute Kidney Injury Test System. Final order
Q38869262	Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Continuous Glucose Monitor Secondary Display. Final order
Q50940924	Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the High Throughput Genomic Sequence Analyzer for Clinical Use. Final order.
Q58080359	Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Insulin Therapy Adjustment Device. Final order
Q58080355	Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Meprobamate Test System. Final order
Q47430138	Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Organophosphate Test System. Final order
Q50104892	Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Reagents for Molecular Diagnostic Instrument Test Systems. Final order
Q47373717	Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Total 25-Hydroxyvitamin D Mass Spectrometry Test System. Final order
Q51139960	Medical Devices; Custom Devices; Technical Amendment. Final rule; technical amendment.
Q51821698	Medical Devices; Ear, Nose, and Throat Devices; Classification of the External Upper Esophageal Sphincter Compression Device. Final order.
Q58542667	Medical Devices; Ear, Nose, and Throat Devices; Classification of the Active Implantable Bone Conduction Hearing System. Final order
Q51090644	Medical Devices; Ear, Nose, and Throat Devices; Classification of the Eustachian Tube Balloon Dilation System. Final order.
Q50317177	Medical Devices; Ear, Nose, and Throat Devices; Classification of the Tympanic Membrane Contact Hearing Aid. Final order
Q90284630	Medical Devices; Exemption From Premarket Notification: Class II Devices; Surgical Apparel. Final order
Q95547694	Medical Devices; Exemption From Premarket Notification: Method, Metallic Reduction, Glucose (Urinary, Nonquantitative) Test System in a Reagent Tablet Format. Final order
Q51633915	Medical Devices; Exemption From Premarket Notification; Class II Devices; Electric Positioning Chair. Final order.
Q47373698	Medical Devices; Exemption From Premarket Notification; Class II Devices; Autosomal Recessive Carrier Screening Gene Mutation Detection System. Final order
Q95592053	Medical Devices; Exemption From Premarket Notification; Class II Devices; Over-the-Counter Denture Repair Kit. Final order
Q95547696	Medical Devices; Exemption From Premarket Notification; Method, Metallic Reduction, Glucose (Urinary, Nonquantitative) Test System in a Reagent Tablet Format. Final order
Q90308791	Medical Devices; Exemptions From Premarket Notification: Class II Devices. Final order
Q51250466	Medical Devices; Gastroenterology-Urology Devices; Classification of the Metallic Biliary Stent System for Benign Strictures. Final order.
Q51633909	Medical Devices; Gastroenterology-Urology Devices; Classification of the Prostate Lesion Documentation System. Final order.
Q90308851	Medical Devices; Gastroenterology-Urology Devices; Classification of the Endoscopic Electrosurgical Clip Cutting System. Final order
Q47441461	Medical Devices; Gastroenterology-Urology Devices; Classification of the Enzyme Packed Cartridge. Final order
Q90308856	Medical Devices; Gastroenterology-Urology Devices; Classification of the Fluid Jet System for Prostate Tissue Removal. Final order
Q47589003	Medical Devices; Gastroenterology-Urology Devices; Classification of the High Intensity Ultrasound System for Prostate Tissue Ablation. Final order
Q47197503	Medical Devices; Gastroenterology-Urology Devices; Classification of the Oral Removable Palatal Space Occupying Device for Weight Management and/or Weight Loss. Final order
Q47258791	Medical Devices; Gastroenterology-Urology Devices; Classification of the Prostatic Artery Embolization Device. Final order
Q51633919	Medical Devices; General Hospital and Personal Use Devices; Classification of the Ultraviolet Radiation Chamber Disinfection Device. Final order.
Q47232396	Medical Devices; General Hospital and Personal Use Devices; Classification of the Image Processing Device for Estimation of External Blood Loss. Final order
Q51271166	Medical Devices; General and Plastic Surgery Devices; Classification of the Electrosurgical Device for Over-the-Counter Aesthetic Use. Final order.
Q51820476	Medical Devices; General and Plastic Surgery Devices; Classification of the Internal Tissue Marker. Final order.
Q51156351	Medical Devices; General and Plastic Surgery Devices; Classification of the Magnetic Surgical Instrument System. Final order.
Q51522138	Medical Devices; General and Plastic Surgery Devices; Classification of the Scalp Cooling System To Reduce the Likelihood of Chemotherapy-Induced Alopecia. Final order.
Q95592052	Medical Devices; General and Plastic Surgery Devices; Classification of the Extracorporeal Shock Wave Device for Treatment of Chronic Wounds. Final order
Q57810047	Medical Devices; General and Plastic Surgery Devices; Classification of the Hemostatic Device for Intraluminal Gastrointestinal Use. Final order
Q50104858	Medical Devices; General and Plastic Surgery Devices; Classification of the Irrigating Wound Retractor Device. Final order
Q57810049	Medical Devices; General and Plastic Surgery Devices; Classification of the Light Based Energy Source Device for Topical Application. Final order
Q90308802	Medical Devices; General and Plastic Surgery Devices; Classification of the Microneedling Device for Aesthetic Use. Final order
Q95588254	Medical Devices; General and Plastic Surgery Devices; Classification of the Non-Absorbable, Hemostatic Gauze for Temporary Internal Use. Final order
Q49821053	Medical Devices; General and Plastic Surgery Devices; Classification of the Surgical Smoke Precipitator. Final order
Q57810051	Medical Devices; General and Plastic Surgery Devices; Classification of the Wound Autofluorescence Imaging Device. Final order
Q90308766	Medical Devices; Hematology and Pathology Devices; Classification of Blood Establishment Computer Software and Accessories. Final rule
Q95588258	Medical Devices; Hematology and Pathology Devices; Classification of Lynch Syndrome Test Systems. Final order
Q50104854	Medical Devices; Hematology and Pathology Devices; Classification of a Cervical Intraepithelial Neoplasia Test System. Final order
Q50104888	Medical Devices; Hematology and Pathology Devices; Classification of the Flow Cytometric Test System for Hematopoietic Neoplasms. Final order
Q50104863	Medical Devices; Hematology and Pathology Devices; Classification of the Whole Slide Imaging System. Final order
Q51670908	Medical Devices; Immunology and Microbiology Devices; Classification of Autosomal Recessive Carrier Screening Gene Mutation Detection System. Final order.
Q51662601	Medical Devices; Immunology and Microbiology Devices; Classification of Gastrointestinal Microorganism Multiplex Nucleic Acid-Based Assay. Final order.
Q51821703	Medical Devices; Immunology and Microbiology Devices; Classification of Trichomonas Vaginalis Nucleic Acid Assay. Final order.
Q41029487	Medical Devices; Immunology and Microbiology Devices; Classification of Clostridium Difficile Toxin Gene Amplification Assay. Final order
Q47392106	Medical Devices; Immunology and Microbiology Devices; Classification of the Aquaporin-4 Autoantibody Immunological Test System. Final order
Q47874937	Medical Devices; Immunology and Microbiology Devices; Classification of the Assayed Quality Control Material for Clinical Microbiology Assays. Final order
Q47441468	Medical Devices; Immunology and Microbiology Devices; Classification of the Automated Image Assessment System for Microbial Colonies on Solid Culture Media. Final order
Q95725098	Medical Devices; Immunology and Microbiology Devices; Classification of the Automated Indirect Immunofluorescence Microscope and Software-Assisted System. Final order
Q47392084	Medical Devices; Immunology and Microbiology Devices; Classification of the BCR–ABL Quantitation Test. Final order
Q90308849	Medical Devices; Immunology and Microbiology Devices; Classification of the Brain Trauma Assessment Test. Final order
Q47392770	Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Microbial Pathogen Nucleic Acids in Cerebrospinal Fluid. Final order
Q47392762	Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Measure Non-Microbial Analyte(s) in Human Clinical Specimens To Aid in Assessment of Patients With Suspected Sepsis. Final order
Q47373707	Medical Devices; Immunology and Microbiology Devices; Classification of the Genetic Health Risk Assessment System. Final order
Q57813346	Medical Devices; Immunology and Microbiology Devices; Classification of the Herpes Virus Nucleic Acid-Based Cutaneous and Mucocutaneous Lesion Panel. Final order
Q47392753	Medical Devices; Immunology and Microbiology Devices; Classification of the Mass Spectrometer System for Clinical Use for the Identification of Microorganisms. Final order
Q47392095	Medical Devices; Immunology and Microbiology Devices; Classification of the Newborn Screening Test for Severe Combined Immunodeficiency Disorder. Final order
Q90308860	Medical Devices; Immunology and Microbiology Devices; Classification of the Next Generation Sequencing Based Tumor Profiling Test. Final order
Q47441479	Medical Devices; Immunology and Microbiology Devices; Classification of the Nucleic Acid-Based Device for the Amplification, Detection, and Identification of Microbial Pathogens Directly From Whole Blood Specimens. Final order
Q47392110	Medical Devices; Immunology and Microbiology Devices; Classification of the Streptococcus SPP. Nucleic Acid-Based Assay. Final order
Q47392744	Medical Devices; Immunology and Microbiology Devices; Classification of the Zinc Transporter 8 Autoantibody Immunological Test System. Final order
Q50940918	Medical Devices; Neurological Devices, Classification of the Vibratory Counter-Stimulation Device. Final order.
Q47870472	Medical Devices; Neurological Devices; Classification of Cranial Motion Measurement Device. Final order
Q51801320	Medical Devices; Neurological Devices; Classification of the Computerized Cognitive Assessment Aid. Final order.
Q47557344	Medical Devices; Neurological Devices; Classification of the Computerized Behavioral Therapy Device for Psychiatric Disorders. Final order
Q48390874	Medical Devices; Neurological Devices; Classification of the Computerized Cognitive Assessment Aid for Concussion. Final order
Q95546612	Medical Devices; Neurological Devices; Classification of the Evoked Photon Image Capture Device. Final order
Q57813344	Medical Devices; Neurological Devices; Classification of the External Upper Limb Tremor Stimulator. Final order
Q50104883	Medical Devices; Neurological Devices; Classification of the External Vagal Nerve Stimulator for Headache. Final order
Q48365897	Medical Devices; Neurological Devices; Classification of the Neurovascular Mechanical Thrombectomy Device for Acute Ischemic Stroke Treatment. Final order
Q95588233	Medical Devices; Neurological Devices; Classification of the Percutaneous Nerve Stimulator for Substance Use Disorders. Final order
Q47838310	Medical Devices; Neurological Devices; Classification of the Thermal System for Insomnia. Final order
Q57810044	Medical Devices; Neurological Devices; Classification of the Thermal Vestibular Stimulator for Headache. Final order
Q51283720	Medical Devices; Obstetrical and Gynecological Devices; Classification of the Gynecologic Laparoscopic Power Morcellation Containment System. Final order.
Q51571541	Medical Devices; Obstetrical and Gynecological Devices; Classification of the Intravaginal Culture System. Final order.
Q47870464	Medical Devices; Obstetrical and Gynecological Devices; Classification of the Closed Loop Hysteroscopic Insufflator With Cutter-Coagulator. Final order
Q47235714	Medical Devices; Obstetrical and Gynecological Devices; Classification of the Fetal Head Elevator. Final order
Q50104870	Medical Devices; Obstetrical and Gynecological Devices; Classification of the Pressure Wedge for the Reduction of Cesarean Delivery. Final order
Q51293839	Medical Devices; Ophthalmic Devices; Classification of Nasolacrimal Compression Device. Final order.
Q51156344	Medical Devices; Ophthalmic Devices; Classification of Strabismus Detection Device. Final order.
Q51313200	Medical Devices; Ophthalmic Devices; Classification of the Diurnal Pattern Recorder System. Final order.
Q57810043	Medical Devices; Ophthalmic Devices; Classification of the Intranasal Electrostimulation Device for Dry Eye Symptoms. Final order
Q51711690	Medical Devices; Ophthalmic Devices; Classification of the Oral Electronic Vision Aid. Final order.
Q47235706	Medical Devices; Ophthalmic Devices; Classification of the Tear Electrostimulation Device. Final order
Q90308808	Medical Devices; Orthopedic Devices; Classification of the In Vivo Cured Intramedullary Fixation Rod. Final order
Q51090647	Medical Devices; Physical Medicine Devices; Classification of the Upper Extremity Prosthesis Including a Simultaneously Powered Elbow and/or Shoulder With Greater Than Two Simultaneous Powered Degrees of Freedom and Controlled by Non-Implanted Elect
Q50104364	Medical Devices; Radiology Devices; Classification of the Absorbable Perirectal Spacer. Final order
Q50104878	Medical Devices; Radiology Devices; Classification of the Rectal Balloon for Prostate Immobilization. Final order
Q83477148	Medical Devices; general and plastic surgery devices; classification of contact cooling system for aesthetic use. Final rule
Q50715320	Medical Devices; hematology and pathology devices; reclassification of automated blood cell separator device operating by filtration principle from class III to class II. Final rule.
Q38712328	Medical Examination of Aliens--Revisions to Medical Screening Process. Final rule
Q95369771	Medical Gas Containers and Closures; Current Good Manufacturing Practice Requirements. Final rule
Q77680758	Medical Professional Standards Review Organization: designation of alternate
Q39095088	Medical Qualification Determinations. Final rule
Q77548788	Medical Radiation Advisory Committee; request for nominations for membership--FDA. Notice
Q74831431	Medical administration of radiation and radioactive materials--NRC. Final rule
Q74724659	Medical and dental reimbursement rates for fiscal year 1992--Department of Defense
Q74832513	Medical and dental reimbursement rates for fiscal year 1996--DoD
Q77083854	Medical and dental reimbursement rates for fiscal year 1997--DoD
Q74762068	Medical and dental reimbursements rates for fiscal year 1993; correction--DoD
Q74792640	Medical and dental reimbursements rates for period April 1, 1994 through September 30, 1994 (fiscal year 1994)--DoD
Q77152138	Medical and dental services fiscal year 1998--DoD. Notice
Q77649324	Medical assistance and child support enforcement programs. Assignment of benefits and collection of medical support and payments--proposed rules
Q77649445	Medical assistance program--Medicaid utilization control: proposed rule
Q77649353	Medical assistance program--timely claims payment: proposed rule
Q77652064	Medical assistance program: Title XIX administrative sanctions--Health Care Financing Administration. Proposed rule
Q77649926	Medical assistance program; Medicaid Management Information Systems: proposed rule
Q77649079	Medical assistance programs--state Medicaid fraud control units: final regulations
Q77649088	Medical assistance programs--state residence requirements: proposed rule
Q52117846	Medical assistance programs: sterilization procedures.
Q77650223	Medical assistance programs; family planning services: proposed rule
Q45330338	Medical benefits for newborn children of certain woman veterans. Final rule.
Q77649931	Medical benefits; grants to states for construction of state home facilities: proposed regulations
Q77460384	Medical benefits; nursing home care in foreign countries--Veterans Administration. Proposed regulation
Q77654521	Medical benefits; recovery of the cost of certain health care--Veterans Administration. Proposed regulations
Q77194068	Medical care collection or recovery--VA. Notice
Q77194061	Medical care collection or recovery--VA. Proposed rule
Q73174700	Medical care collection or recovery. Department of Veterans Affairs. Final rule
Q74731984	Medical care reimbursement rates for FY 92--VA. Notice
Q74802531	Medical care reimbursement rates for FY 95--VA. Notice
Q77551545	Medical care reimbursement rates for fiscal year 1985
Q77436581	Medical device listing: final rule
Q77085921	Medical device recall authority--FDA. Final rule
Q77543184	Medical device reporting--FDA. Final rule
Q77522450	Medical device reporting--FDA. Reproposal
Q35115252	Medical device reporting: electronic submission requirements. Final rule
Q77159933	Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, and distributor reporting--FDA. Direct final rule
Q77175239	Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, distributor reporting--FDA. Direct final rule; withdrawal
Q73018455	Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, distributor reporting. Food and Drug Administration, HHS. Final rule
Q77175246	Medical device warning letter draft pilot; availability--FDA. Notice
Q73172428	Medical device warning letter pilot. Food and Drug Administration, HHS. Notice
Q74368325	Medical device; exemption from premarket notification; class II devices; barium enema retention catheters and tips with or without a bag. Food and Drug Administration, HHS. Final rule
Q77203522	Medical devices containing materials derived from animal sources (except for in vitro diagnostic devices), guidance for FDA reviewers and industry; availability--FDA. Notice
Q77431191	Medical devices--classification procedures: final rule
Q77447118	Medical devices--establishment of procedures to make a device a banned device: final rule
Q77444164	Medical devices: administrative detention procedures
Q51805960	Medical devices: cardiovascular devices: reclassification of the arrhythmia detector and alarm. Final rule
Q48974507	Medical devices: classification of the dental sonography device and jaw tracking device. Final rule.
Q45401280	Medical devices: immunology and microbiology devices: classification of in vitro human immunodeficiency virus drug resistance genotype assay. Final rule
Q77685579	Medical devices: procedures for investigational device exemptions
Q77440182	Medical devices: proposals on development of classification of neurological devices
Q77431187	Medical devices: proposed procedures for development of standards
Q40614545	Medical devices: reclassification and codification of the absorbable polydioxanone surgical suture. Final rule.
Q77784394	Medical devices: reports of corrections and removals; delay of effective data--FDA. Direct final rule; delay of effective date
Q77159861	Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review--FDA. Direct final rule
Q77159866	Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review; companion document to direct final rule--FDA. Proposed rule
Q77174694	Medical devices; 30-day notices and 135-day PMA supplement review--FDA. Direct final rule; withdrawal
Q77194028	Medical devices; 30-day notices and 135-day PMA supplement review--FDA. Final rule
Q74809910	Medical devices; Mammography Quality Standards Act of 1992; inspection fees--FDA. Notice
Q77152308	Medical devices; Mammography Quality Standards Act of 1992; inspection fees--FDA. Notice
Q33829925	Medical devices; Medical Device Data Systems. Final rule.
Q73018441	Medical devices; anesthesiology devices; classification of nitric oxide administration apparatus, nitric oxide analyzer, and nitrogen dioxide analyzer. Food and Drug Administration, HHS. Final rule
Q51710172	Medical devices; apnea monitor; special controls. Final rule.
Q51260137	Medical devices; cardiovascular devices; classification of implantable intra-aneurysm pressure measurement system. Final rule.
Q49013376	Medical devices; classification for medical washer and medical washer-disinfector. Final rule.
Q77453727	Medical devices; classification of neurological devices: final rule
Q77127547	Medical devices; classification of temporomandibular joint implants--FDA. Final rule
Q77162032	Medical devices; classification/reclassification of immunohistochemistry reagents and kits--FDA. Final rule
Q77150313	Medical devices; classification/reclassification; restricted devices; analyte specific reagents--FDA. Final rule
Q53462396	Medical devices; clinical chemistry and clinical toxicology devices; classification of hemoglobin A1c test system. Final order.
Q45161850	Medical devices; clinical chemistry and clinical toxicology devices; classification of newborn screening test systems for amino acids, free carnitine, and acylcarnitines using tandem mass spectrometry. Final rule
Q45085442	Medical devices; clinical chemistry and clinical toxicology devices; classification of sirolimus test system devices. Final rule
Q51663606	Medical devices; clinical chemistry and clinical toxicology devices; classification of the breath nitric oxide test system. Final rule.
Q84820617	Medical devices; clinical chemistry and clinical toxicology devices; classification of the cardiac allograft gene expression profiling test systems
Q51530400	Medical devices; clinical chemistry and clinical toxicology devices; drug metabolizing enzyme genotyping system. Final rule.
Q51530397	Medical devices; clinical chemistry and clinical toxicology devices; instrumentation for clinical multiplex test systems. Final rule.
Q77109623	Medical devices; current good manufacturing practice (CGMP) final fule; quality system regulation--FDA. Final rule
Q51352577	Medical devices; dental devices; classification of oral rinse to reduce the adhesion of dental plaque. Final rule.
Q73474413	Medical devices; designation of special control for eight surgical suture devices. Final rule
Q77122775	Medical devices; device tracking--FDA. Final rule; notification of status under the Safe Medical Devices Act; confirmation of effective date
Q74774216	Medical devices; device tracking--FDA. Final rule; suspension of effective date; notification of status under the Safe Medical Devices Act; technical amendments
Q49023541	Medical devices; device tracking. Final rule.
Q77152931	Medical devices; device tracking; new orders to manufacturers--FDA. Notice
Q50488069	Medical devices; ear, nose and throat devices; reclassification of the endolymphatic shunt tube with valve. Final rule.
Q51174454	Medical devices; ear, nose, and throat devices; classification of olfactory test device. Final rule.
Q50485671	Medical devices; ear, nose, and throat devices; classification of the transcutaneous air conduction hearing aid system. Final rule.
Q50433535	Medical devices; ear, nose, and throat devices; classification of the wireless air-conduction hearing aid. Final rule.
Q73162472	Medical devices; effective date of requirement for premarket approval for a class III preamendments obstetrical and gynecological device. Food and Drug Administration, HHS. Final rule
Q77188869	Medical devices; effective date of requirement for premarket approval for three class III preamendments devices--FDA. Proposed rule; opportunity to request a change in classification
Q48609268	Medical devices; effective date of requirement for premarket approval for three class III preamendments devices. Final rule
Q77168814	Medical devices; effective date of requirement for premarket approval for three class III preamendments physical medicine devices--FDA. Proposed rule; opportunity to request a change in classification
Q73018384	Medical devices; effective date of requirement for premarket approval for three preamendment class III devices. Food and Drug Administration, HHS. Final rule
Q77193940	Medical devices; establishment registration and device listing for manufacturers and distributors of devices--FDA. Direct final rule
Q77193945	Medical devices; establishment registration and device listing for manufacturers and distributors of devices; companion to direct final rule--FDA. Proposed rule
Q77783976	Medical devices; establishment registration and device listing for manufacturers and distributors of devices; correction--FDA. Direct final rule; correction
Q77783983	Medical devices; establishment registration and device listing for manufacturers and distributors of devices; correction--FDA. Proposed rule; correction
Q37898660	Medical devices; exception from general requirements for informed consent. Final rule
Q42016626	Medical devices; exception from general requirements for informed consent. Interim final rule
Q77203571	Medical devices; exemption from premarket notification and reserved devices; Class I--FDA. Proposed rule
Q73018460	Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule
Q77298847	Medical devices; exemption from premarket notification requirements; class I devices; technical amendment. Final rule; technical amendment
Q47959230	Medical devices; exemption from premarket notification; Class II devices; optical impression systems for computer assisted design and manufacturing. Final rule
Q46630864	Medical devices; exemption from premarket notification; class II devices; powered patient transport. Final order
Q74368123	Medical devices; exemption from premarket notification; class II devices; triiodothyronine test system. Food and Drug Administration, HHS. Final rule
Q44970034	Medical devices; exemption from premarket notification; class II devices; wheelchair elevator. Final order.
Q77152292	Medical devices; exemptions from premarket notification and reserved devices; class I--FDA. Notice
Q77203493	Medical devices; exemptions from premarket notification; class II devices--FDA, Final rule
Q77447695	Medical devices; exemptions from premarket notification; class II devices. Final rule
Q73018444	Medical devices; exemptions from premarket notification; class II devices; vascular tunnelers. Food and Drug Administration, HHS. Final rule
Q77783999	Medical devices; exemptions from premarket notification; surgical lamps--FDA. Notice
Q73018627	Medical devices; gastroenterology and urology devices; classification of the electrogastrography system. Food and Drug Administration, HHS. Final rule
Q95390637	Medical devices; gastroenterology-urology devices; classification of pancreatic drainage stent and delivery system. Final order
Q53548647	Medical devices; gastroenterology-urology devices; classification of the colon capsule imaging system. Final order.
Q95481936	Medical devices; gastroenterology-urology devices; classification of the implantable transprostatic tissue retractor system. Final order
Q77575787	Medical devices; gastroenterology-urology devices; classification of the ingestible telemetric gastrointestinal capsule imaging system. Final rule
Q85269249	Medical devices; gastroenterology-urology devices; classification of the rectal control system. Final order
Q53256515	Medical devices; gastroenterology-urology devices; classification of the urethral insert with pump for bladder drainage. Final order.
Q85269246	Medical devices; gastroenterology-urology devices; classification of the vibrator for climax control of premature ejaculation. Final order
Q73018366	Medical devices; gastroenterology-urology devices; nonimplanted, peripheral electrical continence device. Food and Drug Administration, HHS. Final rule
Q50941354	Medical devices; general and plastic surgery devices; classification of absorbable poly(hydroxybutyrate) surgical suture produced by recombinant DNA technology. Final rule.
Q82516995	Medical devices; general and plastic surgery devices; classification of non-powered suction apparatus device intended for negative pressure wound therapy. Final rule
Q53584066	Medical devices; general and plastic surgery devices; classification of the absorbable lung biopsy plug. Final order.
Q50246038	Medical devices; general and plastic surgery devices; classification of the focused ultrasound stimulator system for aesthetic use. Final rule.
Q51324742	Medical devices; general and plastic surgery devices; classification of the low energy ultrasound wound cleaner. Final rule.
Q33872568	Medical devices; general and plastic surgery devices; classification of the low level laser system for aesthetic use. Final rule.
Q53505220	Medical devices; general and plastic surgery devices; classification of the nonabsorbable expandable hemostatic sponge for temporary internal use. Final order.
Q53531309	Medical devices; general and plastic surgery devices; classification of the powered surgical instrument for improvement in the appearance of cellulite. Final order.
Q82408871	Medical devices; general and plastic surgery devices; classification of tissue adhesive with adjunct wound closure device intended for topical approximation of skin. Final rule
Q50876491	Medical devices; general hospital and personal use devices; classification of remote medication management system. Final rule.
Q51569641	Medical devices; general hospital and personal use devices; classification of implantable radiofrequency transponder system for patient identification and health information. Final rule.
Q42008686	Medical devices; general hospital and personal use devices; classification of the filtering facepiece respirator for use by the general public in public health medical emergencies. Final rule.
Q53548644	Medical devices; general hospital and personal use devices; classification of the intravascular administration set, automated air removal system. Final order.
Q44420460	Medical devices; general hospital and personal use monitoring devices; classification of the ingestible event marker. Final order
Q33357412	Medical devices; hearing aids; technical data amendments. Direct final rule.
Q50847791	Medical devices; hematology and pathology devices: reclassification of automated blood cell separator device operating by centrifugal separation principle. Final rule.
Q51066648	Medical devices; hematology and pathology devices; classification of cord blood processing system and storage container. Final rule.
Q53454280	Medical devices; hematology and pathology devices; classification of early growth response 1 gene fluorescence in-situ hybridization test system for specimen characterization. Final order.
Q47941968	Medical devices; hematology and pathology devices; classification of the Factor V Leiden DNA mutation detection systems devices. Final rule.
Q56894421	Medical devices; humanitarian use of devices--FDA. Direct final rule
Q56894387	Medical devices; humanitarian use of devices--FDA. Direct final rule; withdrawal
Q56894375	Medical devices; humanitarian use of devices--FDA. Final rule
Q56894410	Medical devices; humanitarian use of devices; companion to direct final rule--FDA. Proposed rule
Q77124740	Medical devices; illustrative and designated lists for device tracking--FDA. Final rule and request for comments
Q51343666	Medical devices; immunology and microbiology devices; classification of AFP-L3% immunological test systems. Final rule.
Q42241636	Medical devices; immunology and microbiology devices; classification of John Cunningham Virus serological reagents. Final order
Q47590891	Medical devices; immunology and microbiology devices; classification of Plasmodium species antigen detection assays. Final rule
Q51330281	Medical devices; immunology and microbiology devices; classification of cystic fibrosis transmembrane conductance regulator gene mutation detection system. Final rule.
Q40190508	Medical devices; immunology and microbiology devices; classification of dengue virus nucleic acid amplification test reagents. Final order.
Q40205371	Medical devices; immunology and microbiology devices; classification of dengue virus serological reagents. Final order
Q51150409	Medical devices; immunology and microbiology devices; classification of fecal calprotectin immunological test systems. Final rule.
Q50997155	Medical devices; immunology and microbiology devices; classification of gene expression profiling test system for breast cancer prognosis. Final rule.
Q53220309	Medical devices; immunology and microbiology devices; classification of multiplex nucleic acid assay for identification of microorganisms and resistance markers from positive blood cultures. Final order.
Q44109477	Medical devices; immunology and microbiology devices; classification of norovirus serological reagents. Final rule
Q51688857	Medical devices; immunology and microbiology devices; classification of nucleic acid-based devices for the detection of Mycobacterium tuberculosis complex and the genetic mutations associated with antibiotic resistance. Final order.
Q83702099	Medical devices; immunology and microbiology devices; classification of ovarian adnexal mass assessment score test system. Final rule
Q51066653	Medical devices; immunology and microbiology devices; classification of quality control material for cystic fibrosis nucleic acid assays. Final rule.
Q51241744	Medical devices; immunology and microbiology devices; classification of reagents for detection of specific novel influenza A viruses. Final rule.
Q84820612	Medical devices; immunology and microbiology devices; classification of respiratory viral panel multiplex nucleic acid assay. Final rule
Q51366748	Medical devices; immunology and microbiology devices; classification of ribonucleic acid preanalytical systems. Final rule.
Q40547257	Medical devices; immunology and microbiology devices; classification of the West Nile Virus IgM capture Elisa assay. Final rule
Q51523941	Medical devices; immunology and microbiology devices; classification of the automated fluorescence in situ hybridization enumeration systems. Final rule.
Q51610975	Medical devices; immunology and microbiology devices; classification of the beta-glucan serological assay. Final rule.
Q51804028	Medical devices; immunology and microbiology devices; classification of the endotoxin assay. Final rule
Q51676381	Medical devices; immunology and microbiology devices; classification of the immunomagnetic circulating cancer cell selection and enumeration system. Final rule.
Q53441610	Medical devices; immunology and microbiology devices; classification of tryptase test system. Final order.
Q77162066	Medical devices; implementation of third party review under the Food and Drug Administration Modernization Act of 1997; emergency processing request under OMB review--FDA. Notice
Q77630383	Medical devices; intent to initiate proceedings to establish effective dates of requirement for premarket approval for 31 class III preamendments devices--FDA. Advance notice of proposed rulemaking
Q77783960	Medical devices; investigational device exemptions--FDA. Final rule
Q77167689	Medical devices; investigational device exemptions--FDA. Proposed rule
Q77575262	Medical devices; invitation for offers to submit or to develop a performance standard for breathing frequency monitor (neonatal apnea monitor)--FDA. Proposed rule
Q77571696	Medical devices; invitation for offers to submit or to develop a performance standard for cardiac monitor (including cardiotachometer and rate alarm)--FDA. Notice of inquiry
Q74368118	Medical devices; labeling for menstrual tampon for the "ultra" absorbency. Food and Drug Administration, HHS. Final rule
Q51627418	Medical devices; labeling for menstrual tampons; ranges of absorbency, change from "junior" to "light." Final rule.
Q73018358	Medical devices; laser fluorescence caries detection device. Food and Drug Administration, HHS. Final rule
Q74775370	Medical devices; medical device distributor reporting--FDA. Final rule; notification of status under the Safe Medical Devices Act; confirmation of effective date
Q74775367	Medical devices; medical device distributor reporting; opportunity for comments--FDA. Final rule; opportunity for comments
Q51535547	Medical devices; medical device reporting. Direct final rule.
Q47417214	Medical devices; medical device reporting; baseline reports. Direct final rule
Q77069691	Medical devices; medical device reporting; baseline reports; stay of effective date--FDA. Final rule
Q77061323	Medical devices; medical device user facility and manufacturer reporting, certification and registration; Office of Management and Budget approval; extension of effective date--FDA. Final rule; notification of approval of information collection requ
Q74731294	Medical devices; medical device, user facility, distributor, and manufacturer reporting, certification, and registration--FDA. Tentative final rule
Q74738122	Medical devices; medical device, user facility, distributor, and manufacturer reporting, certification, and registration; correction--FDA. Tentative final rule; correction
Q77168805	Medical devices; neurological devices; classification of cranial orthosis--FDA. Final rule
Q84607610	Medical devices; neurological devices; classification of repetitive transcranial magnetic stimulation system. Final rule
Q48582152	Medical devices; neurological devices; classification of the Near Infrared Brain Hematoma Detector. Final rule.
Q48217925	Medical devices; neurological devices; classification of the brain injury adjunctive interpretive electroencephalograph assessment aid. Final order
Q52800378	Medical devices; neurological devices; classification of the limited output transcutaneous piezoelectric stimulator for skin reactions associated with insect bites. Final order.
Q53602877	Medical devices; neurological devices; classification of the neuropsychiatric interpretive electroencephalograph assessment aid. Final order.
Q53503744	Medical devices; neurological devices; classification of the transcranial magnetic stimulator for headache. Final order.
Q95430360	Medical devices; neurological devices; classification of the transcutaneous electrical nerve stimulator to treat headache. Final order
Q80372836	Medical devices; obstetrical and gynecological devices; classification of computerized labor monitoring system. Final rule
Q53256524	Medical devices; obstetrical and gynecological devices; classification of the assisted reproduction embryo image assessment system. Final order.
Q31137966	Medical devices; obstetrical and gynecological devices; classification of the assisted reproduction laser system. Final rule.
Q51843398	Medical devices; obstetrical and gynecological devices; classification of the breast lesion documentation system. Final rule.
Q83933311	Medical devices; obstetrical and gynecological devices; classification of the hemorrhoid prevention pressure wedge. Final rule
Q84895860	Medical devices; ophthalmic devices; classification of the eyelid thermal pulsation system. Final rule
Q47175015	Medical devices; ophthalmic devices; classification of the eyelid weight. Final rule
Q53670977	Medical devices; ophthalmic devices; classification of the scleral plug. Final rule.
Q83225940	Medical devices; ovarian adnexal mass assessment score test system; labeling; black box restrictions. Final rule
Q74697043	Medical devices; patient examination and surgeons' gloves; adulteration--FDA. Final rule
Q51066656	Medical devices; patient examination and surgeons' gloves; test procedures and acceptance criteria. Final rule.
Q77630388	Medical devices; patient examination glove; revocation of exemptions from the premarket notification procedures and the current good manufacturing practice regulations--FDA. Final rule
Q53641364	Medical devices; pediatric uses of devices; requirement for submission of information on pediatric subpopulations that suffer from a disease or condition that a device is intended to treat, diagnose, or cure. Final rule.
Q84041148	Medical devices; pediatric uses of devices; requirement for submission of information on pediatric subpopulations that suffer from a disease or condition that a device is intended to treat, diagnose, or cure; direct final rule. Direct final rule
Q73175018	Medical devices; performance standard for diagnostic x-ray systems; amendment. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule
Q77194186	Medical devices; performance standards for dental and mammographic X-ray devices; amendment--FDA. Proposed rule
Q53503748	Medical devices; physical medicine devices; classification of the nonpowered lower extremity pressure wrap. Final order.
Q53300847	Medical devices; physical medicine devices; classification of the powered exoskeleton. Final order.
Q95384510	Medical devices; physical medicine devices; classification of the powered lower extremity exoskeleton; republication. Final order; republication
Q77159774	Medical devices; preemption of state product liability claims--FDA. Correction
Q77149372	Medical devices; preemption of state product liability claims--FDA. Proposed rule
Q77168789	Medical devices; preemption of state product liability claims--FDA. Withdrawal of proposed rule
Q77473213	Medical devices; procedures for investigational device exemptions--Food and Drug Administration. Final rule
Q74762063	Medical devices; procedures for premarket notification, premarket approval, classification, performance standards establishment, banning devices, and availability of regulatory hearings--FDA. Final rule
Q47300536	Medical devices; radiology devices; reclassification of bone sonometers. Final rule
Q39957811	Medical devices; radiology devices; reclassification of full-field digital mammography system. Final rule
Q73018448	Medical devices; reclassification and codification of Neodymium:Yttrium:Aluminum:Garnet (Nd:YAG) Laser for peripheral iridotomy. Food and Drug Administration, HHS. Final rule
Q74724585	Medical devices; reclassification and codification of absorbable poly(glycolide/L-lactide) surgical suture--FDA. Final rule
Q74762635	Medical devices; reclassification and codification of hip joint metal polymer/metal semi-constrained porous-coated uncemented prosthesis--FDA. Final rule
Q77141323	Medical devices; reclassification and codification of home uterine activity monitor. Final rule
Q74770236	Medical devices; reclassification and codification of microsurgical argon laser for rhinology and laryngology--FDA. Final rule
Q57222596	Medical devices; reclassification and codification of natural nonabsorbable silk surgical suture--FDA. Final rule
Q77154726	Medical devices; reclassification and codification of suction lipoplasty system for aesthetic body contouring--FDA. Final rule
Q73018403	Medical devices; reclassification and codification of the nonabsorbable expanded polytetrafluoroethylene surgical suture. Food and Drug Administration, HHS. Final rule
Q73018387	Medical devices; reclassification and codification of the stainless steel suture. Food and Drug Administration, HHS. Final rule
Q77169737	Medical devices; reclassification and codification of vitamin D test system--FDA. Final rule
Q74481855	Medical devices; reclassification of polymethylmethacrylate (PMMA) bone cement. Final rule
Q77228619	Medical devices; reclassification of six cardiovascular preamendments class III devices into class II. Final rule
Q51310903	Medical devices; reclassification of the cutaneous carbon dioxide and the cutaneous oxygen monitor. Final rule.
Q73163853	Medical devices; reclassification of the knee joint patellofemorotibial metal/polymer porous-coated uncemented prosthesis and the knee joint femorotibial (unicompartmental) metal/polymer porous-coated uncemented prosthesis. Final rule
Q74369082	Medical devices; reclassification of the shoulder joint metal/polymer/metal nonconstrained or semi-constrained porous-coated uncemented prosthesis. Food and Drug Administration, HHS. Final rule
Q33450242	Medical devices; reclassification of the topical oxygen chamber for extremities. Final rule.
Q77447692	Medical devices; reclassification of three anesthesiology preamendments class III devices into class II. Final rule
Q77159771	Medical devices; reclassification of tumor-associated antigen immunological test system--FDA. Final rule
Q77784002	Medical devices; reconditioners, rebuilders of medical devices; revocation of compliance policy guide; request for comments--FDA. Notice
Q77159808	Medical devices; refurbishers, rebuilders, reconditioners, servicers, and "as is" remarketers of medical devices; review and revision of compliance policy guides and regulatory requirements; request for comments and information--FDA. Advance notice
Q77169801	Medical devices; reports of corrections and removals--FDA. Direct final rule
Q77106222	Medical devices; reports of corrections and removals--FDA. Final rule
Q77169807	Medical devices; reports of corrections and removals; companion to direct final rule--FDA. Proposed rule
Q77159840	Medical devices; reports of corrections and removals; lift of stay of effective date--FDA. Final rule; lift of stay of effective date
Q31064093	Medical devices; reprocessed single-use devices; requirement for submission of validation data. Direct final rule
Q77168811	Medical devices; retention in class III and effective date of requirement for premarket approval for three preamendments class III devices--FDA. Proposed rule; opportunity to request a change in classification
Q77166898	Medical devices; retention of three preamendment class III devices in class III--FDA. Final rule
Q77153843	Medical devices; review and revision of compliance policy guides and regulatory requirements for refurbishers, rebuilders, reconditioners, servicers and "as is" remarketers of medical devices; request for comments and information; extension of comme
Q73018568	Medical devices; revocation of cardiac pacemaker registry. Food and Drug Administration, HHS. Final rule
Q74803665	Medical devices; substantial equivalence; 510(K) summaries and 510(K) statements; class III summaries; confidentiality of information--FDA. Final rule
Q77494117	Medical devices; various proposed rules for device classification; withdrawal of proposed rules. Food and Drug Administration. Withdrawal of proposed rules
Q74793563	Medical examination of aliens (AIDS); final rule
Q43438330	Medical examination of aliens (AIDS); notice of proposed rulemaking.
Q77723361	Medical examination of aliens--HHS. Final rule
Q45378508	Medical examination of aliens--removal of human immunodeficiency virus (HIV) infection from definition of communicable disease of public health significance. Final rule.
Q77543167	Medical facility construction and modernization--PHS. Final rule
Q77647471	Medical facility construction and modernization: requirements for provision of services to persons unable to pay; Office of Management and Budget approval of information collection requirements--HRSA. Final rule; effective date
Q77447122	Medical facility construction and modernization; requirements for provision of services to persons unable to pay and community service by assisted health facilities: final rule
Q74809918	Medical facility construction and modernization; requirements for provision of services to persons unable to pay--PHS. Final rule
Q77586064	Medical facility construction and modernization; requirements for provision of services to persons unable to pay--PHS. Final rule
Q77608066	Medical facility construction and modernization; requirements for provision of services to persons unable to pay--PHS. Final rule
Q77564379	Medical facility construction and modernization; requirements for provision of services to persons unable to pay--PHS. Proposed rules
Q74797090	Medical facility construction and modernization; requirements for uncompensated services for persons unable to pay--PHS. Final rule
Q82931470	Medical loss ratio rebate requirements for non-federal governmental plans. Interim final rule with request for comments
Q84164001	Medical loss ratio requirements under the Patient Protection and Affordable Care Act. Final rule
Q82931464	Medical loss ratio requirements under the Patient Protection and Affordable Care Act. Final rule with comment period
Q77462009	Medical participation in control of certain open-panel medical prepayment plans: Federal Trade Commission. Request for comment and advance notice of proposed rulemaking
Q77653217	Medical program; public notice of changes in method or level of reimbursement--Health Care Financing Administration. Interim final rule with comment period
Q77660299	Medical reimbursement rates for fiscal year 1986; inpatient and outpatient medical care--HRA
Q77516360	Medical reimbursements rates for fiscal year 1983; inpatient and outpatient medical care; correction
Q77652390	Medical school and health manpower assistance--Veterans Administration. Proposed rules
Q84296667	Medical use of byproduct material--authorized user clarification. Direct final rule
Q77116792	Medical use of byproduct material: issues and request for public input--NRC. Request for public input on rule development
Q77174750	Medical use of byproduct material; draft policy statement--NRC. draft policy statement
Q73162577	Medical use of byproduct material; policy statement, revision. Nuclear Regulatory Commission. Final policy statement; revision
Q77174745	Medical use of byproduct material; proposed revision--NRC. Proposal rule
Q77168785	Medical use of byproduct material; public meetings--NRC. Notice of public meetings
Q40368862	Medical: advance health care planning. Final rule
Q77194217	Medical: advance healthcare planning--VA. Proposed rule
Q56786335	Medical: informed consent--designate health care professionals to obtain informed consent. Final rule
Q77061329	Medical; nonsubstantive miscellaneous changes--VA. Final rule
Q79318356	Medicare Part B income-related monthly adjustment amount. Final rules
Q82166830	Medicare Part D subsidies. Final rules
Q74689887	Medicare Program, fiscal year 1990; mid-year changes to the inpatient hospital prospective payment system--HCFA. Correction of final rule
Q93264483	Medicare Program: Changes to Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs. Final rule with comment period
Q39095083	Medicare Program: Changes to the Medicare Claims and Entitlement, Medicare Advantage Organization Determination, and Medicare Prescription Drug Coverage Determination Appeals Procedures. Final rule
Q31113837	Medicare Program: Expanding Uses of Medicare Data by Qualified Entities. Final rule
Q49902447	Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs. Final rule with comment period
Q95432850	Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs. Final rule with comment period
Q95369759	Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; Organ Procurement Organization Reporting and Communication; Transplant Outcome Measures and Documentation Requir
Q38633136	Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; Short Inpatient Hospital Stays; Transition for Certain Medicare-Dependent, Small Rural Hospitals Under the
Q48026372	Medicare Program; Advancing Care Coordination Through Episode Payment Models (EPMs); Cardiac Rehabilitation Incentive Payment Model; and Changes to the Comprehensive Care for Joint Replacement Model (CJR). Final rule
Q95724663	Medicare Program; Advancing Care Coordination Through Episode Payment Models (EPMs); Cardiac Rehabilitation Incentive Payment Model; and Changes to the Comprehensive Care for Joint Replacement Model (CJR); Delay of Effective Date. Final rule; delay
Q47786998	Medicare Program; CY 2018 Updates to the Quality Payment Program; and Quality Payment Program: Extreme and Uncontrollable Circumstance Policy for the Transition Year. Final rule with comment period and interim final rule with comment period
Q49898838	Medicare Program; Cancellation of Advancing Care Coordination Through Episode Payment and Cardiac Rehabilitation Incentive Payment Models; Changes to Comprehensive Care for Joint Replacement Payment Model: Extreme and Uncontrollable Circumstances Po
Q91353826	Medicare Program; Certain Changes to the Low-Volume Hospital Payment Adjustment Under the Hospital Inpatient Prospective Payment Systems (IPPS) for Acute Care Hospitals for Fiscal Years 2011 Through 2017. Application of a payment adjustment
Q90308816	Medicare Program; Changes to the Comprehensive Care for Joint Replacement Payment Model (CJR): Extreme and Uncontrollable Circumstances Policy for the CJR Model. Final rule
Q50273279	Medicare Program; Comprehensive Care for Joint Replacement Payment Model for Acute Care Hospitals Furnishing Lower Extremity Joint Replacement Services. Final rule
Q47601197	Medicare Program; Conditions for Coverage for End-Stage Renal Disease Facilities--Third Party Payment. Interim final rule with comment period
Q90274662	Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program. Final rule
Q90284623	Medicare Program; Durable Medical Equipment Fee Schedule Adjustments To Resume the Transitional 50/50 Blended Rates To Provide Relief in Rural Areas and Non-Contiguous Areas. Interim final rule with comment period
Q38404114	Medicare Program; End-Stage Renal Disease Prospective Payment System, Coverage and Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, P
Q93235838	Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, Prosthetics, O
Q95420587	Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, and End-Stage Renal Disease Quality Incentive Program. Final rule
Q38411413	Medicare Program; End-Stage Renal Disease Prospective Payment System, and Quality Incentive Program. Final Rule
Q95544544	Medicare Program; Explanation of FY 2004 Outlier Fixed-Loss Threshold as Required by Court Rulings. Clarification
Q38561856	Medicare Program; FY 2016 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Requirements. Final rule
Q95511371	Medicare Program; FY 2017 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Requirements. Final rule
Q53113291	Medicare Program; FY 2018 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Requirements. Final rule.
Q90771848	Medicare Program; FY 2019 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Requirements. Final rule
Q90771843	Medicare Program; FY 2019 Inpatient Psychiatric Facilities Prospective Payment System and Quality Reporting Updates for Fiscal Year Beginning October 1, 2018 (FY 2019). Final rule
Q50763343	Medicare Program; Final Waivers in Connection With the Shared Savings Program. Final rule.
Q85938619	Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System Policy Changes and Fiscal Year 2016 Rates; Revisions of Quality Reporting Requirements for Specific
Q38932999	Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year 2017 Rates; Quality Reporting Requirements for Specific Pro
Q48577990	Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year 2018 Rates; Quality Reporting Requirements for Specific Providers
Q91329288	Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year 2019 Rates; Quality Reporting Requirements for Specific Providers
Q40302693	Medicare Program; Inpatient Psychiatric Facilities Prospective Payment System--Update for Fiscal Year Beginning October 1, 2015 (FY 2016). Final rule
Q38561854	Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2016. Final rule
Q39485417	Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2017. Final rule
Q38626269	Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2018. Final rule
Q90771819	Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2019. Final rule
Q95450980	Medicare Program; Medicare Clinical Diagnostic Laboratory Tests Payment System. Final rule
Q47254376	Medicare Program; Medicare Shared Savings Program: Extreme and Uncontrollable Circumstances Policies for Performance Year 2017. Interim final rule with comment period
Q54765045	Medicare Program; Medicare Shared Savings Program; Accountable Care Organizations--Revised Benchmark Rebasing Methodology, Facilitating Transition to Performance-Based Risk, and Administrative Finality of Financial Calculations. Final rule.
Q90821220	Medicare Program; Medicare Shared Savings Program; Accountable Care Organizations--Pathways to Success and Extreme and Uncontrollable Circumstances Policies for Performance Year 2017. Final rules
Q51449110	Medicare Program; Merit-Based Incentive Payment System (MIPS) and Alternative Payment Model (APM) Incentive Under the Physician Fee Schedule, and Criteria for Physician-Focused Payment Models. Final rule with comment period.
Q74711031	Medicare Program; OBRA '87 conforming amendments; correction--HCFA. Final rule; correction
Q53097224	Medicare Program; Obtaining Final Medicare Secondary Payer Conditional Payment Amounts via Web Portal. Final rule.
Q95725554	Medicare Program; Prior Authorization Process for Certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Items; Update to the Master List of Items Frequently Subject to Unnecessary Utilization. Master list deletions
Q38683109	Medicare Program; Prior Authorization Process for Certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies. Final rule
Q90850062	Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities (SNF) Final Rule for FY 2019, SNF Value-Based Purchasing Program, and SNF Quality Reporting Program. Final rule
Q30985153	Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities (SNFs) for FY 2016, SNF Value-Based Purchasing Program, SNF Quality Reporting Program, and Staffing Data Collection. Final Rule.
Q38928839	Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities for FY 2017, SNF Value-Based Purchasing Program, SNF Quality Reporting Program, and SNF Payment Models Research. Final rule
Q38626268	Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities for FY 2018, SNF Value-Based Purchasing Program, SNF Quality Reporting Program, Survey Team Composition, and Correction of the Performance Period fo
Q95552117	Medicare Program; Reporting and Returning of Overpayments. Final rule
Q95485678	Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2016. Final rule with comment period
Q31146335	Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2017; Medicare Advantage Bid Pricing Data Release; Medicare Advantage and Part D Medical Loss Ratio Data Release; Medicare Advantag
Q95725099	Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2018; Medicare Shared Savings Program Requirements; and Medicare Diabetes Prevention Program. Final rule
Q38814165	Medicare Program; Temporary Exception for Certain Severe Wound Discharges From Certain Long-Term Care Hospitals Required by the Consolidated Appropriations Act, 2016; Modification of Limitations on Redesignation by the Medicare Geographic Clas
Q90308797	Medicare Program; Update to the Required Prior Authorization List of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Items That Require Prior Authorization as a Condition of Payment. Update to list
Q77165195	Medicare Program; establishment of the Medicare+Choice Program--HCFA. Interim final rule with comment period
Q39281362	Medicare Program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system changes and FY2011 rates; provider agreements and supplier approvals; and hospital conditions of par
Q74792632	Medicare Program; physician performance standard rates of increase for fiscal year 1994 and physician fee schedule update for calendar year 1994--HCFA. Correction of final notice with comment period
Q74734136	Medicare Program; quarterly listing of program issuances and coverage decisions--HCFA. General notice
Q44335346	Medicare Program; revisions to the Medicare Advantage and Prescription Drug Benefit programs. Interim final rule with comment period.
Q77652769	Medicare Program; statistical standards for evaluating intermediary performance during fiscal year 1981--Health Care Financing Administration. General notice with comment period
Q37318084	Medicare Program; termination of non-random prepayment complex medical review. Final rule.
Q40365685	Medicare and Medicaid Program: Conditions of Participation for Home Health Agencies. Final rule
Q40340466	Medicare and Medicaid Programs; CY 2016 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements. Final rule
Q95723992	Medicare and Medicaid Programs; CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements. Final rule
Q47642341	Medicare and Medicaid Programs; CY 2018 Home Health Prospective Payment System Rate Update and CY 2019 Case-Mix Adjustment Methodology Refinements; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements. Final rule
Q93235719	Medicare and Medicaid Programs; CY 2019 Home Health Prospective Payment System Rate Update and CY 2020 Case-Mix Adjustment Methodology Refinements; Home Health Value-Based Purchasing Model; Home Health Quality Reporting Requirements; Home Infusion T
Q38411822	Medicare and Medicaid Programs; Electronic Health Record Incentive Program--Stage 3 and Modifications to Meaningful Use in 2015 Through 2017. Final rules with comment period
Q30151764	Medicare and Medicaid Programs; Emergency Preparedness Requirements for Medicare and Medicaid Participating Providers and Suppliers. Final rule
Q47710640	Medicare and Medicaid Programs; Fire Safety Requirements for Certain Health Care Facilities. Final rule
Q95547752	Medicare and Medicaid Programs; Reform of Requirements for Long-Term Care Facilities. Final rule
Q77298857	Medicare and Medicaid Programs; change of agency name: technical amendments. Final rule with comment period
Q77080406	Medicare and Medicaid Programs; new payment methodology for routine extended care services provided in a swing-bed hospital--HCFA
Q77083865	Medicare and Medicaid Programs; new payment methodology for routine extended care services provided in a swing-bed hospital; correction--HCFA. Correction notice
Q74797073	Medicare and Medicaid Programs; quarterly listing of program issuances and coverage decisions--first quarter 1994--HCFA. Notice
Q74775360	Medicare and Medicaid Programs; quarterly listing of program issuances and coverage decisions--second quarter 1993--HCFA. Notice
Q77649441	Medicare and Medicaid hospice projects: announcements of projects
Q77204688	Medicare and Medicaid program; civil money penalties, assessments, exclusions, and related appeals procedures--HCFA. Final rule with comment period
Q77061331	Medicare and Medicaid program; criteria for a rural hospital to be designated as an essential access community hospital (EACH)--HCFA. Final rule with comment period
Q77653138	Medicare and Medicaid program; less than effective drugs and inpatient hospital tests--Health Care Financing Administration. Interim final rule with comment period
Q77653928	Medicare and Medicaid program; nurse-midwife services--Health Care Financing Administration. Interim final rule with comment period
Q38011186	Medicare and Medicaid program; regulatory provisions to promote program efficiency, transparency, and burden reduction. Final rule.
Q77658872	Medicare and Medicaid program; withholding the federal share of payments to recover Medicare or Medicaid overpayments--HCFA. Final rule
Q77654978	Medicare and Medicaid program; withholding the federal share of payments to recover Medicare or Medicaid overpayments--Health Care Financing Administration. Proposed rule
Q77661433	Medicare and Medicaid programs long-term care survey--HCFA. Final rule
Q77650030	Medicare and Medicaid programs, exclusion of practitioners, providers, and other suppliers of services and suspension of physicians and other individual practitioners: final rules
Q74697060	Medicare and Medicaid programs, freedom of information (FOI) guidelines--HCFA. Notice
Q77549855	Medicare and Medicaid programs, health care financing research and demonstration cooperative agreements and grants and availability of funds for cooperative agreements and grants--HCFA. General notice
Q77653299	Medicare and Medicaid programs, less than effective drugs. Health Care Financing Administration. Notice of legislation affecting implementation and enforcement of interim final rule
Q77653797	Medicare and Medicaid programs, less than effective drugs: Health Care Financing Administration. Notice of legislation affecting implementation and enforcement of interim final rule
Q50548898	Medicare and Medicaid programs: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; electronic reporting pilot; Inpatient Rehabilitation Facilities Quality Reporting Program; revisio
Q30868781	Medicare and Medicaid programs: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; physician-owned hospitals: data sources for expansion exception; physician certification of inpati
Q84042427	Medicare and Medicaid programs: changes affecting hospital and critical access hospital conditions of participation: telemedicine credentialing and privileging. Final rule
Q82517021	Medicare and Medicaid programs: changes to the hospital and critical access hospital conditions of participation to ensure visitation rights for all patients. Final rule
Q77655391	Medicare and Medicaid programs: conditions of participation for hospitals--HCFA. Proposed rule
Q77116807	Medicare and Medicaid programs: effective dates of provider agreements and supplier approvals--HCFA. Final rule
Q81737880	Medicare and Medicaid programs: hospice conditions of participation. Final rule
Q54436095	Medicare and Medicaid programs: hospital outpatient prospective payment and ambulatory surgical center payment systems and quality reporting programs; Hospital Value-Based Purchasing Program; organ procurement organizations; quality improvement orga
Q82824546	Medicare and Medicaid programs: hospital outpatient prospective payment; ambulatory surgical center payment; hospital value-based purchasing program; physician self-referral; and patient notification requirements in provider agreements. Final rule w
Q77652067	Medicare and Medicaid programs: limit on payment for services of independent rural health clinics--Health Care Financing Administration. Proposed notice
Q31028439	Medicare and Medicaid programs: reporting outcome and assessment information set data as part of the conditions of participation for home health agencies. Final rule
Q85199785	Medicare and Medicaid programs: revisions to deeming authority survey, certification, and enforcement procedures. Final rule
Q77652206	Medicare and Medicaid programs: schedules of guidelines for physical therapy and respiratory therapy services--Health Care Financing Administration. Final notice with a request for comments
Q77687954	Medicare and Medicaid programs: suspension of physicians and other individual practitioners
Q85920423	Medicare and Medicaid programs; CY 2015 Home Health Prospective Payment System rate update; Home Health Quality Reporting Requirements; and survey and enforcement requirements for home health agencies. Final rule
Q77659077	Medicare and Medicaid programs; Deficit Reduction Act of 1984; information notice on Medicare and Medicaid amendments--HCFA
Q44768804	Medicare and Medicaid programs; Home Health Prospective Payment System rate update for CY 2014, home health quality reporting requirements, and cost allocation of home health survey expenses. Final rule
Q77668571	Medicare and Medicaid programs; Medicare, Medicaid, and Clinical Laboratories Improvement Act (CLIA) patient confidentiality rules--PHS and HCFA. Final rule
Q74792644	Medicare and Medicaid programs; Medicare-Medicaid coverage data bank requirements: preliminary guidance--HCFA. Notice
Q74703898	Medicare and Medicaid programs; OBRA '87 conforming amendments--HCFA. Final rule with comment period
Q77660960	Medicare and Medicaid programs; OMB control numbers for collection of information requirements contained in HCFA regulations--HCFA. Final rule and correction notice
Q77663521	Medicare and Medicaid programs; OMB control numbers for collection of information requirements contained in HCFA regulations--HCFA. Final rule and correction notice
Q77659073	Medicare and Medicaid programs; OMB control numbers for collections of information contained in HCFA regulations--HCFA. Final rule
Q77656685	Medicare and Medicaid programs; OMB control numbers for collections of information contained in HCFA regulations--HCFA. Final rules
Q77653288	Medicare and Medicaid programs; Omnibus Budget Reconciliation Act of 1981: information notice on Medicare and Medicaid amendments. Health Care Financing Administration. General notice
Q77656057	Medicare and Medicaid programs; Tax Equity and Fiscal Responsibility Act of 1982; information notice on Medicare and Medicaid amendments--HCFA. General notice
Q77660280	Medicare and Medicaid programs; Utilization and Quality Control Peer Review Organization (PRO); correction--HCFA
Q74814500	Medicare and Medicaid programs; advance directives--HCFA. Final rule
Q74739710	Medicare and Medicaid programs; advance directives--HCFA. Interim final rule with comment period
Q52015470	Medicare and Medicaid programs; advance directives; final rule.
Q77153830	Medicare and Medicaid programs; announcement of additional application from hospital requesting waiver for organ procurement service area--HCFA. Notice with comment period
Q77193910	Medicare and Medicaid programs; announcement of additional applications from hospitals requesting waivers for organ procurement service area--HCFA
Q83776350	Medicare and Medicaid programs; approval of the Joint Commission for continued deeming authority for hospices. Final notice
Q74761828	Medicare and Medicaid programs; approved information collection requirements and HCFA's claims collection authority--HCFA. Final rule with comment period
Q74797062	Medicare and Medicaid programs; approved information collection requirements--HCFA. Final rule with comment period
Q74832499	Medicare and Medicaid programs; approved information collection requirements--HCFA. Technical final rule
Q77663915	Medicare and Medicaid programs; benefit period determinations, drug regimen reviews and other technical changes--HCFA. Final rule
Q38471413	Medicare and Medicaid programs; changes in provider and supplier enrollment, ordering and referring, and documentation requirements; and changes in provider agreements. Final rule.
Q38373660	Medicare and Medicaid programs; changes in provider and supplier enrollment, ordering and referring, and documentation requirements; and changes in provider agreements. Interim final rule with comment period
Q83702095	Medicare and Medicaid programs; civil money penalties for nursing homes. Final Rule
Q77659838	Medicare and Medicaid programs; collection of overdue Medicare Part B premiums--HCFA. Notice
Q81324608	Medicare and Medicaid programs; condition of participation: immunization standard for long term care facilities. Final rule
Q34777204	Medicare and Medicaid programs; conditions for coverage for end-stage renal disease facilities. Final rule.
Q34533882	Medicare and Medicaid programs; conditions for coverage for organ procurement organizations (OPOs). Final rule.
Q77063457	Medicare and Medicaid programs; conditions of coverage for organ procurement organizations (OPOs)--HCFA. Final rule with comment period
Q74798942	Medicare and Medicaid programs; conditions of coverage for organ procurement organizations--HCFA. Interim final rule with comment
Q77661165	Medicare and Medicaid programs; conditions of participation for hospitals--HCFA. Final regulations
Q78317406	Medicare and Medicaid programs; conditions of participation: immunization standards for hospitals, long-term care facilities, and home health agencies. Final rule with comment period
Q84930393	Medicare and Medicaid programs; electronic health record incentive program--stage 2. Final rule
Q84631681	Medicare and Medicaid programs; electronic health record incentive program. Final rule
Q77454347	Medicare and Medicaid programs; emergency recertification for coverage for organ procurement organizations (OPOs). Interim final rule with comment period
Q42043533	Medicare and Medicaid programs; end-stage renal disease--waiver of conditions for coverage under a state of emergency in Houston, TX area. Final rule.
Q77665046	Medicare and Medicaid programs; entities performing quality of care review of services provided by risk-basis health maintenance organizations and competitive medical plans--HCFA. Final rule with comment period
Q77662897	Medicare and Medicaid programs; establishment of Chapter V for OIG regulations--HHS. Final rule
Q47881310	Medicare and Medicaid programs; fire safety requirements for certain health care facilities. Final rule.
Q47847856	Medicare and Medicaid programs; fire safety requirements for certain health care facilities; amendment. Final rule
Q46405149	Medicare and Medicaid programs; fire safety requirements for certain health care facilities; amendment. Interim final rule with comment period
Q47823056	Medicare and Medicaid programs; fire safety requirements for long term care facilities, automatic sprinkler systems. Final rule.
Q77672865	Medicare and Medicaid programs; fraud and abuse OIG anti-kickback provisions--HHS. Proposed rule
Q77660008	Medicare and Medicaid programs; fraud and abuse--HHS. Final rule with comment period
Q77669668	Medicare and Medicaid programs; fraud and abuse; administrative adjudication of certain health care exclusion cases--HHS. Final rule
Q77665511	Medicare and Medicaid programs; fraud and abuse; revisions to the civil money penalty statute of limitations--HHS. Final rule
Q77522495	Medicare and Medicaid programs; health care financing issues; solicitation of applications for a research center--HCFA. General notice
Q77668583	Medicare and Medicaid programs; health care financing research and demonstration; availability of funds for cooperative agreements and grants, Medicare Catastrophic Coverage Act of 1988--HCFA. General notice
Q77669502	Medicare and Medicaid programs; health care financing research and demonstration; availability of funds for cooperative agreements and grants--HCFA. General notice
Q51339651	Medicare and Medicaid programs; hospital Conditions of Participation: anesthesia services. Final rule.
Q74368525	Medicare and Medicaid programs; hospital conditions of participation: anesthesia services. Health Care Financing Administration (HCFA), HHS. Final rule
Q43588780	Medicare and Medicaid programs; hospital conditions of participation: laboratory services. Final rule.
Q81334847	Medicare and Medicaid programs; hospital conditions of participation: laboratory services. Interim final rule with comment period
Q79435661	Medicare and Medicaid programs; hospital conditions of participation: patients' rights. Final rule
Q35052614	Medicare and Medicaid programs; hospital conditions of participation: quality assessment and performance improvement. Final rule.
Q48640102	Medicare and Medicaid programs; hospital conditions of participation: requirements for history and physical examinations; authentication of verbal orders; securing medications; and postanesthesia evaluations. Final rule
Q77163712	Medicare and Medicaid programs; hospital conditions of participation; identification of potential organ, tissue, and eye donors and transplant hospitals' provision of transplant-related data--HCFA. Final rule
Q77159783	Medicare and Medicaid programs; hospital conditions of participation; provider agreements and supplier approval--HCFA. Proposed rule
Q77154731	Medicare and Medicaid programs; hospital conditions of participation; provider agreements and supplier approval; extension of comment period--HCFA. Notice of extension of comment period for proposed rule
Q77072528	Medicare and Medicaid programs; hospital standard for potentially HIV infectious blood and blood products--HCFA. Final rule
Q77661444	Medicare and Medicaid programs; intermediate sanction for long-term care facilities--HCFA. Final rule
Q77658280	Medicare and Medicaid programs; intermediate sanction of long-term care facilities--HCFA. Proposed rule
Q77653210	Medicare and Medicaid programs; less than effective drug products subject to a notice of opportunity for hearing; correction--Health Care Financing Administration. Correction of general notice
Q77664585	Medicare and Medicaid programs; limits on payments for drugs--HCFA. Final rule
Q77660019	Medicare and Medicaid programs; long-term care survey--HCFA. Proposed rule
Q73175001	Medicare and Medicaid programs; mandatory use, collection, encoding, and transmission of Outcome and Assessment Information Set (OASIS) for home health agencies. Health Care Financing Administration (HCFA), HHS. Notice
Q77649085	Medicare and Medicaid programs; maternal and child health and crippled children's services; social services programs for individuals and families--disclosure of ownership and related information: proposed rule
Q77662270	Medicare and Medicaid programs; miscellaneous conforming amendments--HCFA. Final rule with comment period
Q50196002	Medicare and Medicaid programs; modifications to the Medicare and Medicaid Electronic Health Record (EHR) Incentive Program for 2014 and other changes to EHR Incentive Program; and health information technology: revision to the certified EHR technol
Q74724627	Medicare and Medicaid programs; nurse aide training and competency evaluation programs--HCFA. Final rule
Q77672539	Medicare and Medicaid programs; organ procurement and transplantation network rules and membership actions--HCFA. General notice
Q77666002	Medicare and Medicaid programs; organ procurement organizations and organ procurement protocols--HCFA. Final rule
Q77663517	Medicare and Medicaid programs; payment for the cost of malpractice insurance--HCFA. Confirmation of final rule
Q77150348	Medicare and Medicaid programs; physicians' referrals to health care entities with which they have financial relationships--HCFA. Proposed rule
Q74368409	Medicare and Medicaid programs; physicians' referrals to health care entities with which they have financial relationships. Health Care Financing Administration (HCFA), HHS. Final rule with comment period
Q52544942	Medicare and Medicaid programs; physicians' referrals to health care entities with which they have financial relationships: partial delay of effective date. Interim final rule with comment period; partial delay in effective date.
Q74761427	Medicare and Medicaid programs; preadmission screening and annual resident review--HCFA. Final rule with comment period
Q74770234	Medicare and Medicaid programs; preadmission screening and annual resident review--HCFA. Final rule; correction
Q77662902	Medicare and Medicaid programs; program integrity--HCFA. Final rule
Q73018477	Medicare and Medicaid programs; programs of all-inclusive care for the elderly (PACE). Health Care Financing Administration (HCFA), HHS. Interim final rule with comment period
Q79435660	Medicare and Medicaid programs; programs of all-inclusive care for the elderly (PACE); program revisions. Final rule
Q77654924	Medicare and Medicaid programs; prospective reimbursement for rural health clinic services--Health Care Financing Administration. Proposed rule
Q77065515	Medicare and Medicaid programs; provider appeals: technical amendments--HCFA. Final rule with comment period
Q74758121	Medicare and Medicaid programs; quarterly listing of program issuances and coverage decisions--HCFA. General notice
Q74762632	Medicare and Medicaid programs; quarterly listing of program issuances and coverage decisions--HCFA. General notice
Q74767757	Medicare and Medicaid programs; quarterly listing of program issuances and coverage decisions--HCFA. Notice
Q74772811	Medicare and Medicaid programs; quarterly listing of program issuances and coverage decisions--first quarter 1993--HCFA. Notice
Q74787486	Medicare and Medicaid programs; quarterly listing of program issuances and coverage decisions--fourth quarter 1993--HCFA. Notice
Q74802518	Medicare and Medicaid programs; quarterly listing of program issuances and coverage decisions--second quarter 1994--HCFA. Notice
Q74782492	Medicare and Medicaid programs; quarterly listing of program issuances and coverage decisions--third quarter 1993--HCFA. Notice
Q77152213	Medicare and Medicaid programs; quarterly listing of program issuances--first quarter 1997--HCFA. Notice
Q77190069	Medicare and Medicaid programs; quarterly listing of program issuances--first quarter, 1998--HCFA. Notice
Q77174717	Medicare and Medicaid programs; quarterly listing of program issuances--fourth quarter 1997--HCFA. Notice
Q77150317	Medicare and Medicaid programs; quarterly listing of program issuances--second quarter 1997--HCFA. Notice
Q77204665	Medicare and Medicaid programs; quarterly listing of program issuances--second quarter, 1998--HCFA. Notice
Q77104863	Medicare and Medicaid programs; quarterly listing of program issuances--third quarter 1996--HCFA. Notice
Q77162038	Medicare and Medicaid programs; quarterly listing of program issuances--third quarter 1997--HCFA. Notice
Q73174807	Medicare and Medicaid programs; quarterly listing of program issuances--third quarter, 1998. Health Care Financing Administration (HCFA), HHS. Notice
Q77106201	Medicare and Medicaid programs; quarterly listing of program issuances; fourth quarter 1996--HCFA. Notice
Q77159888	Medicare and Medicaid programs; recognition of the American Association for Accreditation of Ambulatory Surgery Facilities, Inc. for Ambulatory Surgical Centers Program--HCFA. Proposed notice
Q77784423	Medicare and Medicaid programs; recognition of the Commission for Accreditation of Rehabilitation Facilities--HCFA. Notice with comment period
Q74772801	Medicare and Medicaid programs; recognition of the Joint Commission on Accreditation of Healthcare Organizations standards for home care organizations--HCFA. Final notice
Q77665020	Medicare and Medicaid programs; redesignation of rules concerning federal requirements for health maintenance organizations--HCFA. Final rule
Q38011188	Medicare and Medicaid programs; reform of hospital and critical access hospital conditions of participation. Final rule
Q38211044	Medicare and Medicaid programs; regulatory provisions to promote program efficiency, transparency, and burden reduction; Part II.
Q77652871	Medicare and Medicaid programs; reimbursement for clinical laboratory services: Health Care Financing Administration. Final rule with comment period
Q79336127	Medicare and Medicaid programs; religious nonmedical health care institutions and advance directives. Final rule
Q73018479	Medicare and Medicaid programs; religious nonmedical health care institutions and advance directives. Health Care Financing Administration (HCFA), HHS. Interim final rule with comment period
Q50122372	Medicare and Medicaid programs; requirements for long term care facilities; nursing services; posting of nurse staffing information. Final rule.
Q43433592	Medicare and Medicaid programs; requirements for long-term care (LTC) facilities; notice of facility closure. Final rule
Q77672544	Medicare and Medicaid programs; requirements for long-term care facilities: delay in effective date of regulations--HCFA. Final rule; delay of effective date
Q38119960	Medicare and Medicaid programs; requirements for long-term care facilities; hospice services. Final rule
Q79089796	Medicare and Medicaid programs; requirements for paid feeding assistants in long term care facilities. Final rule
Q77090571	Medicare and Medicaid programs; requirements for physician incentive plans in prepaid health care organizations--HCFA. Final rule
Q77186684	Medicare and Medicaid programs; requirements for physician incentive plans in prepaid health care organizations--HCFA. Final rule correction; notice of changes in compliance dates, with comment period
Q74755205	Medicare and Medicaid programs; revaluation of assets--HCFA. Final rule
Q74767780	Medicare and Medicaid programs; revaluation of assets; correction--HCFA. Correcting amendments
Q77075595	Medicare and Medicaid programs; revisions to conditions of participation for hospitals--HCFA. Final rule
Q77654928	Medicare and Medicaid programs; rural health clinic payment limits and productivity screening guidelines--Health Care Financing Administration, HHS. Final notice
Q77654973	Medicare and Medicaid programs; rural health clinic payment limits and productivity screening guidelines; correction--Health Care Financing Administration. Correction of final notice
Q77654508	Medicare and Medicaid programs; rural hospitals: provision of long-term care services (swing-bed provision); flexibility in application of standards--Health Care Financing Administration. Interim final rule with comment period
Q77152286	Medicare and Medicaid programs; salary equivalency guidelines for physical therapy, respiratory therapy, speech language pathology, and occupational therapy services--HCFA. Final rule
Q77153875	Medicare and Medicaid programs; salary equivalency guidelines for physical therapy, respiratory therapy, speech language pathology, and occupational therapy services; revised effective date and technical correction--HCFA. Final rule; delay of effect
Q77657031	Medicare and Medicaid programs; schedule of limits on home health agency costs per visit for cost reporting periods beginning on or after July 1, 1984--HCFA. Proposed rule
Q77655374	Medicare and Medicaid programs; schedule of limits on home health agency costs per visit--HCFA. Final notice with comment period
Q77653121	Medicare and Medicaid programs; schedule of limits on skilled nursing facility inpatient routine service costs--Health Care Financing Administration. Final notice
Q77650336	Medicare and Medicaid programs; schedule of limits on skilled nursing facility inpatient routine service costs--final notice
Q77656218	Medicare and Medicaid programs; schedules of guidelines for physical therapy and respiratory therapy services--HCFA. Final notice
Q77653660	Medicare and Medicaid programs; schedules of guidelines for physical therapy and respiratory therapy services. Health Care Financing Administration. Notice
Q77652854	Medicare and Medicaid programs; schedules of guidelines for physical therapy and respiratory therapy services: Health Care Financing Administration. Proposed notice
Q77654523	Medicare and Medicaid programs; statement of policy concerning approval of statewide hospital reimbursement systems demonstration projects--Health Care Financing Administration. Statement of policy
Q77149400	Medicare and Medicaid programs; surety bond and capitalization requirements for home health agencies--HCFA. Final rule with comment period
Q77152941	Medicare and Medicaid programs; surety bond requirements for home health agencies--HCFA. Final rule
Q77162028	Medicare and Medicaid programs; surety bond requirements for home health agencies--HCFA. Final rule
Q77169764	Medicare and Medicaid programs; surety bond requirements for home health agencies--HCFA. Final rule
Q77152946	Medicare and Medicaid programs; surety bond requirements for home health agencies--HCFA. Notice of intent to amend regulations
Q74801118	Medicare and Medicaid programs; survey, certification and enforcement of skilled nursing facilities and nursing facilities--HCFA. Final rule
Q74831438	Medicare and Medicaid programs; survey, certification and enforcement of skilled nursing facilities and nursing facilities--HCFA. Final rule and correction to final regulations
Q77655387	Medicare and Medicaid programs; suspension of health care professionals for conviction of program-related crimes--HCFA. Final regulations with comment period
Q77658562	Medicare and Medicaid programs; utilization and quality control peer review organization (PRO): assumption of Medicare review functions and coordination with Medicaid--HCFA. Final rule
Q77657344	Medicare and Medicaid programs; utilization and quality control peer review organization (PRO); assumption of responsibilities and Medicare review functions and coordination of Medicaid with peer review organization--HCFA. Proposed rule
Q84117532	Medicare and Medicaid programs; waiver of disapproval of nurse aide training program in certain cases. Final rule
Q77659230	Medicare and Medicaid programs; withholding the federal share--HCFA. Correction of final rule
Q77652119	Medicare and Medicaid programs;schedules of limits on home health agency costs per visit, hospital inpatient general routine operating costs, and skilled nursing facility inpatient routine service costs--Health Care Financing Administration. General
Q77650213	Medicare and Medicaid providers; disclosure of information and access to provider records; requirements and conditions for participation: final regulation
Q77649883	Medicare and Medicaid regulations: conformance with Professional Standards Review regulations on review, certification, and payment activities-final regulation
Q77649640	Medicare and Medicaid--nursing home provider agreements: effective dates; effect of change in ownership: proposed rules
Q77666899	Medicare and Medicaid: long-term care survey--HCFA. Final rule
Q74760940	Medicare and Medicaid; charges to residents' funds in nursing homes--HCFA. Final rule
Q77659234	Medicare and Medicaid; corrections and conforming changes--HCFA. Final rules and corrections
Q77121773	Medicare and Medicaid; eligibility for premium hospital insurance; state buy-in agreements--HCFA. Final rule with comment period
Q77661440	Medicare and Medicaid; miscellaneous Medicare and Medicaid amendments--HCFA. Confirmation and amendment of interim final rules
Q77654529	Medicare and Medicaid; miscellaneous amendments--Health Care Financing Administration. Interim final rules with comment period
Q77660953	Medicare and Medicaid; payment for the cost of malpractice insurance--HCFA. Interim final rule with comment period
Q74724620	Medicare and Medicaid; requirements for long term care facilities--HCFA. Final rule
Q74755210	Medicare and Medicaid; requirements for long term care facilities--HCFA. Final rule
Q77669370	Medicare and Medicaid; requirements for long term care facilities--HCFA. Final rule with comment period
Q77159822	Medicare and Medicaid; resident assessment in long term care facilities--HCFA. Final rule
Q77654010	Medicare and Medicaid; survey and certification of health care facilities--Health Care Financing Administration. Proposed rules
Q74722090	Medicare and Social Security: fraud and abuse; civil money penalties for misuse of certain terms, symbols and emblems--HHS. Final rule
Q53623824	Medicare and State Health Care Programs: Fraud and Abuse; Revisions to the Office of Inspector General's Civil Monetary Penalty Rules. Final rule.
Q53623821	Medicare and State Health Care Programs: Fraud and Abuse; Revisions to the Safe Harbors Under the Anti-Kickback Statute and Civil Monetary Penalty Rules Regarding Beneficiary Inducements. Final rule.
Q74717668	Medicare and State health care programs: fraud and abuse; OIG anti-kickback provisions--HHS. Final rule
Q77080412	Medicare and state health care programs and program fraud civil remedies: fraud and abuse; civil money penalties inflation adjustments--Office of Inspector General, HHS. Final rule
Q74798944	Medicare and state health care programs: fraud and abuse, civil money penalties and intermediate sanctions for certain violations by health maintenance organizations and competitive medical plans--HHS. Correction to final regulations
Q74794996	Medicare and state health care programs: fraud and abuse, civil money penalties and intermediate sanctions for certain violations by health maintenance organizations and competitive medical plans--HHS. Final rule
Q77454329	Medicare and state health care programs: fraud and abuse; ambulance replenishing safe harbor under the anti-kickback statute. Final rule
Q74774213	Medicare and state health care programs: fraud and abuse; amendments to OIG exclusion and CMP authorities resulting from the Medicare and Medicaid Patient and Program Protection Act--Office of Inspector General (OIG), HHS. Final rule
Q73018476	Medicare and state health care programs: fraud and abuse; clarification of the initial OIG safe harbor provisions and establishment of additional safe harbor provisions under the anti-kickback statute. Office of Inspector General (OIG), HHS. Final r
Q54379258	Medicare and state health care programs: fraud and abuse; electronic health records safe harbor under the anti-kickback statute. Final rule.
Q77174740	Medicare and state health care programs: fraud and abuse; issuance of advisory opinions by the OIG--HHS. Correction
Q77095372	Medicare and state health care programs: fraud and abuse; issuance of advisory opinions by the OIG--HHS. Interim final rule with comment period
Q81401894	Medicare and state health care programs: fraud and abuse; safe harbor for federally qualified health centers arrangements under the anti-kickback statute. Final rule
Q80083335	Medicare and state health care programs: fraud and abuse; safe harbors for certain electronic prescribing and electronic health records arrangements under the anti-kickback statute. Final rule
Q74760476	Medicare and state health care programs: fraud and abuse; safe harbors for protecting health plans--HHS. Interim final rule with request for comment
Q77053016	Medicare and state health care programs: fraud and abuse; safe harbors for protecting health plans--Office of Inspector General, HHS. Final rule
Q44333452	Medicare and state health care programs; fraud and abuse: OIG civil money penalties under the Medicare prescription drug discount card program. Final rule.
Q44333162	Medicare and state health care programs; fraud and abuse: OIG civil money penalties under the Medicare prescription drug discount card program. Interim final rule with comment period.
Q77178370	Medicare and state health programs: fraud and abuse; issuance of advisory opinions by the OIG--HHS. Final rule
Q77671618	Medicare as secondary payer and Medicare recovery against third parties--HCFA. Final rule
Q77656034	Medicare depreciation; useful life guidelines--HCFA. Proposed rule
Q50425906	Medicare determinations and income-related monthly adjustment amounts to Medicare Part B premiums; conforming changes to regulations. Final rule
Q50356568	Medicare determinations and income-related monthly adjustment amounts to Medicare Part B premiums; conforming changes to regulations. Interim final rule with request for comments
Q77668248	Medicare program, carrier bonuses for increasing physicians' participation or payments--HCFA. Notice
Q38481620	Medicare program, changes to the hospital outpatient prospective payment system and calendar year 2004 payment rates. Final rule with comment period
Q77650590	Medicare program, coverage of oxygen for use in a patient's home: Health Care Financing Administration. Proposed notice
Q77671912	Medicare program, data, standards and methodology used to establish budgets for fiscal intermediaries and carriers--HCFA. Final notice with comment period
Q74688543	Medicare program, fiscal year 1990; mid-year changes to the inpatient hospital prospective payment system--HCFA. Final rule with comment period
Q74773409	Medicare program, health maintenance organizations: technical amendments--HCFA. Final rule with comment period
Q77655037	Medicare program, services covered under automobile medical, no-fault, or liability insurance; services furnished to ESRD beneficiaries who are covered under employer group health insurance--Health Care Financing Administration. Final rule
Q77657348	Medicare program, utilization and quality control peer review organization (PRO) reconsiderations and appeals--HCFA. Proposed rule
Q77649632	Medicare program--cost to related organizations: proposed rule
Q77649876	Medicare program--direct apportionment of malpractice costs to Medicare: proposed rule
Q77649879	Medicare program--limitations on reimbursable costs: proposed rule
Q77714088	Medicare program--payments for inpatient services of foreign hospitals: proposed rule
Q77400247	Medicare program--prospective payment system for hospital outpatient services: criteria for establishing additional pass-through categories for medical devices. Interim final rule with comment period
Q74832503	Medicare program--providers and suppliers of specialized services: technical amendments--HCFA. Final rule with comment period
Q77649629	Medicare program--reimbursement for radiological services furnished to a hospital inpatient by a physician in the field of radiology: proposed rule
Q77665027	Medicare program: End-Stage Renal Disease program; revised network area designations--HCFA. Final rule
Q44335340	Medicare program: Medicare Advantage and Prescription Drug Benefit programs: final marketing provisions. Final rule.
Q44335505	Medicare program: Medicare Advantage and prescription drug programs MIPPA drug formulary & protected classes policies. Interim final rule with comment period.
Q77665056	Medicare program: Medicare Economic Index for 1988--HCFA. Notice
Q77516306	Medicare program: access to books, documents, and records of subcontractors--Health Care Financing Administration
Q77664219	Medicare program: application fees for health maintenance organizations--HCFA. Final rule
Q77668162	Medicare program: billing and verification add-on relating to home health agencies cost per visit limits--HCFA. Final notice
Q37695208	Medicare program: changes to the Medicare claims appeal procedures. Final rule
Q36064961	Medicare program: changes to the Medicare claims appeal procedures. Interim final rule with comment period.
Q77065521	Medicare program: changes to the hospital inpatient prospective payment systems and fiscal year 1997 rates; correction--HCFA. Correction notice
Q37310388	Medicare program: changes to the hospital inpatient prospective payment systems and fiscal year 2009 rates; payments for graduate medical education in certain emergency situations; changes to disclosure of physician ownership in hospitals and physic
Q80106997	Medicare program: changes to the hospital outpatient prospective payment system and CY 2008 payment rates, the ambulatory surgical center payment system and CY 2008 payment rates, the hospital inpatient prospective payment system and FY 2008 payment
Q82950172	Medicare program: changes to the hospital outpatient prospective payment system and CY 2010 payment rates; changes to the ambulatory surgical center payment system and CY 2010 payment rates. Final rule with comment period
Q77659611	Medicare program: changes to the inpatient hospital prospective payment system and fiscal year 1986 rates--HCFA. Final rule
Q74731269	Medicare program: changes to the inpatient hospital prospective payment system and fiscal year 1992 rates; correction--HCFA. Final rule; correction
Q77663906	Medicare program: changes to the return on equity capital provisions and the exemption from cost limits for newly established home health agencies--HCFA. Final rule with comment period
Q46504281	Medicare program: conditions of participation (CoPs) for community mental health centers. Final rule
Q74788389	Medicare program: data, standards and methodology used to establish fiscal year 1993 budgets for fiscal intermediaries and carriers--HCFA. Final notice
Q74794988	Medicare program: data, standards, and methodology used to establish fiscal year 1994 budgets for fiscal intermediaries and carriers--HCFA. Final notice
Q77649939	Medicare program: definition of hospital special care units for reimbursement purposes: proposed rule
Q77685489	Medicare program: economic index for physicians' services for the period July 1978 through June 1979
Q39960936	Medicare program: hospital outpatient prospective payment system and CY 2011 payment rates; ambulatory surgical center payment system and CY 2011 payment rates; payments to hospitals for graduate medical education costs; physician self-referral rule
Q77649374	Medicare program: inpatient hospital deductible for 1979
Q77720969	Medicare program: list of covered surgical procedures for certain ambulatory surgical services. Health Care Financing Administration. Proposed notice
Q77649563	Medicare program: payment for durable medical equipment
Q77664223	Medicare program: payments for large rural hospitals that serve a disproportionate share of low-income patients; comment period--HCFA. Final rule with comment period
Q77652073	Medicare program: premium rate for the uninsured aged--Office of the Secretary, HHS. Notice
Q77649769	Medicare program: proposed initial schedule of limits on home health agency costs per visit for cost reporting periods beginning on or after June 1, 1979
Q77687959	Medicare program: proposed schedule of limits on hospital costs for cost reporting periods beginning on or after October 1, 1978
Q77649764	Medicare program: proposed schedule of limits on hospital inpatient general routine operating costs and cost reporting periods beginning on or after July 1, 1979
Q77652059	Medicare program: reimbursement of hospital-based physicians--Health Care Financing Administration. Notice of revised injunction relating to enforcement of rules
Q77193852	Medicare program: request for public comments on implementation of risk adjusted payment for the Medicare+Choice program and announcement of public meeting--HCFA. Solicitation of comments; announcement of meeting
Q77152244	Medicare program: request for public comments on implementation of the Medicare+Choice program, and notice of timeframes for submission of applications for contracts--HCFA. Notice of intent to regulate; solicitation of comments
Q35581111	Medicare program: review of national coverage determinations and local coverage determinations. Final rule
Q77536821	Medicare program: revised criteria for defining a skilled nursing facility when determining spell of illness status--HCFA. Notice of HCFA ruling
Q74787467	Medicare program: revisions to criteria and standards for evaluating intermediaries and carriers--HCFA. Final rule
Q77649382	Medicare program: schedule of guidelines for physical therapy services
Q77649385	Medicare program: schedule of guidelines for respiratory therapy services
Q74787472	Medicare program: schedule of limits for skilled nursing facility inpatient routine service costs--HCFA. Final notice with comment period
Q77657231	Medicare program: schedule of limits on home health agency costs per visit for cost reporting periods beginning on or after July 1, 1984--HCFA. Final rule
Q77649367	Medicare program: schedule of limits on hospital costs for cost reporting periods beginning on or after October 1, 1978: final notice
Q77071754	Medicare program: schedule of prospectively determined payment rates for skilled nursing facility inpatient routine service costs--HCFA. Final notice with comment period
Q77130237	Medicare program: special enrollment periods and waiting period--HCFA. Final rules with comment period
Q77113836	Medicare program: special payment limits for home oxygen--HCFA. Proposed notice
Q74832526	Medicare program: suppliers of specialized services; technical amendment--HCFA. Technical amendment
Q74687743	Medicare program: updated HMO qualification determinations--HCFA. Notice
Q77153854	Medicare program; "without fault" and waiver of recovery from an individual as it applies to Medicare overpayment liability--HCFA. Proposed rule
Q44337627	Medicare program; Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs. Final rule
Q77661840	Medicare program; End Stage Renal Disease Program; redesignation of networks and reorganization of network organizations--HCFA. Final rule
Q77665778	Medicare program; End Stage Renal Disease Program; responsibilities of network organizations--HCFA. Final rule
Q38417939	Medicare program; End-Stage Renal Disease prospective payment system, quality incentive program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies. Final rule
Q74778629	Medicare program; Essential Access Community Hospitals (EACHs) and Rural Primary Care Hospitals (RPCHs)--HCFA. Correction of final rule
Q74771242	Medicare program; Essential Access Community Hospitals (EACHs) and Rural Primary Care Hospitals (RPCHs)--HCFA. Final rule
Q43443602	Medicare program; FY 2014 hospice wage index and payment rate update; hospice quality reporting requirements; and updates on payment reform. final rule
Q54742009	Medicare program; FY 2014 inpatient prospective payment systems: changes to certain cost reporting procedures related to disproportionate share hospital uncompensated care payments. Interim final rule with comment period.
Q48538074	Medicare program; FY 2015 hospice wage index and payment rate update; hospice quality reporting requirements and process and appeals for Part D payment for drugs for beneficiaries enrolled in hospice. Final rule
Q74689972	Medicare program; Geographical Classification Review Board; procedures and criteria--HCFA. Interim final rule with comment period
Q77153814	Medicare program; HCFA market research for providers and other partners--HCFA. General notice with comment period
Q74755157	Medicare program; HHS' recognition of NAIC Model Standards (National Association of Insurance Commissioners) for regulation of Medigap policies--HCFA. Notice
Q38429336	Medicare program; Home Health Prospective Payment System rate update for calendar year 2013, hospice quality reporting requirements, and survey and enforcement requirements for home health agencies. Final rule
Q44336377	Medicare program; Medicare Advantage and prescription drug benefit programs. Final rule.
Q83184788	Medicare program; Medicare Advantage and prescription drug benefit programs: negotiated pricing and remaining revisions. Final rule with comment period
Q44336546	Medicare program; Medicare Advantage and prescription drug benefit programs: negotiated pricing and remaining revisions; prescription drug benefit program: payments to sponsors of retiree prescription drug plans. Final rule.
Q74696855	Medicare program; Medicare Economic Index update for 1991--HCFA. Notice
Q74713093	Medicare program; Medicare Geographic Classification Review Board--procedures and criteria--HCFA. Final rule with comment period
Q38093167	Medicare program; Medicare Hospital Insurance (Part A) and Medicare Supplementary Medical Insurance (Part B). Notice of CMS ruling
Q81334855	Medicare program; Medicare Integrity Program, fiscal intermediary and carrier functions, and conflict of interest requirements. Final rule
Q31161734	Medicare program; Medicare Part D claims data. Final rule.
Q77126461	Medicare program; Medicare Secondary Payer (MSP) amendments--HCFA. General notice
Q82304134	Medicare program; Medicare Shared Savings Program: Accountable Care Organizations. Final rule
Q85356258	Medicare program; Medicare Shared Savings Program: Accountable Care Organizations. Final rule
Q80272876	Medicare program; Medicare ambulance MMA temporary rate increases beginning July 1, 2004. Interim final rule with comment period
Q74755150	Medicare program; Medicare and Laboratory Certification Program; enforcement procedures for laboratories--HCFA. Correction notice
Q74736855	Medicare program; Medicare and laboratory certification program; enforcement procedures for laboratories--HCFA. Final rule
Q77106195	Medicare program; Medicare appeals of individual claims--HCFA. Final rule with comment period
Q74688097	Medicare program; Medicare as secondary payer and Medicare recovery against third parties--HCFA. Final rule; reinstatement of regulations
Q77672159	Medicare program; Medicare as secondary payer and Medicare recovery against third parties; publication of court orders--HCFA. Publication of court orders
Q77163786	Medicare program; Medicare coverage of and payment for bone mass measurements--HCFA. Interim final rule with comment period
Q74689685	Medicare program; Medicare coverage of hepatitis B vaccine for high and intermediate risk individuals, hemophilia clotting factors and certain x-ray services--HCFA. Correction of final rule
Q77178825	Medicare program; Medicare coverage of hepatitis B vaccine for high and intermediate risk individuals, hemophilla clotting factors and certain X-ray services--HCFA. Final rule
Q74803212	Medicare program; Medicare coverage of home health services, Medicare conditions of participation, and home health aide supervision--HCFA. Final rule
Q74808183	Medicare program; Medicare coverage of prescription drugs used in immunosuppressive therapy--HCFA. Final rule
Q74798957	Medicare program; Medicare coverage of screening mammography--HCFA. Final rule
Q74697081	Medicare program; Medicare coverage of screening mammography--HCFA. Interim final rule with comment
Q74810680	Medicare program; Medicare coverage of screening mammography; correction--HCFA. Correcting amendment
Q77655784	Medicare program; Medicare depreciation, useful life guidelines--HCFA. Final rule
Q77659855	Medicare program; Medicare economic index for physicians' services (effective October 1, 1985)--HCFA. Notice
Q42018179	Medicare program; Medicare graduate medical education affiliation provisions for teaching hospitals in certain emergency situations. Interim final rule with comment period.
Q77696773	Medicare program; Medicare hospital reimbursement reforms: limitations on reimbursable costs and the rate of hospital cost increases--HCFA. Interim final rule with comment period
Q77153840	Medicare program; Medicare integrity program, intermediary and carrier functions, and conflict of interest requirements--HCFA. Proposed rule
Q36023056	Medicare program; Medicare prescription drug benefit. Final rule.
Q44333570	Medicare program; Medicare prescription drug benefit; interpretation. Final rule; interpretation
Q44332895	Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
Q44333837	Medicare program; Medicare prescription drug discount card; revision of marketing rules for endorsed drug card sponsors. Final rule
Q81020262	Medicare program; Medicare secondary payer (MSP) amendments. final rule
Q82785088	Medicare program; Medicare secondary payer amendments. Interim final rule with comment period
Q74714582	Medicare program; Medicare secondary payer data match--HCFA. Notice
Q77120426	Medicare program; Medicare secondary payer for disabled active individuals--HCFA. Proposed rule
Q74831390	Medicare program; Medicare secondary payer for individuals entitled to Medicare and also covered under group health plans--HCFA. Final rule with comment period
Q74832523	Medicare program; Medicare secondary payer for individuals entitled to Medicare and also covered under group health plans; correction--HCFA. Final rule with comment period; correcting amendments
Q74787452	Medicare program; Medicare secondary payment--HCFA. General notice
Q77743089	Medicare program; Medicare supplemental policies--HCFA. Correction of interim final rule with comment period
Q77654517	Medicare program; Medicare supplemental policies--Health Care Financing Administration. Interim final rule with comment period
Q73162461	Medicare program; Medicare+Choice program. Health Care Financing Administration (HCFA), HHS. Final rule with comment period
Q44332415	Medicare program; Medicare-Endorsed Prescription Drug Card Assistance Initiative. Final rule.
Q77652108	Medicare program; Medigap--certification of Medicare supplemental health insurance policies: Health Care Financing Administration. Proposed rule
Q74730713	Medicare program; Part A premium for 1992 for the uninsured aged and for certain disabled individuals who have exhausted other entitlement--HCFA. Notice
Q74761430	Medicare program; Part A premium for 1993 for the uninsured aged and for certain disabled individuals who have exhausted other entitlement--HCFA. Notice
Q77125735	Medicare program; Part A premium for 1994 for the uninsured aged and for certain disabled individuals who have exhausted other entitlement--HCFA. Notice
Q74801957	Medicare program; Part A premium for 1995 for the uninsured aged and for certain disabled individuals who have exhausted other entitlement--HCFA. Notice
Q77129040	Medicare program; Part A premium for 1996 for the uninsured aged and for certain disabled individuals who have exhausted other entitlement--HCFA. Notice
Q77130741	Medicare program; Part A premium for 1997 for the uninsured aged and for certain disabled individuals who have exhausted other entitlement--HCFA. Notice
Q77152223	Medicare program; Part A premium for 1998 for the uninsured aged and for certain disabled individuals who have exhausted other entitlement--HCFA. Notice
Q77194139	Medicare program; Part A premium for 1999 for the uninsured aged and for certain disabled individuals who have exhausted other entitlement--HCFA. Notice
Q77668459	Medicare program; Part A premium for the uninsured aged for 1989--HCFA. Notice
Q77672301	Medicare program; Part A premium for the uninsured aged for 1990-- HCFA. Notice
Q77659844	Medicare program; Part A premium for the uninsured aged for the 12-month period beginning January 1, 1986--HCFA. Notice
Q74691693	Medicare program; Part A. Premium for the uninsured aged for 1991--HCFA. Notice
Q77077595	Medicare program; Part B advance payments to suppliers furnishing items or services under Medicare Part B--HCFA. Final rule
Q77667407	Medicare program; Peer Review Organization contracts; solicitation of statements of interest from in-state organizations--HCFA. General notice
Q74765463	Medicare program; Peer Review Organizations: new PRO contracts for all states and territories and the District of Columbia--HCFA. Notice
Q74722118	Medicare program; Peer Review Organizations: revised scopes of work for Delaware, Missouri, Montana, Nebraska, New Jersey, Nevada, Oklahoma, Rhode Island, South Carolina, Washington, and Wyoming--HCFA. Final notice
Q74746892	Medicare program; Peer Review Organizations: revised scopes of work for the District of Columbia, Puerto Rico, the Virgin Islands, and all states except Delaware, Florida, Missouri, Montana, Nebraska, Nevada, Oklahoma, Rhode Island, South Carolina,
Q77654933	Medicare program; Provider Reimbursement Review Board decision on the lack of jurisdiction--Health Care Financing Administration. Notice of HCFA ruling
Q77663673	Medicare program; Provider Reimbursement Review Board jurisdiction over challenge to apportionment of malpractice insurance costs--HCFA. Notice of HCFA ruling
Q77654511	Medicare program; Provider Reimbursement Review Board: expedited administrative review--Health Care Financing Administration. Final rule with comment period
Q77655716	Medicare program; Provider Reimbursement Review Board; expedited administrative review--HCFA. Final rule
Q77668261	Medicare program; SNF coinsurance amount for 1989--HCFA. Notice
Q77671918	Medicare program; SNF coinsurance amount for 1990--HCFA. Notice
Q73018675	Medicare program; State Health Insurance Assistance Program (SHIP). Health Care Financing Administration (HCFA), HHS. Interim final rule with comment period
Q77656950	Medicare program; access to books, documents and records of subcontractors--HCFA. Final rule
Q77654525	Medicare program; access to books, documents and records of subcontractors--Health Care Financing Administration. Proposed rule
Q77567947	Medicare program; acquisition, protection and disclosure of utilization and quality control peer review organization (PRO) information--HCFA. Proposed rule
Q77658570	Medicare program; acquisition, protection, and disclosure of utilization and quality control peer review organization (PRO) information--HCFA. Final rule
Q95428942	Medicare program; additional extension of the payment adjustment for low-volume hospitals and the Medicare-dependent hospital (MDH) program under the hospital Inpatient Prospective Payment Systems (IPPS) for acute care hospitals for fiscal year 2014
Q74839098	Medicare program; additional supplier standards--HCFA. Final rule with comment
Q77152251	Medicare program; additional supplier standards--HCFA. Proposed rule
Q74368058	Medicare program; additional supplier standards. Health Care Financing Administration (HCFA), HHS. Final rule with comment period
Q77724581	Medicare program; additions and deletions from the current list of covered surgical procedures for ambulatory surgical centers--HCFA. Final notice
Q77127641	Medicare program; additions to and deletions from the current list of covered surgical procedures for ambulatory surgical centers--HCFA. Final notice with comment period
Q73175031	Medicare program; adjustment in payment amounts for new technology intraocular lenses furnished by ambulatory surgical centers. Department of Health and Human Services (HHS), Health Care Financing Administration (HCFA). Final rule
Q77132449	Medicare program; adjustment in payment amounts for new technology intraocular lenses--HCFA. Proposed rule
Q77142030	Medicare program; adjustments to cost limits for skilled nursing facility inpatient routine service costs--HCFA. Proposed notice
Q77656224	Medicare program; administrator's review of Provider Reimbursement Review Board decisions-HCFA. Final rule
Q74787484	Medicare program; aggregation of Medicare claims for administrative appeals--HCFA. Final rule
Q74818278	Medicare program; allowing certifications and recertification by nurse practitioners and clinical nurse specialists for certain services--HCFA. Final rule with comment period
Q77668158	Medicare program; alternative sanctions for suppliers of end-stage renal disease (ESRD) services--HCFA. Final rule
Q77655660	Medicare program; ambulance service--HCFA. Final rule
Q77116745	Medicare program; ambulance services--HCFA. Proposed rule
Q77652541	Medicare program; ambulatory surgical centers: Health Care Financing Administration. Notice and request for comment
Q77721225	Medicare program; ambulatory surgical services--Health Care Financing Administration. Final rule
Q77720966	Medicare program; ambulatory surgical services. Health Care Financing Administration. Proposed rule
Q38490995	Medicare program; announcement of the calendar year 2002 conversion factor for the hospital outpatient prospective payment system and a pro rata reduction on transitional pass-through payments. Final rule
Q77654520	Medicare program; annual notice of 1982 target reimbursement rates for institutions furnishing home dialysis supplies, equipment, and support services--Health Care Financing Administration. General notice
Q77658275	Medicare program; annual update to reasonable compensation equivalent limits for services furnished by physicians to providers--HCFA. Final notice with comment period
Q74801950	Medicare program; appeal rights and procedures for beneficiaries enrolled in prepaid health care plans--HCFA. Final rule
Q44550196	Medicare program; appeals of CMS or CMS contractor determinations when a provider or supplier fails to meet the requirements for Medicare billing privileges. Final rule
Q77663910	Medicare program; appeals procedures for determinations that affect participation in Medicare--HCFA. Final rule with comment period
Q37695210	Medicare program; application of certain appeals provisions to the Medicare prescription drug appeals process. Final rule.
Q50119033	Medicare program; application of inherent reasonableness payment policy to Medicare Part B services (other than physician services). Final rule
Q77152299	Medicare program; application of inherent reasonableness to all Medicare Part B services (other than physician services)--HCFA. Interim final rule with comment period
Q77655655	Medicare program; assignment and reassignment of home health agencies to designated regional intermediaries--HCFA. Final rule
Q77658554	Medicare program; assignment and reassignment of home health agencies to designated regional intermediaries--HCFA. Proposed notice
Q77653666	Medicare program; assignment and reassignment of home health agencies to designated regional intermediaries: Health Care Financing Administration. Proposed rule
Q77666528	Medicare program; assignment and reassignment of provider-based home health agencies and hospices to designated regional intermediaries--HCFA. Final rule
Q77655705	Medicare program; assistants at surgery--HCFA. Interim final rule with comment period
Q77654983	Medicare program; assistants at surgery--Health Care Financing Administration. Final rule
Q74832496	Medicare program; authority citations: technical amendments--HCFA. Final rule with comment period
Q34099525	Medicare program; availability of Medicare data for performance measurement. Final rule
Q77653213	Medicare program; availability of information and records to the public--Health Care Financing Administration. Final rule
Q74755166	Medicare program; beneficiary counseling and assistance grants program--HCFA. Interim final rule with comment period
Q77650534	Medicare program; beneficiary liability for certain nonreimbursable services or items--Health Care Financing Administration. Final rule
Q74688524	Medicare program; carrier bonuses for increasing physicians' participation or payments--HCFA. Notice
Q77122912	Medicare program; carrier jurisdiction for claims for durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) and other issues involving suppliers, and criteria and standards for evaluating regional DMEPOS carriers--HCFA. Final rule
Q77125755	Medicare program; carrier jurisdiction for claims for durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS)--HCFA. Final rule
Q74688531	Medicare program; catastrophic outpatient drug benefit, home intravenous drug therapy benefit, and screening mammography services--withdrawal--HCFA. Withdrawal of proposed rules
Q77671416	Medicare program; catastrophic outpatient drug benefit--HCFA. Proposed rule
Q73499221	Medicare program; change in methodology for determining payment for extraordinarily high-cost cases (cost outliers) under the acute care hospital inpatient and long-term care hospital prospective payment systems. Final rule
Q74713971	Medicare program; changes concerning interest rates charged on overpayments and underpayments--HCFA. Final rule
Q77086303	Medicare program; changes concerning suspension of Medicare payments, and determinations of allowable interest expenses--HCFA. Final rule with comment period
Q77671608	Medicare program; changes in payment policy for direct graduate medical education costs--HCFA. Final rule
Q74687450	Medicare program; changes in payment policy for direct graduate medical education--HCFA. Correction of final rule
Q77152161	Medicare program; changes in provider agreement regulations related to federal employees health benefits--HCFA. Final rule
Q38480188	Medicare program; changes to Medicare payment for drugs and physician fee schedule payments for calendar year 2004. Interim final rule with comment period
Q74688257	Medicare program; changes to maintenance of effort requirements (section 421 of the Medicare Catastrophic Coverage Act)--HCFA. Notice
Q77723365	Medicare program; changes to the DRG classification system--HCFA. Final notice
Q73172307	Medicare program; changes to the FY 1999 hospital inpatient prospective payment wage index and standardized amounts resulting from approved requests for wage data revisions. Health Care Financing Administration (HCFA), HHS. Final rule
Q44336198	Medicare program; changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs for contract year 2012 and other changes. Final rule.
Q44336624	Medicare program; changes to the Medicare Advantage and the Medicare prescription drug benefit programs for contract year 2013 and other changes. Final rule with comment period.
Q37471772	Medicare program; changes to the Medicare claims appeal procedures; continuation of effectiveness and extension of timeline for publication of final rule. Interim final rule with comment period; continuation of effectiveness and extension of timelin
Q73172326	Medicare program; changes to the Medicare+Choice program. Health Care Financing Administration (HCFA), HHS. Final rule
Q34226952	Medicare program; changes to the ambulatory surgical centers patient rights conditions for coverage. Final rule
Q83701641	Medicare program; changes to the competitive acquisition of certain durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) by certain provisions of the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA). Interim fi
Q80062097	Medicare program; changes to the criteria for being classified as an inpatient rehabilitation facility. Final rule
Q77663233	Medicare program; changes to the criteria for determination of reasonable charges--HCFA. Final rule
Q38437218	Medicare program; changes to the electronic prescribing (eRx) incentive program. Final rule.
Q51137696	Medicare program; changes to the hospital inpatient prospective payment system for acute care hospitals and fiscal year 2010 rates; and changes to the long-term care hospital prospective payment system and rate years 2010 and 2009 rates. Final rules
Q74755174	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1993 rates--HCFA. Final rule
Q74758117	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1993 rates; correction--HCFA. Final rule; correction
Q74793213	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1994 rates--HCFA. Final rule
Q74775363	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1994 rates--HCFA. Final rule with comment period
Q74782485	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1994 rates; correction--HCFA. Final rule; correction
Q74798932	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1995 rates--HCFA. Final rule with comment period
Q74802527	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1995 rates; correction--HCFA. Final rule; correction
Q74831406	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1996 rates--HCFA. Final rule with comment period
Q77053019	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1996 rates; corrections--HCFA. Correction to final rule
Q77071749	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1997 rates--HCFA. Final rule
Q77089361	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1997 rates; corrections--HCFA. Final rule; correction
Q77135368	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1998 rates--HCFA. Correction
Q77159953	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1998 rates--HCFA. Final rule
Q77116865	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1998 rates--HCFA. Final rule with comment period
Q77116707	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1998 rates--HCFA. Proposed rule
Q77152087	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1998 rates; corrections--HCFA. Final rule with comment period; correction notice
Q77152962	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1998 rates; corrections--HCFA. Final rule with comment period; correction notice
Q77169759	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1999 rates--HCFA. Final rule
Q77159919	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1999 rates--HCFA. Proposed rule
Q77193974	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1999 rates; corrections--HCFA. Final rule; correction notice
Q77159958	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 1999 rates; corrections--HCFA. Proposed rule; correction
Q73175079	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2000 rates. Department of Health and Human Services (HHS), Health Care Financing Administration (HCFA). Final rule
Q73162575	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2001 rates. Health Care Financing Administration (HCFA), HHS. Final rule
Q74567628	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2003 rates. Final rule
Q40570064	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2004 rates. Final rule
Q47868690	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2005 rates. Final rule.
Q36227522	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2006 rates. Final rule.
Q38451946	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan progra
Q30364509	Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2008 rates.
Q39587112	Medicare program; changes to the hospital inpatient prospective payment systems and rates and costs of graduate medical education: fiscal year 2002 rates; provisions of the Balanced Budget Refinement Act of 1999; and provisions of the Medicare, Medi
Q34990122	Medicare program; changes to the hospital outpatient prospective payment system and calendar year 2003 payment rates; and changes to payment suspension for unfiled cost reports. Final rule with comment period.
Q35954534	Medicare program; changes to the hospital outpatient prospective payment system and calendar year 2005 payment rates. Final rule with comment period.
Q38470981	Medicare program; changes to the hospital outpatient prospective payment system and calendar year 2006 payment rates. Final rule with comment period
Q38490923	Medicare program; changes to the hospital outpatient prospective payment system for calendar year 2002. Final rule
Q77661853	Medicare program; changes to the inpatient hospital prospective payment system and FY 1987 rates--HCFA. Correction of final rule
Q74688679	Medicare program; changes to the inpatient hospital prospective payment system and FY 1990 rates; correction and technical amendment--HCFA. Final rule; correction and technical amendment
Q74694214	Medicare program; changes to the inpatient hospital prospective payment system and FY 1991 rates; correction--HCFA. Final rule; correction
Q77701339	Medicare program; changes to the inpatient hospital prospective payment system and fiscal year 1986 rates--HCFA. Correction of final rule
Q77700619	Medicare program; changes to the inpatient hospital prospective payment system and fiscal year 1986 rates--HCFA. Proposed rule
Q77661844	Medicare program; changes to the inpatient hospital prospective payment system and fiscal year 1987 rates--HCFA. Final rule
Q77664821	Medicare program; changes to the inpatient hospital prospective payment system and fiscal year 1988 rates--HCFA. Final rule
Q77706444	Medicare program; changes to the inpatient hospital prospective payment system and fiscal year 1989 rates--HCFA. Final rule with comment period
Q77708097	Medicare program; changes to the inpatient hospital prospective payment system and fiscal year 1990 rates--HCFA. Final rule
Q74690425	Medicare program; changes to the inpatient hospital prospective payment system and fiscal year 1991 rates--HCFA. Correction
Q74694223	Medicare program; changes to the inpatient hospital prospective payment system and fiscal year 1991 rates--HCFA. Correction
Q74719724	Medicare program; changes to the inpatient hospital prospective payment system and fiscal year 1991 rates--HCFA. Final rule
Q74722102	Medicare program; changes to the inpatient hospital prospective payment system and fiscal year 1992 rates--HCFA. Final rule
Q77657631	Medicare program; changes to the inpatient hospital prospective payment system; and FY 1985 rates--HCFA. Correction of final rule
Q77657469	Medicare program; changes to the inpatient hospital prospective payment system; and fiscal year 1985 rates--HCFA. Final rule
Q77657342	Medicare program; changes to the inpatient hospital prospective payment system; and proposed fiscal year 1985 rates--HCFA. Correction
Q77657234	Medicare program; changes to the inpatient hospital prospective payment system; and proposed fiscal year 1985 rates--HCFA. Proposed rule
Q77659063	Medicare program; changes to the inpatient prospective payment system and fiscal year 1986 rates--HCFA. Correction of proposed rule
Q40570059	Medicare program; changes to the inpatient rehabilitation facility prospective payment system and fiscal year 2004 rates. Final rule.
Q77666176	Medicare program; changes to the lesser of costs or charges provisions--HCFA. Final rule
Q74787480	Medicare program; changes to the requirement for annual physician acknowledgement of physician attestation responsibilities--HCFA. Final rule with comment period
Q95384515	Medicare program; changes to the requirements for Part D prescribers. Interim final rule with comment period
Q77660660	Medicare program; changes to the return on equity capital provisions and the exception from the cost limits for newly-established home health agencies--HCFA. Proposed rule
Q77664816	Medicare program; changes to the return on equity capital provisions for outpatient hospital services--HCFA. Final rule
Q77666364	Medicare program; changes to the return on equity capital provisions for outpatient hospital services--HCFA. Final rule
Q77393713	Medicare program; civil money penalties, assessments, and revised sanction authorities. Final rule with comment period
Q77672319	Medicare program; claims payment cycle--HCFA. General notice
Q74814490	Medicare program; clarification of Medicare's accrual basis of accounting policy--HCFA. Final rule
Q74812791	Medicare program; clarification of resumption of entitlement rules for Medicare patients with end-stage renal disease (ESRD)--HCFA. Final rule
Q73921073	Medicare program; clarifying policies related to the responsibilities of Medicare-participating hospitals in treating individuals with emergency medical conditions. Final rule
Q50997175	Medicare program; competitive acquisition for certain durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) and other issues. Final rule.
Q81927738	Medicare program; competitive acquisition of outpatient drugs and biologicals under Part B. Interim final rule with comment period
Q77654945	Medicare program; comprehensive outpatient rehabilitation facility services--Health Care Financing Administration. Final rule
Q77653925	Medicare program; comprehensive outpatient rehabilitation facility services--Health Care Financing Administration. Proposed rule
Q74724604	Medicare program; conditional designation of States in which Medicare SELECT insurance policies may be issued--HCFA. General notice with comment period
Q77721293	Medicare program; conditions for Medicare coverage of surgery to relieve obstructions to vertebral artery blood flow (vertebral artery surgery)--Health Care financing Administration. Notice of HCFA ruling
Q77666005	Medicare program; conditions for Medicare payment--HCFA. Final rule with comment period
Q51233166	Medicare program; conditions for payment of power mobility devices, including power wheelchairs and power-operated vehicles. Final rule.
Q51361844	Medicare program; conditions for payment of power mobility devices, including power wheelchairs and power-operated vehicles. Interim final rule with comment period.
Q77671426	Medicare program; conditions of participation for home intravenous drug therapy providers--HCFA. Proposed rule
Q80783148	Medicare program; continuation of Medicare entitlement when disability benefit entitlement ends because of substantial gainful activity. Final rule
Q77743002	Medicare program; continuation of the current Part B monthly premium rate--HCFA. General notice
Q77656061	Medicare program; continuation of the current premium rate for the uninsured aged--HCFA. General notice
Q74761831	Medicare program; continuous use of durable medical equipment--HCFA. Final rule
Q74724649	Medicare program; continuous use of durable medical equipment--HCFA. Interim final rule with comment period
Q44338071	Medicare program; contract year 2016 policy and technical changes to the Medicare Advantage and the Medicare Prescription Drug Benefit programs. Final rule
Q74831401	Medicare program; contracts with health maintenance organizations (HMOs) and competitive medical plans (CMPs)--HCFA. Final rule with comment period
Q77659213	Medicare program; court ordered regulations regarding prospective payment amount and administrative review--HCFA. Interim rule
Q77659223	Medicare program; court ordered regulations regarding prospective payment amounts and administrative review will not become effective--HCFA. Notice that regulations will not take effect; removal of regulations
Q77162036	Medicare program; coverage and administrative policies for clinical diagnostic laboratory tests; intent to form Negotiated Rulemaking Committee--HCFA. Notice of intent to form Negotiated Rulemaking Committee and notice of meetings
Q38481179	Medicare program; coverage and payment of ambulance services; inflation update for CY 2004. Final rule with comment period.
Q73018536	Medicare program; coverage of ambulance services and vehicle and staff requirements. Health Care Financing Administration (HCFA), HHS. Final rule with comment period
Q74787493	Medicare program; coverage of epoetin (EPO) used by competent home dialysis patients--HCFA. Final rule
Q74722113	Medicare program; coverage of erythropoietin (EPO) used by competent home dialysis patients--HCFA. Interim final rule with comment period
Q77671436	Medicare program; coverage of home intravenous drug therapy services--HCFA. Proposed rule
Q77657223	Medicare program; coverage of optometrists' services--HCFA. Final regulations
Q77654016	Medicare program; coverage of optometrists' services--Health Care Financing Administration. Notice of proposed rulemaking
Q73018431	Medicare program; coverage of, and payment for, paramedic intercept ambulance services. Health Care Financing Administration (HCFA), HHS. Final rule
Q74831427	Medicare program; criteria and procedures for extending coverage to certain devices and related services--HCFA. Final rule with comment period
Q74711024	Medicare program; criteria and standards for evaluating common working file hosts--HCFA. General notice with comment period
Q74755196	Medicare program; criteria and standards for evaluating intermediary and carrier performance during FY 1993--HCFA. General notice with comment period
Q74798934	Medicare program; criteria and standards for evaluating intermediary and carrier performance during FY 1994--HCFA. General notice
Q74777175	Medicare program; criteria and standards for evaluating intermediary and carrier performance during FY 1994--HCFA. General notice with comment period
Q74798937	Medicare program; criteria and standards for evaluating intermediary and carrier performance during FY 1995--HCFA. General notice with comment period
Q77659833	Medicare program; criteria and standards for evaluating intermediary and carrier performance during fiscal year 1986--HCFA. General notice with comment period
Q77665051	Medicare program; criteria and standards for evaluating intermediary and carrier performance during fiscal year 1988--HCFA. General notice with comment period
Q74724601	Medicare program; criteria and standards for evaluating intermediary and carrier performance--HCFA. General notice with comment period
Q77204673	Medicare program; criteria and standards for evaluating intermediary and carrier performance: millennium compliance--HCFA. General notice with comment period
Q74709152	Medicare program; criteria for Medicare coverage of adult liver transplants--HCFA. Final notice
Q74688093	Medicare program; criteria for Medicare coverage of adult liver transplants--HCFA. Proposed notice
Q77664833	Medicare program; criteria for Medicare coverage of heart transplants--HCFA. Notice of HCFA ruling
Q77659227	Medicare program; criteria for Medicare coverage of inpatient hospital rehabilitation services--HCFA. Notice of HCFA ruling
Q74808899	Medicare program; criteria for Medicare coverage of lung transplants--HCFA. Notice with comment period
Q77516286	Medicare program; criteria for defining skilled nursing facility under Section 1861(j)(1) of the Social Security Act--Health Care Financing Administration. Notice of HCFA ruling
Q30704514	Medicare program; criteria for submitting supplemental practice expense survey data under the physician fee schedule. Interim final rule with comment period.
Q74724573	Medicare program; data, standards and methodology used to establish budgets for fiscal intermediaries and carriers--HCFA. Final notice
Q74771650	Medicare program; data, standards and methodology used to establish fiscal year 1992 budgets for fiscal intermediaries and carriers--HCFA. Final notice
Q74814495	Medicare program; date for filing Medicare cost reports--HCFA. Final rule
Q77660518	Medicare program; definition of disproportionate share hospitals--HCFA. Notice
Q77156648	Medicare program; definition of provider-sponsored organization and related requirements--HCFA. Interim final rule with comment period
Q77120539	Medicare program; definition of surgical services--HCFA. Notice of definition of surgical services for physician volume performance standard rates for increase with comment
Q77152202	Medicare program; delay in implementing the adjustments to the practice expense relative value units under the physician fee schedule for calendar year 1998--HCFA. Notice of intent to regulate
Q79994136	Medicare program; delay of the date of applicability for certain provisions of Physicians' Referrals to Health Care Entities With Which They Have Financial Relationships (Phase III). Final rule
Q74778637	Medicare program; demonstration project to develop a uniform cost reporting system for hospitals--HCFA. Final rule
Q77671214	Medicare program; demonstration project to develop a uniform cost reporting system for hospitals--HCFA. Interim final rule with comment period
Q77113021	Medicare program; description of the Health Care Financing Administration's evaluation methodology for the Peer Review Organization 5th Scope of Work contracts--HCFA. General notice with comment period
Q77652866	Medicare program; determination of payment amount for services furnished by independent rural health clinics: Health Care Financing Administration. Final rule with a request for additional comments
Q77661848	Medicare program; determination of reasonable charges for physician and other medical services--HCFA. Final rule with comment period
Q77653292	Medicare program; determination of reasonable charges. Health Care Financing Administration. Interim final rule with a comment period
Q74788891	Medicare program; diagnosis codes on physician bills--HCFA. Final rule
Q36054751	Medicare program; durable medical equipment regional carrier service areas and related matters. Final rule
Q44333927	Medicare program; e-prescribing and the prescription drug program. Final rule.
Q77655638	Medicare program; economic index for physicians' services for the period July 1, 1982 through June 30, 1983--HCFA. Notice
Q77655751	Medicare program; economic index for physicians' services for the period July 1, 1983 through June 30, 1984--HCFA. Notice
Q77657227	Medicare program; economic index for physicians' services for the period July 1, 1984 through June 30, 1985--HCFA. Notice
Q77650180	Medicare program; economic index for physicians' services for the period July 1979 through June 30, 1980
Q77652753	Medicare program; economic index for physicians; services for the period July 1, 1981 through June 30, 1982: Health Care Financing Administration. Notice
Q77090021	Medicare program; electronic cost reporting for skilled nursing facilities and home health agencies--HCFA. Final rule
Q77106227	Medicare program; electronic cost reporting for skilled nursing facilities and home health agencies; correction--HCFA. Final rule; correction
Q51947091	Medicare program; electronic submission of cost reports. Final rule.
Q51929687	Medicare program; electronic submission of cost reports: revision to effective date of cost reporting period. Interim final rule with comment period.
Q77655363	Medicare program; elimination of Medicare indirect subsidy for private rooms--HCFA. Interim final rule with comment period
Q74787470	Medicare program; elimination of additional payments for administrative and general costs of hospital-based home health agencies--HCFA. Final notice with comment period
Q77655689	Medicare program; elimination of inpatient routine nursing salary cost differential--HCFA. Final rule with comment period
Q77661836	Medicare program; elimination of periodic interim payments for hospitals--HCFA. Final rule
Q35754998	Medicare program; elimination of statement of intent procedures for filing Medicare claims. Final rule.
Q77650210	Medicare program; elimination of the combination method of apportionment and modified cost finding for providers; correction
Q77668575	Medicare program; employers and duplicative Medicare benefits--HCFA. Notice
Q77116802	Medicare program; end-stage renal disease (ESRD) payment exception requests and organ procurement costs--HCFA. Final rule
Q77655814	Medicare program; end-stage renal disease program; prospective reimbursement for dialysis services and approval of special purpose renal dialysis facilities--HCFA. Final rule
Q38435891	Medicare program; end-stage renal disease prospective payment system and quality incentive program; ambulance fee schedule; durable medical equipment; and competitive acquisition of certain durable medical equipment prosthetics, orthotics and suppli
Q38429327	Medicare program; end-stage renal disease prospective payment system, quality incentive program, and bad debt reductions for all Medicare providers. Final rule
Q38423332	Medicare program; end-stage renal disease prospective payment system, quality incentive program, and durable medical equipment, prosthetics, orthotics, and supplies
Q84743681	Medicare program; end-stage renal disease prospective payment system. Final rule
Q83282370	Medicare program; end-stage renal disease quality incentive program. Final rule
Q77663239	Medicare program; enrollment provisions concerning health maintenance organizations and competitive medical plans--HCFA. Final rule with comment period
Q84969144	Medicare program; establishing additional Medicare durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) supplier enrollment safeguards. Final rule
Q74694236	Medicare program; establishing procedures for transmitting information between Medicare carriers and Medicare supplemental insurers--HCFA. General notice
Q74687605	Medicare program; establishment of Medicare Economic Index effective April 1, 1990--HCFA. Notice
Q77106178	Medicare program; establishment of an expedited review process for Medicare beneficiaries enrolled in health maintenance organizations, competitive medical plans, and health care prepayment plans--HCFA. Final rule with comment period
Q81565438	Medicare program; establishment of the Medicare Advantage Program; interpretation. Final rule; interpretation
Q35669741	Medicare program; establishment of the Medicare Coverage Advisory Committee and request for nominations for members. Notice.
Q81335521	Medicare program; establishment of the Medicare advantage program. Final rule
Q77166912	Medicare program; establishment of the Medicare+Choice program--HCFA. Correction
Q77193966	Medicare program; establishment of the Medicare+Choice program--HCFA. Correction of interim final rule with comment period
Q74703888	Medicare program; establishment of the advisory committee on Medicare-Physician Relationships; establishment--HCFA
Q77655672	Medicare program; exclusion from Medicare coverage of DMSO for conditions other than interstitial cystitis--HCFA. Notice of ruling
Q77655791	Medicare program; exclusion from Medicare coverage of certain food allergy tests and treatments--HCFA. Proposed notice
Q77659067	Medicare program; exclusion of cytotoxic leukocyte testing from Medicare coverage--HCFA. Notice of ruling
Q74368390	Medicare program; expanded coverage for outpatient diabetes self-management training and diabetes outcome measurements. Health Care Financing Administration (HCFA), HHS. Final rule
Q35964351	Medicare program; expedited determination procedures for provider service terminations. Final rule with comment period
Q74722136	Medicare program; explanation of enrollee rights and other provisions applicable to health maintenance organizations and competitive medical plans--HCFA. Final rule
Q95577250	Medicare program; extension of the payment adjustment for low-volume hospitals and the Medicare-dependent hospital (MDH) program under the hospital inpatient prospective payment systems (IPPS) for acute care hospitals for fiscal year 2014. Interim f
Q77701382	Medicare program; fee schedule for payment of ambulance services and revisions to the physician certification requirements for coverage of nonemergency ambulance services. Final rule with comment period
Q74770898	Medicare program; fee schedule for physicians' services for calendar year 1993--HCFA. Correction of final notice with comment period
Q77123866	Medicare program; fee schedule for physicians' services for calendar year 1993--HCFA. Final notice with comment period
Q74758092	Medicare program; fee schedule for physicians' services--HCFA. Correction of final rule
Q77122179	Medicare program; fee schedule for physicians' services--HCFA. Final rule
Q77669734	Medicare program; fee schedules for radiologist services--HCFA. Interim rule with comment period
Q74752241	Medicare program; fee schedules for the services of certified registered nurse anesthetists--HCFA. Final rule
Q48555910	Medicare program; final waivers in connection with the Shared Savings Program. Interim final rule with comment period
Q51777186	Medicare program; final waivers in connection with the shared savings program; continuation of effectiveness and extension of timeline for publication of final rule. Interim final rule; continuation of effectiveness and extension of timeline for pub
Q77661176	Medicare program; fiscal year 1986 changes to the inpatient hospital prospective payment system--HCFA. Interim final rule comment period
Q77662276	Medicare program; fiscal year 1987 changes to the inpatient hospital prospective payment system--HCFA. Final rule with comment period
Q77666357	Medicare program; fiscal year 1988 legislative changes to the inpatient hospital prospective payment system--HCFA. Notice of legislative changes with comment period
Q77659828	Medicare program; forms used for applying for entitlement or enrollment or claiming payment--HCFA. Final rule
Q77657472	Medicare program; forms used for claiming payment--HCFA. Proposed rule
Q77663523	Medicare program; fraud and abuse; civil monetary penalties and exclusions for assistants at cataract surgery--HHS. Final rule with comment period
Q77660656	Medicare program; freestanding home health agencies to designated regional intermediaries; assignment and reassignment--HCFA. Final notice
Q74724614	Medicare program; grace period and termination for nonpayment of Supplementary Medical Insurance (Part B) premiums for insured and uninsured persons--HCFA. Final rule
Q74780870	Medicare program; granting and withdrawal of deeming authority to national accreditation organizations--HCFA. Final rule
Q38455946	Medicare program; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care. Interim final rule with comment period
Q77654958	Medicare program; health care payment plans, correction
Q77654950	Medicare program; health care prepayment plans--Health Care Financing Administration. Final rule
Q77671072	Medicare program; home health agencies: conditions of participation and reduction in recordkeeping requirements--HCFA. Interim final rule with comment period
Q74717074	Medicare program; home health agencies: conditions of participation--HCFA. Final rule
Q74724654	Medicare program; home health agencies: conditions of participation--HHS. Correction of final rule
Q77660321	Medicare program; home health agencies; financial security requirements--HCFA. Proposed rule
Q77148188	Medicare program; home health agency physician certification regulations--HCFA. Decision to reexamine interpretations, with comment
Q38476851	Medicare program; home health prospective payment system rate update for calendar year 2005. Final rule.
Q36309889	Medicare program; home health prospective payment system rate update for calendar year 2006. Final rule
Q38465412	Medicare program; home health prospective payment system rate update for calendar year 2007 and Deficit Reduction Act of 2005 changes to Medicare payment for oxygen equipment and capped rental durable medical equipment; final rule.
Q38441897	Medicare program; home health prospective payment system rate update for calendar year 2011; changes in certification requirements for home health agencies and hospices. Final rule
Q38436104	Medicare program; home health prospective payment system rate update for calendar year 2012. Final rule
Q38460473	Medicare program; home health prospective payment system refinement and rate update for calendar year 2008. Final rule with comment period
Q38446288	Medicare program; home health prospective payment system; rate update for calendar year 2010. Final rule.
Q77663236	Medicare program; hospice "core" service; nursing--HCFA. Final rule
Q77660668	Medicare program; hospice "core" services; nursing--HCFA. Proposed rule
Q77664793	Medicare program; hospice cap--HCFA. Notice
Q77668252	Medicare program; hospice cap--HCFA. Notice
Q77671598	Medicare program; hospice cap--HCFA. Notice
Q50121136	Medicare program; hospice care amendments. Final rule.
Q74696096	Medicare program; hospice care amendments: Medicare--HCFA. Final rule with comment period
Q77657089	Medicare program; hospice care and prospective payment for Medicare inpatient hospital services; correction--HCFA. Correction to final rules
Q77656543	Medicare program; hospice care--HCFA. Final rule
Q77656064	Medicare program; hospice care--HCFA. Proposed rule
Q52093891	Medicare program; hospice care--final rule.
Q77660289	Medicare program; hospice payment cap--HCFA. Notice
Q36219475	Medicare program; hospice wage index for fiscal year 2006. Final rule.
Q81334860	Medicare program; hospice wage index for fiscal year 2008. Final rule
Q39859943	Medicare program; hospice wage index for fiscal year 2009. Final rule.
Q39897417	Medicare program; hospice wage index for fiscal year 2010. Final rule.
Q84677275	Medicare program; hospice wage index for fiscal year 2012. Final rule
Q77116797	Medicare program; hospice wage index--HCFA. Final rule
Q77194016	Medicare program; hospice wage index--HCFA. Notice
Q77152094	Medicare program; hospice wage index; correction--HCFA. Correction notice
Q77203584	Medicare program; hospice wage index; corrections--HCFA. Notice; correction notice
Q80197089	Medicare program; hospital conditions of participation: requirements for approval and re-approval of transplant centers to perform organ transplants. Final rule
Q50147759	Medicare program; hospital direct and indirect graduate medical education policy changes; notice. Final rule; clarification.
Q51169361	Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and FY 2012 rates; hospitals' FTE resident caps for graduate medical education payment. Final rules.
Q38131513	Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and Fiscal Year 2014 rates; quality reporting requirements for specific providers; hospital conditio
Q44887304	Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and fiscal year 2013 rates; hospitals' resident caps for graduate medical education payment purposes
Q38244235	Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and fiscal year 2015 rates; quality reporting requirements for specific providers; reasonable compen
Q44637134	Medicare program; hospital inpatient value-based purchasing program. Final rule
Q77655023	Medicare program; hospital insurance entitlement and benefits--Health Care Financing Administration, Final rule
Q77668562	Medicare program; hospital insurance entitlement and supplementary medical insurance enrollment and entitlement--HCFA. Final rule
Q31081077	Medicare program; hospital outpatient prospective payment system and CY 2007 payment rates; CY 2007 update to the ambulatory surgical center covered procedures list; Medicare administrative contractors; and reporting hospital quality data for [...]
Q38480196	Medicare program; hospital outpatient prospective payment system; payment reform for calendar year 2004. Interim final rule with comment period
Q77660955	Medicare program; hospital-based skilled nursing facility cost limits effective for cost reporting periods beginning October 1, 1982, and July 1, 1984--HCFA. Final notice
Q44335931	Medicare program; identification of backward compatible version of adopted standard for e-prescribing and the Medicare prescription drug program (NCPDP SCRIPT 10.6). Interim final rule with comment period
Q44334267	Medicare program; identification of backward compatible version of adopted standard for e-prescribing and the Medicare prescription drug program (version 8.1). Interim final rule with comment period.
Q35099996	Medicare program; improvement to the Medicare+Choice appeal and grievance procedures. Final rule with comment period
Q77163065	Medicare program; incentive programs-fraud and abuse--HCFA. Final rule with comment period
Q77663670	Medicare program; inclusion of labor/delivery room days in the calculation of inpatient days--HCFA. Notice of HCFA ruling
Q77667400	Medicare program; indirect Part B payment procedure--HCFA. Final rule
Q77650221	Medicare program; initial schedule of limits on home health agency costs per visit for cost reporting periods beginning on or after July 1, 1979: correction
Q77664831	Medicare program; inpatient hospital deductible and coinsurance amounts and Part A premium for the uninsured aged for 1988--HCFA. Notice
Q77657618	Medicare program; inpatient hospital deductible and coinsurance amounts for 1985--HHS. Notice
Q77659850	Medicare program; inpatient hospital deductible and coinsurance amounts for 1986--HCFA. Notice
Q74689101	Medicare program; inpatient hospital deductible and coinsurance and skilled nursing facility coinsurance for 1990--HCFA. Notice
Q74761424	Medicare program; inpatient hospital deductible and hospital and extended care services coinsurance amounts for 1993--HCFA. Notice
Q74780472	Medicare program; inpatient hospital deductible and hospital and extended care services coinsurance amounts for 1994--HCFA. Notice
Q74801959	Medicare program; inpatient hospital deductible and hospital and extended care services coinsurance amounts for 1995--HCFA. Notice
Q74832518	Medicare program; inpatient hospital deductible and hospital and extended care services coinsurance amounts for 1996--HCFA. Notice
Q77080425	Medicare program; inpatient hospital deductible and hospital and extended care services coinsurance amounts for 1997--HCFA. Notice
Q77152218	Medicare program; inpatient hospital deductible and hospital and extended care services coinsurance amounts for 1998--HCFA. Notice
Q77194124	Medicare program; inpatient hospital deductible and hospital and extended care services coinsurance amounts for 1999--HCFA. Notice
Q74694219	Medicare program; inpatient hospital deductible and hospital and skilled nursing facility coinsurance amounts for 1991--HCFA. Notice
Q74730701	Medicare program; inpatient hospital deductible and hospital and skilled nursing facility coinsurance amounts for 1992--HCFA. Notice
Q77655695	Medicare program; inpatient hospital deductible for 1983--HHS. General notice
Q77656208	Medicare program; inpatient hospital deductible for 1984--HHS. General notice
Q77671604	Medicare program; inpatient hospital deductible for 1990--HCFA. Notice
Q51917554	Medicare program; inpatient psychiatric facilities prospective payment system payment update for rate year beginning July 1, 2006 (RY 2007). Final rule.
Q95484069	Medicare program; inpatient psychiatric facilities prospective payment system--update for fiscal year beginning October 1, 2014 (FY 2015). Final rule
Q84053629	Medicare program; inpatient psychiatric facilities prospective payment system--update for rate year beginning July 1, 2011 (RY 2012). Final rule
Q81075855	Medicare program; inpatient rehabilitation facility prospective payment system for FY 2006. Final rule
Q51142841	Medicare program; inpatient rehabilitation facility prospective payment system for federal fiscal year 2007; certain provisions concerning competitive acquisition for durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS); accredit
Q80769958	Medicare program; inpatient rehabilitation facility prospective payment system for federal fiscal year 2008. Final rule
Q40033584	Medicare program; inpatient rehabilitation facility prospective payment system for federal fiscal year 2009. Final rule.
Q39897421	Medicare program; inpatient rehabilitation facility prospective payment system for federal fiscal year 2010. Final rule.
Q37912112	Medicare program; inpatient rehabilitation facility prospective payment system for federal fiscal year 2012; changes in size and square footage of inpatient rehabilitation units and inpatient psychiatric units. Final rule
Q38127185	Medicare program; inpatient rehabilitation facility prospective payment system for federal fiscal year 2014. Final rule
Q50106040	Medicare program; inpatient rehabilitation facility prospective payment system for federal fiscal year 2015.
Q77653133	Medicare program; inpatient routine nursing salary cost differential--Health Care Financing Administration. Interim final rule with comment period
Q80398786	Medicare program; interest calculation. Final Rule
Q77657476	Medicare program; interest charges on overpayments and underpayments to providers and suppliers of services--HCFA. Final rule and correction
Q77657707	Medicare program; interest charges on overpayments and underpayments to providers and suppliers of services--HCFA. Final rule; correction
Q77654937	Medicare program; interest charges on overpayments and underpayments to providers and suppliers of services--Health Care Financing Administration. Final rule with comment period
Q74781972	Medicare program; intermediary and carrier checks that are lost, stolen, defaced, mutilated, destroyed or paid on forged endorsements--HCFA. Final rule with comment period
Q77656086	Medicare program; invalidation of the wage index in the schedule of limits on Hospital per diem inpatient general routine operating costs for cost reporting periods beginning on or after July 1, 1981 and ending with cost reporting periods beginning
Q77665179	Medicare program; legislative changes affecting payments to hospitals--HCFA. Notice of legislative changes
Q77672548	Medicare program; legislative changes concerning payment to hospitals for federal fiscal year 1990--HCFA. Notice of legislative changes
Q74698078	Medicare program; legislative changes concerning payment to hospitals for federal fiscal year 1991--HCFA. Notice of legislative changes
Q77658756	Medicare program; limit on payments for direct medical education costs--HCFA. Proposed rule
Q77150327	Medicare program; limit on the valuation of a depreciable asset recognized as an allowance for depreciation and interest on capital indebtedness after a change of ownership--HCFA. Final rule with comment period
Q77655684	Medicare program; limitation of reasonable charges for services in hospital outpatient settings--HCFA. Final rule with comment period
Q77659865	Medicare program; limitation on payment for services furnished to employed aged and aged spouses of employed individuals--HCFA. Final rule
Q77665343	Medicare program; limitation on reasonable charges for physician services in outpatient settings--HCFA. Final rule
Q84718601	Medicare program; limitation on recoupment of provider and supplier overpayments. Final rule
Q77655043	Medicare program; limitations on payment for services furnished to employed aged and their spouses--Health Care Financing Administration. Final rule with comment period
Q77567605	Medicare program; limitations on reimbursable hospital costs and the rate of hospital cost increases--HCFA. Final rules
Q77660273	Medicare program; limitations on reimbursement of nonphysician medical services--HCFA. Final rule
Q77659236	Medicare program; limitations on the reimbursement of nonphysician medical services--HCFA. Proposed rule
Q77784402	Medicare program; limited additional opportunity to request certain hospital wage data revisions for FY 1999--HCFA. Final rule with comment period
Q77650039	Medicare program; limiting reimbursement for provider costs and for services by hospital-based physicians: final regulation
Q77723591	Medicare program; list of covered surgical procedures for ambulatory surgical centers--HCFA. Correction of final notice
Q77723195	Medicare program; list of covered surgical procedures for ambulatory surgical centers--HCFA. Final notice
Q77532775	Medicare program; list of covered surgical procedures for ambulatory surgical centers--HCFA. Proposed notice and request for comment
Q77721227	Medicare program; list of covered surgical procedures for certain ambulatory surgical services--Health Care Financing Administration. Final notice
Q30959883	Medicare program; manufacturer submission of manufacturer's average sales price (ASP) data for Medicare Part B drugs and biologicals. Final rule.
Q30919675	Medicare program; manufacturer submission of manufacturer's average sales price (ASP) data for Medicare Part B drugs and biologicals. Interim final rule with comment period.
Q44337119	Medicare program; medical loss ratio requirements for the Medicare Advantage and the Medicare Prescription Drug Benefit Programs
Q74698082	Medicare program; mid-year FY 1991 changes to the inpatient hospital prospective payment system--HCFA. Final rule with comment period
Q74704741	Medicare program; mid-year FY 1991 changes to the inpatient hospital prospective payment system; correction--HCFA. Final rule with comment period; correction
Q74689967	Medicare program; model fee schedule for physicians' services--HCFA. Notice with comment period
Q81235710	Medicare program; modification to the weighting methodology used to calculate the low-income benchmark amount. Final rule
Q73853333	Medicare program; modifications to managed care rules. Final rule
Q77743112	Medicare program; monthly actuarial rates and Part B premium rates beginning January 1, 1986--HCFA. Notice
Q77665017	Medicare program; monthly actuarial rates and Part B premium rates beginning January 1, 1988--HCFA. Notice
Q77656215	Medicare program; monthly actuarial rates and monthly premium rate--HHS. General notice
Q77743085	Medicare program; monthly actuarial rates and monthly premium rate--HHS. General notice
Q77657627	Medicare program; monthly actuarial rates and monthly premium rate. Correction
Q74832521	Medicare program; monthly actuarial rates and monthly supplementary medical insurance premium rate beginning January 1, 1996--HCFA. Notice
Q77080415	Medicare program; monthly actuarial rates and monthly supplementary medical insurance premium rate beginning January 1, 1997--HCFA. Notice
Q77148183	Medicare program; monthly actuarial rates and monthly supplementary medical insurance premium rate beginning January 1, 1998--HCFA. Notice
Q77194132	Medicare program; monthly actuarial rates and monthly supplementary medical insurance premium rate beginning January 1, 1999--HCFA. Notice
Q74705209	Medicare program; monthly actuarial rates and monthly supplementary medical insurance premium rates beginning January 1, 1991--HCFA. Notice
Q74730706	Medicare program; monthly actuarial rates and monthly supplementary medical insurance premium rates beginning January 1, 1992--HCFA. Notice
Q74761433	Medicare program; monthly actuarial rates and monthly supplementary medical insurance premium rates beginning January 1, 1993--HCFA. Notice
Q74780054	Medicare program; monthly actuarial rates and monthly supplementary medical insurance premium rates beginning January 1, 1994--HCFA. Notice
Q77127447	Medicare program; monthly actuarial rates and monthly supplementary medical insurance premium rates beginning January 1, 1995--HCFA. Notice
Q77672311	Medicare program; monthly actuarial rates, supplementary medical insurance premium rate, and catastrophic coverage premium beginning January 1, 1990--HCFA. Correction
Q77671922	Medicare program; monthly actuarial rates, supplementary medical insurance premium rate, and catastrophic coverage premium beginning January 1, 1990--HCFA. Notice
Q74688399	Medicare program; monthly supplementary medical insurance premium beginning January 1, 1990--HCFA. Notice
Q77671201	Medicare program; national coverage decisions--HCFA. General notice
Q34486693	Medicare program; negotiated rulemaking: coverage and administrative policies for clinical diagnostic laboratory services. Final rule
Q77655380	Medicare program; nonrenewal of carrier contracts HCFA. Final rule with comment period
Q79391281	Medicare program; notification of hospital discharge appeal rights. Final rule
Q85977797	Medicare program; obtaining final Medicare secondary conditional payment amounts via web portal. Interim final rule with comment period
Q74740767	Medicare program; offset of Medicare payments to individuals to collect past-due obligations arising from breach of scholarship and loan contracts--HCFA. Final rule
Q74817206	Medicare program; optional payment system for low Medicare volume skilled nursing facilities--HCFA. Final rule
Q77671428	Medicare program; outpatient prescription drugs: list of covered home i.v. drugs--HCFA. Proposed notice
Q77657614	Medicare program; part A premium for the uninsured aged for the 12-month period beginning January 1, 1985--HHS. Notice
Q74788376	Medicare program; partial hospitalization services in community mental health centers--HCFA. Interim final rule with comment period
Q74793478	Medicare program; participation in CHAMPUS and CHAMPVA, hospital admissions for veterans, discharge rights notice, and hospital responsibility for emergency care--HCFA and OIG. Interim final rule with comment period
Q77664589	Medicare program; payment adjustments for sole community hospitals--HCFA. Final rule with comment period
Q74760943	Medicare program; payment change for home dialysis--HCFA. Final rule
Q77671420	Medicare program; payment for covered outpatient drugs--HCFA. Proposed rule
Q74772797	Medicare program; payment for customized wheelchairs--HCFA. Final rule
Q74732806	Medicare program; payment for customized wheelchairs--HCFA. Interim final rule with comment period
Q77128552	Medicare program; payment for durable medical equipment and orthotic and prosthetic devices--HCFA. Final rule
Q77123917	Medicare program; payment for durable medical equipment and orthotic, and prosthetic devices--HCFA. Interim final rule with comment period
Q77723425	Medicare program; payment for facility services related to ambulatory surgical procedures performed in hospitals on an outpatient basis--HCFA. Final rule
Q77061318	Medicare program; payment for federally qualified health center services--HCFA. Final rule
Q74746879	Medicare program; payment for federally qualified health center services--HCFA. Final rule with comment period
Q77671929	Medicare program; payment for home intravenous drug therapy services--HCFA. Proposed rule
Q74713099	Medicare program; payment for hospice care--HCFA. Final rule with comment period
Q77660663	Medicare program; payment for indirect costs of medical education--HCFA. Proposed rule
Q77650530	Medicare program; payment for inpatient services of foreign hospitals--Health Care Financing Administration. Final rule
Q77669506	Medicare program; payment for kidneys sent to foreign countries or transplanted in patients other than Medicare beneficiaries--HCFA. Final rule
Q74368460	Medicare program; payment for nursing and allied health education. Health Care Financing Administration (HCFA), HHS. Final rule
Q77120724	Medicare program; payment for outpatient surgery at eye specialty hospitals and eye and ear specialty hospitals--HCFA. Final rule
Q74689518	Medicare program; payment for physician outpatient maintenance dialysis services and other physician services for ESRD patients--HCFA. Final rule
Q77655735	Medicare program; payment for physician services furnished in hospitals, skilled nursing facilities, and comprehensive outpatient rehabilitation facilities--HCFA. Final rule; delay in effective date
Q77655005	Medicare program; payment for physician services furnished in hospitals, skilled nursing facilities, and comprehensive outpatient rehabilitation facilities--Health Care Financing Administration. Final rule with comment period
Q77656077	Medicare program; payment for physician services furnished in hospitals, skilled nursing facilities, and comprehensive outpatient rehabilitation facilities; combined billing--HCFA. Final rule
Q77655678	Medicare program; payment for physician services furnished in institutional providers of services--HCFA. Proposed rule
Q77153778	Medicare program; payment for preadmission services--HCFA. Final rule
Q74787501	Medicare program; payment for preadmission services--HCFA. Interim final rule with comment period
Q46945609	Medicare program; payment for respiratory assist devices with bi-level capability and a backup rate. Final rule
Q77163720	Medicare program; payment for teleconsultations in rural health professional shortage areas--HCFA. Proposed rule
Q77658869	Medicare program; payment for the costs of malpractice insurance for hospitals and skilled nursing facilities--HCFA. Proposed rule
Q38446255	Medicare program; payment policies under the physician fee schedule and other revisions to Part B for CY 2010. Final rule with comment period
Q38441666	Medicare program; payment policies under the physician fee schedule and other revisions to Part B for CY 2011. Final rule with comment period.
Q37965181	Medicare program; payment policies under the physician fee schedule, five-year review of work relative value units, clinical laboratory fee schedule: signature on requisition, and other revisions to part B for CY 2012. Final rule with comment period
Q74698655	Medicare program; payment to federally funded health facilities--HCFA. Technical amendments
Q77658752	Medicare program; payment to health maintenance organizations and competitive medical plans--HCFA. Correction of final rule with comment period
Q77661827	Medicare program; payment to health maintenance organizations and competitive medical plans--HCFA. Final rule
Q77551586	Medicare program; payment to health maintenance organizations and competitive medical plans--HCFA. Final rules with comment period
Q77657085	Medicare program; payment to health maintenance organizations and competitive medical plans--HCFA. Proposed rule
Q74758125	Medicare program; payment to hospitals for furnishing photocopies to peer review organizations--HCFA. Final rule
Q77390618	Medicare program; payments for new medical services and new technologies under the acute care hospital inpatient prospective payment system. Final rule
Q74831410	Medicare program; payments to HMOs and CMPs and appeals: technical amendments--HCFA. Final rule with comment period
Q77664229	Medicare program; payments under Medicare and awards under the Federal Tort Claims Act--HCFA. Notice of HCFA ruling
Q77169742	Medicare program; peer review organization contracts: solicitation of statements of interest from in-state organizations--Alaska, Delaware, the District of Columbia, Hawaii, Idaho, Illinois, Kentucky, Maine, Nebraska, Nevada, South Carolina, Vermont
Q77726003	Medicare program; peer review organizations; area designation--HCFA. Final notice with comment period
Q77725989	Medicare program; peer review organizations; revised scopes of work for Maryland; New Jersey; the Virgin Islands; and Guam, American Samoa, the Northern Mariana Islands, and the Trust Territory of the Pacific Islands--HCFA
Q77656538	Medicare program; performance criteria and statistical standards for evaluating intermediary performance during fiscal year 1983--HCFA. Final notice
Q77654993	Medicare program; performance criteria and statistical standards for evaluating intermediary performance during fiscal year 1983--Health Care Financing Administration, HHS. General notice with comment period
Q77656953	Medicare program; performance criteria and statistical standards for evaluating intermediary performance during fiscal year 1984--HCFA. Proposed notice
Q74795561	Medicare program; periodic interim payments for hospitals and other providers--HCFA. Final rule
Q77665781	Medicare program; periodic interim payments for hospitals and other providers--HCFA. Final rule with comment period
Q35602411	Medicare program; photocopying reimbursement methodology. Final rule.
Q77661447	Medicare program; physician fee freeze sanctions--HHS. Final rule
Q77660013	Medicare program; physician fee freeze sanctions--HHS. Notice of proposed rulemaking
Q77152195	Medicare program; physician fee schedule conversion factor for calendar year 1998 and sustainable growth rate for fiscal year 1998--HCFA. Final notice
Q74836541	Medicare program; physician fee schedule update for calendar year 1996 and physician volume performance standard rates of increase for federal fiscal year 1996--HCFA. Final notice
Q77131065	Medicare program; physician fee schedule update for calendar year 1997 and physician volume performance standard rates of increase for Federal fiscal year 1997--HCFA. Final notice
Q38485216	Medicare program; physician fee schedule update for calendar year 2003. Final rule
Q74818426	Medicare program; physician financial relationships with, and referrals to, health care entities that furnish clinical laboratory services and financial relationship reporting requirements--HCFA. Final rule with comment period
Q74688389	Medicare program; physician involvement in physical therapy and speech pathology services--HCFA. Final rule
Q77671591	Medicare program; physician involvement in physical therapy and speech pathology services--HCFA. Interim final rule with comment
Q74689523	Medicare program; physician liability on non-assigned claims--HCFA. Final rule
Q77672553	Medicare program; physician performance standard rate of increase for federal fiscal year 1990--HCFA. Announcement of physician performance standard rate of increase
Q74697076	Medicare program; physician performance standard rates of increase for federal fiscal year 1991--HCFA. Notice
Q74839091	Medicare program; physician self-referral regulations: change in date for submission of group attestation statement--HCFA. Final rule--technical amendment
Q80083341	Medicare program; physicians referrals to health care entities with which they have financial relationships; exceptions for certain electronic prescribing and electronic health records arrangements. Final rule
Q53195661	Medicare program; physicians' referrals to health care entities with which they have financial relations (Phase II); continuation of effectiveness and extension of timeline for publication of final rule. Interim final rule; continuation of effective
Q79835839	Medicare program; physicians' referrals to health care entities with which they have financial relationships (Phase II). Interim final rule with comment period
Q81334865	Medicare program; physicians' referrals to health care entities with which they have financial relationships (Phase III). Final rule
Q44946594	Medicare program; physicians' referrals to health care entities with which they have financial relationships: exception for certain electronic health records arrangements. Final rule
Q77150344	Medicare program; physicians' referrals; issuance of advisory opinions--HCFA. Final rule with comment period
Q44335897	Medicare program; policy and technical changes to the Medicare Advantage and the Medicare prescription drug benefit programs. Final rule.
Q44335131	Medicare program; policy and technical changes to the Medicare prescription drug benefit. Final rule
Q77656053	Medicare program; premium rate for the uninsured aged--HHS. General notice
Q77656211	Medicare program; premium rate for the uninsured aged--HHS. General notice
Q77653296	Medicare program; premium rate for the uninsured aged. Office of the Secretary. General notice
Q77650592	Medicare program; premium rate for the uninsured aged: Office of the Secretary. Notice
Q81020256	Medicare program; prior determination for certain items and services. Final rule
Q77661169	Medicare program; procedures for determining whether providers, practitioners, or other suppliers of services are liable for certain noncovered services--HCFA. Final rule
Q77658158	Medicare program; procedures for determining whether providers, practitioners, or other suppliers of services are liable for certain noncovered services--HCFA. Proposed rule
Q73174695	Medicare program; procedures for making national coverage decisions. Health Care Financing Administration (HCFA), HHS. General notice
Q77660653	Medicare program; processing of claims by electronic means as a condition of qualification for the periodic interim payment method of reimbursement--HCFA proposed rule
Q77649096	Medicare program; prohibition against reassignment of claims by providers and suppliers: proposed rule
Q37307793	Medicare program; prohibition of midyear benefit enhancements for Medicare Advantage organizations. Final rule.
Q77650051	Medicare program; proposed schedule of limits on skilled nursing facility inpatient routine service costs--cost reporting periods beginning on or after October 1, 1979
Q77656620	Medicare program; prospective payment for Medicare inpatient hospital services--HCFA
Q50766941	Medicare program; prospective payment system and consolidated billing for skilled nursing facilities for FY 2006. Final rule.
Q80756701	Medicare program; prospective payment system and consolidated billing for skilled nursing facilities for FY 2008. Final rule
Q39859938	Medicare program; prospective payment system and consolidated billing for skilled nursing facilities for FY 2009. Final rule.
Q33494893	Medicare program; prospective payment system and consolidated billing for skilled nursing facilities for FY 2010; minimum data set, version 3.0 for skilled nursing facilities and Medicaid nursing facilities. Final rule
Q84713457	Medicare program; prospective payment system and consolidated billing for skilled nursing facilities for FY 2012. Final rule
Q50160387	Medicare program; prospective payment system and consolidated billing for skilled nursing facilities for FY 2014. Final rule
Q40214839	Medicare program; prospective payment system and consolidated billing for skilled nursing facilities for FY 2015. Final rule
Q77159949	Medicare program; prospective payment system and consolidated billing for skilled nursing facilities--HCFA. Interim final rule with comment period
Q73162565	Medicare program; prospective payment system and consolidated billing for skilled nursing facilities--update. Health Care Financing Administration (HCFA), HHS. Final rule
Q73175096	Medicare program; prospective payment system and consolidated billing for skilled nursing facilities--update. Health Care Financing Administration (HCFA), HHS. Notice
Q39656962	Medicare program; prospective payment system and consolidated billing for skilled nursing facilities--update. Final rule.
Q50688100	Medicare program; prospective payment system and consolidated billing for skilled nursing facilities--update. Final rule.
Q73175076	Medicare program; prospective payment system and consolidated billing for skilled nursing facilities. Department of Health and Human Services (HHS), Health Care Financing Administration (HCFA). Final rule
Q77194008	Medicare program; prospective payment system and consolidated billing for skilled nursing facilities; correction--HCFA. Correction of interim final rule with comment period
Q77167674	Medicare program; prospective payment system and consolidated billing for skilled nursing facilities; extension of comment period--HCFA. Notice of extension of comment period for interim final rule
Q77783979	Medicare program; prospective payment system and consolidated billing for skilled nursing facilities; reopening of comment period--HCFA. Notice of reopening of comment period for interim final rule
Q95355461	Medicare program; prospective payment system for federally qualified health centers; changes to contracting policies for rural health clinics; and changes to Clinical Laboratory Improvement Amendments of 1988 enforcement actions for proficiency test
Q73162470	Medicare program; prospective payment system for home health agencies. Health Care Financing Administration (HCFA), HHS. Final rule
Q77658546	Medicare program; prospective payment system for hospital inpatient services; redesignation of rules--HCFA. Final rule
Q77659217	Medicare program; prospective payment system for hospital inpatient services; redesignation of rules; correction--HCFA
Q77193858	Medicare program; prospective payment system for hospital outpatient services--HCFA. Proposed rule
Q74368249	Medicare program; prospective payment system for hospital outpatient services. Health Care Financing Administration (HCFA), HHS. Interim final rule with comment period
Q73162581	Medicare program; prospective payment system for hospital outpatient services: revisions to criteria to define new or innovative medical devices, drugs, and biologicals eligible for pass-through payments and corrections to the criteria for the grand
Q93920929	Medicare program; prospective payment system for hospital outpatient services; extension of comment period--HCFA. Notice of extension of comment period for proposed rule
Q74734145	Medicare program; prospective payment system for inpatient hospital capital-related costs; correction--HCFA. Final rule; correction
Q35954539	Medicare program; prospective payment system for inpatient psychiatric facilities. Final rule.
Q77498003	Medicare program; prospective payment system for inpatient rehabilitation facilities. Final rule
Q50782023	Medicare program; prospective payment system for long-term care hospitals RY 2007: annual payment rate updates, policy changes, and clarification. Final rule.
Q51102045	Medicare program; prospective payment system for long-term care hospitals RY 2008: annual payment rate updates, and policy changes; and hospital direct and indirect graduate medical education policy changes. Final rule.
Q46918620	Medicare program; prospective payment system for long-term care hospitals RY 2009: annual payment rate updates, policy changes, and clarifications; and electronic submission of cost reports: revision to effective date of cost reporting period. Final
Q50720397	Medicare program; prospective payment system for long-term care hospitals: annual payment rate updates and policy changes. Final rule.
Q50743884	Medicare program; prospective payment system for long-term care hospitals: annual payment rate updates and policy changes. Final rule.
Q50761056	Medicare program; prospective payment system for long-term care hospitals: annual payment rate updates, policy changes, and clarification. Final rule.
Q74723019	Medicare program; prospective payment system for long-term care hospitals: implementation and FY 2003 rates. Final rule
Q77696800	Medicare program; prospective payments for Medicare inpatient hospital services--HCFA. Interim final rule with comment period
Q77656227	Medicare program; prospective payments for Medicare inpatient hospital services; correction--Interim rule; correction
Q74688864	Medicare program; protocol for the reuse of dialysis bloodlines--HCFA. Final rule
Q77667393	Medicare program; protocol for the reuse of dialysis bloodlines--HCFA. Proposed rule
Q37208685	Medicare program; provider reimbursement determinations and appeals. Final rule
Q74805039	Medicare program; providers and suppliers of specialized services: technical amendments--HCFA. Final rule with comment period
Q73162571	Medicare program; provisions of the Balanced Budget Refinement Act of 1999; hospital inpatient payments and rates and costs of graduate medical education. Health Care Financing Administration (HCFA), HHS. Interim final rule with comment period
Q34449409	Medicare program; provisions of the Benefits Improvement and Protection Act of 2000; inpatient payments and rates and costs of graduate medical education. Interim final rule with comment period.
Q74798959	Medicare program; qualified health maintenance organizations: technical amendments--HCFA. Final rule with comment period
Q74700978	Medicare program; quarterly listing of program issuances and coverage decisions--HCFA. General notice
Q74714577	Medicare program; quarterly listing of program issuances and coverage decisions--HCFA. General notice
Q74731264	Medicare program; quarterly listing of program issuances and coverage decisions--HCFA. General notice
Q74740749	Medicare program; quarterly listing of program issuances and coverage decisions--HCFA. General notice
Q74746107	Medicare program; quarterly listing of program issuances and coverage decisions--HCFA. General notice
Q77667234	Medicare program; reasonable charge limitations--HCFA. Final rule
Q77661831	Medicare program; reasonable charge limitations--HCFA. Final rule with comment period
Q77784005	Medicare program; recognition of NAIC model standards for regulation of Medicare supplemental insurance--HCFA. Notice
Q77660973	Medicare program; recognition of State reimbursement control systems--HCFA. Final rule
Q77658875	Medicare program; recognition of state reimbursement control systems--HCFA. Proposed rule
Q77783991	Medicare program; recognition of the American Association for Accreditation of Ambulatory Surgery Facilities, Inc. for ambulatory surgical centers program-HCFA. Final notice
Q28140315	Medicare program; recognition of the Community Health Accreditation Program standards for home care organizations--HCFA. Final notice
Q73174671	Medicare program; recognition of the Community Health Accreditation Program, Inc. (CHAP) for hospices. Health Care Financing Administration (HCFA), HHS. Final notice
Q77662909	Medicare program; redesignation of reasonable cost regulations--HCFA. Final rule with comment period
Q79336130	Medicare program; reduction in Medicare Part B premiums as additional benefits under Medicare+Choice plans. Final rule
Q77655769	Medicare program; reduction in the number of providers and health maintenance organizations dealing directly with HCFA. Notice of proposed rulemaking
Q77656683	Medicare program; reduction in the number of providers dealing directly with HCFA. Final rule
Q74803676	Medicare program; refinements to geographic adjustment factor values, revisions to payment policies, adjustments to the relative value units (RVUs) under the physician fee schedule for calendar year 1995, and the 5-year refinement of RVUs--HCFA. Cor
Q74802872	Medicare program; refinements to geographic adjustment factor values, revisions to payment policies, adjustments to the relative value units (RVUs) under the physician fee schedule for calendar year 1995, and the 5-year refinement of RVUs--HCFA. Fin
Q74816578	Medicare program; refinements to geographic adjustment factor values, revisions to payment policies, adjustments to the relative value units (RVUs) under the physician fee schedule for calendar year 1995, and the 5-year refinement of RVUs; correctio
Q77652091	Medicare program; reimbursement for costs incurred in relation to union activities--Health Care Financing Administration. Final notice
Q77650226	Medicare program; reimbursement for costs of approved internship and residency programs: proposed rule
Q77657979	Medicare program; reissuance of the wage index in the 1981 schedule of limits on hospital per diem inpatient general routine operating costs--HCFA
Q77699746	Medicare program; reissuance of the wage index in the 1981 schedule of limits on hospital per diem inpatient general routine operating costs--HCFA. Final notice
Q77656696	Medicare program; reissuance of the wage index in the 1981 schedule of limits on hospital per diem inpatient general routine operating costs--HCFA. Proposed notice
Q74368133	Medicare program; removal of the requirements for the cardiac pacemaker registry. Health Care Financing Administration, HHS. Final rule
Q77390598	Medicare program; replacement of reasonable charge methodology by fee schedules for parenteral and enteral nutrients, equipment, and supplies. Final rule
Q77077586	Medicare program; reporting of interest from zero coupon bonds--HCFA. Final rule
Q74731499	Medicare program; reporting requirements for financial relationships between physicians and health care entities that furnish selected items and services--HCFA. Interim final rule with comment period
Q74781391	Medicare program; required laboratory procedures for rural health clinics--HCFA. Final rule with comment period
Q77650218	Medicare program; requirements for ESRD network organization and functions: proposed rule
Q83192438	Medicare program; requirements for providers and suppliers to establish and maintain Medicare enrollment. Final rule
Q77390623	Medicare program; requirements for recredentialing of Medicare+Choice organization providers. Final rule
Q86291409	Medicare program; requirements for the Medicare incentive reward program and provider enrollment. Final rule
Q74722131	Medicare program; review of information collection and recordkeeping requirements for providers of outpatient physical therapy and/or speech pathology services--HCFA. Final rule
Q80733372	Medicare program; revised civil money penalties, assessments, exclusions, and related appeals procedures. Final rule
Q74772804	Medicare program; revised designation of states in which Medicare SELECT insurance policies may be issued--HCFA. Notice
Q77655649	Medicare program; revised market basket inflation rates for provider cost limits--HCFA. General notice
Q36903474	Medicare program; revised payment system policies for services furnished in ambulatory surgical centers (ASCs) beginning in CY 2008. Final rule.
Q74758133	Medicare program; revised procedures for paying claims from providers of services--HCFA. Final notice
Q77120349	Medicare program; revision of ambulatory surgical center payment rate methodology--HCFA. Final notice of payment rates
Q77660455	Medicare program; revision of explanation of Medicare benefit notice and review procedures for beneficiaries; supplementary medical insurance (Part B); court order--HCFA. Notice with comment period
Q74761422	Medicare program; revision of the Medicare Economic Index--HCFA. Final rule
Q79867296	Medicare program; revision of the deadline for submission of emergency graduate medical education affiliation agreements. Final rule
Q77174710	Medicare program; revision of the procedures for requesting exceptions to cost limits for skilled nursing facilities and elimination of reclassifications--HCFA. Proposed rule
Q73175062	Medicare program; revision of the procedures for requesting exceptions to cost limits for skilled nursing facilities and elimination of reclassifications. Department of Health and Human Services (HHS), Health Care Financing Administration (HCFA).
Q77159987	Medicare program; revision to accrual basis of accounting policy--HCFA. Proposed rule
Q74070215	Medicare program; revision to accrual basis of accounting policy. Department of Health and Human Services (HHS), Health Care Financing Administration (HCFA). Final rule
Q73018625	Medicare program; revision to accrual basis of accounting policy. Health Care Financing Administration (HCFA), HHS. Final rule
Q84025750	Medicare program; revisions to FY 2009 Medicare severity-long-term care diagnosis-related group (MS-LTC-DRG) weights. Interim final rule with comment period
Q74811956	Medicare program; revisions to criteria and standards for evaluating intermediaries and carriers--HCFA. CFR correction
Q77654988	Medicare program; revisions to criteria and standards for evaluating intermediaries--Health Care Financing Administration. Final rule with comment period
Q74797067	Medicare program; revisions to payment policies and adjustments to the relative value units under the Physician Fee Schedule for calendar year 1994--HCFA. Correction
Q74794993	Medicare program; revisions to payment policies and adjustments to the relative value units under the physician fee schedule for calendar year 1994--HCFA. Correction of final rule with comment period
Q77125814	Medicare program; revisions to payment policies and adjustments to the relative value units under the physician fee schedule for calendar year 1994--HCFA. Final rule with comment period
Q74836537	Medicare program; revisions to payment policies and adjustments to the relative value units under the physician fee schedule for calendar year 1996--HCFA. Final rule with comment period
Q77194242	Medicare program; revisions to payment policies and adjustments to the relative value units under the physician fee schedule for calendar year 1999--HCFA. Final rule with comment period
Q77152190	Medicare program; revisions to payment policies and adjustments to the relative value units under the physician fee schedule, other Part B payment policies, and establishment of the clinical psychologist fee schedule for calendar year 1998--HCFA. Fi
Q77152282	Medicare program; revisions to payment policies and adjustments to the relative value units under the physician fee schedule, other Part B payment policies, and establishment of the clinical psychologist fee schedule for calendar year 1998; correcti
Q77131057	Medicare program; revisions to payment policies and five-year review of and adjustments to the relative value units under the physician fee schedule for calendar year 1997--HCFA. Final rule with comment period
Q77099517	Medicare program; revisions to payment policies and five-year review of and adjustments to the relative value units under the physician fee schedule for calendar year 1997; correction--HCFA. Correction of final rule with comment period
Q34473182	Medicare program; revisions to payment policies and five-year review of and adjustments to the relative value units under the physician fee schedule for calendar year 2002. Final rule with comment period.
Q50169359	Medicare program; revisions to payment policies under the Physician Fee Schedule, Clinical Laboratory Fee Schedule, access to identifiable data for the Center for Medicare and Medicaid Innovation Models & other revisions to Part B for CY 2015. Final
Q81020244	Medicare program; revisions to payment policies under the Physician Fee Schedule, and other part B payment policies for CY 2008; delay of the date of applicability of the revised anti-markup provisions for certain services furnished in certain locat
Q77115032	Medicare program; revisions to payment policies under the physician fee for schedule, other Part B payment policies, and establishment of the clinical psychologist fee schedule for calendar year 1998--HCFA. Proposed rule
Q77201744	Medicare program; revisions to payment policies under the physician fee schedule for calendar year 1999--HCFA. Proposed rule
Q77193867	Medicare program; revisions to payment policies under the physician fee schedule for calendar year 1999; correction--HCFA. Correction of proposed rule
Q73018579	Medicare program; revisions to payment policies under the physician fee schedule for calendar year 2000. Health Care Financing Administration (HCFA), HHS. Final rule with comment period
Q74368158	Medicare program; revisions to payment policies under the physician fee schedule for calendar year 2001. Health Care Financing Administration (HCFA), HHS. Final rule with comment period
Q38486017	Medicare program; revisions to payment policies under the physician fee schedule for calendar year 2003 and inclusion of registered nurses in the personnel provision of the critical access hospital emergency services requirement for frontier areas a
Q38481626	Medicare program; revisions to payment policies under the physician fee schedule for calendar year 2004. Final rule with comment period
Q38476434	Medicare program; revisions to payment policies under the physician fee schedule for calendar year 2005. Final rule with comment period
Q38470838	Medicare program; revisions to payment policies under the physician fee schedule for calendar year 2006 and certain provisions related to the Competitive Acquisitions Program of outpatient drugs and biologicals under Part B. Final rule with comment.
Q85453065	Medicare program; revisions to payment policies under the physician fee schedule, DME face-to-face encounters, elimination of the requirement for termination of non-random prepayment complex medical review and other revisions to Part B for CY 2013.
Q80106993	Medicare program; revisions to payment policies under the physician fee schedule, and other Part B payment policies for CY 2008; revisions to the payment policies of ambulance services under the ambulance fee schedule for CY 2008; and the amendment
Q54436989	Medicare program; revisions to payment policies under the physician fee schedule, clinical laboratory fee schedule & other revisions to Part B for CY 2014. Final rule with comment period.
Q77116811	Medicare program; revisions to payment policies under the physician fee schedule, other Part B payment policies, and establishment of the clinical psychologist fee schedule for calendar year 1998; correction--HCFA. Correction of proposed rule
Q36685286	Medicare program; revisions to payment policies, five-year review of work relative value units, changes to the practice expense methodology under the physician fee schedule, and other changes to payment under part B; revisions to the payment policie
Q37026889	Medicare program; revisions to the Medicare Advantage and Part D prescription drug contract determinations, appeals, and intermediate sanctions processes. Final rule with comment period.
Q44335418	Medicare program; revisions to the Medicare Advantage and prescription drug benefit programs: clarification of compensation plans. Interim final rule with comment period.
Q83657358	Medicare program; revisions to the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) supplier safeguards. Final rule
Q95356497	Medicare program; right of appeal for Medicare secondary payer determinations relating to liability insurance (including self-insurance), no-fault insurance, and workers' compensation laws and plans. Final rule
Q76377554	Medicare program; rural health clinics: amendments to participation requirements and payment provisions; and establishment of a quality assessment and performance improvement program. Final rule
Q79179556	Medicare program; rural health clinics: amendments to participation requirements and payment provisions; and establishment of a quality assessment and performance improvement program; suspension of effectiveness. Interim final rule with comment peri
Q74709170	Medicare program; schedule of limits for skilled nursing facility inpatient routine service costs--HCFA. Correction
Q77665041	Medicare program; schedule of limits for skilled nursing facility inpatient routine service costs--HCFA. Final notice of schedule of limits
Q74706227	Medicare program; schedule of limits for skilled nursing facility inpatient routine service costs--HCFA. Final notice with comment period
Q74758113	Medicare program; schedule of limits for skilled nursing facility inpatient routine service costs--HCFA. Final notice with comment period
Q77660306	Medicare program; schedule of limits for skilled nursing facility inpatient routine service costs--HCFA. Proposed notice
Q77653116	Medicare program; schedule of limits on home health agency costs per visit effective October 1, 1981--Health Care Financing Administration. Final notice
Q77659070	Medicare program; schedule of limits on home health agency costs per visit for cost reporting periods beginning on or after July 1, 1985--HCFA. Final notice
Q77658749	Medicare program; schedule of limits on home health agency costs per visit for cost reporting periods beginning on or after July 1, 1985--HCFA. Proposed notice
Q77668257	Medicare program; schedule of limits on home health agency costs per visit for cost reporting periods beginning on or after July 1, 1988. HCFA--Notice with comment period
Q74709127	Medicare program; schedule of limits on home health agency costs per visit for cost reporting periods beginning on or after July 1, 1989--HCFA. Final notice
Q74731512	Medicare program; schedule of limits on home health agency costs per visit for cost reporting periods beginning on or after July 1, 1991--HCFA. Notice with comment period
Q74747741	Medicare program; schedule of limits on home health agency costs per visit for cost reporting periods beginning on or after July 1, 1992--HCFA. Notice with comment period
Q74755191	Medicare program; schedule of limits on home health agency costs per visit for cost reporting periods beginning on or after July 1, 1992; correction--HCFA. Notice with comment period; correction
Q74772808	Medicare program; schedule of limits on home health agency costs per visit for cost reporting periods beginning on or after July 1, 1993--HCFA. Notice with comment period
Q77113822	Medicare program; schedule of limits on home health agency costs per visit for cost reporting periods beginning on or after July 1, 1997--HCFA. Notice with comment period
Q77149387	Medicare program; schedule of limits on home health agency costs per visit for cost reporting periods beginning on or after October 1, 1997--HCFA. Notice with comment period
Q74808907	Medicare program; schedule of limits on home health agency costs per visit--HCFA. Notice with comment period
Q77652748	Medicare program; schedule of limits on home health agency costs per visit: Health Care Financing Administration. Final notice
Q77742777	Medicare program; schedule of limits on hospital inpatient general routine operating costs for cost reporting periods beginning on or after July 1, 1979: correction
Q77650044	Medicare program; schedule of limits on hospital inpatient general routine operating costs for cost reporting periods beginning on or after July 1, 1979: final notice
Q77696794	Medicare program; schedule of limits on hospital inpatient operating costs for cost reporting periods beginning on or after October 1, 1982--HCFA. Final notice
Q77696781	Medicare program; schedule of limits on hospital inpatient operating costs for cost reporting periods beginning on or after October 1, 1982--HCFA. Interim final notice with comment period
Q77696789	Medicare program; schedule of limits on hospital inpatient operating costs for cost reporting periods beginning on or after October 1, 1982. Correction
Q77652743	Medicare program; schedule of limits on hospital per diem inpatient general routine operating cost for cost reporting periods beginning on or after July 1, 1981: Health Care Financing Administration
Q77653112	Medicare program; schedule of limits on hospital per diem inpatient general routine operating costs--Health Care Financing Administration. Final notice
Q77655368	Medicare program; schedule of limits on skilled nursing facility inpatient routine service costs--HCFA. Final notice with comment period
Q77660314	Medicare program; schedule of limits on skilled nursing facility inpatient routine service costs--HFCA. Proposed notice
Q77153879	Medicare program; schedule of per-beneficiary limitations on home health agency costs for cost reporting periods beginning on or after October 1, 1997--HCFA. Final rule with comment period
Q77656623	Medicare program; schedule of target rate percentages for limits on the rate of hospital cost increases and updating factors for transition prospective payment rates (second quarter FY 84)--HCFA
Q77657092	Medicare program; schedule of target rate percentages for limits on the rate of hospital cost increases and updating factors for transition prospective payment rates (second quarter FY 84); correction--HCFA
Q77656080	Medicare program; schedule of target rate percentages for limits on the rate of hospital cost increases and updating factors for transition prospective payments rates--HCFA. Interim final notice with comment period
Q77652096	Medicare program; schedule of target reimbursement rates for institutions furnishing home dialysis supplies, equipment, and support services: Health Care Financing Administration. Final notice
Q77142018	Medicare program; schedules of limits and prospectively determined payment rates for skilled nursing facility inpatient routine service costs--HCFA. Final notice with comment period
Q77664225	Medicare program; schedules of limits on home health agency costs per visit for cost reporting periods beginning on or after July 1, 1986 but before July 1, 1987 and cost reporting periods beginning on or after July 1, 1987-HCFA. Notice with comment
Q77174721	Medicare program; schedules of per-visit and per-beneficiary limitations on home health agency costs for cost reporting periods beginning on or after October 1, 1998--HCFA. Notice with comment period
Q77194172	Medicare program; schedules of per-visit and per-beneficiary limitations on home health agency costs for cost reporting periods beginning on or after October 1, 1998; correction--HCFA. Correction of notice with comment period
Q77158199	Medicare program; scope of Medicare benefits and application of the outpatient mental health treatment limitation to clinical psychologist and clinical social worker services--HCFA. Final rule
Q77664809	Medicare program; selected performance information on hospitals providing care to Medicare beneficiaries--HCFA. Correction
Q77664800	Medicare program; selected performance information on hospitals providing care to Medicare beneficiaries--HCFA. Notice with comment period
Q74793207	Medicare program; self-implementing coverage and payment provisions: 1993 legislation--HCFA. Final rule with comment period
Q74780470	Medicare program; self-implementing coverage and payments provisions: 1990 legislation--HCFA. Confirmation of final rule
Q74755154	Medicare program; self-implementing coverage and payments provisions: 1990 legislation--HCFA. Final rule with comment period
Q77653933	Medicare program; services covered under automobile, liability, and employer group health insurance--Health Care Financing Administration. Proposed rule
Q77652103	Medicare program; shared-services organizations and cost to related organizations--Health Care Financing Administration. Withdrawal of notices of proposed rulemaking
Q77693137	Medicare program; solicitation of hospitals and medical centers to participate in a study of heart transplants: Health Care Financing Administration. Notice
Q73018555	Medicare program; solvency standards for provider-sponsored organizations. Health Care Financing Administration (HCFA), HHS. Final rule
Q77135409	Medicare program; solvency standards for provider-sponsored organizations; intent to form negotiated rulemaking committee--HCFA. Intent to form negotiated rulemaking committee and notice of meetings
Q81737891	Medicare program; special enrollment period and Medicare premium changes. Final rule
Q74805028	Medicare program; special payment limits for home blood glucose monitors--HCFA. Final notice
Q77655780	Medicare program; special solicitation; preventive services demonstration--HCFA. General notice
Q74730725	Medicare program; standard claim forms for Part B claims completed and submitted by physicians, suppliers and other persons--HCFA. General notice with comment period
Q77660522	Medicare program; standardized per capita rates of payments for health maintenance organizations and competitive medical plans for 1986--HCFA. Notice
Q77657622	Medicare program; standards and criteria for evaluating intermediary and carrier performance during fiscal year 1985--HCFA. General notice with comment period
Q38390441	Medicare program; standards for e-prescribing under Medicare Part D and identification of backward compatible version of adopted standard for e-prescribing and the Medicare prescription drug program (version 8.1). Final rule.
Q74832483	Medicare program; standards for quality of water used in dialysis and revised guidelines on reuse of hemodialysis filters for end-stage renal disease (ESRD) patients--HCFA. Final rule
Q77665023	Medicare program; standards for reuse of hemodialyzer filters and other dialysis supplies--HCFA. Final rule
Q77654919	Medicare program; statistical standards for evaluating intermediary performance during fiscal year 1982--Health Care Financing Administration. General notice with comment period
Q73018575	Medicare program; suggestion program on methods to improve Medicare efficiency. Health Care Financing Administration (HCFA), HHS. Final rule with comment period
Q78309169	Medicare program; supplementary medical insurance premium surcharge agreements. Final rule
Q77665503	Medicare program; supplementary medical insurance premiums--HCFA. Final rule with comment period
Q77194251	Medicare program; sustainable growth rate for fiscal year 1999--HCFA. Notice with comment period
Q74729712	Medicare program; swing-bed program changes--HCFA. Final rule
Q77671433	Medicare program; swing-bed program changes--HCFA. Interim rule with comment period
Q77655726	Medicare program; temporary delay in periodic interim payments (PIP) to hospitals--HCFA. General notice
Q73710902	Medicare program; third party liability insurance regulations. Final rule with comment period
Q77655710	Medicare program; treatment of cost of uncompensated services furnished in fulfillment of a Hill-Burton free care obligation--HCFA. Final rule with comment period
Q74814487	Medicare program; uniform electronic cost reporting system for hospitals--HCFA. Final rule
Q74793211	Medicare program; uniform electronic cost reporting system for hospitals--HCFA. Final rule with comment period
Q74689881	Medicare program; uniform relative value guide for anesthesia services furnished by physicians--HCFA. Final rule
Q77128812	Medicare program; update of ambulatory surgical center (ASC) payment rates effective for services on or after October 1, 1995-HCFA. Notice
Q35096461	Medicare program; update of ambulatory surgical center list of covered procedures effective July 1, 2003. Final rule with comment period
Q81714813	Medicare program; update of ambulatory surgical center list of covered procedures. Interim final rule with comment period
Q77122260	Medicare program; update of ambulatory surgical center payment rates and additions to and deletions from the current list of covered surgical procedures--HCFA. Notice with comment period
Q74689407	Medicare program; update of ambulatory surgical center payment rates effective July 1, 1990--HCFA. Notice with comment period
Q77724040	Medicare program; update of ambulatory surgical center payment rates--HCFA. Notice of proposed rates
Q77123639	Medicare program; update of ambulatory surgical center payment rates--HCFA. Notice with comment period
Q77174756	Medicare program; update of ratesetting methodology, payment rates, payment policies, and the list of covered procedures for ambulatory surgical centers effective October 1, 1998; extension of comment period--HCFA. Notice of extension of comment per
Q93920930	Medicare program; update of ratesetting methodology, payment rates, payment policies, and the list of covered procedures for ambulatory surgical centers effective October 1, 1998; extension of comment period--HCFA. Notice of extension of comment per
Q77193980	Medicare program; update of ratesetting methodology, payment rates, payment policies, and the list of covered procedures for ambulatory surgical centers effective October 1, 1998; reopening of comment period and delay in adoption of the proposed rul
Q77163678	Medicare program; update of ratesetting methodology, payment rates, payment policies, and the list of covered surgical procedures for ambulatory surgical centers effective October 1, 1998--HCFA. Proposed rule
Q77106191	Medicare program; update of the reasonable compensation equivalent limits for services furnished by physicians--HCFA. Notice
Q77660958	Medicare program; update to freestanding and hospital-based skilled nursing facility cost limits effect for cost reporting periods starting May 1, 1986--HCFA. Final notice
Q81737887	Medicare program; use of repayment plans. Final rule
Q77567856	Medicare program; utilization and quality control Peer Review Organization (PRO) area designations and definitions of eligible organizations--HCFA. Final rule
Q77567859	Medicare program; utilization and quality control Peer Review Organization (PRO) area designations--HCFA. Final notice
Q77567559	Medicare program; utilization and quality control peer review organization (PRO) area designations--HCFA. Notice
Q77658574	Medicare program; utilization and quality control peer review organization (PRO) reconsiderations and appeals--HCFA. Final rule
Q77658568	Medicare program; utilization and quality control peer review organizations--imposition of sanctions on health care practitioners and providers of health care services--HCFA. Final rule
Q77656956	Medicare program; utilization and quality control peer review organizations; imposition of sanctions on health care practitioners and providers of health care services--HCFA. Proposed rule
Q77660045	Medicare program; utilization and quality control peer review program; solicitation of comments on proposed PRO program scope of work--HCFA. Notice
Q77667941	Medicare program; utilization and quality control peer review program; third Scope of Work for peer review organizations--HCFA. Notice
Q77649935	Medicare program; validation of accreditation surveys of hospitals: proposed rule
Q77077591	Medicare program; waiver of recovery of overpayments--HCFA. Final rule
Q77159914	Medicare program; waiver requirements and solvency standards for provider-sponsored organizations--HCFA. Interim final rule with comment period
Q77121449	Medicare program; withdrawal of coverage of certain investigational intraocular lenses.--HCFA. Final notice
Q74705203	Medicare program; withdrawal of coverage of extracranial-intracranial arterial bypass surgery for the treatment or prevention of stroke--HCFA. Final notice
Q74688395	Medicare program; withdrawal of coverage of extracranial-intracranial arterial bypass surgery for the treatment or prevention of stroke--HCFA. Proposed notice
Q74761416	Medicare program; withdrawal of coverage of thermography--HCFA. Final notice
Q74781387	Medicare program; withdrawal of the Provider Reimbursement Review Board Hearing Manual--PRRB, HHS. Notice
Q77652017	Medicare program; withholding of payments to practitioners, providers, and suppliers of services--Health Care Financing Administration. Proposed rule
Q73172361	Medicare program; year 2000 readiness letter. Health Care Financing Administration (HCFA), HHS. Notice
Q83860480	Medicare programs: changes to the end-stage renal disease prospective payment system transition budget-neutrality adjustment. Interim final rule with comment period
Q77653478	Medicare programs; end-stage renal disease program; prospective reimbursement for dialysis services: Health Care Financing Administration. Proposed rule
Q77567555	Medicare programs; utilization and quality control peer reviews organization (PRO) area designations and definitions of eligible organizations--HCFA. Proposed rule
Q77148202	Medicare+Choice program; collection of user fees from Medicare+Choice plans and risk-sharing contractors--HCFA. Interim final rule with request for comments
Q74763028	Medicare, Medicaid and CLIA programs; CLIA program fee collection; correction--HCFA. Correcting amendments
Q74802524	Medicare, Medicaid and CLIA programs; extension of certain effective dates for clinical laboratory requirements and personnel requirements for cytologists--HCFA. Final rule with comment period
Q77124069	Medicare, Medicaid and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and Clinical Laboratory Improvement Act Program fee collection--HCFA. Final rule with comment period
Q77122427	Medicare, Medicaid and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA)--HCFA. Final rule with comment period
Q77124684	Medicare, Medicaid and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988--HCFA. Final rule; correction
Q77125547	Medicare, Medicaid and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988--HCFA. Final rule; correction
Q74688251	Medicare, Medicaid and CLIA programs; revision of the laboratory regulations for the Medicare, Medicaid, and Clinical Laboratories Improvement Act of 1967 programs--HCFA. Final rule with comment period
Q74689916	Medicare, Medicaid and CLIA programs; revisions of the laboratory regulations for the Medicare, Medicaid, and Clinical Laboratories Improvement Act of 1967 programs; correction--HCFA. Final rule; correction notice
Q48282673	Medicare, Medicaid, Children's Health Insurance Programs; transparency reports and reporting of physician ownership or investment interests. Final rule.
Q77113818	Medicare, Medicaid, and CLIA programs; Clinical Laboratory Improvement Amendments of 1988 continuance of exemption of laboratories licensed by the State of Washington--HCFA. Notice
Q77131891	Medicare, Medicaid, and CLIA programs; clinical laboratory requirements--extension of certain effective dates for clinical laboratory requirements under CLIA--CDC, HCFA. Final rule with comment period
Q77194084	Medicare, Medicaid, and CLIA programs; extension of certain effective dates for clinical laboratory requirements under CLIA--CDC, HCFA. Final rule with comment period
Q74368385	Medicare, Medicaid, and CLIA programs; extension of certain effective dates for clinical laboratory requirements under CLIA. Centers for Disease Control and Prevention (CDC) and Health Care Financing Administration (HCFA), HHS. Final rule with comm
Q78838519	Medicare, Medicaid, and CLIA programs; laboratory requirements relating to quality systems and certain personnel qualifications. Final rule
Q74787468	Medicare, Medicaid, and CLIA programs; personnel requirements for cytotechnologists--HCFA. Final rule with comment period
Q95490221	Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of the Implementation and Extension of Temporary Moratoria on Enrollment of Part B Non-Emergency Ground Ambulance Suppliers and Home Health Agencies in Designated Geogr
Q91353780	Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Revisions to the Provider Enrollment Moratoria Access Waiver Demonstration for Part B Non-Emergency Ground Ambulance Suppliers and Home Health Agencies in Moratoria-Desig
Q49817360	Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of the Extension of Temporary Moratoria on Enrollment of Part B Non-Emergency Ground Ambulance Suppliers and Home Health Agencies in Designated Geographic Locations. Extensio
Q53137275	Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of the Extension of Temporary Moratoria on Enrollment of Part B Non-Emergency Ground Ambulance Suppliers and Home Health Agencies in Designated Geographic Locations. Extensio
Q90737703	Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of the Extension of Temporary Moratoria on Enrollment of Part B Non-Emergency Ground Ambulance Suppliers and Home Health Agencies in Designated Geographic Locations. Extensio
Q50187927	Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of the Provider Enrollment Moratoria Access Waiver Demonstration of Part B Non-Emergency Ground Ambulance Suppliers and Home Health Agencies in Moratoria-Designated Geo
Q95484050	Medicare, Medicaid, and Children's Health Insurance Programs: announcement of the extended temporary moratoria on enrollment of ambulance suppliers and home health agencies in designated geographic locations. Extension of temporary moratoria
Q51551259	Medicare, Medicaid, and Children's Health Insurance Programs; additional screening requirements, application fees, temporary enrollment moratoria, payment suspensions and compliance plans for providers and suppliers. Final rule with comment period.
Q74768517	Medicare, Medicaid, and Clinical Laboratories Improvement Act (CLIA) patient confidentiality rules; proposed rule
Q77516313	Medicare, Medicaid, and Maternal and Child Health Services Block Grant programs; civil money penalties and assessments for false or improper claims--Department of Health and Human Services. Notice of proposed rulemaking
Q77666360	Medicare/Medicaid program; revisions in reporting, recordkeeping, and other requirements--HCFA. Final rule
Q77613177	Medicare/Medicaid programs; fire safety standards for hospitals, skilled nursing facilities, hospices, intermediate care facilities and ambulatory surgical centers--HCFA. Final rule
Q77668227	Medicare: criteria and standards for evaluating intermediary and carrier performance during fiscal year 1989--HCFA. General notice with comment period
Q77660036	Medicare; delay in implementing certain changes to the prospective payment system--HCFA. Notice
Q77660963	Medicare; limitations on reimbursement of nonphysician medical services--HCFA. Correction of final rule
Q95546608	Medication Assisted Treatment for Opioid Use Disorders Reporting Requirements. Final rule
Q44338539	Medication Assisted Treatment for Opioid Use Disorders. Final rule
Q45839804	Medication prescribed by non-VA physicians. Final rule
Q39383881	Medications prescribed by non-VA providers. Final rule
Q77152267	Medtronic, Inc.; premarket approval of the Interstim Sacral Nerve Stimulation (SNS) System--FDA. Notice
Q77166927	Memorandum of understanding between the Food and Drug Administration and the Defense Alliance for Advanced Medical Terminology--FDA. Notice
Q77167694	Memorandum of understanding between the Food and Drug Administration and the Indian Health Service--FDA. Notice
Q77163668	Memorandum of understanding between the Food and Drug Administration and the National Institutes of Health's National Institute of Dental Research--FDA. Notice
Q73174825	Memorandum of understanding between the Food and Drug Administration and the U.S. Army Medical Research and Material Command. Food and Drug Administration, HHS. Notice
Q34860625	Mental health and substance abuse emergency response criteria. Final rule.
Q77115036	Mental health parity and newborns' and mothers' health protection--HCFA. Solicitation of comments
Q51904666	Mental health parity. Interim final amendment to regulation.
Q77123998	Methadone in maintenance treatment of narcotic addicts; joint revision of conditions for use; interim maintenance treatment; human immunodeficiency virus disease counseling--FDA and SAMHSA. Final rule
Q74747723	Method for evaluating and establishing reimbursement rates for health care services authorized under the Indian Health Service contract health services regulations--selected IHS sites--IHS. Addition of sites to the IHS pilot project
Q77193904	Methodology for determining whether an increase in a state's child poverty rate is the result of the TANF program--Administration for Children and Families, HHS. Proposed rule
Q40373524	Microbiology Devices; Reclassification of Influenza Virus Antigen Detection Test Systems Intended for Use Directly With Clinical Specimens. Final order
Q84718595	Microbiology devices; reclassification of Herpes simplex virus types 1 and 2 serological assays. Direct final rule
Q45419404	Microbiology devices; reclassification of hepatitis A virus serological assays. Final rule
Q44222523	Microbiology devices; reclassification of herpes simplex virus types 1 and 2 serological assays. Final rule.
Q51720377	Microbiology devices; reclassification of nucleic acid-based systems for mycobacterium tuberculosis complex in respiratory specimens. Final rule.
Q95521464	Minimum Value of Eligible Employer-Sponsored Plans and Other Rules Regarding the Health Insurance Premium Tax Credit. Final regulations
Q86062996	Minimum essential coverage and other rules regarding the shared responsibility payment for individuals. Final regulations
Q77516278	Minimum funding requirements and minimum funding excise taxes--Internal Revenue Service. Notice of proposed rulemaking
Q77516250	Minimum guidelines and requirements for accessible design--Architectural and Transportation Barriers Compliance Board. Final rule
Q77484792	Minimum guidelines and requirements for accessible design--Architectural and Transportation Barriers Compliance Board. Proposed rule
Q77168772	Minor corrections, clarifying changes, and a minor policy change--NRC. Final rule
Q73174682	Minority fellowship program. CMHS, CSAP, and CSAT, SAMHSA, DHHS. Notice of planned awards for renewal of clinical training grants under the Minority Fellowship Program (MFP) to the American Nurses Association, the American Psychiatric Association (A
Q77669159	Miscellaneous Medicare and Medicaid amendments--HCFA. Final rule
Q77516426	Miscellaneous amendments to the HHS procurement regulations--Department of Health and Human Services. Proposed rule
Q77522476	Miscellaneous amendments to the HHS procurement regulations--HHS. Final rule
Q77116787	Miscellaneous amendments--HHS. Final rule
Q95384921	Mitigation Strategies To Protect Food Against Intentional Adulteration. Final rule
Q50200454	Modification of Treatment of Certain Health Organizations. Final regulations
Q79699869	Modification of certain medical standards and procedures and duration of certain medical certificates. Final rule
Q86340082	Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification rules under the Health Information Technology for Economic and Clinical Health Act and the Genetic Information Nondiscrimination Act; other modifications to the HIPAA
Q73175085	Modifications to the disability determination procedures; disability claims process redesign prototype. Social Security Administration. Notice of a prototype involving modifications to the disability determination procedures
Q77442759	Modified price standards for medical, dental, other insurance providers, and for petroleum refiners; change in percentage margin standard for wholesale and retail trade and reporting procedures for insurance companies and petroleum refiners
Q77610993	Monitoring of clinical investigations; availability of guideline--FDA. Notice
Q77298853	Montgomery GI Bill--active duty. Final rule
Q77654954	Monthly actuarial rates and monthly premium rate--Health and Human Services Department. General notice
Q77742836	Monthly actuarial rates and monthly premium rate. Office of the Secretary. General notice
Q77652079	Monthly actuarial rates and monthly premium rates--Office of the Secretary, HHS. Notice
Q77650837	Monthly adequate actuarial rates and monthly premium rates: Office of the Secretary (OS), HEW. Notice
Q93237718	Moral Exemptions and Accommodations for Coverage of Certain Preventive Services Under the Affordable Care Act. Final rules
Q95724978	Moral Exemptions and Accommodations for Coverage of Certain Preventive Services Under the Affordable Care Act. Interim final rules with request for comments
Q77441219	Mortgage and loan insurance programs under National Housing Act: final rule
Q77441230	Mortgage and loan insurance programs under the National Housing Act: permit insurance of advances for buildling components stored off-site; amendments
Q77545257	Mortgage insurance requirements for private and public hospitals--Office of the Assistant Secretary for Housing--Federal Housing Commissioner. HUD. Proposed rule
Q77693132	Multidisciplinary centers of gerontology program: long term care gerontology centers--Office of Human Development Services. Announcement of availability of financial assistance for the long term care gerontology centers program
Q77475803	Multiple-address radio systems, allocation of forty-eight 25 kHz channels in the 900 MHz range; and establishment of a new standard for frequency tolerance in the 952-960 MHz band: Federal Communications Commission. Third notice of proposed rulemaki
Q77153904	Mutual Recognition of the Food and Drug Administration and European Community Member State Conformity Assessment Procedures; pharmaceutical GMP inspection reports, medical device quality system evaluation reports, and certain medical device premarke
Q77203532	Mutual recognition of pharmaceutical good manufacturing practice inspection reports, medical device quality system audit reports, and certain medical device product evaluation reports between the United States and the European Community--FDA. Final
Q77393675	NASA Safety and Health (Short Form). Final rule
Q77573149	NIH Center grants--PHS. Final rule
Q77548786	NIH center grants--PHS. Notice of proposed rulemaking
Q15229223	NIST hash function competition
Q53658935	National Bioethics Advisory Commission proposed charter; request for comments.
Q77061326	National Center for Health Statistics; ICD-9-CM E-Code revisions--NCHS. Notice
Q77453732	National Commission on Unemployment Compensation: unemployment compensation programs assessment; inquiry
Q77143598	National Committee on Vital and Health Statistics: publication of recommendations relating to HIPAA health data standards--HHS. Notice
Q77615308	National Disaster Medical System; medical manpower component establishment--Health Resources and Services Administration, HHS. Notice
Q77431196	National Health Service Corps. Subpart A--assignment of National Health Service Corps personnel: notice of proposed rulemaking
Q73174947	National Institute for Occupational Safety and Health; a cooperative agreement for research, prevention education, and clinical services in occupational safety and health clinics. Centers for Disease Control and Prevention
Q77152124	National Institute for Occupational Safety and Health; certification of respiratory devices used to protect workers in hazardous environments--NIOSH. Notice of priorities for rulemaking
Q73174895	National Institute for Occupational Safety and Health; intervention effectiveness; notice of availability of funds. Centers for Disease Control and Prevention
Q77152142	National Institute for Occupational Safety and Health; occupational exposure to inorganic lead: request for comments and information; republication--NIOSH. Request for comments and information relevant to occupational exposure to inorganic lead
Q73174638	National Institute for Occupational Safety and Health; research on young worker safety and health risks in construction; notice of availability of funds. Centers for Disease Control and Prevention
Q73174647	National Institute for Occupational Safety and Health; safety and health interventions in the construction industry; notice of availability of funds. Centers for Disease Control and Prevention
Q73174495	National Institute of Environmental Health Sciences (NIEHS); the Murine Local Lymph Node Assay: a Test Method for Assessing the Allergic Contact Dermatitis Potential of Chemicals/Compounds, report now available. Public Health Service
Q77721052	National Institute of Handicapped Research; proposed funding priorities for fiscal year 1983--Education Department. Notice of proposed funding priorities for fiscal year 1983
Q73174722	National Institute on Disability and Rehabilitation Research; notice of final funding priorities for fiscal years 1999-2000 for certain centers and projects. Department of Education
Q50342793	National Institutes of Health Center Grants. Final rule.
Q77457361	National Institutes of Health--statement of organization, functions, and delegations of authority
Q73172350	National Institutes of Health. Notice of establishment
Q73172344	National Institutes of Health. Statement of Organization, Functions, and Delegations of Authority
Q77457384	National Institutes of Health: proposed guidelines for research involving recombinant DNA molecules
Q77453737	National Institutes of Health: recombinant DNA research; final plan for a program to assess the risks of recombinant DNA research
Q74697886	National Institutes of Health; statement of organization, functions and delegations of authority--PHS
Q77491263	National Institutes of Health; statement of organization, functions, and delegations of authority
Q77578048	National Institutes of Health; statement of organization, functions, and delegations of authority
Q74763809	National Institutes of Health; statement of organization, functions, and delegations of authority--HHS
Q74760954	National Institutes of Health; statement of organization, functions, and delegations of authority: Office of Research on Minority Health (ORMH) and Office of Research on Women's Health (ORWH)--HHS
Q74714567	National Library of Medicine programs--PHS. Final rule
Q77549863	National Library of Medicine programs--PHS. Notice of proposed rulemaking
Q74368372	National Medical Support Notice. Office of Child Support Enforcement, Administration for Children and Families, HHS. Final rule
Q74368366	National Medical Support Notice. Pension and Welfare Benefits Administration, Labor. Final rule
Q73172390	National Minority Organizations Immunization Projects notice of availability of funds. Centers for Disease Control and Prevention
Q74706240	National Practitioner Data Bank change in user fee--HRSA
Q74706233	National Practitioner Data Bank for Adverse Information on Physicians and Other Health Care Practitioners--PHS. Final regulations
Q74801954	National Practitioner Data Bank for Adverse Information on Physicians and Other Health Care Practitioners: amendments to data bank regulations to comply with court order and technical correction--HRSA. Final regulations
Q77784419	National Practitioner Data Bank for Adverse Information on Physicians and Other Health Care Practitioners: medical malpractice payments reporting requirements--HRSA. Notice of proposed rulemaking
Q33452438	National Practitioner Data Bank for Adverse Information on Physicians and Other Health Care Practitioners: reporting on adverse and negative actions. Final rule.
Q74815742	National Practitioner Data Bank for Adverse Information on Physicians and Other Health Care Practitioners; payment of fees--HRSA. Final rule
Q73172305	National Practitioner Data Bank for Adverse Information on Physicians and other Health Care Practitioners: charge for self-queries. Health Resources and Services Administration, HHS. Final rule
Q77154736	National Practitioner Data Bank for adverse information on physicians and other health care practitioners: availability of and fee for public use data file--HRSA
Q77062333	National Practitioner Data Bank: availability of and cost options for copies of public use data file--HRSA
Q74808193	National Practitioner Data Bank: change in user fee
Q74794990	National Practitioner Data Bank: change in user fee--HRSA
Q77098739	National Practitioner Data Bank: change in user fee--HRSA. Notice
Q74684680	National Practitioner Data Bank; announcement of opening date--PHS. Notice of opening
Q74815744	National Practitioner Data Bank; change in methods of fee payment--HRSA
Q77152278	National Practitioner Data Bank; change in user fee and elimination of diskette queries--HRSA
Q77153787	National Practitioner Data Bank; change in user fee and elimination of diskette queries--HRSA. Withdrawal
Q74770897	National Practitioner Data Bank; change in user fee--HRSA
Q43810545	National Research Service Awards. Final rule
Q47727371	National School Lunch Program and School Breakfast Program: Eliminating Applications Through Community Eligibility as Required by the Healthy, Hunger-Free Kids Act of 2010. Final rule
Q47727395	National School Lunch Program and School Breakfast Program: Nutrition Standards for All Foods Sold in School as Required by the Healthy, Hunger-Free Kids Act of 2010. Final rule and interim final rule
Q43753627	National School Lunch Program and School Breakfast Program: nutrition standards for all foods sold in school as required by the Healthy, Hunger-Free Kids Act of 2010. Interim final rule
Q77159923	National Vaccine Injury Compensation Program (VICP): effective date provisions of coverage of certain vaccines to the vaccine injury table--HRSA. Final rule
Q85443944	National Vaccine Injury Compensation Program: Addition of Intussusception as Injury for Rotavirus Vaccines to the Vaccine Injury Table. Final rule
Q47581380	National Vaccine Injury Compensation Program: Revisions to the Vaccine Injury Table. Final rule
Q73175060	National Vaccine Injury Compensation Program: addition of vaccines against rotavirus to the program. Department of Health and Human Services (HHS), Public Health Service (PHS), Health Resources and Services Administration (HRSA). Final rule
Q73172353	National Vaccine Injury Compensation Program: revised amount of the average cost of a health insurance policy
Q77153886	National Vaccine Injury Compensation Program: revised amount of the average cost of a health insurance policy--HRSA
Q84419040	National Vaccine Injury Compensation Program: revisions to the vaccine injury table. Final rule
Q77783996	National emission standards for hazardous air pollutants for ethylene oxide commercial sterilization and fumigation operations--EPA. Interim final rule
Q74711021	National emission standards for hazardous air pollutants--EPA. Final rule
Q77680746	National guidelines for health planning
Q77498614	National guidelines for health planning--rescission of computed tomographic scanner standards--Public Health Service. Notice of proposed rulemaking
Q77473242	National guidelines for health planning: Public Health Service, HHS. Notice of proposed rulemaking
Q77509628	National guidelines for health planning; rescission of computed tomographic scanner standards--Public Health Service. Final rule
Q74684674	National practitioner data bank; user fee--HRSA
Q43350743	National primary drinking water regulations: Long Term 1 Enhanced Surface Water Treatment Rule. Final rule
Q77159907	National standard health care provider identifier--HCFA. Proposed rule
Q84451524	National standards to prevent, detect, and respond to prison rape. Final rule; request for comment on specific issue
Q40186940	National vaccine injury compensation program: calculation of average cost of a health insurance policy. Final rule
Q77141997	Natural rubber-containing medical devices; user labeling--FDA. Final rule
Q77175270	Natural rubber-containing medical devices; user labeling; cold seal adhesives partial stay--FDA. Final rule
Q77159893	Natural rubber-containing medical devices; user labelling--FDA. Final rule; interpretation
Q91503828	Net Worth, Asset Transfers, and Income Exclusions for Needs-Based Benefits. Final rule
Q90821218	Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses. Final order
Q51782823	Neurological devices; classification of human dura mater. Final rule.
Q73018408	Nevada State plan; final approval determination. Occupational Safety and Health Administration (OSHA), U.S. Department of Labor. Final State plan approval--Nevada
Q77687950	New directions for skilled nursing and intermediate care facilities
Q77524509	New drug and antibiotic regulations--FDA. Proposed rule
Q53432317	New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Final rule.
Q83776345	New drug applications and abbreviated new drug applications; technical amendment. Final rule; technical amendment
Q73018464	New drug applications; drug master files. Food and Drug Administration, HHS. Final rule
Q74762300	New drug, antibiotic, and biological drug product regulations; accelerated approval--FDA. Final rule
Q77152966	New drugs for human use; clarification of requirements for patent holder notification--FDA. Proposed rule
Q77522470	New examination for alien foreign medical graduates Visa requirement
Q74751493	New examination for alien foreign medical graduates visa requirement--HHS
Q73172320	New vaccine information materials for hepatitis B, Haemophilus influenzae type b (Hib), and varicella (chickenpox) vaccines, and revised vaccine information materials for measles, mumps, rubella (MMR) vaccines. Centers for Disease Control and Preve
Q53406603	Ninety-day waiting period limitation and technical amendments to certain health coverage requirements under the Affordable Care Act. Final rule.
Q95428946	Ninety-day waiting period limitation. Final rules
Q73174720	Nomination of topics for Evidence-based Practice Centers (EPCs). Agency for Health Care Policy and Research
Q77187933	Non discrimination on the basis of disability in air travel. Final rule
Q77441212	Nonclinical laboratory studies: good laboratory practice regulations
Q77719853	Nondiscrimination based on handicap in federally assisted programs--implementation of Section 504 of the Rehabilitation Act of 1973 and Executive Order 11914. Department of Justice--proposed rule
Q95360009	Nondiscrimination in Health Programs and Activities. Final rule
Q77456030	Nondiscrimination in federally assisted programs; Title VI of the Civil Rights Act of 1964; policy interpretation--Office for Civil Rights, Department of Health, Education, and Welfare
Q77453746	Nondiscrimination on the basis of age in programs or activities receiving federal financial assistance from HEW: proposed rules
Q77524533	Nondiscrimination on the basis of age in programs or activities receiving federal financial assistance from HHS. Final rules
Q77121648	Nondiscrimination on the basis of disability by public accommodations and in commercial facilities--Department of Justice. Final rule
Q77124306	Nondiscrimination on the basis of disability by public accommodations and in commercial facilities; Americans With Disabilities Act accessibility guidelines for buildings and facilities--Department of Justice. Final rule: technical amendment
Q50450875	Nondiscrimination on the basis of disability in air travel. Final rule
Q73018660	Nondiscrimination on the basis of disability in air travel; compensation for damage to wheelchairs and other assistive devices. Office of the Secretary, DOT. Final rule
Q77121653	Nondiscrimination on the basis of disability in state and local government services--Department of Justice. Final rule
Q77720030	Nondiscrimination on the basis of handicap in programs and activities receiving or benefiting from federal financial assistance: Department of Labor. Proposed rule
Q77519524	Nondiscrimination on the basis of handicap in the provision of health care to handicapped infants--Office of the Secretary, HHS. Notice of court order declaring rule invalid
Q74793569	Nondiscrimination on the basis of handicap in the provision of health care to handicapped infants; notice of court order declaring rule invalid
Q77721389	Nondiscrimination on the basis of handicap relating to health care for handicapped infants--Office of the Secretary, HHS. Proposed rules
Q77721299	Nondiscrimination on the basis of handicap--Office of the Secretary, HHS. Interim final rule
Q74792795	Nondiscrimination on the basis of handicap; procedures and guidelines relating to health care for handicapped infants
Q77721597	Nondiscrimination on the basis of handicap; procedures and guidelines relating to health care for handicapped infants--HHS. Final rules
Q77453724	Nonimmigrant alien (H-1) nurses; proposed examination requirement
Q77687956	Nonimmigrant alien physicians (H-1); patient care incidental to teaching and research
Q77444177	Noninflationary pay and price behavior; special procedural rules
Q81597560	Nonpayment of benefits when the Social Security Administration receives notice that an insured person is departed or removed from the United States. Final rule
Q73174613	Notice inviting applications for new award for fiscal year 1999. The Office of the Assistant Secretary for Planning and Evaluation (ASPE), DHHS
Q74808188	Notice of attestations filed by facilities using nonimmigrant aliens as registered nurses--Employment and Training Administration, DOL. Notice
Q73174674	Notice of availability of funding for alternative projects, known as Wilson/Fish Projects, to implement alternative means of providing interim financial assistance, medical assistance, social services, and case management to refugees and Cuban and H
Q77203577	Notice of availability of funds; cooperative agreement for national programs to prevent HIV infection and other important health problems among youth strengthen coordinated school health programs--CDC
Q77175951	Notice of availability of funds; economic and outcome analysis of antimicrobial resistance in hospital-acquired infections among intensive care unit patients--CDC
Q73174794	Notice of availability of funds; grant for Community-Based Intervention Research for Children Riding in Motor Vehicles. Centers for Disease Control and Prevention
Q73174606	Notice of availability of funds; infrastructure development initiatives related to oral disease prevention and oral health promotion. Centers for Disease Control and Prevention
Q73174796	Notice of availability of funds; innovative demonstration projects to screen and treat asymptomatic males for Chlamydia Trachomatis infection using urine-based diagnostic tests: translational research. Centers for Disease Control and Prevention
Q73174916	Notice of availability of funds; innovative technology development grant for the detection and monitoring of diabetic hypoglycemia by non- or minimally-invasive techniques. Centers for Disease Control and Prevention
Q73174957	Notice of availability of funds; technology translation and transfer of effective HIV behavioral interventions; notice of availability of funds. Centers for Disease Control and Prevention
Q73174804	Notice of availability of funds; varicella surveillance and epidemiologic studies. Centers for Disease Control and Prevention
Q74788368	Notice of interest rate on overdue debts--HHS
Q77131791	Notice of specific list for categorization of laboratory test systems, assays, and examinations by complexity--CDC. Notice with comment period
Q74762629	Notice regarding Federally Supported Health Centers Assistance Act of 1992--HRSA. Notice
Q77201756	Notice regarding HRSA grant requirement--participation in the 340B drug pricing program--HRSA. Notice
Q74831439	Notice regarding Section 602 of the Veterans Health Care Act of 1992; new drug pricing--PHS. Final notice
Q73174484	Notice regarding requirement for annual submission of the quantity of nicotine contained in smokeless tobacco products manufactured, imported, or packaged in the United States. Centers for Disease Control and Prevention (CDC), Department of Health
Q74792634	Notice regarding section 602 of the Veterans Health Care Act of 1992 inclusion of outpatient hospital facilities--PHS. Notice
Q77116848	Notice regarding section 602 of the Veterans Health Care Act of 1992 rebate option--HRSA. Notice
Q77165207	Notice regarding section 602 of the Veterans Health Care Act of 1992--rebate option--HRSA. Final notice
Q74832492	Notice regarding the Federally Supported Health Centers Assistance Act of 1992--HRSA. Notice
Q74713975	Notice to Medicare providers--HCFA
Q77091664	Notification procedures for states implementing "alternative mechanisms" in the individual health insurance market--HCFA. Notice
Q77465561	Nuclear Regulatory Commission--Alexandria Hospital order imposing civil monetary penalties
Q77626851	Nursing Student Loan program--PHS. Final regulations
Q77465558	Nursing homes and intermediate care facilities mortgage insurance eligibility requirements definitions: Department of Housing and Urban Development (HUD). Final rule
Q77153889	Nursing recruitment program for Indians--IHS. Notice of competitive grant applications for the nursing recruitment program for Indians
Q77682450	Nursing schools educational programs: proposed grant provisions
Q74717671	Nursing student loan program--PHS. Final regulation
Q77543181	Nursing student loan program--PHS. Notice of proposed rulemaking
Q50962258	Nutrition standards in the National School Lunch and School Breakfast Programs. Final rule.
Q77152132	OCHAMPUS; state victims of crime compensation programs; voice prostheses--DoD. Interim final rule; request for comments
Q39024458	ONC Health IT Certification Program: Enhanced Oversight and Accountability. Final rule
Q53640836	Objectivity in research; final rule.
Q77484796	Obligated service for mental health traineeships; interim rule--Public Health Service. Interim rule with request for comments
Q77431217	Obligations of clinical investigators of regulated articles--proposed establishment of regulations
Q77175934	Obstetric and gynecologic devices; reclassification and classification of medical devices used for in vitro fertilization and related assisted reproduction procedures--FDA. Final rule
Q48617974	Obstetric and gynecology devices; effective date of requirement for premarket approval for glans sheath devices. Final rule.
Q57068168	Obstetrical and Gynecological Devices; Reclassification of Single-Use Female Condom, To Be Renamed Single-Use Internal Condom. Final order
Q51571546	Obstetrical and Gynecological Devices; Reclassification of Surgical Mesh for Transvaginal Pelvic Organ Prolapse Repair; Final order.
Q51052081	Obstetrical and Gynecological Devices; Reclassification of Surgical Instrumentation for Use With Urogynecologic Surgical Mesh. Final order.
Q73018645	Obstetrical and gynecological devices; classification of female condoms. Food and Drug Administration, HHS. Final rule
Q53120035	Obstetrical and gynecological devices; designation of special controls for male condoms made of natural rubber latex.
Q46559892	Obtaining evidence beyond the current "special arrangement sources." Interim final rule with request for comments
Q48001695	Occupational Exposure to Beryllium. Final rule
Q51413659	Occupational Exposure to Respirable Crystalline Silica. Final rule.
Q77465553	Occupational Safety and Health Administration--Access to employee exposure and medical records. Final rule
Q77441203	Occupational Safety and Health field research project
Q77441215	Occupational Safety and Health standards: means of egress; hazardous materials and fire protection; proposed amendments and revisions to safety standards
Q74731995	Occupational exposure to bloodborne pathogens--OSHA. Final rule
Q77190040	Occupational exposure to bloodborne pathogens: request for information--OSHA. Request for information
Q74742354	Occupational exposure to bloodborne pathogens; approval of information collection requirements--OSHA. Final rule; approval of information collection requirements
Q74747735	Occupational exposure to bloodborne pathogens; correction--OSHA. Final rule, correction
Q74368530	Occupational exposure to bloodborne pathogens; needlestick and other sharps injuries; final rule. Occupational Safety and Health Administration (OSHA), Department of Labor. Final rule; request for comment on the Information Collection (Paperwork)
Q77187759	Occupational exposure to cotton dust
Q77548792	Occupational exposure to ethylene oxide--OSHA. Final rule: supplemental statement of reasons
Q77541655	Occupational exposure to ethylene oxide--OSHA. Final standard
Q77519511	Occupational exposure to ethylene oxide--Occupational Safety and Health Administration. Proposed rule and notice of hearing
Q77492749	Occupational exposure to ethylene oxide; Occupational Safety and Health Administration. Advance notice of proposed rulemaking
Q74746101	Occupational exposure to formaldehyde--OSHA. Response to Court remand; final rule
Q43740045	Occupational exposure to hepatitis B virus and human immunodeficiency virus: advance notice of proposed rulemaking.
Q51249996	Occupational exposure to hexavalent chromium. Final rule.
Q77152128	Occupational exposure to tuberculosis--OSHA. Proposed rule and notice of public hearing
Q85333511	Occupational injury and illness recording and reporting requirements--NAICS update and reporting revisions. Final rule
Q38491005	Occupational injury and illness recording and reporting requirements. Final rule
Q50487269	Occupational injury and illness recording and reporting requirements. Final rule.
Q74368545	Occupational injury and illness recording and reporting requirements. Occupational Safety and Health Administration (OSHA), U.S. Department of Labor. Final rule
Q74729740	Office for Civil Rights; statement of organization, functions and delegations of authority--HHS
Q74762626	Office of Administration and Management; statement of organization, functions, and delegations of authority--Administration on Aging
Q77458584	Office of Federal Statistical Policy and Standards, Department of Commerce: notice of final standards for establishing metropolitan statistical areas following the 1980 census
Q77692500	Office of Human Development Services--Grants for state and community programs on aging. Final rule
Q77468435	Office of Human Development Services--Grants to Indian tribes for social and nutrition services. Final rule
Q77456051	Office of Human Development Services--service programs for families and children, individuals and families, and aged, blind, or disabled persons; federal financial participation in state claims for abortions
Q82274342	Office of Inspector General; Medicare and state health care programs: fraud and abuse; issuance of advisory opinions by the OIG. Final rule
Q73018415	Office of Inspector General; Medicare program; prospective payment system for hospital outpatient services. Health Care Financing Administration (HCFA), HHS, and Office of Inspector General (OIG), HHS. Final rule with comment period
Q74847322	Office of Management and Budget control numbers under the Paperwork Reduction Act--OSHA. Final rule
Q73174809	Office of Recombinant DNA Activities; recombinant DNA research: action under the guidelines. National Institutes of Health (NIH), PHS, DHHS. Notice of action under the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines
Q73174725	Office of Special Education and Rehabilitative Services; National Institute on Disability and Rehabilitation Research; notice inviting applications for new awards under the Disability and Rehabilitation Research Project and Centers Program for fisca
Q77152151	Office of inspector general; statement of organization, functions and delegations of authority--HHS
Q77742800	Office of the Assistant Secretary for Health--Health maintenance organizations; supplement to March list. Notice, supplement to March list of qualified health maintenance organizations
Q74697066	Office of the Assistant Secretary for Health; delegation of authority
Q77743730	Office of the Assistant Secretary for Planning and Evaluation: national long-term care channeling demonstration program; intent to initiate program
Q30229865	Office of the Assistant Secretary for Preparedness and Response; HHS Public Health Emergency Medical Countermeasures Enterprise implementation plan for chemical, biological, radiological and nuclear threats. Notice.
Q77162058	Office of the Secretary Assistant Secretary for Planning and Evaluation notice inviting applications for new award for fiscal year 1998--HHS. Announcement of the availability of funds and request for applications from states to determine the status
Q77463471	Office of the Secretary of Defense--Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); clarification of medical indications for head and body CT scans. Guidelines to rule
Q77465577	Office of the Secretary--Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); clarification of home oxygen therapy and physician standby charges. Statement of policy
Q77465581	Office of the Secretary--Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); double coverage; correction. Correction to final rule
Q79778155	Office of the Secretary; Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); transitional assistance management program; early eligibility for TRICARE for certain reserve component members. Final rule
Q79778146	Office of the Secretary; TRICARE; changes included in the National Defense Authorization Act for fiscal year 2005; TRICARE dental program. Final rule
Q74368381	Old-age, survivors, and disability insurance and Supplemental Security Income for the aged, blind, and disabled; substantial gainful activity amounts; "services" for trial work period purposes--monthly amounts; student child earned income exclusion.
Q73174661	Old-age, survivors, and disability insurance and supplemental security income for the aged, blind, and disabled; substantial gainful activity amounts. Social Security Administration. Final rules
Q74802521	Omnibus Budget Reconciliation Act of 1993--VA. Final rule
Q77451472	One-way radio paging in the special emergency radio service: notice of proposed rulemaking
Q77451467	One-way radio paging in the special emergency radio service: order suspending conversion date
Q74779755	Operator service access and pay telephone compensation rules--FCC. Final rule
Q74752252	Operator service access and pay telephone compensation--Federal Communications Commission. Final rule; order on reconsideration
Q35068728	Ophthalmic drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment.
Q77153793	Ophthalmic drug products for over-the-counter human use; proposed amendment of final monograph--FDA. Proposed rule
Q74368490	Opioid drugs in maintenance and detoxification treatment of opiate addiction; Substance Abuse and Mental Health Services Administration, HHS. Final rule
Q44341642	Opioid drugs in maintenance and detoxification treatment of opiate addiction; addition of buprenorphine and buprenorphine combination to list of approved opioid treatment medications. Interim final rule.
Q44337089	Opioid drugs in maintenance and detoxification treatment of opiate addiction; proposed modification of dispensing restrictions for buprenorphine and buprenorphine combination as used in approved opioid treatment medications. Final rule.
Q77623889	Opportunity to request change in classification of continuous ventilator--FDA. Notice; final rule-related
Q80189496	Optometrists as "acceptable medical sources" to establish a medically determinable impairment. Final rules
Q74730696	Order for transitional class III devices; submission of safety and effectiveness information under section 520(1)(5)(A) of the Federal Food, Drug, and Cosmetic Act--FDA. Notice
Q77492727	Orderly closure, transfer, and financial self-sufficiency of Public Health Service hospitals and clinics; delegation of authority
Q73174652	Oregon State Standards; notice of approval. Occupational Safety and Health Administration
Q77153898	Organ Procurement and Transplantation Network--HRSA. Final rule with comment period
Q73018609	Organ Procurement and Transplantation Network. Health Resources and Services Administration, HHS. Final rule
Q77166902	Organ Procurement and Transplantation Network; final rule revision of comment period and effective dates--HRSA. Extension of comment period and delay of effective date for the Organ Procurement and Transplantation Network
Q80197027	Organ procurement and transplantation network. Final rule
Q45953756	Organ procurement and transplantation network. Final rule.
Q38488348	Organ procurement and transplantation: implementation of the HIV Organ Policy Equity Act. Final rule
Q45977176	Organ-specific warnings; internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final monograph. Final rule.
Q74767773	Organization, functions, and authority delegations--FDA. Final rule
Q77175281	Organization, functions, and delegations of authority: HIV/AIDS prevention--International Research and Support Division--CDC
Q47938953	Organizational integrity of entities that are implementing programs and activities under the Leadership Act. Final rule
Q46030483	Orphan drug regulations. Final rule.
Q51054006	Orthopedic Devices; Reclassification of Pedicle Screw Systems, Henceforth To Be Known as Thoracolumbosacral Pedicle Screw Systems, Including Semi-Rigid Systems. Final order.
Q77168797	Orthopedic devices: classification and reclassification of pedicle screw spinal systems--FDA. Final rule
Q77187986	Orthopedic devices: classification and reclassification of pedicle screw spinal systems; technical amendment. Final rule; technical amendment
Q78022914	Orthopedic devices: reclassification of the hip joint metal/polymer constrained cemented or uncemented prosthesis. Final Rule
Q73474409	Orthopedic devices; classification for the resorbable calcium salt bone void filler device. Final rule
Q30967448	Orthopedic devices; effective data of requirement for premarket approval for hip joint metal/polymer or ceramic/polymer semiconstrained resurfacing cemented prosthesis. Final rule.
Q50955315	Orthopedic devices; reclassification of the intervertebral body fusion device. Final rule.
Q73172364	Over-the-counter drug products containing analgesic/antipyretic active ingredients for internal use; required alcohol warning; final rule; compliance date. Food and Drug Administration, HHS
Q73175073	Over-the-counter drug products containing colloidal silver ingredients or silver salts. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule
Q73172367	Over-the-counter human drugs; labeling requirements. Food and Drug Administration, HHS. Final rule
Q73018371	Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment
Q37045171	Over-the-counter vaginal contraceptive and spermicide drug products containing nonoxynol 9; required labeling. Final rule
Q52117848	PHS supported programs: sterilization procedures.
Q77566526	PSRO hospital review: final rule
Q81591419	Parent-to-child deeming from stepparents. Final rule
Q74768184	Parental notification requirements applicable to projects for family planning services; final rule
Q34414085	Part 1028--Protection of human subjects: issuance of regulations.
Q74729724	Participation in the National Practitioner Data Bank--Department of Veterans Affairs. Final rule
Q48350560	Partners invited to participate in Steps to a HealthierUS. Notice
Q51428436	Patient Engagement Advisory Committee. Final rule.
Q51147923	Patient Protection and Affordable Care Act: preexisting condition exclusions, lifetime and annual limits, rescissions, and patient protections. Interim final rules with request for comments.
Q95726199	Patient Protection and Affordable Care Act; Adoption of the Methodology for the HHS-Operated Permanent Risk Adjustment Program for the 2018 Benefit Year Final Rule. Final rule
Q95384361	Patient Protection and Affordable Care Act; Exchange functions: standards for Navigators and non-Navigator assistance personnel; consumer assistance tools and programs of an Exchange and certified application counselors. Final rule
Q38768706	Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2017. Final rule
Q89484456	Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2018; Amendments to Special Enrollment Periods and the Consumer Operated and Oriented Plan Program. Final rule
Q90274669	Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2019. Final rule
Q51243355	Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2015. Final rule.
Q38433147	Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2016. Final rule
Q51339347	Patient Protection and Affordable Care Act; Market Stabilization. Final rule.
Q51256359	Patient Protection and Affordable Care Act; annual eligibility redeterminations for exchange participation and insurance affordability programs; health insurance issuer standards under the Affordable Care Act, including standards related to exchange
Q44426685	Patient Protection and Affordable Care Act; establishment of exchanges and qualified health plans; Small Business Health Options Program. Final rule
Q83818381	Patient Protection and Affordable Care Act; establishment of exchanges and qualified health plans; exchange standards for employers. Final rule, Interim final rule
Q95621683	Patient Protection and Affordable Care Act; establishment of the Multi-State Plan Program for the Affordable Insurance Exchanges. Final rule
Q86340245	Patient Protection and Affordable Care Act; establishment of the multi-state plan program for the Affordable Insurance Exchanges
Q39186048	Patient Protection and Affordable Care Act; exchange and insurance market standards for 2015 and beyond. Final rule
Q38087967	Patient Protection and Affordable Care Act; health insurance market rules. Final rule.
Q44018423	Patient Protection and Affordable Care Act; maximizing January 1, 2014 coverage opportunities. Interim final rule with comment period
Q43481403	Patient Protection and Affordable Care Act; program integrity: Exchange, SHOP, and eligibility appeals. Final rule
Q43851845	Patient Protection and Affordable Care Act; program integrity: exchange, premium stabilization programs, and market standards; amendments to the HHS notice of benefit and payment parameters for 2014. Final rule
Q86340176	Patient Protection and Affordable Care Act; standards related to essential health benefits, actuarial value and accreditation. Final rule
Q38000268	Patient Protection and Affordable Care Act; standards related to reinsurance, risk corridors, and risk adjustment. Final rule
Q40182101	Patient Protection and Affordable Care Act; third party payment of qualified health plan premiums. Interim final rule with comment period
Q43688772	Patient access to records. Final rule
Q34352299	Patient protection and Affordable Care Act; data collection to support standards related to essential health benefits; recognition of entities for the accreditation of qualified health plans. Final rule
Q37234609	Patient safety and quality improvement. Notice of proposed rulemaking
Q84718597	Patient safety and quality improvement: civil money penalty inflation adjustment. Direct final rule
Q77654941	Patients' rights--Veterans Administration. Final rule
Q53680556	Patients' rights. Final rule.
Q40361095	Payment for Physician and Other Health Care Professional Services Purchased by Indian Health Programs and Medical Charges Associated With Non-Hospital-Based Care. Final rule with comment period
Q44719807	Payment for home health services and hospice care to non-VA providers. Final rule
Q48945737	Payment for inpatient and outpatient health care professional services at non-departmental facilities and other medical charges associated with non-VA outpatient care. Final rule
Q77168777	Payment for non-VA physician services associated with either outpatient or inpatient care provided at non-VA facilities--VA. Final rule
Q77113840	Payment for non-VA physician services associated with either outpatient or inpatient care provided at non-VA facilities--VA. Proposed rule
Q74709101	Payment method for health care services under the Supplemental Health Care Program for Active Duty Members of the Uniformed Services; adoption of CHAMPUS procedures--DoD. Final rule
Q74709111	Payment method for health care services under the Supplemental Health Care Program for Active Duty Members of the Uniformed Services; adoption of CHAMPUS procedures--DoD. Final rule amendment
Q48067959	Payment of Emergency Medication by VA. Final rule
Q45330299	Payment of reimbursement for emergency treatment furnished by non-VA providers in non-VA facilities to certain veterans with service-connected or nonservice-connected disabilities. Final rule
Q47888298	Payment or Reimbursement for Certain Medical Expenses for Camp Lejeune Family Members. Final rule
Q38254259	Payment or reimbursement for certain medical expenses for Camp Lejeune family members. Interim final rule
Q48680059	Payment or reimbursement for emergency services for nonservice-connected conditions in non-VA facilities. Final rule.
Q77649643	Payment under Medicare for items and services furnished by Indian Health Service hospitals and skilled nursing facilities: final rule
Q77649924	Payments for services; public notice of changes in method or level of reimbursement: final rule
Q77742767	Payments for services; timely claims payment: final regulation
Q74675396	Pediatric acquired immune deficiency syndrome (AIDS); health care demonstration projects--HRSA. Notice of availability of funds
Q35676586	Pediculicide drug products for over-the-counter human use; amendment of final monograph. Final rule.
Q50199849	Penalty Inflation Adjustments for Civil Money Penalties. Interim Final Rule
Q77453717	Pension and Welfare Benefit Programs: rules and regulations for fiduciary responsibility; proposed regulations relating to definition of plan assets and to establishment of trust
Q74719174	Pensions, savings, health expenditures, long-term care, and retirement grant announcement--HHS
Q93371259	Per Diem Paid to States for Care of Eligible Veterans in State Homes. Final rule
Q73018467	Per diem for nursing home care of veterans in State homes. Department of Veterans Affairs. Final rule
Q77203539	Per diem for nursing home care of veterans in state homes--VA. Proposed rule
Q45331463	Per diem for nursing home care of veterans in state homes. Final rule.
Q41980310	Per diem payments for the care provided to eligible veterans evacuated from a state home as a result of an emergency. Final rule
Q77228672	Performance of functions under this chapter; claims for compensation under the Energy Employees Occupational Illness Compensation Program Act. Interim final rule; request for comments
Q38464012	Performance of functions; claims for compensation under the Energy Employees Occupational Illness Compensation Program Act of 2000, as amended. Final rule.
Q81825156	Performance of functions; claims for compensation under the Energy Employees Occupational Illness Compensation Program Act. Interim final rule; request for comments
Q74722072	Performance standards for ionizing radiation emitting products: diagnostic x-ray systems and their major components; computed tomography equipment; removal of a requirement; citizen petition--FDA. Final rule
Q74724590	Performance-oriented packaging standards; revisions to transitional provisions--Department of Transportation. Final rule; partial response to petitions for reconsideration and revisions
Q52661713	Permanent Discontinuance or Interruption in Manufacturing of Certain Drug or Biological Products. Final rule.
Q82805097	Permanent certification program for health information technology; revisions to ONC-Approved Accreditor processes. Final rule
Q77116830	Personal Responsibility and Work Opportunity Reconciliation Act of 1996 (PRWORA); interpretation of "federal means-tested public benefit"--HHS. Notice with comment period
Q77169775	Personal Responsibility and Work Opportunity Reconciliation Act of 1996 (PRWORA); interpretation of "federal public benefit"--HHS. Notice with comment period
Q77063451	Personal protective equipment for general industry--OSHA. Final rule; technical amendment
Q36901079	Petition to request an exemption from 100 percent identity testing of dietary ingredients: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements. Interim final rule.
Q77516314	Pharmaceutical Reimbursement Board; final maximum allowable cost (MAC) determinations for certain drug products--Health Care Financing Administration. Final notice
Q77522395	Pharmaceutical Reimbursement Board; maximum allowable cost (MAC) limits and announcement of public hearing--HCFA. Proposed notice
Q77522403	Pharmaceutical Reimbursement Board; rinal maximum allowable cost (MAC) determinations for certain drug products--HCFA. Final notice for maximum allowable cost determinations
Q77526365	Pharmaceutical Reimbursement Board; suspension of maximum allowable cost limits on specific drug products--HCFA
Q51230720	Physical Medicine Devices; Reclassification of Iontophoresis Device Intended for Any Other Purposes. Final order.
Q48725630	Physical Medicine Devices; Reclassification of Shortwave Diathermy for All Other Uses, Henceforth To Be Known as Nonthermal Shortwave Therapy. Final order; technical correction
Q53571865	Physical medicine devices; reclassification of stair-climbing wheelchairs. Final order.
Q74367991	Physical qualification of drivers; medical examination; certificate. Federal Motor Carrier Safety Administration (FMCSA), DOT. Final rule
Q77488232	Physician agreements to control medical prepayment plans: Federal Trade Commission. Adoption and publication of enforcement policy with respect to physician agreements to control medical prepayment plans
Q77482115	Physician agreements to control medical prepayment plans: Federal Trade Commission. Notice of initiation of case-by-case law enforcement program
Q74731275	Physician fee schedule update for calendar year 1992 and physician performance standard rates of increase for federal fiscal year 1992--HCFA. Notice
Q74802875	Physician fee schedule update for calendar year 1995 and physician volume performance standard rates of increase for federal fiscal year 1995--HCFA. Final notice
Q77123870	Physician performance standard rates of increase for federal fiscal year 1993 and physician fee schedule update for calendar year 1993--HCFA. Final notice with comment period
Q74781395	Physician performance standard rates of increase for federal fiscal year 1994 and physician fee schedule update for calendar year 1994--HCFA. Final notice with comment period
Q73018495	Placement of gamma-butyrolactone in List I of the Controlled Substances Act (21 U.S.C. 802(34)). Drug Enforcement Administration, Justice. Final rule
Q77159830	Plans established or maintained pursuant to collective bargaining agreements under section 3(40)(A)--Pension and Welfare Benefits Administration. Notice of intent to form a negotiated rulemaking advisory committee
Q53851898	Plant pests; introduction of organisms and products altered or produced through genetic engineering; proposed rule and notice of public hearings; Advanced notice of proposed guidelines for biotechnology research.
Q53951331	Poison prevention packaging requirements; exemption of hormone replacement therapy products. Final rule.
Q77154722	Policy on 180-day marketing exclusivity for drugs marketed under abbreviated new drug applications; clarification--FDA. Clarification
Q74790557	Policy on the inclusion of women and racial and ethnic minorities in externally awarded research; notice
Q77570191	Policy statement; class II medical devices--FDA. Notice
Q77650428	Position statement on access to early and periodic screening, diagnosis, and treatment (EPSDT) services through schools--Office of Education and the Health Care Financing Administration
Q95529710	Possession, Use, and Transfer of Select Agents and Toxins-- Addition of Bacillus Cereus Biovar Anthracis to the HHS List of Select Agents and Toxins. Interim final rule and request for comments
Q30151458	Possession, Use, and Transfer of Select Agents and Toxins; Biennial Review of the List of Select Agents and Toxins and Enhanced Biosafety Requirements. Final rule
Q30351672	Possession, use, and transfer of select agents and toxins--reconstructed replication competent forms of the 1918 pandemic influenza virus containing any portion of the coding regions of all eight gene segments. Interim final rule.
Q82686310	Possession, use, and transfer of select agents and toxins. Final rule
Q30233089	Possession, use, and transfer of select agents and toxins. Final rule.
Q30224005	Possession, use, and transfer of select agents and toxins; biennial review. Final rule
Q74257679	Postmarket surveillance. Final rule
Q35186901	Postmarketing safety reports for human drug and biological products; electronic submission requirements. Final rule
Q74368154	Postmarketing studies for approved human drug and licensed biological products; status reports. Food and Drug Administration, HHS. Final rule
Q83128288	Posttraumatic stress disorder. Interim final rule
Q57211114	Powerplant and Industrial Fuel Use Act (existing facilities): proposed implementation rules
Q57211111	Powerplant and Industrial Fuel Use Act of 1978: proposed forms for petitioning for exemptions; request for comment
Q44749588	Pre-Existing Condition Insurance Plan program. Interim final rule with comment period
Q84900840	Pre-existing condition insurance plan program. Amendment to interim final rule with request for comments
Q84631690	Pre-existing condition insurance plan program. Interim final rule with comment period
Q77431167	Preliminary notification of hazardous waste activities: proposed procedures
Q77194053	Premerger notification: reporting and waiting period requirements--FTC. Notice of adoption of formal interpretation and request for comments
Q74728582	Prepaid health care: obsolete provisions--HCFA. Final rule
Q77447100	Prepaid medical service plans; revocation of part
Q74805035	Preparation, transfer for commercial distribution, and use of byproduct material for medical use--NRC. Final rule; clarification
Q44334261	Prescription Drug Marketing Act Pedigree Requirements; effective date and compliance policy guide; request for comment. Final rule; announcement of effective date; notice of availability; request for comment
Q73018481	Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures. Food and Drug Administration, HHS. Final rule
Q44333046	Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures; delay of effective date. Final rule; delay of effective date.
Q73018565	Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures; delay of effective date; reopening of administrative record. Food and Drug Administration, HHS. Final rule; delay o
Q77436577	Prescription drug dispensing container requirements: final rule
Q77783985	Prescription drug product labeling; medication guide requirements--FDA. Final rule
Q77475766	Prescription drug products that require patient package inserts; ampicillin and phenytoin--Food and Drug Administration. Final rule
Q77451397	Prescription drug products; patient labeling requirements: proposed rule
Q77740506	Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule
Q77509596	Prescription drug products; revocation of patient package insert requirements--Food and Drug Administration. Final rule
Q77509601	Prescription drugs; revocation of final guideline patient package inserts and withdrawal of draft guideline patient package inserts--Food and Drug Administration. Notice
Q77463486	Prescriptions for Schedule II controlled substances: Drug Enforcement Administration, Justice. Notice of proposed rulemaking
Q77522452	Prescriptions; dispensing controlled substances in institutional practitioner emergency rooms--Drug Enforcement Administration, Justice. Withdrawal of proposed rule
Q74709107	Prescriptions; requirements clarification--Drug Enforcement Administration (DEA). Final rule
Q77298654	President's Task Force to Improve Health Care delivery for Our Nation's Veterans
Q19046005	Presidential Determination No. 2000-08
Q19046012	Presidential Determination No. 2000-24
Q19046021	Presidential Determination No. 99-29
Q19046098	Presidential Memo - Federal Benefits and Non-Discrimination
Q19046128	Presidential Memo - Mexico City Policy and Assistance for Voluntary Population Planning
Q19046250	Presidential Memorandum - Engaging in Public Health Research on the Causes and Prevention of Gun Violence
Q47250696	Presidential Memorandum - Respecting the Rights of Hospital Patients to Receive Visitors and to Designate Surrogate Decision Makers for Medical Emergencies
Q57211057	Presidential documents: national energy supply shortage
Q48026583	Presumption of Herbicide Exposure and Presumption of Disability During Service for Reservists Presumed Exposed to Herbicide. Interim final rule.
Q57802830	Presumption of Herbicide Exposure and Presumption of Disability During Service for Reservists Presumed Exposed to Herbicides. Final rule
Q51782907	Presumption of service connection for amyotrophic lateral sclerosis. Final rule.
Q53683710	Presumption of service connection for osteoporosis for former prisoners of war. Final rule.
Q40410311	Presumptions of service connection for diseases associated with service involving detention or internment as a prisoner of war. Affirmation of interim final rule as final rule.
Q45977174	Presumptive service connection for disease associated with exposure to certain herbicide agents: AL amyloidosis. Final rule.
Q48627617	Presumptive service connection for diseases associated with service in the Southwest Asia theater of operations during the Persian Gulf War: functional gastrointestinal disorders. Final rule.
Q77393693	Pretax allotments for health insurance premiums. Final rule
Q74795003	Preventing the Spread of Vancomycin Resistance--A Report from the Hospital Infection Control Practices Advisory Committee prepared by the Subcommittee on Prevention and Control of Antimicrobial-Resistant Microorganisms in Hospitals; comment period a
Q81744921	Preventing the accumulation of surplus controlled substances at long term care facilities. Final rule
Q43546853	Prevention of Salmonella enteritidis in shell eggs during production, storage, and transportation. Final rule.
Q43834228	Prevention of alcohol misuse and prohibited drug use in transit operations. Final rule
Q73174629	Primate model for studying the pathogenesis of measles infections and for development of improved measles vaccines; notice of availability of funds. Centers for Disease Control and Prevention
Q74794305	Principles for federal oversight of biotechnology: planned introduction into the environment of organisms with modified hereditary traits
Q77649619	Principles of reimbursement for provider costs and for services by hospital-based physicians--depreciation: allowance for depreciation based on asset costs: final rule
Q77649637	Principles of reimbursement for provider costs and for services by hospital-based physicians--effect of capital stock transactions: final rule
Q77649622	Principles of reimbursement for provider costs and for services by hospital-based physicians--elimination of the combination method of apportionment and modified cost finding for providers: final rule
Q77650035	Principles of reimbursement for provider costs and for services by hospital-based physicians; direct apportionment of malpractice costs to Medicare: final rule
Q30228351	Prior notice of imported food under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule
Q77694038	Privacy ACt 1974; report of a new system of records 09-90-0089. Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services. Notification of new system of records--National Long-Term Care Survey
Q77652465	Privacy Act of 1974--Department of Health and Human Services. Notification of a new system of records
Q74787447	Privacy Act of 1974--HCFA. Notice of a matching program--between HCFA and the Wisconsin Bureau of Workers' Compensation--HCFA will receive information from the state concerning work-related injuries and diseases
Q77667240	Privacy Act of 1974--HCFA. Notice of new system of records
Q77539116	Privacy Act of 1974--PHS. Notification of establishment of a new Privacy Act system of records
Q77585061	Privacy Act of 1974--Public Health Service. Notification of new systems of records
Q77653794	Privacy Act of 1974: Access to records: Veterans Administration. Final rule
Q77541660	Privacy Act of 1974: amendment of existing system of records--HHS
Q77532767	Privacy Act of 1974: amendment of existing system of records--HHS. Notice of intent to amend a Privacy Act system of record for purposes of the Debt Collection Act of 1982
Q77608063	Privacy Act of 1974: annual review of systems of records--HCFA
Q77516262	Privacy Act of 1974; Report on new system--Health and Human Services Department. Notification of report on new system. Health care program violations
Q77741512	Privacy Act of 1974; addition of routine use to existing system of records--PHS
Q77162047	Privacy Act of 1974; addition of routine uses to an existing system of records--HRSA. Notification of an addition of routine uses to an existing system of records
Q77579984	Privacy Act of 1974; addition of routine uses to an existing system of records--PHS
Q77721447	Privacy Act of 1974; addition to routine use--PHS. Notification of a proposal to add a routine use to an existing system of records; 09-30-0034
Q77524538	Privacy Act of 1974; altered system of records--PHS. Notification of altered Privacy Act system of records 09-25-0074
Q77710912	Privacy Act of 1974; altered system of records--PHS. Notification of altered system of records: 09-30-0036, "Alcohol, Drug Abuse, and Mental Health Epidemiologic and Biometric Research Data, HHS/ADAMHA/OA"
Q77529747	Privacy Act of 1974; annual publication of records--NIH
Q77710776	Privacy Act of 1974; annual publication of systems of records--ADAMHA
Q77710779	Privacy Act of 1974; annual publication of systems of records--CDC
Q77529755	Privacy Act of 1974; annual publication of systems of records--FDA
Q77524505	Privacy Act of 1974; annual publication of systems of records--NIH. Privacy Act; annual republication of notices systems of records
Q77529751	Privacy Act of 1974; annual publication of systems of records--PHS
Q77568848	Privacy Act of 1974; annual publication of systems of records--PHS
Q93922534	Privacy Act of 1974; annual publication of systems of records--PHS
Q77522479	Privacy Act of 1974; clarification of record system notice--Office of the Assistant Secretary for Personnel Administration, HHS. Notice of changes to routine uses
Q73174731	Privacy Act of 1974; computer matching program (SSA/Department of Labor (DOL)--SSA) match number 1013. Social Security Administration (SSA). Notice of computer matching program
Q74687920	Privacy Act of 1974; computer matching program--HCFA. Clarification--computer match between HCFA and the Internal Revenue Service (IRS)--notice published in the Federal Register on July 5, 1989
Q74694209	Privacy Act of 1974; computer matching program--HCFA. Notice of a matching program--HCFA's Health Insurance (HI) Master Record and information from four Railroad Retirement Board (RRB) systems of records
Q77668591	Privacy Act of 1974; computer matching program--HCFA. Notice of a matching program--federal Medicare records (Medicare physician identification and eligibility records) and American Medical Association (AMA) extract data
Q77532772	Privacy Act of 1974; exempt record system--DHHS. Notice of proposed rulemaking
Q77524528	Privacy Act of 1974; exempt record system--HHS. Final rule
Q74690417	Privacy Act of 1974; matching program--HCFA. Notice of a matching program--the Internal Revenue Service (IRS), the Social Security Administration (SSA), and HCFA--disclosure of IRS taxpayer identity and filing status information to be matched with S
Q77571688	Privacy Act of 1974; matching program--HHS physician records/Federation of State Medical Boards of the United States, Inc. disciplinary records--HHS
Q77709562	Privacy Act of 1974; matching program; federal Medicare records/workers' compensation agencies' records--HCFA. Notice of a matching program
Q77659060	Privacy Act of 1974; modification of system of records--HCFA
Q74675402	Privacy Act of 1974; new routine use and system of records name change--HHS. Notification of a new routine use and system of records name change
Q74805067	Privacy Act of 1974; new system of records
Q77475813	Privacy Act of 1974; new system of records--Department of Health and Human Services. Notification of new system of records. Mental Health Epidemiologic and Biometric Research Data
Q77479184	Privacy Act of 1974; new system of records--Department of Health and Human Services; Public Health Service. Notification of a new system of records: 09-25-0143
Q77710475	Privacy Act of 1974; new system of records--Public Health Service. Notification of a new system of records: 09-30-0045, "Respondents in a validity/reliability study of self-reported drinking"
Q77498599	Privacy Act of 1974; new system of records--Public Health Service. Notification of establishment of a new Privacy Act system of records, 09-25-0151
Q77655757	Privacy Act of 1974; notice of new routine uses--HCFA. Notification of new routine uses
Q77534379	Privacy Act of 1974; notice of new system of records--HHS. Notice of new system of records
Q77519488	Privacy Act of 1974; notification of new routine use--Public Health Service
Q77524540	Privacy Act of 1974; notification of new system of records--PHS. Notification of new system of records, "Health Resources and Services Administration Loan Repayment/Debt Management Records System
Q77657983	Privacy Act of 1974; proposed amendment to system of records--HCFA
Q77659057	Privacy Act of 1974; proposed amendment to system of records--HCFA
Q77660030	Privacy Act of 1974; proposed amendment to system of records--HCFA. Notice
Q77500293	Privacy Act of 1974; proposed amendment to system of records--Office of the Secretary, HHS. Notice of proposed new routine use for existing system of records
Q73018689	Privacy Act of 1974; proposed implementation. Office of the Secretary, HHS. Final rule
Q77721443	Privacy Act of 1974; proposed major alteration to existing system of records--PHS. Notification of proposed major alteration to an existing system of records: 09-30-0041
Q77509605	Privacy Act of 1974; proposed major alterations to an existing system of records--Public Health Service. Notice of proposed major alterations
Q77522457	Privacy Act of 1974; proposed new routine uses--PHS. Notification of new routine uses permitting disclosure of information from four Privacy Act systems of records
Q77527834	Privacy Act of 1974; proposed new routine uses--PHS. Notification of new routine uses permitting disclosures of information from five Privacy Act systems of records
Q77543171	Privacy Act of 1974; report of altered system of records and new routine uses Privacy Act instructions--SSA
Q77492731	Privacy Act of 1974; report of altered system. Health Care Financing Administration. Notice of altered system
Q77720474	Privacy Act of 1974; report of altered system. Health Care Financing Administration. Notification of altered system
Q77167714	Privacy Act of 1974; report of altered systems--HCFA. Notice of the global addition of three new routine uses to designated HCFA systems of records
Q77652776	Privacy Act of 1974; report of amended routine uses--Health Care Financing Administration. Notification of amended routine uses
Q77540679	Privacy Act of 1974; report of new routine use and minor revisions--SSA
Q77516245	Privacy Act of 1974; report of new routine uses--Health Care Financing Administration. Notification of new routine uses
Q74793204	Privacy Act of 1974; report of new system
Q77538076	Privacy Act of 1974; report of new system of records--SSA, HHS
Q77531427	Privacy Act of 1974; report of new system--HCFA
Q77657975	Privacy Act of 1974; report of new system--HCFA
Q74737293	Privacy Act of 1974; report of new system--HCFA. Notice of new system of records
Q74762065	Privacy Act of 1974; report of new system--HCFA. Notice of new system of records
Q74771645	Privacy Act of 1974; report of new system--HCFA. Notice of new system of records
Q77162071	Privacy Act of 1974; report of new system--HCFA. Notice of new system of records
Q77169728	Privacy Act of 1974; report of new system--HCFA. Notice of new system of records
Q77534375	Privacy Act of 1974; report of new system--HCFA. Notice of new system of records
Q77549869	Privacy Act of 1974; report of new system--HCFA. Notice of new system of records
Q77554263	Privacy Act of 1974; report of new system--HCFA. Notice of new system of records
Q77657610	Privacy Act of 1974; report of new system--HCFA. Notice of new system of records
Q77668567	Privacy Act of 1974; report of new system--HCFA. Notice of new system of records
Q77670490	Privacy Act of 1974; report of new system--HCFA. Notice of new system of records
Q77670974	Privacy Act of 1974; report of new system--HCFA. Notice of new system of records
Q77671210	Privacy Act of 1974; report of new system--HCFA. Notice of new system of records
Q77697661	Privacy Act of 1974; report of new system--HCFA. Notice of new system of records
Q77709558	Privacy Act of 1974; report of new system--HCFA. Notice of new system of records
Q93920747	Privacy Act of 1974; report of new system--HCFA. Notice of new system of records
Q77652883	Privacy Act of 1974; report of new system--Health Care Financing Administration. Notice of new system of records
Q77653651	Privacy Act of 1974; report of new system. Health Care Financing Administration. Notification of new system of records
Q74688859	Privacy Act of 1974; report of new systems of records--HCFA. Notice of new system of records
Q77522514	Privacy Act of 1974; report of routine use--Social Security Administration. New routine use disclosure
Q77784434	Privacy Act of 1974; republication of systems of records--Consumer Product Safety Commission. Republication and revision of systems of records
Q52081881	Privacy Act of 1974; revision of system of records.
Q77668241	Privacy Act of 1974; revision to existing system of records--HCFA. Notice of revision of Privacy Act system of records
Q74793370	Privacy Act of 1974; system of records
Q77109615	Privacy Act of 1974; system of records--HCFA
Q74697036	Privacy Act of 1974; system of records--HCFA. Amendment of an existing system of records
Q77174731	Privacy Act of 1974; system of records--HCFA. Notice of new system of records
Q77671206	Privacy Act of 1974; system of records--HCFA. Notice of new system of records
Q77724117	Privacy Act of 1974; system of records--HCFA. Notice of new system of records
Q77668595	Privacy Act of 1974; system of records--HCFA. Notice of proposed new routine use for an existing system of records
Q74700992	Privacy Act of 1974; system of records--HCFA. Notice of proposed new routine use for existing system of records
Q77669163	Privacy Act of 1974; system of records--HCFA. Notice of proposed new routine uses for an existing system of records
Q77529770	Privacy Act of 1974; system of records--PHS
Q77585642	Privacy Act of 1974; system of records--PHS
Q77568845	Privacy Act of 1974; system of records--PHS
Q77532781	Privacy Act of 1974; system of records--PHS. Notification of a new system of records: 09-30-0046, "Survey of alcohol use among youth and young adults"
Q77540672	Privacy Act of 1974; system of records--PHS. Notification of a proposal to add a routine use and to add a special disclosure statement to the existing system of records 09-37-0015
Q77539118	Privacy Act of 1974; system of records--PHS. Notification of a proposal to add routine uses
Q77711069	Privacy Act of 1974; system of records--PHS. Notification of an altered system of records: 09-30-0014, "Saint Elizabeths Hospital Financial System, HHS/ADAMHA/NIMH"
Q77540677	Privacy Act of 1974; system of records--PHS. Notification of establishment of a new Privacy Act system of records
Q77529735	Privacy Act of 1974; system of records--PHS. Notification of establishment of a new Privacy Act system of records 09-25-0154, "Biomedical Research: Records of Subjects in Cancer Research
Q77546217	Privacy Act of 1974; system of records--PHS. Revision and addition of new routine uses to system of records 09-15-0045, entitled "Health Resources and Services Administration Loan Repayment/Debt Management Records System, HHS/HRSA/OA"
Q77524555	Privacy Act of 1974; system of records--PHS. Waiver of advance notice period for a new system of records
Q77524535	Privacy Act of 1974; systems of records, table of contents/index for the annual republication--HHS
Q74687911	Privacy Act of 1974; systems of records--HCFA. Deletion of Privacy Act System of Records from HCFA Inventory
Q77671935	Privacy Act of 1974; systems of records--HCFA. Notice of proposed modification to the "End Stage Renal Disease (ESRD) Program Management and Medical Information System (Registry)"--HCFA
Q74688685	Privacy Act of 1974; systems of records--HCFA. Notice of proposed new routine use for an existing system of records
Q77706963	Privacy Act of 1974; systems of records--HCFA. Notice of proposed new routine use for an existing system of records
Q77671613	Privacy Act of 1974; systems of records--HCFA. Notice of proposed new routine uses for existing systems of records
Q77532763	Privacy Act of 1974; systems of records--PHS
Q77524502	Privacy Act of 1974; systems of records: annual publication--HCFA. Annual republication of notices of systems of records
Q77491257	Privacy Act system of records; amendment of a routine use and change in locations. Public Health Service. Amendment of a routine use and change in locations for Privacy Act system of records 09-15-0007
Q77536830	Privacy Act; exempt record system--HHS. Final rule
Q77522511	Privacy Act; exempt record system--Office of the Secretary, DHHS. Notice of proposed rulemaking
Q73018672	Privacy Act; implementation. Office of Inspector General (OIG), HHS. Final rule
Q77720893	Privacy Act; notification of a new system of records. Public Health Service. Notification of a new system of records: 09-30-0039, "Drug Abuse Treatment Outcome Prospective Study (TOPS)"
Q80372842	Privacy and disclosure of official records and information. Final rules
Q77522436	Private Land Mobile Radio Services--Federal Communications Commission. Final rule
Q77496928	Private Land Mobile Radio Services; amendment of the commission's rules concerning mobile station, control point and control system authorization procedures for common user systems for a certain MHz frequency--Federal Communications Commission. Fina
Q77494089	Private land mobile radio services; amendment of the Commission's rules concerning general eligibility in the industrial radio services: Federal Communications Commission. Final rule
Q77480824	Private land mobile radio services; bio-medical telemetry operations--Federal Communications Commission. Final rule
Q39045874	Procedures for Handling Retaliation Complaints Under Section 31307 of the Moving Ahead for Progress in the 21st Century Act (MAP-21). Final rule
Q49323791	Procedures for designating classes of employees as members of the Special Exposure Cohort under the Energy Employees Occupational Illness Compensation Program Act of 2000; Final rule. Final rule.
Q77116871	Procedures for disclosure or production of information under the Freedom of Information Act; amendments--Consumer Product Safety Commission. Final Rule
Q95553293	Procedures for the Handling of Retaliation Complaints Under Section 1558 of the Affordable Care Act. Final rule
Q38087966	Procedures for the handling of retaliation complaints under section 1558 of the Affordable Care Act. Interim final rule; request for comments.
Q37234613	Procedures for transportation workplace drug and alcohol testing programs. Final rule.
Q74368351	Procedures for transportation workplace drug and alcohol testing programs. Office of the Secretary, DOT. Final rule
Q46447543	Procedures for transportation workplace drug and alcohol testing programs: state laws requiring drug and alcohol rule violation information. Interim final rule
Q43856585	Procedures for transportation workplace drug and alcohol testing programs; technical amendments. Final rule
Q77723049	Procedures relating to health care for handicapped infants--DHHS
Q77457357	Procedures to minimize medical x-ray exposure of the human embryo and fetus; recommendations for medical radiation exposure of women of childbearing potential--Food and Drug Administration. Proposed rule
Q90308819	Process for Department of Veterans Affairs (VA) Physicians To Be Added to the National Registry of Certified Medical Examiners. Final rule
Q74791153	Process for determining need for updates of clinical practice guidelines--AHCPR
Q74781398	Process for health care technology assessments and recommendations for coverage--AHCPR
Q107120695	Proclamation 10164
Q19065343	Proclamation 2605
Q19065348	Proclamation 2695
Q19065372	Proclamation 3044
Q19076040	Proclamation 6632
Q19076408	Proclamation 6694
Q19077396	Proclamation 6854
Q19077783	Proclamation 6920
Q19078019	Proclamation 6959
Q19079235	Proclamation 7153
Q19079559	Proclamation 7203
Q19079963	Proclamation 7265
Q19080158	Proclamation 7295
Q19080298	Proclamation 7316
Q19080306	Proclamation 7317
Q19080672	Proclamation 7373
Q19080728	Proclamation 7382
Q19081232	Proclamation 7463
Q19081531	Proclamation 7510
Q19082305	Proclamation 7631
Q19082416	Proclamation 7647
Q19083412	Proclamation 7799
Q19084612	Proclamation 7984
Q19084913	Proclamation 8031
Q19085354	Proclamation 8112
Q44615465	Proclamation 8207
Q43983370	Proclamation 8325
Q19096050	Proclamation 8387
Q43879596	Proclamation 8459
Q38166796	Proclamation 8529
Q19114531	Proclamation 8685
Q38395067	Proclamation 8989
Q45918270	Proclamation 9234
Q38862978	Proclamation 9374
Q38003824	Proclamation 9465
Q47087414	Proclamation 9478
Q38739065	Proclamation 9548
Q37997228	Proclamation 9558
Q38537015	Proclamation 9565
Q77524531	Procurement forms and administrative matters--HHS. Proposed rule
Q77519507	Procurement regulations--Office of Personnel Management. Final rule
Q77649431	Professional Standards Review Organization: imposition of sanctions on health care practitioners and providers of health care services--proposed rule
Q77685544	Professional Standards Review Organizations: conditions for grants
Q34414095	Professional Standards Review Organizations: confidentiality and disclosure of information.
Q77566160	Professional Standards Review--area designations: final regulations
Q77567142	Professional standards review; Professional Standards Review Organization (PSRO)--Health Care Financing Administration. Interim final regulation with a comment period
Q73018572	Progestational drug products for human use; requirements for labeling directed to the patient. Food and Drug Administration, HHS. Final rule
Q77635341	Program announcement and proposed funding priority for nursing education opportunities for individuals from disadvantaged backgrounds--HRSA
Q74679779	Program announcement for scholarships for the Undergraduate Education of Professional Nurses Grant Program--HHS
Q77617807	Program announcement, funding preferences, proposed funding priorities, and grant orientation conferences for the Health Careers Opportunity Program--HRSA
Q77637482	Program announcement, proposed funding categories, proposed review criteria and proposed funding preference for training grants for acquired immunodeficiency syndrome (AIDS) Regional Education and Training Centers Program--HRSA
Q77636118	Program announcement, proposed special consideration, and proposed funding priorities for nursing special project grants--HRA
Q77630376	Program announcement, special consideration and funding priorities for advanced nurse education grants--HRSA
Q77630379	Program announcement, special considerations and funding priority for grants for nurse practitioner and nurse midwifery programs--HRSA
Q77106218	Program exclusions: April 1997--OIG, HHS. Notice of program exclusions
Q74797083	Program exclusions: July 1994--OIG. Notice of program exclusions
Q77116782	Program exclusions: June 1997--Office of Inspector General, HHS. Notice of program exclusions
Q77152239	Program exclusions: October 1997--Office of Inspector General, HHS. Notice of program exclusions
Q74778634	Program exclusions: September 1993--HHS. Notice of program exclusions
Q77551562	Program grants for black lung clinics--PHS. Final rule
Q77527819	Program grants for black lung clinics--PHS. Notice of proposed rulemaking
Q73174930	Program to Build Capacity to Conduct Environmental Health Education Activities; notice of availability of funds. Agency for Toxic Substances and Disease Registry
Q73174727	Program to build capacity to develop, implement, and evaluate health education and promotion activities in tribal communities; notice of availability of funds. Agency for Toxic Substances and Disease Registry
Q73174617	Program to build environmental public health capacity within tribal colleges and universities; notice of availability of funds. Agency for Toxic Substances and Disease Registry
Q73174857	Program to facilitate environmental justice in minority and under served communities; notice of availability of funds. Agency for Toxic Substances and Disease Registry
Q77685127	Prohibition against reassignment of provider claims
Q77174688	Prohibition of "gag clauses" in the Federal Employees Health Benefits Program--OPM. Final rule making
Q77162053	Prohibition of "gag clauses" in the Federal Employees Health Benefits Program--OPM. Notice of proposed rule making
Q95420582	Prohibition of Children’s Toys and Child Care Articles Containing Specified Phthalates. Final rule
Q74814822	Project grants for genetic diseases testing and counseling programs
Q77475757	Project grants for migrant health; proposed rulemaking--Public Health Service. Notice of proposed rulemaking
Q77710654	Project grants for preventive health services--Centers for Disease Control. Final rule
Q74775977	Project grants for preventive health services; sexually transmitted diseases research and demonstration--CDC
Q77613949	Project grants for renovation or construction of non-acute care intermediate and long term care facilities for patients with acquired immune deficiency syndrome (AIDS)--HRSA. Notice of availability of funds
Q77475754	Projects grants for community health services; proposed rulemaking--Public Health Service. Notice of proposed rulemaking
Q74793049	Proposal for a coordinated framework for regulation of biotechnology
Q77190052	Proposed amendments to Summary Plan Description Regulations--Department of Labor. Notice of proposed rulemaking
Q57211101	Proposed grants program for schools and hospitals and for buildings owned by units of local government and public care institutions: availability of environmental assessment and negative determination
Q74794178	Proposed guidelines for research involving the planned introduction into the environment of organisms with deliberately modified hereditary traits; notice
Q77135381	Proposed information collection; Indian Health Service, community health representative activity reporting sample--IHS
Q77456073	Proposed interim private sector metric conversion planning guidelines: United States Metric Board
Q77457379	Proposed interpretations; Age Discrimination in Employment Act--Equal Employment Opportunity Commission
Q74791155	Proposed methodology for establishing priorities for health care technology assessments--AHCPR
Q34412781	Proposed model federal policy for protection of human subjects; response to the First Biennial Report of the President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research.
Q77477289	Proposed procedural regulations--Equal Employment Opportunity Commission. Proposed regulations; request for comments
Q34413257	Proposed recommendations of the Task Force on Genetic Testing; notice of meeting and request for comment
Q77585453	Proposed redesignation of three health service areas in Illinois--HRA. General notice
Q77585553	Proposed redesignation of three health service areas in Illinois--HRSA
Q52109727	Proposed restrictions applicable to sterilizations funded by the Department of Health, Education, and Welfare.
Q77784019	Proposed revisions to certain regulations regarding annual reporting and disclosure requirements--Pension and Welfare Benefits Administration, DOL. Notice of proposed rulemaking
Q77175318	Proposed vaccine information materials for hepatitis B, Haemophilus influenzae type b (Hib), Varicella (chickenpox), and measles, mumps, rubella (MMR) vaccines--CDC. Notice with comment period
Q74722107	Prospective payment system for inpatient hospital capital-related costs--HCFA. Final rule
Q50431336	Protecting the public and our employees in our hearing process. Final rule
Q36406767	Protection for subjects in human research. Final rule.
Q95401890	Protection of Human Subjects
Q77162050	Protection of human research subjects--HHS. Notice of proposed rulemaking
Q74368486	Protection of human research subjects. Department of Health and Human Services (DHHS). Final rule
Q77405468	Protection of human research subjects. Final rule
Q77451458	Protection of human research subjects: proposed rule
Q74812719	Protection of human subjects
Q77675001	Protection of human subjects
Q74814091	Protection of human subjects of biomedical and behavioral research
Q34409331	Protection of human subjects of biomedical and behavioral research.
Q77447104	Protection of human subjects of biomedical and behavioral research: notice of report and recommendations for public comments
Q77473247	Protection of human subjects--Department of Energy. Proposed rule
Q77431177	Protection of human subjects--research involving children: proposed rule
Q34414282	Protection of human subjects. Use of psychosurgery in practice and research: report and recommendations of National Commission for the Protection of Human Subjects
Q77440187	Protection of human subjects: Institutional Review Board; report and recommendations of National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research
Q77203559	Protection of human subjects: categories of research that may be reviewed by the Institutional Review Board (IRB) through an expedited review procedure--FDA. Notice
Q34414205	Protection of human subjects: fetuses, pregnant women, and in vitro fertilization.
Q58670610	Protection of human subjects: first biennial report on the adequacy and uniformity of federal rules and policies, and their implementation for the protection of human subjects in biomedical and behavioral research; Report of the President's Commissio
Q74767775	Protection of human subjects: informed consent; definition amended to include advice on compensation
Q52980445	Protection of human subjects: policies and procedures.
Q74816435	Protection of human subjects: proposed amendments concerning fetuses, pregnant women, and in vitro fertilization
Q77685569	Protection of human subjects: proposed establishment of regulations
Q74812408	Protection of human subjects: proposed policy
Q74815494	Protection of human subjects: proposed policy
Q77680775	Protection of human subjects: proposed regulations on research involving prisoners
Q77437807	Protection of human subjects: proposed regulations on research involving those institutionalized as mentally disabled
Q74813556	Protection of human subjects: research involving prisoners
Q34414200	Protection of human subjects: technical amendments.
Q77445080	Protection of human subjects; Belmont Report: notice of report for public comment
Q58672829	Protection of human subjects; HEW support of human in vitro fertilization and embryo transfer: report of the Ethics Advisory Board
Q58670166	Protection of human subjects; compensating for research injuries; request for comments on report of the President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research
Q77077611	Protection of human subjects; informed consent--FDA. Final rule
Q77475794	Protection of human subjects; informed consent--Food and Drug Administration. Final rule
Q77653648	Protection of human subjects; informed consent; correction. Food and Drug Administration. Final rule; correction
Q34412081	Protection of human subjects; informed consent; proposed rule.
Q74714537	Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations--FDA. Final rule
Q77627618	Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations--FDA. Proposed rule
Q34412758	Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations; and clinical investigations which may be reviewed through expedited review procedures
Q34409361	Protection of human subjects; new drugs for investigational use; conforming amendments; final rule.
Q74792509	Protection of human subjects; prisoners used as research subjects; reproposal of regulations
Q74792485	Protection of human subjects; prisoners used as subjects in research. Final rule
Q74768056	Protection of human subjects; prisoners used as subjects in research; change of effective date
Q74792505	Protection of human subjects; prisoners used as subjects in research; delay of effective date
Q77484781	Protection of human subjects; prisoners used as subjects in research; stay of effective date--Food and Drug Administration. Final rule; stay of effective date
Q77445087	Protection of human subjects; proposed establishment of regulations
Q58669443	Protection of human subjects; reports of the President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research--Office of the Assistant Secretary for Health, HHS. Notice of availability of reports
Q77685526	Protection of human subjects; research involving those institutionalized as mentally infirm: report and recommendations of the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research
Q77475796	Protection of human subjects; standards for institutional review boards for clinical investigations--Food and Drug Administration. Final rule
Q74767848	Protection of identity--research subjects
Q77445069	Protection of identity--research subjects: final regulations
Q77457372	Protection of privacy of individuals: Department of Health, Education, and Welfare--proposed rule
Q77709342	Providing for operation of tactile paging devices for the deaf, blind, and physically handicapped: Federal Communications Commission. Proposed rule making
Q50580391	Provision of Early Intervention and Special Education Services to Eligible DoD Dependents. Final rule.
Q74768029	Provision of abortion services by the Indian Health Service
Q74792519	Provision of abortion services by the Indian Health Service
Q77167686	Provision of drugs and medicines to certain veterans in state homes--VA. Interim final rule with request for comments
Q77142007	Provision of health care to Vietnam veterans' children with spina bifida--VA. Final rule
Q30228848	Provision of hospital care and medical services during certain disasters or emergencies. Final rule.
Q57195060	Provision of sterilization in federally assisted programs of the Public Health Service
Q77142012	Provision of vocational training and rehabilitation to Vietnam veterans' children with spina bifida--VA. Final rule
Q73172405	Public Health Conference Support Cooperative Agreement Program for Human Immunodeficiency Virus (HIV) Prevention; notice of availability of funds
Q84312513	Public Health Service Act, Rural Physician Training Grant Program, definition of "underserved rural community." Interim final rule with request for comment
Q81754081	Public Health Service policies on research misconduct. Final rule
Q74776471	Public Health Service, Centers for Disease Control; statement of organization, functions, and delegations of authority--HHS
Q77469778	Public Health Service, Health Resources Administration--list of health manpower shortage areas designated under section 332 of the Public Health Service Act
Q77468437	Public Health Service--Grants for allied health projects. Final rule
Q77468436	Public Health Service--Grants for community mental health centers; Final rule
Q77465584	Public Health Service--Grants for construction of teaching facilities, educational improvements, scholarships and student loans; grants for nurse practitioner traineeship programs. Interim-final regulations
Q77468446	Public Health Service--Grants for graduate programs in health administration. Final rule
Q77712343	Public Health Service--Grants for physician assistant training programs. Final regulations
Q77473235	Public Health Service--Grants for traineeships in health administration, hospital administration, or health policy analysis and planning at public or nonprofit private educational institutions other than schools of public health. Final rule
Q77471414	Public Health Service--Grants for training in emergency medical services. Final regulations
Q77473226	Public Health Service--Health maintenance organizations; employees' health benefits plans. Final regulations
Q77473231	Public Health Service--Health maintenance organizations; requirements for a health maintenance organization. Final regulations
Q77471963	Public Health Service--Health systems agency and state health planning and development agency reviews: certificate of need programs. Final regulation
Q77467281	Public Health Service--Information regarding requirements for health maintenance organizations. Correction notice: information regarding requirements for qualified health maintenance organizations
Q77465579	Public Health Service--Information regarding requirements for health maintenance organizations. Notice, information regarding requirements for qualified health maintenance organizations
Q77720252	Public Health Service--Maternal and Child Health and Crippled Children's Services; delegations of authority
Q77463503	Public Health Service--Migrant health centers; delegations of authority
Q77469771	Public Health Service--National Health Service Corps Scholarship Program. Final regulations
Q77468433	Public Health Service--National Institutes of Health; statement of organization, functions, and delegations of authority
Q77485570	Public Health Service--Privacy Act of 1974. Notification of establishment of a new Privacy Act System of Records 09-25-0148
Q77474960	Public Health Service--Privacy Act of 1974. Notification of new system of records: "clinical research; records of subjects in intramural research, epidemiology, demography, and biometry studies on aging.".
Q77468449	Public Health Service--Special project grants for graduate programs in public health. Final rule
Q77460375	Public Health Service--assignment of National Health Service Corps personnel; requirements. Final regulation
Q77650733	Public Health Service--cumulative list of qualified Health Maintenance Organizations
Q77469774	Public Health Service--financial distress grants to health profession schools. Final regulations
Q77456026	Public Health Service--grants for residency training in general internal medicine or general pediatrics: final regulations
Q77463492	Public Health Service--health maintenance organization loans and loan guarantees for acquisition and construction of ambulatory health care facilities. Interim regulations
Q77469781	Public Health Service--health maintenance organizations: final regulations
Q77460368	Public Health Service--health systems agencies and state health planning and development agencies; certificate of need reviews. Notice regarding certificate of need programs
Q77473238	Public Health Service-Criteria for designation of health manpower shortage areas. Final regulations
Q77710256	Public Health Service; Center for Disease Control; Office of the Assistant Secretary for Health; statement of organization, functions, and delegations of authority
Q77740477	Public Health Service; Food and Drug Administration; statement of organization, functions, and delegations of authority
Q77473220	Public Health Service; National Institutes of Health; statement of organization, functions, and delegations of authority
Q77710972	Public Health Service; program announcement; alternate testing sites to perform HTLV-III antibody testing
Q17146045	Public Papers of the Presidents
Q77451434	Public contracts and property management; federal standards for federally funded grants and agreements: final rule
Q77670226	Public emergency shelters for the homeless, exclusion of underpayments, increase in benefit rate for individuals in medical care facilities--SSA. Interim rules with request for comments
Q73172376	Public health assessments completed. Agency for Toxic Substances and Disease Registry (ATSDR), Department of Health and Human Services (HHS). Notice
Q74746885	Public information collection requirements submitted to the Office of Management and Budget for clearance--HCFA. Supporting statement for the CLIA application forms, HCFA-114 AND HCFA-116
Q77168801	Public information; communications with state and foreign government officials--FDA. Proposed rule
Q77516385	Public inspection of exempt organization returns--Internal Revenue Service. Notice of proposed rulemaking
Q77516356	Public mobile radio services; regulatory policies and procedures for the Domestic Public Land Mobile Radio Service--Federal Communications Commission. Final rule
Q77159858	Publication of OIG Special Fraud Alert: fraud and abuse in nursing home arrangements with hospices--OIG. Notice
Q77065509	Publication of OIG Special Fraud Alert: fraud and abuse in the provision of services in nursing facilities--HHS. Notice
Q74817211	Publication of OIG Special Fraud Alerts: home health fraud, and fraud and abuse in the provision of medical supplies to nursing facilities--HHS. Notice
Q77175235	Publication of OIG compliance program guidance for clinical laboratories--HHS. Notice
Q77169815	Publication of the OIG compliance program guidance for home health agencies--OIG. Notice
Q77153804	Publication of the OIG compliance program guidance for hospitals--OIG. Notice
Q77099525	Publication of the OIG model compliance plan for clinical laboratories--HHS. Notice
Q77194203	Publication of the OIG's provider self-disclosure protocol--Office of Inspector General (OIG), HHS. Notice
Q77489798	Qualification of health maintenance organizations: Public Health Service. Notice of proposed rulemaking
Q77558016	Quality assurance in nuclear medicine facilities; availability of final recommendations--FDA. Notice
Q77457399	Quality assurance programs for diagnostic radiology facilities: Food and Drug Administration. Final recommendation
Q77649615	Quality control and proficiency testing standards for laboratories in Medicare Hospitals: final rule
Q77682480	Quality control and proficiency testing standards for laboratories in Medicare hospitals
Q77152155	Quality mammography standards--FDA. Final rule
Q77203511	Quality mammography standards--FDA. Proposed rule
Q73175023	Quality mammography standards. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Direct final rule
Q77201751	Quality mammography standards; correcting amendment--FDA. Final rule; correcting amendment
Q77152229	Quality mammography standards; correction--FDA. Final rule; correction
Q74717664	Quality management program and misadministrations--Nuclear Regulatory Commission. Final rule
Q74755183	Quality management program and misadministrations; NRC override of OMB disapproval of NRC information collection request--Nuclear Regulatory Commission. Final rule
Q74782490	Quality standards and certification requirements for mammography facilities--FDA. Interim rule with request for comments
Q74798952	Quality standards and certification requirements for mammography facilities--FDA. Interim rule; opportunity for public comment
Q17165302	Quarterly Publication of Individuals Who Have Chosen to Expatriate
Q74688262	Quarterly listing of program issuances and coverage determinations--HCFA. General notice
Q74689527	Quarterly listing of program issuances--HCFA. General Notice
Q74688538	Quarterly listing of program issuances--HCFA. General notice
Q74690410	Quarterly listing of program issuances--HCFA. General notice
Q77666776	Quarterly listing of program issuances--HCFA. General notice
Q77668237	Quarterly listing of program issuances--HCFA. General notice
Q77669899	Quarterly listing of program issuances--HCFA. General notice
Q77670486	Quarterly listing of program issuances--HCFA. General notice
Q77671587	Quarterly listing of program issuances--HCFA. General notice
Q73174819	Racial and Ethnic Approaches to Community Health 2010; (REACH 2010) Demonstration Projects; Notice of Availability of Funds. Centers for Disease Control and Prevention
Q77682444	Radiation protection guidance to federal agencies for diagnostic x rays: approval of recommendations
Q77440173	Radiation surveys of therapy patients: final rule
Q77522483	Radiological health; evaluation of radiation exposure in diagnostic radiology examinations; availability of draft recommendations--FDA. Notice
Q77159879	Radiology devices; classifications for five medical image management devices--FDA. Final rule
Q77175225	Radiology devices; classifications for five medical image management devices; correction--FDA. Final rule; correction
Q77610985	Radiology devices; general provisions and classifications of 59 devices--FDA. Final rule
Q37878451	Rate increase disclosure and review. Final rule with comment period
Q37926973	Rate increase disclosure and review: definitions of "individual market" and "small group market." Final rule
Q74368174	Reasonable charges for medical care or services. Department of Veterans Affairs. Interim final rule
Q38393377	Reasonable charges for medical care or services. Final rule.
Q77298662	Reasonable charges for medical care or services. Interim final rule
Q77685131	Reasonable cost reimbursement of inpatient hospital services
Q81235686	Reauthorization of the Temporary Assistance for Needy Families (TANF) program. Final rule
Q74758129	Receipt of byproduct and special nuclear material--NRC. Final rule
Q77492753	Receipt of petition of rulemaking from the American Association of Physicists in Medicine. Nuclear Regulatory Commission. Publication of a petition for rulemaking
Q39095105	Recognition of Tribal Organizations for Representation of VA Claimants. Final rule
Q77201786	Recognition of organizations and accreditation of representatives, attorneys, and agents--VA. Proposed rule
Q74814814	Recombinant DNA Advisory Committee, meeting; Recombinant DNA research, proposed guidelines and actions
Q74813293	Recombinant DNA Research Guidelines
Q74793422	Recombinant DNA molecules research, proposed actions under guidelines; notice
Q47664728	Recombinant DNA research guidelines: draft environmental impact statement
Q74791066	Recombinant DNA research: action under the guidelines; notice
Q74793011	Recombinant DNA research: actions under guidelines
Q77529739	Recombinant DNA research: actions under the guidelines--NIH. Notice of actions under NIH guidelines for research involving recombinant DNA molecules
Q34412124	Recombinant DNA research: actions under the guidelines; notice.
Q34411616	Recombinant DNA research: notice of intent to propose amendments to the NIH Guidelines for research involving recombinant DNA molecules (NIH Guidelines) regarding enhanced mechanisms for NIH oversight of recombinant DNA activities.
Q74768282	Recombinant DNA research: proposed actions under guidelines
Q34412636	Recombinant DNA research: proposed actions under the guidelines
Q34409298	Recombinant DNA research: proposed actions under the guidelines; notice
Q74791069	Recombinant DNA research: proposed actions under the guidelines; notice
Q74813630	Recombinant DNA research: proposed revised guidelines
Q74813776	Recombinant DNA research: proposed revised guidelines
Q74767814	Recombinant DNA research: revised guidelines
Q77522429	Recombinant DNA research; actions under guidelines--NIH. Notice of actions under NIH guidelines for research
Q34412001	Recombinant DNA research; actions under guidelines; notice
Q74768589	Recombinant DNA research; actions under guidelines; notice
Q74792819	Recombinant DNA research; actions under guidelines; notice
Q74793328	Recombinant DNA research; actions under guidelines; notice
Q74793419	Recombinant DNA research; actions under guidelines; notice
Q45880658	Recombinant DNA research; actions under guidelines; notice -- B. Public Information brochure -- "Gene therapy for human patients.
Q45880661	Recombinant DNA research; actions under guidelines; notice -- E. Points to consider for protocols for the transfer of recombinant DNA into the genome of human subjects.
Q54200148	Recombinant DNA research; actions under guidelines; notice of actions.
Q74793382	Recombinant DNA research; advisory committee meeting and proposed action under guidelines; notices
Q46950449	Recombinant DNA research; availability of environmental assessment for public comment; request for comments on need for a programmatic environmental impact statement; notice
Q74792517	Recombinant DNA research; final plan for a program to assess the risks
Q74768570	Recombinant DNA research; physical containment recommendations for large-scale uses of organisms containing recombinant DNA molecules
Q74792513	Recombinant DNA research; proposed actions under guidelines
Q74793265	Recombinant DNA research; proposed actions under guidelines
Q77457388	Recombinant DNA research; proposed actions under guidelines--National Institutes of Health
Q74793613	Recombinant DNA research; proposed actions under guidelines; notice
Q74793666	Recombinant DNA research; proposed actions under guidelines; notice
Q74793737	Recombinant DNA research; proposed actions under guidelines; notice
Q74793675	Recombinant DNA research; proposed actions under guidelines; notices
Q74792490	Recombinant DNA research; proposed revised guidelines
Q45880653	Recombinant DNA research; request for public comment on "Points to consider in the design and submission of human somatic-cell gene therapy protocols.
Q74767822	Recombinant DNA: intent to propose regulations
Q77579976	Recommendations to minimize diagnostic nuclear medicine exposure to the embryo, fetus, and infant; availability of final recommendations--FDA. Notice
Q77152926	Reconsideration of denied claims--VA. Proposed rule
Q77649873	Reconsiderations and appeals of Professional Standards Review Organization determinations
Q45210603	Recordkeeping and reporting requirements for drug products containing gamma-hydroxybutyric acid (GHB). Final rule.
Q77121664	Recordkeeping and reporting under Title VII and the ADA--EEOC. Final rule
Q74831423	Records and reports regulations for radiation emitting electronic products--FDA. Final rule
Q77053025	Records and reports regulations for radiation emitting electronic products; correction--FDA. Final rule; correction
Q74746897	Recovery of cost of hospital and medical care and treatment furnished by the United States--Department of Justice. Final rule
Q84030722	Recovery of cost of hospital and medical care and treatment furnished by the United States; delegation of authority. Final rule
Q77561999	Recovery of funds in transaction affecting ownership of federally assisted health professions and nurse teaching facilities--HRSA. Statement of general policy
Q74767783	Redesignation of Contract Health Service Delivery Area--Indian Health Service, HHS. Final notice
Q77585810	Redesignation of Illinois health service area 7 and 8--HRSA
Q77585191	Redesignation; Iowa Health Service Area No. 1--Health Resources Administration. Proposed redesignation
Q74732797	Reduction because of hospitalization--VA. Final rule
Q77649886	Reduction in grace period days where payment is made for certain nonreimbursable expenses: final rule
Q77495536	Refugee resettlement program and Cuban/Haitian entrant program: cash and medical assistance policies. Social Security Administration. Interim final rule
Q74832486	Regional offices and Health Resources and Services Administration; statement of organization, functions and delegations of authority--PHS
Q53420699	Registration and reregistration application fees. Confirmation of final rule, remanded for further notice and comment, and response to comments.
Q74646721	Registration and reregistration application fees. Final rule; remanded for further notice and comment
Q30232982	Registration of food facilities under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule.
Q43115174	Registration requirements for importers and manufacturers of prescription drug products containing ephedrine, pseudoephedrine, or phenylpropanolamine. Final rule.
Q83477146	Regulation for the enforcement of federal health care provider conscience protection laws. Final rule
Q77441232	Regulation of the medical uses of radioisotopes; statement of general policy
Q47427307	Regulations Under the Americans With Disabilities Act; Genetic Information Nondiscrimination Act. Final rule
Q77162061	Regulations for in vivo radiopharmaceuticals used for diagnosis and monitoring--FDA. Proposed rule
Q73174792	Regulations for in vivo radiopharmaceuticals used for diagnosis and monitoring. Food and Drug Administration, HHS. Final rule
Q77168820	Regulations for in vivo radiopharmaceuticals used for diagnosis and monitoring; extension of comment period--FDA. Proposed rule; extension of comment period
Q46119934	Regulations implementing the Byrd Amendments to the Black Lung Benefits Act: determining coal miners' and survivors' entitlement to benefits. Final rule.
Q74368355	Regulations implementing the Federal Coal Mine Health and Safety Act of 1969, as amended. Employment Standards Administration, Labor. Final rule
Q73018355	Regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body. Food and Drug Administration, HHS. Final rule
Q74367948	Regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body; partial stay of compliance. Food and Drug Administration, HHS. Final rule; partial stay of compliance
Q44336736	Regulations regarding income-related monthly adjustment amounts to Medicare beneficiaries' prescription drug coverage premiums. Final rule.
Q44336086	Regulations regarding income-related monthly adjustment amounts to Medicare beneficiaries' prescription drug coverage premiums. Interim final rule with request for comments.
Q77783993	Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients--FDA. Final rule
Q84041142	Regulations restricting the sale and distribution of cigarettes and smokeless tobacco to protect children and adolescents. Final rule
Q77516369	Regulatory policies and procedures for the Domestic Public Land Mobile Radio Service--Federal Communications Commission. Proposed rule
Q77500301	Regulatory policies and procedures for the Domestic Public Land Mobile Radio Service--Federal Communications Commission. Second report and order
Q47659440	Reimbursement for Emergency Treatment. Interim final rule
Q77649559	Reimbursement for organ procurement and histocompatibility testing and for home dialysis equipment
Q56378285	Reimbursement of Qualifying Adoption Expenses for Certain Veterans. Interim final rule
Q48830750	Reimbursement offsets for medical care or services. Final rule
Q77682456	Reimbursement on a reasonable cost related basis for skilled nursing and intermediate care facility services; supplemental statement of basis and purpose of regulations
Q77106211	Reimbursement rates for calendar year 1997--IHS
Q77661437	Reimbursement rates for health care services authorized under the Indian Health Service contract health service regulations--HRSA. Issuance of statement of policy
Q81300754	Reinstatement of entitlement to disability benefits. Final rules
Q40268862	Release of VA Records Relating to HIV. Final rule
Q77175946	Release of information from Department of Veterans Affairs records--VA. Proposed rule
Q93235873	Religious Exemptions and Accommodations for Coverage of Certain Preventive Services Under the Affordable Care Act. Final rules
Q95724977	Religious Exemptions and Accommodations for Coverage of Certain Preventive Services Under the Affordable Care Act. Interim final rules with request for comments
Q48605173	Removal of 30-day residency requirement for per diem payments. Direct final rule
Q44924631	Removal of 30-day residency requirement for per diem payments. Final rule; confirmation of effective date
Q49664063	Removal of Certain Time of Inspection and Duties of Inspector Regulations for Biological Products. Direct final rule
Q38734227	Removal of Review and Reclassification Procedures for Biological Products Licensed Prior to July 1, 1972. Final rule
Q77104857	Removal of certain limitations on cost comparisons related to contracting out of activities at VA health-care facilities--VA. Final rule
Q77725966	Removal of obsolete regulations on hemophilia treatment centers and genetic disease testing and counseling programs--HRSA, PHS. Final rule
Q74674336	Removal of obsolete regulations on limitation on federal participation for capital expenditures under Section 1122 of the Social Security Act--HCFA. Final rule
Q77662280	Removal of obsolete rules; peer review organizations; Medicare program--HCFA. Final rule
Q48374867	Removal of penalty for breaking appointments. Final rule
Q83818383	Removal of regulations on black lung benefits. Final rule
Q77159928	Removal of regulations regarding certification of antibiotic drugs--FDA. Direct final rule
Q77159939	Removal of regulations regarding certification of antibiotic drugs; companion document to direct final rule--FDA. Proposed rule
Q77159967	Removal of regulations regarding certification of drugs composed wholly or partly of insulin--FDA. Direct final rule
Q77159963	Removal of regulations regarding certification of drugs composed wholly or partly of insulin; companion document to direct final rule--FDA. Proposed rule
Q74813883	Removal of standard setting requirements for medical and nonmedical facilities where SSI recipients reside--HHS. Final rule
Q42979200	Removal of thresholds for the List I chemicals pseudoephedrine and phenylpropanolamine. Final rule.
Q47917623	Repayment by VA of Educational Loans for Certain Psychiatrists. Final rule
Q48614854	Reporting by multiple employer welfare arrangements and certain other entities that offer or provide coverage for medical care to the employees of two or more employers. Final rule.
Q74775382	Reporting health care practitioners to state licensing boards--VA. Final rule
Q77159883	Reporting health care professionals to state licensing boards--VA. Final rule
Q77143591	Reporting health care professionals to state licensing boards--VA. Proposed rule
Q79264966	Representative payment policies and administrative procedure for imposing penalties for false or misleading statements or withholding of information. Final rules
Q83107602	Representative payment under titles II, VIII and XVI of the Social Security Act. Final rule
Q74679787	Request for comments: technical assistance to rural hospitals--HRSA. Notice: request for comments
Q73174663	Request for planning ideas. Agency for Health Care Policy and Research, HHS. Notice
Q77653003	Request of General Electric Co. to exempt medical diagnostic equipment from the Commission's rules--Federal Communications Commission. Proposed rule
Q77509592	Request of General Electric Company to exempt medical diagnostic equipment from the Commission's rules--Federal Communications Commission. Report & Order in Gen. Docket 81-461
Q77509622	Requests that certain areas be designated as medically underserved areas--Health Resources and Services Administration. Notice
Q84419048	Required warnings for cigarette packages and advertisements. Final rule
Q77475810	Requirements and procedures applicable to appeals before the Departmental Grant Appeals Board--Department of Health and Human Services. Notice of proposed rulemaking
Q77494099	Requirements applicable to projects for family planning services: Public Health Service. Proposed rule
Q74799292	Requirements applicable to sterilizations (hysterectomies)
Q77654915	Requirements applicable to sterilizations (hysterectomies)--Health Care Financing Administration. Final rule
Q77475774	Requirements applicable to sterilizations (hysterectomies)--Health Care Financing Administration. Proposed rule
Q36118659	Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs That Are Regulated Under a Biologics License Application, and Animal Drugs. Final rule
Q95724294	Requirements for Notification, Evaluation and Reduction of Lead-Based Paint Hazards in Federally Owned Residential Property and Housing Receiving Federal Assistance; Response to Elevated Blood Lead Levels. Final rule
Q77475778	Requirements for a health maintenance organization--Public Health Service. Final regulations
Q77451413	Requirements for a health maintenance organization: interim regulations
Q74782487	Requirements for accrediting bodies of mammography facilities--FDA. Interim rule with request for comments
Q41205493	Requirements for blood and blood components intended for transfusion or for further manufacturing use. Final rule
Q77451450	Requirements for dispensing containers for prescription drugs; stay of effective date
Q77390606	Requirements for facilities transferring or receiving select agents. Final rule
Q77437779	Requirements for provisions of services to persons unable to pay and community services by assisted health care facilities: proposed rulemaking; public hearing
Q33433530	Requirements for submission of bioequivalence data; final rule. Final rule
Q33195901	Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule
Q40674063	Requirements for testing human blood donors for evidence of infection due to communicable disease agents. Final rule.
Q80376316	Requirements for the group health insurance market; non-federal governmental plans exempt from HIPAA Title I requirements. Final rule
Q77650047	Requirements of the contract between the Secretary and a Health Maintenance Organization under Medicare: final rule
Q44334105	Requirements on content and format of labeling for human prescription drug and biological products. Final rule
Q37936985	Requiring use of electronic services by certain claimant representatives. Final rules.
Q77477286	Research activities which may be reviewed through expedited review procedures set forth in HHS regulations for protection of human research subjects--Department of Health and Human Services. Notice
Q77722731	Research grants on alcohol and immunology including acquired immunodeficiency syndrome (AIDS)--NIAAA
Q73174910	Research studies to characterize the clinical relevance of HIV superinfection; notice of availability of funds. Centers for Disease Control and Prevention
Q77150322	Respiratory protection--OSHA. Final rule; request for comment on paperwork requirements
Q77158195	Respiratory protection; correction--OSHA. Final rule; correction
Q74792649	Respiratory protective devices--NIOSH. Notice of proposed rulemaking
Q48753428	Responding to disruptive patients. Final rule
Q47359708	Responsibilities of awardee and applicant institutions for dealing with and reporting possible misconduct in science; final rule.
Q48597765	Responsibility of applicants for promoting objectivity in research for which public health service funding is sought and responsible prospective contractors. Final rule.
Q74812742	Restrictions applicable to sterilization procedures in federally assisted family planning projects
Q52116454	Restrictions applicable to sterilization procedures in federally assisted family planning projects.
Q79179560	Retail sales of scheduled listed chemical products; self-certification of regulated sellers of scheduled listed chemical products. Interim final rule with request for comment
Q77570194	Retrospective review of the performance standard for diagnostic x-ray equipment; availability of report--FDA. Notice; final rule-related
Q38727399	Returning Evidence at the Appeals Council Level. Final rule
Q34442094	Review of benefit claims decisions. Final rule.
Q77649757	Review responsibility and authority of Professional Standards Review Organizations (PSROs): proposed rule
Q40404508	Revised Medical Criteria for Evaluating Human Immunodeficiency Virus (HIV) Infection and for Evaluating Functional Limitations in Immune System Disorders. Final rule
Q47917798	Revised Medical Criteria for Evaluating Mental Disorders. Final rules
Q50199846	Revised Medical Criteria for Evaluating Neurological Disorders. Final rule
Q50203703	Revised Medical Criteria for Evaluating Respiratory System Disorders. Final rule
Q77150354	Revised diphtheria, tetanus, and pertussis (DTP/DTaP/DT) vaccine information materials--CDC. Notice
Q77531419	Revised federal allotments to states for social services expenditure pursuant to Title XX--Social Services Block Grant Act; promulgation for fiscal year 1985--HHS
Q77529742	Revised federal allotments to states for social services expenditures pursuant to Title XX--Social Services Block Grant Act; promulgation for fiscal year 1984--HHS. Notification
Q77524498	Revised federal allotments to states for social services expenditures pursuant to the Title XX--Social Services Block Grant Act; promulgation for fiscal year 1983-HHS. Revised notification
Q47391926	Revised listings for growth disorders and weight loss in children. Final rule
Q77153834	Revised medical criteria for determination of disability, endocrine system and related criteria--SSA. Proposed rule
Q73175065	Revised medical criteria for determination of disability, endocrine system and related criteria. Social Security Administration (SSA). Final rule
Q77447702	Revised medical criteria for determination of disability, musculoskeletal system and related criteria. Final rules with request for comments
Q73892892	Revised medical criteria for evaluating amyotrophic lateral sclerosis. Final rules
Q50914517	Revised medical criteria for evaluating cancer (malignant neoplastic diseases). Final rule.
Q82491001	Revised medical criteria for evaluating cardiovascular impairments. Final rules
Q44314870	Revised medical criteria for evaluating congenital disorders that affect multiple body systems. Final rule
Q81512151	Revised medical criteria for evaluating digestive disorders. Final rule
Q83860485	Revised medical criteria for evaluating endocrine disorders. Final rules
Q51777188	Revised medical criteria for evaluating genitourinary disorders. Final rules.
Q81924649	Revised medical criteria for evaluating genitourinary impairments. Final rules
Q50437832	Revised medical criteria for evaluating hearing loss. Final rules.
Q50930418	Revised medical criteria for evaluating hematological disorders. Final rules.
Q37157492	Revised medical criteria for evaluating immune system disorders. Final rules
Q36247206	Revised medical criteria for evaluating impairments that affect multiple body systems. Final rules
Q37624639	Revised medical criteria for evaluating malignant neoplastic diseases. Final rule.
Q81025757	Revised medical criteria for evaluating malignant neoplastic diseases. Final rules
Q73162653	Revised medical criteria for evaluating mental disorders and traumatic brain injury. Social Security Administration. Final rules
Q80182573	Revised medical criteria for evaluating skin disorders. Final rules
Q79375803	Revised medical criteria for evaluating visual disorders. Final rules
Q95526647	Revised medical criteria for evaluating visual disorders. Final rules
Q77451438	Revised method of filing notice of intent to terminate; proposed rulemaking: proposed rule
Q77712352	Revised physician labelling for neuroleptic drugs: Food and Drug Administration. Notice
Q77135414	Revised precautionary measures to reduce the possible transmission of Creutzfeldt-Jakob disease (CJD) by blood and blood products; guidance document; availability--FDA. Notice
Q74762060	Revised standards for protection against radiation; minor amendments--NRC. Final rule: minor corrective and conforming amendments
Q77116817	Revision of Department of Justice Freedom of Information Act and Privacy Act Regulations and Implementation of Electronic Freedom of Information Act Amendments of 1996--DoJ. Proposed Rule
Q31153648	Revision of Import and Export Requirements for Controlled Substances, Listed Chemicals, and Tableting and Encapsulating Machines, Including Changes To Implement the International Trade Data System (ITDS); Revision of Reporting Requirements for Domes
Q77056367	Revision of airman medical standards and certification procedures and duration of medical certificates--FAA. Final rule
Q77120719	Revision of ambulatory surgical center payment rate methodology; Medicare program--HCFA. Correction of final notice
Q74751500	Revision of fee schedules; 100% fee recovery, FY 1992--NRC. Final rule
Q74730690	Revision of fee schedules; 100% fee recovery; clarification of size standards--Nuclear Regulatory Commission. Final rule
Q77524487	Revision of health service area boundaries; interim regulation--PHS
Q77534383	Revision of income criteria for eligibility for uncompensated services--HRA. Notice
Q77554247	Revision of income criteria for eligibility for uncompensated services--HRSA. Notice
Q77516413	Revision of income criteria for eligibility for uncompensated services--Health Resources and Services Administration. Rule-related notice
Q73174833	Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human). Food and Drug Administration, HHS. Direct final rule
Q73162661	Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human). Food and Drug Administration, HHS. Final rule
Q73174835	Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human); companion document to direct final rule. Food and Drug Administration, HHS. Proposed rule
Q73018435	Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human); confirmation in part and technical amendment. Food and Drug Administration, HHS. Direct final rule; confirmation in part and techni
Q45912058	Revision of the requirements for constituent materials. Final rule.
Q81512148	Revision of the requirements for live vaccine processing. Direct final rule
Q81235700	Revision of the requirements for live vaccine processing; confirmation of effective date. Direct final rule; confirmation of effective date
Q74368335	Revision to requirements for licensed Anti-Human Globulin and Blood Grouping Reagents. Food and Drug Administration, HHS. Direct final rule
Q53815894	Revisions to Exceptions Applicable to Certain Human Cells, Tissues, and Cellular and Tissue-Based Products. Final rule.
Q39095101	Revisions to Rules Regarding the Evaluation of Medical Evidence. Final rules
Q50978415	Revisions to direct fee payment rules. Final rules.
Q37975502	Revisions to labeling requirements for blood and blood components, including source plasma. Final rule.
Q37975204	Revisions to rules of conduct and standards of responsibility for representatives. Final rules
Q77158183	Revisions to the general safety requirements for biological products--FD. Direct final rule
Q77158186	Revisions to the general safety requirements for biological products; companion document to direct final rule--FDA. Proposed rule
Q77169788	Revisions to the general safety test requirements for biological products--FDA. Direct final rule: confirmation in part and withdrawal in part
Q81232191	Revisions to the requirements applicable to blood, blood components and source plasma. Direct final rule
Q81020251	Revisions to the requirements applicable to blood, blood components and source plasma; confirmation of effective date and technical amendment. Direct final rule; confirmation of effective date and technical amendment
Q73175056	Revisions to the requirements applicable to blood, blood components, and source plasma. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Direct final rule
Q77319827	Revisions to the requirements applicable to blood, blood components, and source plasma. Final rule
Q74368450	Revisions to the requirements applicable to blood, blood components, and source plasma; confirmation in part and technical amendment. Food and Drug Administration, HHS. Direct final rule; confirmation in part and technical amendment
Q38544068	Revocation of General Safety Test Regulations That Are Duplicative of Requirements in Biologics License Applications. Final rule
Q73174745	Revocation of Office of Generic Drug's interim policy statement on inactive ingredients. Food and Drug Administration, HHS. Notice
Q73174868	Revocation of advisory opinion entitled "FD&C Act Trade Correspondence 61". Food and Drug Administration, HHS. Notice; revocation
Q77159779	Revocation of regulation on positron emission tomography drug products--FDA. Final rule; revocation
Q81564586	Revocation of status of specific products; Group A streptococcus. Direct final rule
Q39411505	Ricky Ray Hemophilia Relief Fund Program. Adoption of interim final rule as final rule with amendments.
Q74368284	Risk management. National Aeronautics and Space Administration (NASA). Interim rule adopted as final with changes
Q77460381	Rules and regulations for reporting disclosure; summary plan description requirements; final regulations--Department of Labor. Adoption of final regulations
Q83910664	Rules for helping blind and disabled individuals achieve self-support. Final rules
Q79375802	Rules for the issuance of work report receipts, payment of benefits for trial work period service months after a fraud conviction, changes to the student earned income exclusion, and expansion of the reentitlement period for childhood disability ben
Q77465556	Rules of agency practice and procedure concerning OSHA access to employee medical records. The Occupational Safety and Health Administration of the United States Department of Labor (OSHA). Final rule
Q34450498	Rules of practice: medical opinions from the Veterans Health Administration. Interim final rule with request for comments
Q77457392	Rules on confidentiality, access to records and council factfinding: Council on Wage and Price Stability. Publication of Final Rules
Q38108329	Rules on determining hearing appearances. Final rule
Q95481955	Rules regarding the health insurance premium tax credit. Final and temporary regulations
Q93922479	Rural Development Loan Fund--Office of Community Services. HHS. Proposed rule
Q86340215	Rural health care support mechanism. Final rule
Q76377551	Rural health care support mechanism. Final rule; denial of petition for reconsideration
Q81235716	Rural health care support mechanism. Final rule; petition for reconsideration
Q77649365	Rural health clinic services: screening guidelines and payment limit for Medicare and Medicaid reimbursement
Q77682462	Rural health clinics: conditions for certification
Q77203546	Ryan White Care Act requirement--Secretary's determination on HIV testing of newborns--CDC. Notice and request for comments
Q38955328	Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use. Final rule
Q47278319	Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use. Final rule
Q77516393	Sanctions applicable to letter of credit administration--Office of the Secretary, HHS. Proposed rule
Q43347379	Sanitary Transportation of Human and Animal Food. Final rule
Q77159944	Sanofi Pharmaceuticals, Inc., et al.; withdrawal of approval of 21 new drug applications and 62 abbreviated new drug applications--FDA. Notice
Q90313712	Schedule for Rating Disabilities: Skin. Final rule
Q58103049	Schedule for Rating Disabilities: The Hematologic and Lymphatic Systems. Final rule
Q90274658	Schedule for Rating Disabilities: the Organs of Special Sense and Schedule of Ratings--Eye. Final rule
Q47798833	Schedule for Rating Disabilities; Dental and Oral Conditions. Final rule
Q90274653	Schedule for Rating Disabilities; Gynecological Conditions and Disorders of the Breast. Final rule
Q47721870	Schedule for Rating Disabilities; the Endocrine System. Final rule
Q48084940	Schedule for rating disabilities--mental disorders and definition of psychosis for certain VA purposes. Final rule
Q48233533	Schedule for rating disabilities--mental disorders and definition of psychosis for certain VA purposes. Interim final rule
Q77167681	Schedule for rating disabilities: cold injuries--VA. Final rule
Q34438873	Schedule for rating disabilities: disabilities of the liver. Final rule
Q48724418	Schedule for rating disabilities; AL amyloidosis (primary amyloidosis). Final rule
Q36798410	Schedule for rating disabilities; Appendices A, B, and C. Final rule.
Q73174799	Schedule for rating disabilities; diseases of the ear and other sense organs. Department of Veterans Affairs. Final rule
Q48845939	Schedule for rating disabilities; evaluation of residuals of traumatic brain injury (TBI). Final rule
Q79793274	Schedule for rating disabilities; evaluation of scars. Final rule
Q83107608	Schedule for rating disabilities; eye. Final rule
Q73175027	Schedule for rating disabilities; fibromyalgia. Department of Veterans Affairs (VA). Final rule
Q74811507	Schedule for rating disabilities; gynecological conditions and disorders of the breast--VA. Final regulation
Q74832489	Schedule for rating disabilities; hemic and lymphatic systems--VA. Final rule
Q43856586	Schedule of controlled substances: placement of dichloralphenazone into Schedule IV. Final rule
Q50354793	Schedule of controlled substances: placement of tramadol into schedule IV. Final rule
Q43251925	Schedule of controlled substances; placement of fospropofol into schedule IV. Final rule.
Q95560531	Schedules of Controlled Substances: Extension of Temporary Placement of 10 Synthetic Cathinones in Schedule I of the Controlled Substances Act. Final order
Q95725139	Schedules of Controlled Substances: Extension of Temporary Placement of MAB–CHMINACA in Schedule I of the Controlled Substances Act. Temporary rule; temporary scheduling order; extension
Q95549863	Schedules of Controlled Substances: Extension of Temporary Placement of PB-22, 5F-PB-22, AB-FUBINACA and ADB-PINACA in Schedule I of the Controlled Substances Act. Final order
Q53532706	Schedules of Controlled Substances: Extension of Temporary Placement of THJ-2201, AB-PINACA and AB-CHMINACA in Schedule I of the Controlled Substances Act. Temporary order.
Q34501735	Schedules of Controlled Substances: Extension of Temporary Placement of Three Synthetic Phenethylamines in Schedule I. Final order
Q57066386	Schedules of Controlled Substances: Placement in Schedule V of Certain FDA-Approved Drugs Containing Cannabidiol; Corresponding Change to Permit Requirements. Final order
Q50310056	Schedules of Controlled Substances: Placement of 10 Synthetic Cathinones Into Schedule I. Final rule
Q50073501	Schedules of Controlled Substances: Placement of AB-CHMINACA, ABPINACA and THJ-2201 Into Schedule I. Final rule
Q89272380	Schedules of Controlled Substances: Placement of AH-7921 Into Schedule I. Final order
Q47287858	Schedules of Controlled Substances: Placement of Acetyl Fentanyl Into Schedule I. Final order
Q53393577	Schedules of Controlled Substances: Placement of Brivaracetam Into Schedule V. Final rule.
Q28275630	Schedules of Controlled Substances: Placement of Brivaracetam Into Schedule V. Interim final rule, with request for comments
Q90278894	Schedules of Controlled Substances: Placement of Butyryl Fentanyl and U–47700 Into Schedule I. Final order
Q50351528	Schedules of Controlled Substances: Placement of Eluxadoline Into Schedule IV. Final rule
Q95725100	Schedules of Controlled Substances: Placement of FDA-Approved Products of Oral Solutions Containing Dronabinol [(-)-delta-9-trans- tetrahydrocannabinol (delta-9-THC)] in Schedule II. Final rule
Q53393574	Schedules of Controlled Substances: Placement of FDA-Approved Products of Oral Solutions Containing Dronabinol [(-)-delta-9-transtetrahydrocannabinol (delta-9-THC)] in Schedule II. Interim final rule, with request for comments.
Q95726119	Schedules of Controlled Substances: Placement of Furanyl Fentanyl, 4- Fluoroisobutyryl Fentanyl, Acryl Fentanyl, Tetrahydrofuranyl fentanyl, and Ocfentanil in Schedule I. Final order
Q49858742	Schedules of Controlled Substances: Placement of MT-45 Into Schedule I. Final order
Q50348493	Schedules of Controlled Substances: Placement of PB-22, 5F-PB-22, AB-FUBINACA and ADB-PINACA into Schedule I. Final rule
Q47394145	Schedules of Controlled Substances: Placement of Thiafentanil Into Schedule II. Interim final rule with request for comments
Q95546601	Schedules of Controlled Substances: Placement of Three Synthetic Phenethylamines Into Schedule I. Final rule
Q50349299	Schedules of Controlled Substances: Placement of UR-144, XLR11, and AKB48 into Schedule I. Final rule
Q47678669	Schedules of Controlled Substances: Removal of Naldemedine From Control. Final rule
Q47653914	Schedules of Controlled Substances: Removal of [123I]Ioflupane From Schedule II of the Controlled Substances Act. Final rule
Q51530878	Schedules of Controlled Substances: Table of Excluded Nonnarcotic Products: Nasal Decongestant Inhaler/Vapor Inhaler. Final rule.
Q48689981	Schedules of Controlled Substances: Table of Excluded Nonnarcotic Products: Vicks® VapoInhaler®.
Q55059729	Schedules of Controlled Substances: Temporary Placement of Butyryl Fentanyl and Beta-Hydroxythiofentanyl Into Schedule I. Final order.
Q47297194	Schedules of Controlled Substances: Temporary Placement of 4-Fluoroisobutyryl Fentanyl into Schedule I. Temporary scheduling order
Q34485714	Schedules of Controlled Substances: Temporary Placement of Acetyl Fentanyl Into Schedule I. Final order.
Q47272929	Schedules of Controlled Substances: Temporary Placement of Acryl Fentanyl Into Schedule I. Temporary scheduling order
Q50104851	Schedules of Controlled Substances: Temporary Placement of Cyclopropyl Fentanyl in Schedule I. Temporary amendment; temporary scheduling order
Q95725030	Schedules of Controlled Substances: Temporary Placement of FUB–AMB Into Schedule I. Temporary amendment; temporary scheduling order
Q34546373	Schedules of Controlled Substances: Temporary Placement of Furanyl Fentanyl Into Schedule I. Final order
Q91353839	Schedules of Controlled Substances: Temporary Placement of N-Ethylpentylone in Schedule I. Temporary amendment; temporary scheduling order
Q95725472	Schedules of Controlled Substances: Temporary Placement of Seven Fentanyl-Related Substances in Schedule I. Temporary amendment; temporary scheduling order
Q95724277	Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB- CHMICA and MDMB-FUBINACA) Into Schedule I. Notice of Intent
Q95517999	Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I. Temporary Scheduling Order
Q95369491	Schedules of Controlled Substances: Temporary Placement of U-47700 Into Schedule I. Final order
Q95725028	Schedules of Controlled Substances: Temporary Placement of ortho-Fluorofentanyl, Tetrahydrofuranyl Fentanyl, and Methoxyacetyl Fentanyl Into Schedule I. Temporary amendment; temporary scheduling order
Q95549859	Schedules of Controlled Substances: Temporary Placement of the Synthetic Cannabinoid MAB-CHMINACA Into Schedule I. Final order
Q95725473	Schedules of Controlled Substances:Temporary Placement of Fentanyl-Related Substances in Schedule I. Temporary amendment; temporary scheduling order
Q95384520	Schedules of controlled substances: extension of temporary placement of UR-144, XLR11, and AKB48 in schedule I of the Controlled Substances Act. Final order
Q85219796	Schedules of controlled substances: extension of temporary placement of methylone into schedule I of the Controlled Substances Act. Final order
Q34155717	Schedules of controlled substances: placement of 5-methoxy-N,N-dimethyltryptamine into Schedule I of the Controlled Substances Act. Final rule
Q46418698	Schedules of controlled substances: placement of Zopiclone into schedule IV. Final rule.
Q35904580	Schedules of controlled substances: placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into schedule I of the Controlled Substances Act. Final rule.
Q50432217	Schedules of controlled substances: placement of ezogabine into Schedule V. Final rule.
Q45977170	Schedules of controlled substances: placement of lacosamide into schedule V. Final rule.
Q80372863	Schedules of controlled substances: placement of lisdexamfetamine into schedule II. Final rule
Q50356208	Schedules of controlled substances: placement of perampanel into Schedule III. Final rule
Q34437776	Schedules of controlled substances: placement of pregabalin into schedule V. Final rule.
Q34435704	Schedules of controlled substances: placement of suvorexant into Schedule IV. Final rule
Q45977167	Schedules of controlled substances: placement of tapentadol into schedule II. Final rule.
Q50352988	Schedules of controlled substances: removal of naloxegol from control. Final rule
Q34945657	Schedules of controlled substances: rescheduling of buprenorphine from schedule V to schedule III. Final rule
Q50354430	Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule.
Q73175020	Schedules of controlled substances: rescheduling of the Food and Drug Administration approved product containing synthetic dronabinol [(-) - [DELTA] less than 9 greater than - (trans)-tetrahydrocannabinol] in sesame oil and encapsulated in soft gela
Q95563786	Schedules of controlled substances: temporary placement of 10 synthetic cathinones into Schedule I. Final order
Q44391895	Schedules of controlled substances: temporary placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into Schedule I. Final rule
Q34408874	Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. Final order
Q95544835	Schedules of controlled substances: temporary placement of three synthetic cannabinoids into Schedule I. Final order
Q34465242	Schedules of controlled substances: temporary placement of three synthetic cannabinoids into schedule I. Final order
Q82131955	Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order
Q45392509	Schedules of controlled substances: temporary placement of three synthetic phenethylamines into Schedule I. Final order
Q46606397	Schedules of controlled substances; exempt anabolic steroid products. Final rule.
Q35695864	Schedules of controlled substances; placement of 2,5-dimethoxy-4-(n)-propylthiophenethylamine and N-benzylpiperazine into Schedule I of the Controlled Substances Act. Final rule.
Q43103313	Schedules of controlled substances; table of excluded nonnarcotic products: nasal decongestant inhalers manufactured by Classic Pharmaceuticals, LLC. Final rule.
Q51782668	School food safety program based on hazard analysis and critical control point principles. Final rule.
Q48384425	Secondary service connection for diagnosable illnesses associated with traumatic brain injury. Final rule
Q39801456	Section 506 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003--limitation on charges for services furnished by Medicare participating inpatient hospitals to individuals eligible for care purchased by Indian health program
Q77174736	Security and electronic signature standards--HCFA. Proposed rule
Q51040007	Self-certification and employee training of mail-order distributors of scheduled listed chemical products. Interim final rule with request for comment.
Q50867075	Self-contained breathing apparatus remaining service-life indicator performance requirements. Final rule.
Q77496917	Semi-annual agenda of regulations: Health and Human Services Department. Publication of semi-annual agenda of regulations
Q73174966	Service connection of dental conditions for treatment purposes. Department of Veterans Affairs. Final rule
Q48617119	Service dogs. Final rule
Q48667327	Servicemembers' Group Life Insurance Traumatic Injury Protection Program--genitourinary losses. Final rule.
Q48792020	Servicemembers' Group Life Insurance Traumatic Injury Protection program--genitourinary losses. Interim final rule.
Q45328720	Servicemembers' Group Life Insurance--Veterans' Group Life Insurance regulation update--ABO, VGLI application, SGLI 2-year disability extension. Final rule
Q77548779	Services and treatment for disabled infants; interim model guidelines for health care providers to establish infant care review committees--HHS. Notice of opportunity to comment
Q77554283	Services and treatment for disabled infants; model guidelines for health care providers to establish infant care review committees--HHS
Q37771001	Setting the time and place for a hearing before an administrative law judge. Final rules.
Q48030748	Sexual Assault Prevention and Response (SAPR) Program procedures. Interim final rule
Q44641470	Sexual Assault Prevention and Response (SAPR) Program. Final rule
Q83499891	Sexual Assault Prevention and Response (SAPR) Program. Interim final rule
Q95546605	Sexual Assault Prevention and Response (SAPR) Program. Interim final rule; amendment
Q38421862	Shared responsibility for employers regarding health coverage. Final regulations
Q95417549	Shared responsibility payment for not maintaining minimum essential coverage. Final regulations
Q45329945	Sharing information between the Department of Veterans Affairs and the Department of Defense. Final rule
Q45330425	Sharing information between the Department of Veterans Affairs and the Department of Defense. Interim final rule.
Q90737735	Short-Term, Limited-Duration Insurance. Final rule
Q73018693	Sick leave for family care purposes. Office of Personnel Management. Final rule
Q74368189	Sickness benefits. Railroad Retirement Board. Final rule
Q77121954	Silicone gel-filled breast prostheses; silicone inflatable breast prostheses: patient risk information--FDA. Notice
Q77104854	Site registration fee schedule and related matters for facilities transferring or receiving select agents--CDC. Notice
Q77649760	Skilled nursing and intermediate care facilites: appeals proceedings for denial, termination or nonrenewal of certifications and provider agreements: final regulation
Q35154630	Skin protectant drug products for over-the-counter human use; astringent drug products; final monograph; direct final rule. Direct final rule
Q35144794	Skin protectant drug products for over-the-counter human use; final monograph. Final rule.
Q35603573	Skin protectant drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment.
Q74368259	Small business size standards; health care. Small Business Administration. Final rule
Q73892889	Smallpox Vaccine Injury Compensation Program: Smallpox (Vaccinia) Vaccine Injury Table. Interim final rule
Q83910689	Smallpox Vaccine Injury Compensation Program: administrative implementation. Adoption of interim final rule as final rule with amendments
Q79368953	Smallpox Vaccine Injury Compensation Program: administrative implementation. Interim final rule
Q83910685	Smallpox vaccine injury compensation program: Smallpox (Vaccinia) Vaccine Injury Table. Adoption of interim final rule as final rule with an amendment
Q90329485	Social Security Administration Violence Evaluation and Reporting System. Final rule
Q77519490	Social Security Amendments of 1983--Public Health Service. Notice of changes in the review thresholds under Section 1122
Q77153870	Social Security Ruling, SSR 98-1p; Title XVI: determining medical equivalence in childhood disability claims when a child has marked limitations in cognition and speech--SSA. Notice of Social Security Ruling
Q73174749	Social Security Ruling, SSR 99-2p.; titles II and XVI; evaluating cases involving chronic fatigue syndrome (CFS). Social Security Administration. Notice of Social Security ruling
Q77579995	Social Security benefits and supplemental security income; continued payment of benefits to persons in vocational rehabilitation programs--SSA. Interim rule with request for comments
Q77522499	Social Security benefits and supplemental security income; disability termination hearings at the reconsideration level--SSA. Notice of proposed rulemaking
Q77522503	Social Security benefits; disability insurance benefits; deductions, reductions, and nonpayments of benefits--SSA. Final rules with comment period
Q73174919	Social and environmental interventions to reduce HIV incidence; availability of funds. Centers for Disease Control and Prevention
Q77650215	Social services programs for individuals and families; disclosure by providers of certain ownership interests and other information: final rule
Q56910107	Solicitation of comments on the OIG/HCFA Special Advisory Bulletin on the patient anti-dumping statute--OIG and HCFA. Notice of proposed special advisory bulletin
Q77194000	Solicitation of information and recommendations for developing OIG compliance program guidance for certain Medicare+Choice organizations--OIG, HHS. Correction
Q77193874	Solicitation of information and recommendations for developing OIG compliance program guidance for certain Medicare+Choice organizations--OIG, HHS. Notice
Q77169810	Solicitation of information and recommendations for developing OIG compliance program guidance for the durable medical equipment industry--HHS. Notice
Q77784014	Solicitation of new safe harbors and special fraud alerts--OIG, HHS. Notice of intent to develop regulations
Q77148218	Solicitation of new safe harbors and special fraud alerts--Office of Inspector General, HHS. Notice of intent to develop regulations
Q90284604	Special Monthly Compensation for Veterans With Traumatic Brain Injury. Final rule
Q39893577	Special Supplemental Nutrition Program for Women, Infants and Children (WIC): Implementation of Electronic Benefit Transfer-Related Provisions. Final rule
Q37157496	Special Supplemental Nutrition Program for Women, Infants and Children (WIC): miscellaneous vendor-related provisions. Final rule.
Q73018540	Special Supplemental Nutrition Program for Women, Infants and Children (WIC): non-discretionary funding provisions of the William F. Goodling Child Nutrition Reauthorization Act of 1998. Food and Nutrition Service, USDA. Final rule
Q73018547	Special Supplemental Nutrition Program for Women, Infants, and Children (WIC): bloodwork requirements. Food and Nutrition Service, USDA. Final rule
Q74709131	Special conditions: modified Boeing Model 767-200 and -300 series airplanes; installation of a medical oxygen system utilizing liquid oxygen--Federal Aviation Administration. Final special conditions; request for comments
Q74368330	Special demonstration programs. Office of Special Education and Rehabilitative Services, Department of Education. Final regulations
Q45328628	Special home adaptation grants for members of the Armed Forces and veterans with certain vision impairment. Final rule
Q77085934	Special issuance of third-class airman medical certificates to insulin-treated diabetic airman applicants--FAA. Policy statement
Q77610990	Special project grants--maternal and child health services federal set-aside program--HRSA. Notice of potential availability of funds
Q77577009	Special project grants--maternal and child health services--PHS. Final rule
Q73174852	Special surveillance list of chemicals, products, materials and equipment used in the clandestine production of controlled substances or listed chemicals. Drug Enforcement Administration (DEA), Justice. Final notice
Q48223894	Specially adapted housing eligibility for amyotrophic lateral sclerosis beneficiaries. Final rule
Q48391898	Specially adapted housing eligibility for amyotrophic lateral sclerosis beneficiaries. Interim final rule
Q77122437	Specific list for categorization of laboratory test systems, assays and examinations by complexity--PHS. Notice with comment period
Q77123034	Specific list for categorization of laboratory test systems, assays and examinations by complexity--PHS. Notice with comment period
Q77123520	Specific list for categorization of laboratory test systems, assays and examinations by complexity--PHS. Notice with comment period
Q77123524	Specific list for categorization of laboratory test systems, assays and examinations by complexity--PHS. Notice with comment period
Q95484061	Specifications for medical examinations of coal miners. Interim final rule
Q40062577	Specifications for medical examinations of underground coal miners. Final rule
Q38837500	Standard Preparations, Limits of Potency, and Dating Period Limitations for Biological Products. Direct final rule
Q39123354	Standard claims and appeals forms. Final rule.
Q77529759	Standard setting requirements for medical and nonmedical facilities where SSI recipients reside--Office of Human Development Services. Final rule
Q77516365	Standard-setting requirements for medical and nonmedical facilities where SSI recipients reside--Office of Human Development Services, HHS. Final rule with comment period
Q81231942	Standards Improvement Project-Phase II. Final rule
Q77496911	Standards applicable to owners and operators of hazardous waste treatment, storage, and disposal facilities: liability requirements. Environmental Protection Agency. Revised interim final rule
Q77501508	Standards applicable to owners and operators of hazardous waste treatment, storage, and disposal facilities; liability coverage requirements--Environmental Protection Agency. Final rule and notice of extension of effective date
Q51052070	Standards for Accessible Medical Diagnostic Equipment. Final rule.
Q77500246	Standards for determining coal miner's total disability or death due to pneumoconiosis; claims for benefits under Part C of Title IV of the Federal Mine Safety and Health Act, as amended--Employment Standards Administration, Labor. Notice of propose
Q77431220	Standards for institutional review boards for clinical investigations: proposed establishment of regulations
Q74614528	Standards for privacy of individually identifiable health information. Final rule
Q77164891	Standards for privacy of individually identifiable health information. Final rule; correction of effective and compliance dates
Q74368376	Standards for privacy of individually identifiable health information. Office of the Assistant Secretary for Planning and Evaluation, DHHS. Final rule
Q73018527	Standards for privacy of individually identifiable health information. Office of the Assistant Secretary for Planning and Evaluation, DHHS. Proposed rule
Q34409317	Standards for privacy of individually identifiable health information; proposed rule.
Q74710168	Standards for protection against radiation--Nuclear Regulatory Commission. Final rule
Q77440192	Standards for protection against radiation--burial of small quantities of radionuclides: proposed rule
Q74755161	Standards for protection against radiation; extension of implementation date--NRC. Final rule
Q77571701	Standards for the accreditation of educational programs for and the credentialing of radiologic personnel--PHS. Final rulemaking
Q77522462	Standards for the accreditation of educational programs for and the credentialing of radiologic personnel--PHS. Notice of proposed rulemaking
Q73162467	Standards of compliance for abortion-related services in family planning services projects. Office of Population Affairs, OPHS, DHHS. Final rules
Q77135402	Standards of performance for new stationary sources and emission guidelines for existing sources: hospital/medical/infectious waste incinerators--EPA. Final rule
Q95563788	Standards to prevent, detect, and respond to sexual abuse and assault in confinement facilities. Final rule
Q86421803	Standards to prevent, detect, and respond to sexual abuse and sexual harassment involving unaccompanied children. Interim final rule (IFR)
Q53413991	State Children's Health Insurance Program; eligibility for prenatal care and other health services for unborn children. Final rule.
Q95411618	State Health Insurance Assistance Program (SHIP). Final rule
Q95549856	State Health Insurance Assistance Program (SHIP). Interim final rule
Q95619524	State Long-Term Care Ombudsman programs. Final rule
Q77656530	State Medicaid contracts--HCFA. Final rules
Q74368495	State Vocational Rehabilitation Services Program. Office of Special Education and Rehabilitative Services, Department of Education. Final regulations
Q74368697	State Vocational Rehabilitation Services Program. Office of Special Education and Rehabilitative Services, Department of Education. Final regulations
Q73172441	State and local childhood lead poisoning prevention programs; notice of availability of funds. Centers for Disease Control and Prevention
Q77655313	State certification of mammography facilities. Final rule
Q73018638	State child health; State Children's Health Insurance Program allotments and payments to states. Health Care Financing Administration (HCFA), HHS. Final rule
Q74368476	State child health; implementing regulations for the State Children's Health Insurance Program. Health Care Financing Administration (HCFA), HHS. Final rule
Q34449396	State child health; revisions to the regulations implementing the State Children's Health Insurance Program. Interim final rule with comment period; revisions, delay of effective date, and technical amendments to final rule
Q73174703	State grants to support the evaluation of 5 a day nutrition programs; notice of availability of funds. Centers for Disease Control and Prevention
Q77524547	State hazardous waste programs; procedures for revision of state RCRA programs--EPA. Proposed rule
Q77441228	State medical facilities plan: notice of proposed rulemaking
Q74694229	State of organization, functions, and delegations of authority--HCFA
Q77153798	State offices of rural health grant program--HRSA. Notice of availability of funds
Q43580598	State systems Advance Planning Document (APD) process. Final rule
Q73174924	State-based core injury program development; availability of funds. Centers for Disease Control and Prevention
Q77166908	Statement of Organization, Functions and Delegations of Authority--HRSA
Q73172330	Statement of Organization, Functions, and Delegations of Authority
Q77458577	Statement of organization and functions of the commission: United States Commission on Civil Rights. Final rule
Q77298843	Statement of organization and functions. Final rule
Q74690414	Statement of organization, function and delegations of authority--HCFA
Q74697891	Statement of organization, functions and delegation of authority--HHS
Q74693736	Statement of organization, functions and delegations of authority--HCFA
Q74698660	Statement of organization, functions and delegations of authority--HCFA
Q74710163	Statement of organization, functions and delegations of authority--HCFA
Q77167698	Statement of organization, functions and delegations of authority--HRSA. Office for the Advancement of Telehealth (RAB)
Q77741529	Statement of organization, functions and delegations of authority--PHS
Q73174632	Statement of organization, functions and delegations of authority. Health Resources and Services Administration
Q77579980	Statement of organization, functions, and delegation of authority; Office of the General Counsel--HHS
Q77163081	Statement of organization, functions, and delegations of authority--CDC
Q77175325	Statement of organization, functions, and delegations of authority--Center for Managed Care--HRSA
Q74677208	Statement of organization, functions, and delegations of authority--FDA
Q74682740	Statement of organization, functions, and delegations of authority--HCFA
Q74687600	Statement of organization, functions, and delegations of authority--HCFA
Q74690245	Statement of organization, functions, and delegations of authority--HCFA
Q74714562	Statement of organization, functions, and delegations of authority--HCFA
Q74724595	Statement of organization, functions, and delegations of authority--HCFA
Q74729729	Statement of organization, functions, and delegations of authority--HCFA
Q74781400	Statement of organization, functions, and delegations of authority--HCFA
Q74805032	Statement of organization, functions, and delegations of authority--HCFA
Q77106183	Statement of organization, functions, and delegations of authority--HCFA
Q77163782	Statement of organization, functions, and delegations of authority--HCFA
Q73174742	Statement of organization, functions, and delegations of authority. Centers for Disease Control and Prevention
Q73174609	Statement of organization, functions, and delegations of authority. National Institutes of Health
Q74677912	Statement of organization, functions, and delegations of authority; Indian Health Service--PHS
Q93920479	Statement of organization, functions, and delegations of authority; Indian Health Service--PHS
Q74709115	Statement of organization, functions, and delegations of authority; Office of Coordinated Care Policy and Planning and the Office of Prepaid Health Care Operations and Oversight--HCFA
Q77635344	Statement of organization, functions, and delegations of authority; Region IX-San Francisco--HCFA
Q74738544	Statement of organization, functions, and delegations of authority; freedom of choice waivers--HCFA
Q74794986	Statement of organization, functions, and delegations of authority; reorganization of the Medicaid Bureau--HCFA
Q74818429	Statement of organization, functions, and delegations of authority; substructure for the Bureau of Program Operations--HHS
Q74787497	Statement of organization, functions, and delegations of authority; substructure reorganization of the Health Care Financing Administration
Q74709123	Statement of organizations, functions, and delegations of authority; Office of Prepaid Health Care Operations and Oversight divisions--HCFA
Q77680763	Statewide Professional Standards Review Councils: membership, organization, and duties of advisory groups
Q77159845	Status of certain additional over-the-counter drug category II and III active ingredients--FDA. Final rule
Q34127737	Status of certain additional over-the-counter drug category II and III active ingredients. Final rule
Q74058079	Status of certain additional over-the-counter drug category II and III active ingredients. Final rule
Q77610987	Statutory prohibition on use of appropriated funds in programs where abortion is a method of family planning; standard of compliance for family planning services projects--PHS. Final rules
Q74768592	Statutory prohibition on use of appropriated funds in programs where abortion is a method of family planning; standard of compliance for family planning services projects; proposed rules
Q79828752	Steps to a HealthierUS: a community-focused initiative to reduce the burden of asthma, diabetes, and obesity; Notice of availability of funds
Q73018657	Sterility requirement for aqueous-based drug products for oral inhalation. Food and Drug Administration, HHS. Final rule
Q52116725	Sterilization restrictions: federally funded programs and projects.
Q77649449	Sterilizations and abortions--federal financial participation: final rules
Q56898517	Strengthening HIV/AIDS and STD prevention through use of behavioral data in programmatic decision making; notice of availability of funds. Centers for Disease Control and Prevention
Q49117471	Stressor determinations for posttraumatic stress disorder. Final rule
Q44452645	Structure and practices of the video relay service program; telecommunications relay services and speech-to-speech services for individuals with hearing and speech disabilities. Final rule
Q51182269	Student health insurance coverage. Final rule.
Q74768279	Student rights in research, experimental activities, and testing
Q50930430	Submission of evidence in disability claims. Final rule.
Q34472514	Substance Abuse and Mental Health Services Administration; mental health and substance abuse emergency response criteria. Interim final rule.
Q77152109	Substance Abuse and Mental Health Services Administration; requirements applicable to protection and advocacy of individuals with mental illness; final rule--Center for Mental Health Services, SAMHSA. Final rule
Q53836118	Substances temporarily controlled under schedule I of the Controlled Substances Act. Final rule; technical amendment.
Q77201762	Summary of precedent opinions of the General Counsel--VA. Notice
Q73174863	Sunscreen drug products for over-the-counter human use; final monograph. Food and Drug Administration, HHS. Final rule
Q48282539	Supplemental Nutrition Assistance Program: Nutrition Education and Obesity Prevention Grant Program. Final rule
Q77194234	Supplemental Security Income for the Aged, Blind and Disabled (SSI) program demonstration project; treatment of cash received and conserved to pay for medical or social services--SSA. Notice
Q77721386	Supplemental Security Income for the aged, blind, and disabled; deeming of income and resources--SSA. Interim rules with comment period
Q77492740	Supplemental Security Income for the aged, blind, and disabled; eligibility; amount of benefits; residence and citizenship. Social Security Administration. Final rules
Q77656693	Supplemental Security Income for the aged, blind, and disabled; income, resources and exclusions deeming of income and resources: Medicaid program; financial requirements for categorically needy--HHS. Final rules
Q74367909	Supplemental Security Income: determining disability for a child under age 18. Social Security Administration. Final rules
Q28299005	Supplemental applications proposing labeling changes for approved drugs, biologics, and medical devices. Final rule
Q73174709	Supplemental grant to continue cooperative agreements with 10 predictor variables grantees and their research coordinating center. CSAP, SAMHSA, HHS. Supplement to support an additional year of intervention follow-up and data collection among the Pr
Q77666524	Supplemental security income for the aged, blind and disabled; Medicaid eligibility determinations--Social Security Administration, HHS. Final rule
Q77612066	Supplemental security income for the aged, blind and disabled; presumptive disability and presumptive blindness; categories of impairments--AIDS--Social Security Administration, HHS. Final rule
Q77121787	Supplemental security income for the aged, blind, and disabled; federal administration of State supplementary payments to individuals in Medicaid facilities--SSA. Final rule
Q48345049	Supplemental standards of ethical conduct and financial disclosure requirements for employees of the Department of Health and Human Services. Interim final rule with request for comments.
Q77742738	Supplementary Medical Insurance for the aged and disabled (Part B of Medicare): monthly actuarial rate and monthly premium rate
Q50741889	Supplements and other changes to an approved application. Final rule.
Q40670363	Suspension of TRICARE-eligible's enrollment in the Federal Employees Health Benefits (FEHB) Program. Interim rule.
Q40267577	Suspension of enrollment in the Federal Employees Health Benefits (FEHB) Program for Peace Corps volunteers. Final rule
Q80112930	TRICARE Program; inclusion of anesthesiologist assistants as authorized providers; coverage of cardiac rehabilitation in freestanding cardiac rehabilitation facilities. Final rule
Q83469991	TRICARE Program; surgery for morbid obesity. Final rule
Q95551516	TRICARE Young Adult. Final rule
Q77152098	TRICARE formerly known as the Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); fiscal year 1998 mental health rate updates--DoD. Notice of updated mental health per diem rates
Q80168860	TRICARE program; TRICARE Prime Remote for active duty family members and TRICARE Prime enrollment period. Final rule
Q95607928	TRICARE program; clarification of benefit coverage of durable equipment and ordering or prescribing durable equipment; clarification of benefit coverage of assistive technology devises under the Extended Care Health Option Program. Final rule
Q84469305	TRICARE reimbursement revisions. Final rule
Q38213722	TRICARE revision to CHAMPUS DRG-based payment system, pricing of hospital claims. Final rule
Q77167721	TRICARE senior demonstration of military managed care--DOD. Notice of demonstration project
Q77203505	TRICARE/CHAMPUS: FY99 DRG updates--DoD. Notice of DRG revised rates
Q77152185	TRICARE/CHAMPUS; FY98 DRG updates--DoD. Notice of DRG revised rates
Q84296672	TRICARE: Civilian Health and Medical Program of the Uniformed Services (CHAMPUS) changes included in the John Warner National Defense Authorization Act (NDAA) for fiscal year (FY) 2007; authorization of forensic examinations. Final rule
Q73162552	TRICARE: Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); nonavailability statement requirement for maternity care. Office of the Secretary, DoD. Final Rule
Q84758293	TRICARE: Transitional Assistance Management Program (TAMP). Final rule
Q48761197	TRICARE: certified mental health counselors. Interim final rule.
Q51548672	TRICARE: changes included in the National Defense Authorization Act for Fiscal Year 2007; improvements to descriptions of cancer screening for women. Final rule
Q83217062	TRICARE: changes included in the National Defense Authorization Act for Fiscal Year 2010; enhancement of transitional dental care for members of the Reserve Component on active duty for more than 30 days in support of a contingency operation. Final
Q83217066	TRICARE: elimination of co-payments for authorized preventive services for certain TRICARE Standard beneficiaries. Final rule
Q84758290	TRICARE: non-physician referrals for physical therapy, occupational therapy, and speech therapy. Final rule
Q84050839	TRICARE: relationship between the TRICARE program and employer-sponsored group health coverage. Final rule
Q86340200	TRICARE: smoking cessation program. Final rule
Q77203599	TRICARE: the Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); specialized treatment services (STS) program--DoD. Notice
Q93920934	TRICARE: the Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); specialized treatment services (STS) program--DoD. Notice
Q84973434	TRICARE: unfortunate sequelae from noncovered services in a military treatment facility. Final rule
Q48557867	TRICARE; Changes included in the John Warner National Defense Authorization Act for Fiscal Year 2007; authorization of anesthesia and other costs for dental care for children and certain other patients. Final rule
Q45954036	TRICARE; Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); bonus payments in medically underserved areas. Final rule.
Q34456068	TRICARE; Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); eligibility and payment procedures for CHAMPUS beneficiaries age 65 and over. Interim final rule.
Q77390596	TRICARE; Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); payments for professional services in low-access locations. Final rule
Q39705171	TRICARE; Continued Health Care Benefit Program expansion. Final rule
Q80390031	TRICARE; Individual Case Management Program; Program for Persons with Disabilities; extended benefits for disabled family members of active duty service members; custodial care. Final Rule
Q47695719	TRICARE; Mental Health and Substance Use Disorder Treatment. Final rule
Q50104866	TRICARE; Reimbursement of Long Term Care Hospitals and Inpatient Rehabilitation Facilities. Final rule
Q51124543	TRICARE; Reserve and Guard family member benefits. Final rule.
Q95560532	TRICARE; Revision of Nonparticipating Providers Reimbursement Rate; Removal of Cost Share for Dental Sealants; TRICARE Dental Program. Final rule
Q84758296	TRICARE; TRICARE delivery of health care in Alaska. Final rule
Q48690043	TRICARE; TRICARE retiree dental program (TRDP) basic benefit descriptions and administrative corrections. Final rule.
Q86340186	TRICARE; TRICARE sanction authority for third-party billing agents. Final rule
Q81591431	TRICARE; certain survivors of deceased active duty members; and adoption intermediaries. Final rule
Q79760564	TRICARE; certain survivors of deceased active duty members; and adoption intermediaries. Interim final rule
Q51937493	TRICARE; changes included in the National Defense Authorization Act for Fiscal Year 2003(NDAA-03). Final rule.
Q84973435	TRICARE; changes included in the National Defense Authorization Act for Fiscal Year 2010; expansion of survivor eligibility under the TRICARE Dental Program. Final rule
Q81243083	TRICARE; changes included in the National Defense Authorization Act for fiscal year 2005; TRICARE Dental Program. Interim final rule
Q39596161	TRICARE; constructive eligibility for TRICARE benefits of certain persons otherwise ineligible under retroactive determination of entitlement to Medicare Part A hospital insurance benefits. Final rule
Q51731341	TRICARE; coverage of National Cancer Institute (NCI) sponsored Phase I studies. Final rule.
Q95607923	TRICARE; coverage of care related to non-covered initial surgery or treatment. Final rule
Q42942932	TRICARE; diabetic education. Final rule.
Q51931178	TRICARE; elimination of non-availability statement and referral authorization requirements and elimination of specialized treatment services program. Final rule.
Q50719567	TRICARE; elimination of the non-availability statement (NAS) requirement for non-emergency inpatient mental health care. Final rule.
Q51149526	TRICARE; elimination of voluntary disenrollment lock-out. Final rule.
Q79994240	TRICARE; expansion of geographic scope of the TRICARE Retiree Dental Program. Final rule
Q84701740	TRICARE; extended care health option. Final rule
Q84469310	TRICARE; off-label uses of devices; partial list of examples of unproven drugs, devices, medical treatments or procedures. Final rule
Q81232188	TRICARE; outpatient hospital prospective payment system (OPPS). Interim final rule
Q64042469	TRICARE; rare diseases definition. Final rule
Q45340575	TRICARE; reimbursement of sole community hospitals and adjustment to reimbursement of critical access hospitals. Final rule
Q45896749	TRICARE; removal of the prohibition to use addictive drugs in the maintenance treatment of substance dependence in TRICARE beneficiaries. Final rule
Q81403998	TRICARE; sub-acute care program; uniform skilled nursing facility benefit; home health care benefit; adopting Medicare payment methods for skilled nursing facilities and home health care providers. Final rule
Q93920932	TRICARE; the Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); specialized treatment services (STS) program--DoD. Notice
Q77201780	Tamper-evident packaging requirements for over-the-counter human drug products--FDA. Final rule
Q73018427	Tax treatment of cafeteria plans. Internal Revenue Service (IRS), Treasury. Final regulations
Q57211080	Technical assistance and energy conservation measures: grant programs for schools and hospitals and for building owned by units of local government and public care institutions: final rule
Q45330486	Technical revisions to conform to the Caregivers and Veterans Omnibus Health Services Act of 2010. Final rule.
Q78002863	Technical revisions to medical criteria for determinations of disability. Final rules
Q47745815	Technical revisions to update reference to the required assessment tool for state nursing homes receiving per diem payments from VA. Final rule.
Q48041074	Telephone Enrollment in the VA Healthcare System. Final rule
Q48060871	Telephone Enrollment in the VA Healthcare System. Interim final rule
Q84050829	Temporary Assistance for Needy Families (TANF) carry-over funds. Final rule
Q73174655	Temporary Assistance for Needy Families program (TANF). Administration for Children and Families, HHS. Final rule
Q74839085	Temporary alien workers seeking H classification for the purpose of obtaining graduate medical education or training--INS. Final rule
Q74740318	Temporary alien workers seeking H-1B classification under the Immigration and Nationality Act--Immigration and Naturalization Service. Interim rule with requests for comments
Q74730731	Temporary alien workers seeking classification under the Immigration and Nationality Act--Immigration and Naturalization Service. Final rule
Q80207646	Temporary extension of attorney fee payment system to Title XVI; 5-year demonstration project extending fee withholding and payment procedures to eligible non-attorney representatives; definition of past-due benefits; and assessment for fee payment
Q43460783	Tentative eligibility determinations; presumptive eligibility for psychosis and other mental illness. Final rule
Q77152205	Termination of the Prospective Payment Assessment Commission and the Physician Payment Review Commission--GAO. Notice of termination of commissions
Q85637345	The $500,000 deduction limitation for remuneration provided by certain health insurance providers. Final regulations
Q77498529	The American Medical Association, et al.; prohibited trade practices, and affirmative corrective actions--Federal Trade Commission. Modifying order
Q74771642	The Family and Medical Leave Act of 1993--Wage and Hour Division, Department of Labor. Interim final rule; request for comments
Q44072566	The Family and Medical Leave Act. Final rule
Q74709143	The Safe Medical Devices Act of 1990--FDA. Notice
Q73018669	The State Vocational Rehabilitation Services Program. Office of Special Education and Rehabilitative Services, Department of Education. Final regulations
Q73162524	The Veterans Millennium Health Care and Benefits Act. Department of Veterans Affairs. Final rule
Q77194211	The development of technical and spectrum requirements for meeting federal, state and local public safety agency communication requirements through the year 2010, establishment of rules and requirements for priority access service--FCC. Final rule
Q77194225	The development of technical and spectrum requirements for meeting federal, state and local public safety agency communication requirements through the year 2010, establishment of rules and requirements for priority access service--FCC. Proposed rul
Q77500278	The hazardous waste management system--Environmental Protection Agency. Interim final amendments to interim final and final rules
Q77454349	The ticket to work and self-sufficiency program. Final rules
Q83331599	The use of ingredients of potential public health concern. Compliance with the HACCP system regulations and request for comment
Q90308869	Third Party Billing for Medical Care Provided Under Special Treatment Authorities. Final rule
Q77522467	Third party billing for cost and care provided by Indian Health Service--HRSA Options for Indian Health Service
Q38779886	Tiered Pharmacy Copayments for Medications. Final rule
Q77653094	Time limits for states to file claims--Office of the Secretary, HHS. Final rule
Q74813792	Title 10--Energy, Chapter III, Part 745--Protection of human subjects
Q34414079	Title 10--Energy, Chapter III, Part 745--Protection of human subjects.
Q80372802	Title I--improving the academic achievement of the disadvantaged; Individuals with Disabilities Education Act (IDEA)--assistance to states for the education of children with disabilities. Final regulations
Q84514878	Tobacco products, exemptions from substantial equivalence requirements. Final rule
Q83107522	Toll-free number for reporting adverse events on labeling for human drug products. Final rule
Q81020237	Toll-free number for reporting adverse events on labeling for human drug products. Interim final rule
Q77516408	Top-heavy plans--Internal Revenue Service. Notice of proposed rulemaking
Q34523446	Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Final rule.
Q73162664	Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Food and Drug Administration, HHS. Final rule
Q77453740	Trade regulation rulemaking procedures; procedures for asserting privilege in response to compulsory process or request for voluntary production of material. Federal Trade Commission--final rule
Q74368194	Traineeships. National Institutes of Health, HHS. Final rule
Q39336431	Traumatic injury protection rider to Servicemembers' Group Life Insurance. Final rule.
Q77720140	Treatment of certain elderly care facilities: Internal Revenue Service, Treasury. Notice of proposed rulemaking
Q77516297	Treatment of certain hospital services; proposed rulemaking--Internal Revenue Service. Notice of proposed rulemaking
Q77152956	Treatment of research-related injuries to human subjects--VA. Final rule
Q74131872	Tribal Self-Governance Amendments of 2000. Final rule
Q83225951	Tribal child welfare. Interim final rule
Q73018558	Tricare; Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); nonavailability statement requirement for maternity care. Office of the Secretary, DoD. Interim final rule
Q77682469	Ultrasonic therapy products: radiation safety performance standard
Q77152177	Unified agenda of federal regulatory and deregulatory actions--HHS. Semiannual regulatory agenda
Q77159871	Unified agenda of federal regulatory and deregulatory actions--HHS. Semiannual regulatory agenda
Q77203564	Unified agenda of federal regulatory and deregulatory actions--HHS. Semiannual regulatory agenda
Q77159874	Unified agenda of federal regulatory and deregulatory actions--VA. Semiannual regulatory agenda
Q77203568	Unified agenda of federal regulatory and deregulatory actions--VA. Semiannual regulatory agenda
Q77556130	Unified agenda of regulation--DHHS. Publication of unified agenda of regulations
Q77516273	Unified agenda of regulations--Department of Health and Human Services. Publication of unified agenda of regulations
Q74795565	Uniform administrative requirements for grants and agreements with institutions of higher education, hospitals and other non-profit organizations, and with commercial organizations, foreign governments, organizations under the jurisdiction of foreig
Q74814483	Uniform administrative requirements for grants and agreements with institutions of higher education, hospitals and other non-profit organizations--OMB Circular A-110 (revised)--HUD. Final rule
Q74780872	Uniform administrative requirements for grants and agreements with institutions of higher education, hospitals and other non-profit organizations--OMB. Final revision to OMB circular A-110
Q77175336	Uniform administrative requirements for grants and agreements with institutions of higher education, hospitals, other non-profit, and commercial organizations--Department of Commerce. Interim final rule
Q77649626	Uniform reporting systems for health services facilities and organizations: proposed rule
Q38443953	Unique device identification system. Final rule.
Q74801020	United Network for Organ Sharing; policies and rationale for transplantation of organs for foreign nationals and exportation of organs outside the United States; general notice
Q77193991	United States of America v. Medical Mutual of Ohio; proposed final judgment and competitive impact statement--DoJ
Q77174699	Universal service order; protective order for non-rural local exchange carriers--FCC. Policy statement
Q77152166	Universal service--FCC. Final rule
Q50114732	Unsuccessful Work Attempts and Expedited Reinstatement Eligibility. Final rules
Q47845626	Updating OSHA Standards Based on National Consensus Standards; Eye and Face Protection. Final rule
Q80237515	Updating OSHA standards based on national consensus standards. Direct final rule
Q81235706	Updating OSHA standards based on national consensus standards. final rule; confirmation of effective date
Q47783982	Updating fire safety standards. Final rule; affirmation
Q77653655	Updating of National Service and U.S. Government Life Insurance regulations: Veterans Administration. Final regulations
Q53758026	Use of Ozone-Depleting Substances. Direct final rule.
Q47722748	Use of Symbols in Labeling. Final rule
Q74758136	Use of alternative dispute resolution--HHS. Notice of interim policy
Q43843785	Use of materials derived from cattle in human food and cosmetics; reopening of the comment period. Interim final rule; reopening of the comment period.
Q50997160	Use of ozone-depleting substances; removal of essential use designations; confirmation of effective date. Direct final rule; confirmation of effective date.
Q43099875	Use of ozone-depleting substances; removal of essential-use designation (flunisolide, etc.). Final rule.
Q46418703	Use of ozone-depleting substances; removal of essential-use designations. Final rule.
Q77516292	Use of personal sampling devices during inspection--Occupational Safety and Health Administration. Final rule
Q77567599	Utilization and Quality Control Peer Review Program; solicitation of comments on proposed PRO program scope of work--HCFA. Notice
Q77567863	Utilization and quality control Peer Review Program; solicitation of comments on proposed scope of work for waivered and exempt PRO areas--HCFA. Notice
Q45014454	VA Dental Insurance Program--federalism. Direct final rule
Q48320603	VA Dental Insurance Program--federalism. Direct final rule; confirmation of effective date
Q46313975	VA Dental Insurance Program. Final rule
Q95513615	VA Dental Insurance Program. Final rule
Q43577375	VA Health Professional Scholarship and Visual Impairment and Orientation and Mobility Professional Scholarship Programs. Final rule
Q48500882	VA Homeless Providers Grant and Per Diem Program. Final rule.
Q77203543	VA acquisition regulations: simplified acquisition procedures for health care resources--VA. Proposed rule
Q77094385	VA homeless providers grant and per diem program clarification of per diem eligibility--VA. Final rule
Q74808184	VA homeless providers grant and per diem program--VA. Final rule
Q74368210	VA payment for non-VA public or private hospital care and non-VA physician services that are associated with either outpatient or inpatient care. Department of Veterans Affairs. Final rule
Q77175289	Verification of eligibility for public benefits--INS. Correction
Q77169779	Verification of eligibility for public benefits--INS. Proposed rule
Q45139052	Vet Center services. Final rule
Q48062238	Vet Centers. Final rule
Q48076618	Vet Centers. Interim final rule.
Q77680769	Veterans Administration Privacy Act of 1974: proposed amendment of system notice; additional routine uses
Q77465563	Veterans Administration--Grants to states for construction of state home facilities. Final regulations
Q77465574	Veterans Administration--Medical benefits; readjustment counseling for Vietnam era veterans. Final regulations
Q77465566	Veterans Administration--VA Consumer Affairs Program. VA consumer program
Q77651993	Veterans Administration--Veterans education; eligibility for vocational rehabilitation and educational assistance--character of discharge. Final regulations
Q77650937	Veterans Administration--Veterans' benefits; institutional awards. Final regulation
Q77453743	Veterans Administration--clinical support wing and psychiatric outpatient building, VAMC, Denver, Colo.; finding of no significant impact
Q77654021	Veterans Administration--medical care reimbursement rates for fiscal year 1983
Q77485566	Veterans Administration: schedule of reviews for "contracting out"; initiative of Veterans Administration's Department and Surgery
Q45334202	Veterans Benefits Administration nomenclature changes. Final rule.
Q45334198	Veterans Benefits and Health Care Improvement Act of 2000. Final rule
Q45327339	Veterans Employment Pay for Success Grant Program. Interim final rule
Q45327604	Veterans Transportation Service. Final rule
Q45329834	Veterans' Group Life Insurance (VGLI) no-health period extension. Final rule.
Q83929122	Vocational Rehabilitation and Employment Program--basic entitlement; effective date of induction into a rehabilitation program; cooperation in initial evaluation. Final rule
Q83941817	Vocational Rehabilitation and Employment Program--periods of eligibility. Final rule
Q83941819	Vocational Rehabilitation and Employment program--self-employment. Final rule
Q80197078	Vocational rehabilitation and Employment program--initial evaluations. Final rule
Q48724448	Vocational rehabilitation and employment program--changes to subsistence allowance. Final rule.
Q84418249	Vocational rehabilitation service projects for American Indians with disabilities. Final regulations
Q77522413	Voluntary protection programs to supplement enforcement and to provide safe and healthful working conditions--OSHA. Notice of implementation of revised voluntary protection programs
Q74689096	Waiver of certain membership requirements for certain health maintenance organizations (HMOs), and state option for disenrollment restrictions for certain HMOs under Medicaid--HCFA. Final rule
Q77578046	Waiver of recovery rights in federally assisted construction--PHS. Notice
Q74813222	Waiver of the two-year home country physical presence requirement for certain foreign medical graduates--INS. Interim rule with request for comments
Q74832515	Waiver of two-year home-country physical presence requirement, foreign medical graduates, exchange visitor program--USIA. Final rule
Q51090094	Walking-Working Surfaces and Personal Protective Equipment (Fall Protection Systems). Final rule.
Q52566399	Weekly List 2/3/83
Q77194192	Well grounded claims/duty to assist--VA. Advance notice of proposed rulemaking
Q73162528	Wireless medical telemetry service. Federal Communications Commission. Final rule
Q77538081	Withdrawals from list of designated primary care health manpower shortage areas--HRSA
Q82557557	Work activity of persons working as members of advisory committees established under the Federal Advisory Committee Act (FACA). Final rule
Q127957123	Works Containing Material Generated by Artificial Intelligence
Q47777454	World Trade Center Health Program requirements for the addition of new WTC-related health conditions. Final rule.
Q38887559	World Trade Center Health Program; Addition of New-Onset Chronic Obstructive Pulmonary Disease and WTC-Related Acute Traumatic Injury to the List of WTC-Related Health Conditions. Final rule
Q47597497	World Trade Center Health Program; Amendments to Definitions, Appeals, and Other Requirements. Final rule
Q41973829	World Trade Center Health Program; addition of certain types of cancer to the list of WTC-related health conditions. Final rule
Q44362743	World Trade Center Health Program; amendments to list of WTC-related health conditions; cancer; revision. Interim final rule
Q77400257	Written and oral information or statements affecting entitlement to benefits. Final rule
Q73174844	Year 2000 (Y2K) computer compliance guide; guidance for FDA personnel. Food and Drug Administration. Notice
Q7241458	presidential proclamation
Q28274462	Medicaid and Children's Health Insurance Programs; Mental Health Parity and Addiction Equity Act of 2008; the Application of Mental Health Parity Requirements to Coverage Offered by Medicaid Managed Care Organizations, the Children's Health Insuranc

government gazette	Q2065227
scientific journal	Q5633421

P5801	Academia.edu topic ID	federal_register
P6981	ACNP journal ID	16786
		2477385
P6123	B3Kat dataset ID	BV013533714
P2581	BabelNet ID	03438788n
		03438788n
P2390	Ballotpedia ID	Federal_Register
P268	Bibliothèque nationale de France ID	32773417v
P9885	Bing entity ID	e8d7b98d-fed9-a87f-e34c-39373f0c14e5
P5199	British Library system number	017255817
P11496	CiNii Research ID	1130282268573912064
P1159	CODEN	FEREAC
P2088	Crunchbase organization ID	office-of-the-federal-register
P973	described at URL	https://www.llsdc.org/fr-cfr-research-guide
P6180	Dimensions Source ID	1088711
P4272	DPLA subject term	Federal Register
P8089	EZB ID	61006
P8608	Fatcat ID	container_mpywgvxhoncxdiavpscjj3sldq
P646	Freebase ID	/m/02vxtn
P953	full work available at URL	https://www.govinfo.gov/app/collection/FR/
		https://www.loc.gov/collections/federal-register
P9100	GitHub topic	federal-register
P7502	Golden ID	Federal_Register
P5337	Google News topics ID	CAAqIggKIhxDQkFTRHdvSkwyMHZNREoyZUhSdUVnSmxiaWdBUAE
P8903	HAL journal ID	22241
P1844	HathiTrust ID	000598886
P724	Internet Archive ID	pub_federal-register-find
P1160	ISO 4 abbreviation	Fed. Regist.
P236	ISSN	0097-6326
		2167-2520
P7363	ISSN-L	0097-6326
P7368	JournalBase ID	11280
P3827	JSTOR topic ID (archived)	federal-register
P6721	K10plus PPN ID	130072281
P1144	Library of Congress Control Number (LCCN) (bibliographic)	36026246
P1182	LIBRIS editions	11338695
P5587	Libris-URI	5phh4f1h3c4kjvg
P6366	Microsoft Academic ID	10441410
P9035	Muck Rack media outlet ID	federalregister
P1739	NACSIS-CAT bibliography ID	AA00182832
P1055	NLM Unique ID	7808722
P6201	OBV edition ID	AC02731612
P243	OCLC control number	1768512
P856	official website	https://www.federalregister.gov/
P5396	Online Books Page publication ID	fedregister
P3847	Open Library subject ID	federal_register
P10283	OpenAlex ID	V10441410
P7461	Publons journals/conferences ID	11391
P3417	Quora topic ID	Federal-Register
P5485	SBN books ID	BVE0448566
P10376	ScienceDirect topic ID	computer-science/federal-register
		engineering/federal-register
P1156	Scopus source ID	12871
P1025	SUDOC editions	03896306X
P1044	SWB editions	01561137X
P10402	ULI ID	001740140
P1161	Z39.5 abbreviation	Fed Regist
P1042	ZDB ID	2029448-7
		443285-X

P495	country of origin	United States of America	Q30
P8359	Dewey Decimal Classification (works and editions)	353.005
P457	foundational text	Federal Register Act	Q55231327
P747	has edition or translation	Public Papers of the Presidents	Q17146045
P571	inception	1936-03-14
P8875	indexed in bibliographic review	Scopus	Q371467
P407	language of work or name	English	Q1860
P8360	Library of Congress Classification (works and editions)	KF70 .A2
P921	main subject	administrative law	Q171251
		delegated legislation	Q694045
P291	place of publication	Washington, D.C.	Q61
P872	printed by	United States Government Publishing Office	Q2928358
P2896	publication interval	1
P123	publisher	Office of the Federal Register	Q2402343
P1476	title	Federal Register
P1687	Wikidata property	Federal Register Document Number	P1544

Q85760062	Combating Anti-Semitism
Q115160926	agricultural research
Q3270419	micropolitan statistical area
Q5951278	urban area of the United States
Q104774089	urban cluster
Q104774075	urbanized area

Q38065790	1 Recombinant DNA techniques
Q70880083	1,3‐Dinitrobenzene: Toxic effects in vivo and in vitro
Q40293074	17 Plasmid cloning vehicles derived from plasmids ColE1, F, R6K, and RK2
Q28328549	4,5,6,7-Tetrahydro-7-oxobenzo[b]thien-4-ylurea; Sulbenox, a novel animal growth stimulant
Q34474197	A Client-Developed Methadone Maintenance Program
Q40155569	A Critical Review of the Literature on Carbon Disulfide Toxicity
Q39189238	A Manpower Policy for Primary Health Care
Q39785480	A Review of the Specifications and Toxicity of Synthetic Food Colors Permitted in Canada
Q52516970	A comparison of organochlorine insecticide contents in specimens of maternal blood, placenta, and umbilical‐cord blood from stillborn and live‐born cases
Q67752840	A model research curriculum for emergency medicine
Q66958501	A simple, sensitive determination and identification of vinyl chloride by gas chromatography with a Hall detector
Q42802000	Abiotic Reduction of Pendimethalin and Trifluralin in Controlled and Natural Systems Containing Fe(II) and Dissolved Organic Matter
Q52701951	Absorption of Triazolam from Pelleted Drug-Diet Mixtures by the Mouse: Quantitation of α-Hydroxytriazolam in Urine
Q67444855	Aflatoxin inactivation: Treatment of peanut meal with formaldehyde and calcium hydroxide
Q40434797	An overview and analysis of the impact of the emergency medical treatment and active labor act
Q93807906	Anhydrotetracycline and 4-ePianhydrotetracycline in Market Tetracyclines and Aged Tetracycline Products
Q40632402	Asbestos abatement in schools: observations and experiences
Q84796336	Assessing Phytotoxicity of Heavy Metals in Remediated Soil
Q42915174	Assessment of Sewer Source Contamination of Drinking Water Wells Using Tracers and Human Enteric Viruses
Q70879001	Automated dissolution testing of combination drug product using high-pressure liquid chromatography
Q44773353	Available Thyroid Protection
Q41199848	Bacteriological in vitro investigations with cefaclor. Correlation of inhibition zone diameter and minimal inhibitory concentration (author's transl)
Q67027541	Bioavailability of Sulfadiazine Solutions, Suspensions, and Tablets in Humans
Q34057734	Biohazards of methanol in proposed new uses
Q39448885	Body mass index as a correlate of postoperative complications and resource utilization
Q35121003	BrucellaStationary-Phase Gene Expression and Virulence
Q41791430	Carcinogenic effects of Bis(2,3-dibromopropyl)-phosphate in wistar rats
Q72868501	Changes in the NIH guidelines for recombinant DNA research (Appendix 3: September 1979–April 1980)
Q39899370	Changes in the NIH guidelines for recombinant DNA research (appendix 1: January to May, 1979)
Q39908753	Changes in the NIH guidelines for recombinant DNA research (appendix 2: June–August, 1979)
Q66704757	Chromatographic analysis of hormone residues in food
Q37219626	Clinical Considerations in the Design of Protocols for Somatic Gene Therapy
Q44441439	Comparative Analysis of Acid Resistance between Susceptible and Multi-Antimicrobial-Resistant Salmonella Strains Cultured under Stationary-Phase Acid Tolerance–Inducing and Noninducing Conditions
Q67021295	Comparative Bioavailability of Four Commercial Quinidine Sulfate Tablets
Q37037377	Comparative Dose-Response Relationships of Asbestos Fiber Types: Magnitudes and Uncertainties
Q42213647	Comparative studies on nephrotoxic effects of Tris (2,3-dibromopropyl) phosphate and Bis (2,3-dibromopropyl) phosphate on rat urinary metabolites
Q50102686	Comparison of Homogenization Methods for Recovering Salmonella Enteritidis from Eggs
Q40739033	Compensation of subjects injured in experimental medicine programs: The ethical and legal considerations
Q39785474	Critical Review and Evaluation of the Neurological and Behavioral Sequelae of Inorganic Lead Absorption
Q84621479	Deciphering Phenotypic Diversity of Ralstonia solanacearum Strains Pathogenic to Potato
Q42831460	Depleting Methyl Bromide Residues in Soil by Reaction with Bases
Q66958281	Determination of 3,3′-dichloro-4,4′-diaminodiphenylmethane in air
Q52533409	Determination of organochlorine pesticides and metabolites in drinking water, human blood serum, and adipose tissue
Q67842191	Determination of sun-screen agents in cosmetic products by micellar liquid chromatography
Q39710447	Determination of vitamin a in foods ‐ a review
Q39826170	Determination of vitamin d in foods: A review
Q42827294	Developing a Systems Approach for Sternochetus mangiferae (Coleoptera: Curculionidae) in South Africa
Q37785074	Dioxins: An Overview and History
Q47612639	Dip Application of Phosphates and Marinade Mix on Shelf Life of Vacuum-Packaged Chicken Breast Fillets
Q70879015	Dissolution profiles and specifications for dihydroergotoxine sublingual tablets using a new in vitro method
Q66913454	Drug Stability in Veterinary Dosage Forms
Q38596575	Dust control in a conventional asbestos textile factory
Q48131534	Effect of route of administration on the development of organophosphate‐induced delayed neurotoxicity in 4‐week‐old chicks
Q52518628	Effect of the insecticides toxaphene and carbaryl on induction of lung tumors by benzo[a]pyrene in the mouse
Q50104306	Effectiveness of Electrolyzed Acidic Water in Killing Escherichia coli O157:H7, Salmonella Enteritidis, and Listeria monocytogenes on the Surfaces of Tomatoes
Q39577743	Effects of 90 days exposure to catalytically treated automobile exhaust in rats
Q40440827	Effects of Genetically Engineered Microorganisms on Microbial Populations and Processes in Natural Habitats
Q67056227	Environmental carbon monoxide from cigarette smoking—a critique
Q34240560	Environmental lead and children: The Omaha study
Q34236192	Epidemiology and Pathology of a Tetrachlorodibenzodioxin Poisoning Episode
Q36480901	Ergot on cereal grains
Q67042907	Evaluation of the 21-Day Outpatient Heroin Detoxification
Q66977407	Evaluation of the availability of drugs incorporated in rat laboratory diet
Q39801058	Exocellular, Microbial Polysaccharides
Q42857657	Exposure to airborne organophosphates originating from hydraulic and turbine oils among aviation technicians and loaders
Q50102680	Fate of Salmonellae in Citrus Oils and Aqueous Aroma
Q51191348	Fear, Fiat, and Fiasco: Causation in Cancer Risk Assessment
Q44332618	Federal Regulation in the Absence of Prescription Drug Legislation: The Bush Administration's Proposal to Speed Generics to Market
Q52117138	Full Services in Methadone Treatment
Q66935640	GLC Determination of Saccharin in Pharmaceutical Products
Q57268197	Genetics and epidemiology: Medical interventions and public policy
Q70994861	Heavy metal Concentrations in the Holston River Basin (Tennessee)
Q66958525	High-performance liquid chromatographic determination of pentaerythritol in plasma
Q66962614	High‐Performance Liquid Chromatographic Assay of Cyclophosphamide in Raw Material and Parenteral Dosage Forms
Q93501681	Holistic Medicine
Q41412201	How Do Health-Maintenance Organizations Achieve Their “Savings”?
Q44640141	Impact of Transition Metals on Reductive Dechlorination Rate of Hexachloroethane by Mackinawite
Q47595491	Improving the performance of US Environmental Protection Agency Method 300.1 for monitoring drinking water compliance
Q50102688	Inactivation of Escherichia coli O157:H7, Listeria monocytogenes, and Salmonella in Cranberry, Lemon, and Lime Juice Concentrates
Q40632349	Indoor asbestos pollution: application of hazard criteria
Q79076993	Influence of NaCl Content and Cooling Rate on Outgrowth of Clostridium perfringens Spores in Cooked Ham and Beef
Q38592097	Iron sources used in food fortification and their changes due to food processing∗
Q67774185	Isomeric amphetamines — A problem for urinalysis?
Q36827838	Liability Considerations Presented by Human Gene Therapy
Q67880625	Liquid chromatographic determination of ethylenethiourea using pulsed amperometric detection
Q42006469	Major issues raised by the OMB report from the perspective of the regulatory agencies
Q58243836	Measurement of Urine Temperature as an Alternative to Observed Urination in a Narcotic Treatment Program
Q72109793	Mechanized determination of n-octanol/water partition constants using liquid—liquid segmented flow extraction
Q71820287	Methadone: Prescribing Maintenance, Pursuing Abstinence
Q68301004	NIH Drug Tests
Q46623514	Narcotic Addiction in New York City: Trends from 1968 to Mid-1973
Q46443832	Neonicotinoid Metabolism: Compounds, Substituents, Pathways, Enzymes, Organisms, and Relevance
Q72630117	Normal Serum Alpha-Fetoprotein Levels during Mid-Pregnancy
Q54169409	Partial characterisation of pediocin PO2 and comparison with nisin for biopreservation of meat products
Q43957521	Pertussis Vaccine: Reasonable Doubt?
Q34343219	Pharmaceutical Sciences—1974: Literature Review of Pharmaceutics
Q39252079	Pharmacokinetics of Salicylate in Man
Q44410060	Photonic Crystal Aqueous Metal Cation Sensing Materials
Q51655757	Plasma and erythrocyte concentrations of free amino acids in adult humans administered abuse doses of aspartame
Q28203979	Potential Adverse Health Effects of Genetically Modified Crops
Q44433493	Prevalence of Escherichia coli O157:H7 and Performance by Beef Feedlot Cattle Given Lactobacillus Direct-Fed Microbials
Q41696118	Priorities in prevention of chronic lung diseases
Q39624359	Problems with Iodometric Assay of Penicillin V Benzathine
Q85176062	Proposed modifications of Environmental Protection Agency Method 1601 for detection of coliphages in drinking water, with same-day fluorescence-based detection and evaluation by the performance-based measurement system and alternative test protocol
Q36916024	Quantitative assessment of a human carcinogenic potency for propylene oxide
Q66835023	Quantitative chromatographic method for the determination of low levels of nitrilotriacetic and ethylenediaminetetraacetic acids in diethylenetriaminepentaacetic acid
Q34290300	Ralstonia solanacearum Dps Contributes to Oxidative Stress Tolerance and to Colonization of and Virulence on Tomato Plants
Q40588448	Reconstruction of Benzene Exposure for the Pliofilm Cohort (1936-1976) Using Monte Carlo Techniques
Q73273383	Recovery Rate of Listeria monocytogenes from Commercially Prepared Frankfurters during Extended Refrigerated Storage
Q24289103	Reproducible Science
Q66995281	Reproduction and teratogenic studies of a 2:1 mixture of 3,4,4′-trichlorocarbanilide and 3-trifluoromethyl-4,4′-dichlorocarbanilide in rats and rabbits
Q42830425	Residue organic mixtures from drinking water showin vitromutagenic and transforming activity
Q35224352	Review Article: Interpreting the Delaney Clause in the 21st Century
Q40438463	Rodent bladder tumors do not always predict for humans
Q44517786	Role of Carbonate in Aluminum Hydroxide Gel Established by Raman and IR Analyses
Q40030027	Role of the Genetics and Physiology of Bordetella pertussis in the Production of Vaccine and the Study of Host–Parasite Relationships in Pertussis
Q66935196	Safety evaluation and biochemical behavior of monotertiarybutylhydroquinone
Q46553619	Sampling and analysis of airborne residues of paraquat in treated cotton field environments
Q50103940	Serial Disinfection with Heat and Chlorine To Reduce Microorganism Populations on Poultry Transport Containers
Q70625243	Spectrophotometric Determination of Fe(II), Fe(III), and Total Fe
Q39721408	Stability of Pharmaceuticals
Q29620758	Sterile host yeasts (SHY): A eukaryotic system of biological containment for recombinant DNA experiments
Q39868241	Studies of a progestogen (MGA)1as related to residues and human consumption
Q40632313	Surveillance of high-risk groups exposed to asbestos in the United States
Q54048755	Survey of Microbial Contamination of Ophthalmic Ointments▲
Q50102693	Survival of Escherichia coli O157:H7, Listeria monocytogenes, and Salmonella in Juice Concentrates
Q41528353	The Marketing of Estrogens for Menopausal and Postmenopausal Women
Q58300222	The Role of Ancillary Services in Methadone Maintenance Treatment
Q38583618	The carcinogenicity of d1(2‐ethylhexyl) phthalate (dehp) in perspective
Q41242931	The distribution and elimination of 2,5,2′,5′-[14C]tetrachlorobiphenyl in rainbow trout (Salmo gairdneri)
Q47308774	The effect of crystal size on the bioavailability of benoxaprofen: Studies utilizing deuterium labeled drug
Q39643100	The effect of epigenetic regulation of fucosylation on TRAIL-induced apoptosis
Q38594450	The nutritional and physiological impact of cereal products in human nutrition
Q40148207	The role of toxicology in drug research and development
Q30412484	The unique role of rodents in the detection of possible human carcinogens and mutagens
Q40979124	Therapy of serious infections with cefamandole
Q39710432	Toxicants in plants and plant products
Q45866945	Transfer of the CFTR Gene to the Lung of Nonhuman Primates with E1-Deleted, E2a-Defective Recombinant Adenoviruses: A Preclinical Toxicology Study
Q39860528	Trichloroethylene. I. An overview
Q67433491	Use of oral agents in treating diabetes mellitus a perspective
Q41036441	Use of statistics when examining lifetime studies in rodents to detect carcinogenicity
Q39068820	Vehicle for Stabilizing Aluminum Hydroxide Gel

Federal Register

official journal of the U.S. Federal Government

Reverse relations

The articles in Wikimedia projects and languages

P1544	Federal Register Document Number	issued by	P2378
Q121840925	Federal Register Notice	part of	P361
Q17146045	Public Papers of the Presidents	edition or translation of	P629
Q55231327	Federal Register Act	main subject	P921

	Category:Federal Register	wikimedia
Arabic (ar / Q13955)	السجل الفيدرالي الأمريكي	wikipedia
	Federal Register	wikipedia
	Federal Register	wikipedia
Esperanto (eo / Q143)	Federacia Registro de Usono	wikipedia
	Registro Federal (Estados Unidos)	wikipedia
Persian (fa / Q9168)	فدرال رجیستر	wikipedia
	Federal Register	wikipedia
	連邦官報	wikipedia
	Federal Register	wikipedia
nb	Federal Register	wikipedia
	Federal Register	wikipedia
	Federal Register	wikipedia
	Federal Register	wikipedia
	Federal Register	wikipedia
	聯邦公報	wikipedia
	Federal Register	wikisource